
<html lang="en"     class="pb-page"  data-request-id="597ba202-20ba-48b1-8422-d59e4bc6d65d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-12;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b01383;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="In Vitro Activation of Cytochrome P450 46A1 (CYP46A1) by Efavirenz-Related Compounds" /></meta><meta name="dc.Creator" content="Natalia  Mast" /></meta><meta name="dc.Creator" content="Peter  Verwilst" /></meta><meta name="dc.Creator" content="Clayton J.  Wilkey" /></meta><meta name="dc.Creator" content="F. Peter  Guengerich" /></meta><meta name="dc.Creator" content="Irina A.  Pikuleva" /></meta><meta name="dc.Description" content="Cytochrome P450 46A1 (CYP46A1) is a central nervous system-specific enzyme, which catalyzes cholesterol 24-hydroxylation. Currently CYP46A1 is being evaluated in a clinical trial for activation by ..." /></meta><meta name="Description" content="Cytochrome P450 46A1 (CYP46A1) is a central nervous system-specific enzyme, which catalyzes cholesterol 24-hydroxylation. Currently CYP46A1 is being evaluated in a clinical trial for activation by ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 16, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01383" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01383" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01383" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01383" /></link>
        
    
    

<title>In Vitro Activation of Cytochrome P450 46A1 (CYP46A1) by Efavirenz-Related Compounds | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01383" /></meta><meta property="og:title" content="In Vitro Activation of Cytochrome P450 46A1 (CYP46A1) by Efavirenz-Related Compounds" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0008.jpeg" /></meta><meta property="og:description" content="Cytochrome P450 46A1 (CYP46A1) is a central nervous system-specific enzyme, which catalyzes cholesterol 24-hydroxylation. Currently CYP46A1 is being evaluated in a clinical trial for activation by small doses of the anti-HIV drug efavirenz. Eight efavirenz-related compounds were investigated for CYP46A1 activation in vitro, induction of a CYP46A1 spectral response, spectral Kd values, interaction with the P450 allosteric sites, and a model of binding to the enzyme active site. We gained insight into structure–activity relationships of efavirenz for CYP46A1 activation and found that the investigated efavirenz primary metabolites are stronger and better activators of CYP46A1 than efavirenz. We also established that CYP46A1 is activated by racemates and that a conformational-selection mechanism is operative in CYP46A1. The results suggest structural modifications of efavirenz to further increase CYP46A1 activation without inhibition at high compound concentrations. It is possible that not only efavirenz but its metabolites activate CYP46A1 in vivo." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01383"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01383">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01383&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01383&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01383&amp;href=/doi/10.1021/acs.jmedchem.9b01383" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 6477-6488</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01947" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Featured Article</span><a href="/doi/10.1021/acs.jmedchem.9b01995" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">In Vitro Activation of Cytochrome P450 46A1 (CYP46A1) by Efavirenz-Related Compounds</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Natalia Mast</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Natalia Mast</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Ophthalmology and Visual Sciences, Case Western Reserve University, Cleveland, Ohio 44106, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Natalia++Mast">Natalia Mast</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peter Verwilst</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter Verwilst</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Korea University, Seoul 02841, Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Verwilst">Peter Verwilst</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Clayton J. Wilkey</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Clayton J. Wilkey</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Clayton+J.++Wilkey">Clayton J. Wilkey</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">F. Peter Guengerich</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">F. Peter Guengerich</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=F.+Peter++Guengerich">F. Peter Guengerich</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7458-3048" title="Orcid link">http://orcid.org/0000-0002-7458-3048</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Irina A. Pikuleva</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Irina A. Pikuleva</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Ophthalmology and Visual Sciences, Case Western Reserve University, Cleveland, Ohio 44106, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#9af3fbeaa2daf9fbe9ffb4fffeef"><span class="__cf_email__" data-cfemail="e8818998d0a88b899b8dc68d8c9d">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Irina+A.++Pikuleva">Irina A. Pikuleva</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9742-6232" title="Orcid link">http://orcid.org/0000-0001-9742-6232</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01383&amp;href=/doi/10.1021%2Facs.jmedchem.9b01383" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 6477–6488</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 16, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 August 2019</li><li><span class="item_label"><b>Published</b> online</span>16 October 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 June 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01383" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01383</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ec-1612971054143.svg" alt="ACS Editors’ Choice" /></img><span>ACS Editors’ Choice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01383"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4222</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01383" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;In Vitro Activation of Cytochrome P450 46A1 (CYP46A1) by Efavirenz-Related Compounds&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Natalia&quot;,&quot;last_name&quot;:&quot;Mast&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Verwilst&quot;},{&quot;first_name&quot;:&quot;Clayton&quot;,&quot;last_name&quot;:&quot;J. Wilkey&quot;},{&quot;first_name&quot;:&quot;F.&quot;,&quot;last_name&quot;:&quot;Peter Guengerich&quot;},{&quot;first_name&quot;:&quot;Irina&quot;,&quot;last_name&quot;:&quot;A. Pikuleva&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;6477-6488&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01383&quot;},&quot;abstract&quot;:&quot;Cytochrome P450 46A1 (CYP46A1) is a central nervous system-specific enzyme, which catalyzes cholesterol 24-hydroxylation. Currently CYP46A1 is being evaluated in a clinical trial for activation by small doses of the anti-HIV drug efavirenz. Eight efavirenz-related compounds were investigated for CYP46A1 activation in vitro, induction of a CYP46A1 spectral response, spectral Kd values, interaction with the P450 allosteric sites, and a model of binding to the enzyme active site. We gained insight into structure–activity relationships of efavirenz for CYP46A1 activation and found that the investigated efavirenz primary metabolites are stronger and better activators of CYP46A1 than efavirenz. We also established that CYP46A1 is activated by racemates and that a conformational-selection mechanism is operative in CYP46A1. The results suggest structural modifications of efavirenz to further increase CYP46A1 activation without inhibition at high compound concentrations. It is possible that not only efavirenz but its &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01383&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01383" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01383&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01383" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01383&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01383" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01383&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01383&amp;href=/doi/10.1021/acs.jmedchem.9b01383" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01383" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01383" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01383%26sid%3Dliteratum%253Aachs%26pmid%3D31617715%26genre%3Darticle%26aulast%3DMast%26date%3D2020%26atitle%3DIn%2BVitro%2BActivation%2Bof%2BCytochrome%2BP450%2B46A1%2B%2528CYP46A1%2529%2Bby%2BEfavirenz-Related%2BCompounds%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D12%26spage%3D6477%26epage%3D6488%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291413" title="Cholesterol">Cholesterol</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/jmcmar.2020.63.issue-12/20200625/jmcmar.2020.63.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/medium/jm9b01383_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01383&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Cytochrome P450 46A1 (CYP46A1) is a central nervous system-specific enzyme, which catalyzes cholesterol 24-hydroxylation. Currently CYP46A1 is being evaluated in a clinical trial for activation by small doses of the anti-HIV drug efavirenz. Eight efavirenz-related compounds were investigated for CYP46A1 activation in vitro, induction of a CYP46A1 spectral response, spectral <i>K</i><sub>d</sub> values, interaction with the P450 allosteric sites, and a model of binding to the enzyme active site. We gained insight into structure–activity relationships of efavirenz for CYP46A1 activation and found that the investigated efavirenz primary metabolites are stronger and better activators of CYP46A1 than efavirenz. We also established that CYP46A1 is activated by racemates and that a conformational-selection mechanism is operative in CYP46A1. The results suggest structural modifications of efavirenz to further increase CYP46A1 activation without inhibition at high compound concentrations. It is possible that not only efavirenz but its metabolites activate CYP46A1 in vivo.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/63/12"><issue-title>Drug Metabolism and Toxicology</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64750" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64750" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">CYP46A1 is an endoplasmic reticulum cytochrome P450 enzyme, which is expressed in the central nervous system, normally in the soma and dendrites of multiple neuron types.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2−4)</a> CYP46A1 converts cholesterol to 24-hydroxycholesterol (24HC), an oxysterol that rapidly diffuses across the blood–brain barrier to the systemic circulation and is delivered to the liver for further degradation to bile acids.<a onclick="showRef(event, 'ref2 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref2 ref5 ref6">(2,5,6)</a> Initially CYP46A1 was recognized for its key roles in brain cholesterol elimination and turnover.<a onclick="showRef(event, 'ref2 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref2 ref7 ref8">(2,7,8)</a> CYP46A1 was later discovered to be linked to other brain processes including memory and learning.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12">(9−12)</a> CYP46A1 is now a focus for intensive investigations as a potential target for treatment of different brain disorders with both enzyme inhibition and activation having therapeutic potential.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Animal studies suggest that increased CYP46A1 activity can ameliorate the manifestations of Alzheimer’s and Huntington’s diseases.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18">(14−18)</a> Conversely, a decreased CYP46A1 activity is hypothesized to reduce seizure frequency and is now being tested in two clinical trials in subjects with Dravet, Lennox-Gastaut, and Duplication 15q syndromes as well as CDKL5 deficiency disorder.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> In addition to the brain, CYP46A1 is of importance for the retina and retinal blood vessels.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">This laboratory discovered that CYP46A1 could be activated pharmacologically in mice by (<i>S</i>)-efavirenz (EFV), an anti-HIV drug.<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20−22)</a> Remarkably, the CYP46A1 activating EFV dose was very low (0.1 (mg/day)/kg body weight), at least 80 times lower than that (600 mg/day) given to HIV-positive individuals to keep their viral load low. When administered orally to normal (C57BL/6J) mice or a model of Alzheimer’s disease (5XFAD mice), this low EFV dose not only activated CYP46A1 in the brain but also elicited a compensatory increase in cholesterol biosynthesis and hence turnover.<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20−22)</a> As a result, the steady-state levels of cholesterol in the brain remained unchanged in C57BL/6J mice and were normalized in 5XFAD mice. In the latter, EFV treatment also led to behavioral improvements with the effect on the total brain amyloid β load being the treatment paradigm-specific.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> However, when the EFV dose was increased to 0.22 (mg/day)/kg body weight, CYP46A1 activation was no longer observed and the higher 0.32 (mg/da)/kg body dose even inhibited the enzyme.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Thus, the therapeutic window for CYP46A1 activation by EFV in mice appears to be quite narrow.</div><div class="NLM_p">In vitro studies utilizing purified recombinant CYP46A1 revealed that the concentration dependence curves of EFV for the CYP46A1-mediated cholesterol 24-hydroxylation were bell-shaped with the enzyme activation at low compound concentrations and inhibition at high concentartions.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Subsequent mechanistic investigations suggested an allosteric site for EFV on CYP46A1,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> which was then mapped experimentally to the cytosolic (proximal) surface of the P450 molecule.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> This site was close to the redox partner binding site but away from the CYP46A1 active site, a banana-shaped tunnel extending from the lipid-embedded distal CYP46A1 surface to the interior of the protein molecule.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> We proposed that at low concentrations EFV binds to the allosteric site and activates CYP46A1, whereas at high concentrations the drug likely binds to both the allosteric and active sites and inhibits CYP46A1 because of the competition with cholesterol for the active site.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> EFV was also found to increase the rate of the fast CYP46A1 reduction and the total amount of reduced P450.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Furthermore, the analysis of the CYP46A1 crystal structure<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> suggested that EFV could displace the water molecule in the allosteric site and thereby alter the hydrogen bond network that connects the allosteric and active sites and determines in part the hydration of the active site.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p last">Currently, we are involved in an ongoing clinical trial of EFV in patients with mild cognitive impairment due to Alzheimer’s disease (NCT03706885, ClinicalTrials.gov), which tests the 50 and 200 mg/day EFV doses. In parallel, we have a goal of generating a compound with a broader therapeutic window for CYP46A1 activation than EFV and preferably more potent to lower a possibility of CYP46A1 inhibition and hence side effects while perhaps enhancing the potentially beneficial drug effects. Therefore we initiated the current study to gain insights into the role of some of the EFV functionalities. We tested two types of EFV-related compounds for the effects on purified CYP46A1 in vitro: some of the primary EFV metabolites produced during hepatic drug clearance<a onclick="showRef(event, 'ref4 ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref4 ref25 ref26 ref27 ref28">(4,25−28)</a> and EFV analogs with changes in the oxazinone and cyclopropyl rings.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26365" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26365" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> CYP46A1 Activation by (<i>S</i>)-EFV and Related Compounds</h3><div class="NLM_p">In mammals, (<i>S</i>)-EFV is mainly oxidized to (<i>S</i>)-8-hydroxyEFV (<b>1</b>), with the metabolism to (<i>S</i>)-7-hydroxyEFV (<b>2</b>) occurring to a lesser extent (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a). Both of these metabolites can be further hydroxylated to yield (<i>S</i>)-8,14-dihydroxyEFV (<b>3</b>) and (<i>S</i>)-7,8-dihydroxyEFV (<b>4</b>).<a onclick="showRef(event, 'ref4 ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref4 ref25 ref26 ref27 ref28">(4,25−28)</a> (<i>S</i>)-EFV also has secondary metabolites produced as a result of glucuronidation and/or sulfation of the EFV oxidation products.<a onclick="showRef(event, 'ref25 ref29'); return false;" href="javascript:void(0);" class="ref ref25 ref29">(25,29)</a> Of the primary EFV metabolites, only (<i>S</i>)-<b>1</b> is commercially available along with racemic (<i>rac</i>)-<b>1</b>, <i>rac</i>-<b>2</b>, and <i>rac</i>-<b>3</b>. Hence, all these compounds were tested in the enzyme assay using purified recombinant CYP46A1. Similar to CYP46A1 activation by (<i>S</i>)-EFV, the concentration dependence curves for (<i>S</i>)-<b>1</b>, <i>rac</i>-<b>1</b>, and <i>rac</i>-<b>2</b> were bell-shaped, whereas that for <i>rac</i>-<b>3</b> was essentially hyperbolic (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b). All of the tested metabolites had a maximal CYP46A1 activation higher than that with (<i>S</i>)-EFV (5.8-6.2-fold vs 4.1-fold, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), which was observed at the same 20 μM metabolite concentration. (<i>S</i>)-<b>1</b> and <i>rac</i>-<b>1</b> had almost identical concentration dependence curves and along with <i>rac</i>-<b>2</b> did not inhibit CYP46A1 at the 60–100 μM concentrations that were inhibitory for (<i>S</i>)-EFV. Thus, EFV hydroxylations at C-7, -8, and -14 render the drug properties that we sought when the study was initiated, namely, an increase in CYP46A1 activation at lower metabolite concentrations and a decrease in enzyme inhibition at higher compound concentrations. We then evaluated commercially available EFV analogs (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>c): <i>rac-</i><b>5</b>, which has a C atom instead of N-1; (<i>S</i>)-<b>6</b>, lacking the keto group; <i>rac-</i><b>7</b>, which has a methyl group instead of the keto group; <i>rac</i>-<b>8</b>, which has a C atom instead of O-3; <i>rac</i>-<b>9</b>, which has an ethyl group instead of a cyclopropyl ring. All of these compounds, except <i>rac</i>-<b>5</b>, had bell-shaped concentration dependence curves, and CYP46A1 activation was either similar (<i>rac</i>-<b>8</b>) or lower than that with (<i>S</i>)-EFV(<i>rac</i>-<b>5</b>, (<i>S</i>)-<b>6</b>, <i>rac</i>-<b>7</b>, and <i>rac</i>-<b>9</b>). P450 inhibition was decreased for all compounds at their higher concentrations, and <i>rac</i>-<b>5</b> as well as (<i>S</i>)-<b>6</b> did not inhibit the enzyme at the concentrations tested. Thus, lack of O-3 (<i>rac</i>-<b>8</b>) did not significantly impair CYP46A1 activation by the derivative but decreased CYP46A1 inhibition at higher compound concentrations. Similarly, CYP46A1 inhibition was decreased by the replacement or elimination of EFV functionalities at positions 1 (<i>rac-</i><b>5</b>), 2 ((<i>S</i>)-<b>6</b>), and 14 (<i>rac-</i><b>9</b>), but the enzyme activation was less than that by (<i>S</i>)-EFV.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/medium/jm9b01383_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. EFV metabolites and analogs. (a, c) Chemical structures of EFV, its metabolites, and analogs studied in the present work. Structural divergence from EFV is highlighted in either red font or circles. EFV metabolism by the cytochrome P450 enzymes is also shown and taken with permission from ref <a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a>. (b, d) Dependence of CYP46A1 activity in vitro on the concentration of (<i>S</i>)-EFV or an EFV-related compound. CYP46A1 activity (the rate of cholesterol 24-hydroxylation) is presented as nanomoles of 24-hydroxycholesterol (24HC) formed per nmole of CYP46A1 per min. The range of the tested compound concentrations is based on our previous study,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> in which 100 μM (<i>S</i>)-EFV almost completely inhibited CYP46A1. The results are the mean ± SD of the measurements from the three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01383&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Summary of the CYP46A1 Responses to the Studied EFV-Related Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">interacts via the allosteric site for</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">substrate-free CYP46A1<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">cholesterol-bound CYP46A1<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">maximal activation (fold)</th><th class="colsep0 rowsep0" align="center">maximal activation in the presence of <span class="smallcaps smallerCapital">l</span>-Glu (fold)</th><th class="colsep0 rowsep0" align="center">EFV</th><th class="colsep0 rowsep0" align="center">Glu</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-EFV</td><td class="colsep0 rowsep0" align="left">type 2; H</td><td class="colsep0 rowsep0" align="left">reverse type 1; S</td><td class="colsep0 rowsep0" align="left">4.1</td><td class="colsep0 rowsep0" align="left">4.9</td><td class="colsep0 rowsep0" align="left">+</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>1</b></td><td class="colsep0 rowsep0" align="left">type 2; H</td><td class="colsep0 rowsep0" align="left">reverse type 1; S</td><td class="colsep0 rowsep0" align="left">6.2</td><td class="colsep0 rowsep0" align="left">7.4</td><td class="colsep0 rowsep0" align="left">+</td><td class="colsep0 rowsep0" align="left">+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>rac</i>-<b>2</b></td><td class="colsep0 rowsep0" align="left">type 2; H</td><td class="colsep0 rowsep0" align="left">reverse type 1; S</td><td class="colsep0 rowsep0" align="left">5.8</td><td class="colsep0 rowsep0" align="left">6.8</td><td class="colsep0 rowsep0" align="left">+</td><td class="colsep0 rowsep0" align="left">+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>rac</i>-<b>5</b></td><td class="colsep0 rowsep0" align="left">type 1; S</td><td class="colsep0 rowsep0" align="left">no spectral response</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">+</td><td class="colsep0 rowsep0" align="left">+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>rac</i>-<b>3</b></td><td class="colsep0 rowsep0" align="left">type 2; H</td><td class="colsep0 rowsep0" align="left">reverse type 1; H</td><td class="colsep0 rowsep0" align="left">6.1</td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>6</b></td><td class="colsep0 rowsep0" align="left">type 1; H</td><td class="colsep0 rowsep0" align="left">no spectral response</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">abolished</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>rac</i>-<b>7</b></td><td class="colsep0 rowsep0" align="left">type 1; H</td><td class="colsep0 rowsep0" align="left">no spectral response</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">abolished</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>rac</i>-<b>8</b></td><td class="colsep0 rowsep0" align="left">type 1; H</td><td class="colsep0 rowsep0" align="left">reverse type 1; S</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">4.6</td><td class="colsep0 rowsep0" align="left">+</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>rac</i>-<b>9</b></td><td class="colsep0 rowsep0" align="left">type I; H</td><td class="colsep0 rowsep0" align="left">reverse type 1; S</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="left">+</td><td class="colsep0 rowsep0" align="left">–</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Presented is the spectral response type and fit: H, hyperbolic fit; S, sigmoidal fit.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Spectral Responses in CYP46A1 Induced by (<i>S</i>)-EFV and Related Compounds</h3><div class="NLM_p">CYP46A1 is a hemoprotein and, as with most P450s, has a water molecule coordinating its heme iron in the sixth axial position when in the resting, substrate-free state.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> When this water molecule is displaced and the heme iron is left uncoordinated, the CYP46A1 difference spectrum has a peak at ∼390 nm and a trough at ∼422 nm,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> a so-called type I spectral response, elicited in many cases by the P450 substrates.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30−32)</a> However, when the heme iron becomes coordinated with a nitrogen atom, a trough around ∼410 nm and a peak at ∼421–435 nm appear in the P450 difference spectrum,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> a so-called type 2 spectral response, often produced by P450 inhibitors.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30−32)</a> A third type of the spectral response for the P450 enzymes has also been described, reverse type I, which represents a mirror reflection of a type I difference spectrum (a trough at 380–390 nm and peak at 415–420 nm).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> This response is believed to reflect the formation of an Fe–O bond, where the oxygen donor atom is from either a water molecule or the added compound.<a onclick="showRef(event, 'ref32 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref34">(32,34)</a> Previously we reported that titrations with (<i>S</i>)-EFV induced a type 2 spectral response in substrate-free CYP46A1 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), which could be fit (Δ<i>A</i>) to a hyperbolic curve.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> These data suggested that in the absense of cholesterol, EFV binds to the CYP46A1 active site and coordinates the heme iron with its N-1 atom. Similarly, type 2 spectral responses that fit to a hyperbolic curve were observed in substrate-free CYP46A1 upon the addition of (<i>S</i>)-<b>1</b>, <i>rac</i>-<b>1</b>, <i>rac</i>-<b>2</b>, and <i>rac</i>-<b>3</b>, an indication that the hydroxyl groups at C-7, C-8, and C-8,14 do not prevent EFV derivatives from binding to the CYP46A1 active site in an orientation that enables the formation of the N–Fe coordinate bond (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Yet the apparent <i>K</i><sub>d</sub> values of the hydroxylated EFV metabolites were 2–5 times higher than that of (<i>S</i>)-EFV, suggesting that the affinity of these compounds for CYP46A1 was decreased (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b). Conversely, <i>rac</i>-<b>5</b>, (<i>S</i>)-<b>6</b>, <i>rac</i>-<b>7</b>, <i>rac</i>-<b>8</b>, and <i>rac</i>-<b>9</b> elicited a type 1 spectral response in substrate-free CYP46A1 consistent with absence of N-1 (<i>rac</i>-<b>5</b>) as well as the hydrogen bond-forming functionalities ((<i>S</i>)-<b>6</b>, <i>rac</i>-<b>7</b>, <i>rac</i>-<b>8</b>) that may help EFV bind in the CYP46A1 active site in the orientation suitable for the ligation of the heme iron. In addition, testing of <i>rac</i>-<b>9</b> revealed the importance of the EFV cyclopropyl ring for the drug coordination of the heme iron. As with type 2 ligands, the binding of type 1 ligands can be fit to a hyperbolic curve except in the case of <i>rac</i>-<b>5</b>, whose curve was sigmoidal and may underlie the sigmoidal-like curve in the concentration dependence enzyme assay (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>d).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/medium/jm9b01383_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Spectral responses induced in substrate-free CYP46A1 by EFV-related compounds. Data for (<i>S</i>)-EFV are shown in the center. Δ<i>A</i> is the amplitude of spectral changes in the P450 difference spectra (insets). The results are presented as the mean ± SD of the measurements in the three spectral titrations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01383&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The allosteric response of CYP46A1 was only revealed when EFV was added to the P450 in the presence of the saturating (20 μM) cholesterol, i.e., substrate-bound enzyme.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The spectral titration curve became sigmoidal, and the spectral response was of a reverse type 1 nature (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). On the basis of this and other data, we suggested EFV binding to an allosteric site and interpreted this response as an altered hydration of the CYP46A1 active site with the subsequent formation of the Fe–O coordinate bond.<a onclick="showRef(event, 'ref20 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref23">(20,23)</a> Similarly, sigmoidal curves and a reverse type 1-like spectral response were observed in CYP46A1 upon addition of (<i>S</i>)-<b>1</b>, <i>rac</i>-<b>1</b>, <i>rac</i>-<b>2</b>, <i>rac</i>-<b>8</b>, and <i>rac</i>-<b>9</b>, consistent with comparable (≤25%) or higher CYP46A1 activation by these compounds at lower concentrations and their bell-shape concentration dependence curves (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b,d). <i>rac</i>-<b>3</b> also elicited a reverse type 1-like spectral response in cholesterol-bound CYP46A1, but its spectral binding was of a hyperbolic nature. Since this metabolite essentially did not inhibit CYP46A1 in the concentration dependence enzyme assay (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b), we suggest that this response could reflect preferential EFV binding only to the allosteric site. Lastly, <i>rac-</i><b>5</b>, (<i>S</i>)-<b>6</b>, and <i>rac-</i><b>7</b> did not seem to elicit a quantifiable spectral response in cholesterol-bound CYP46A1 while still activating the P450 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>d), although to a lower extent than EFV (up to 2.6-fold vs 4.1-fold). These data suggest that compound interactions with the allosteric site(s) could be spectrally silent and that this spectral silence could be due to absence of the hydrogen-forming N-1 (<i>rac</i>-<b>5</b>) as well as the 2-keto group ((<i>S</i>)-<b>6</b> and <i>rac</i>-<b>7</b>) in the tested derivatives. CYP46A1 spectral titrations with different EFV-related compounds are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/medium/jm9b01383_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Spectral responses induced in cholesterol-bound CYP46A1 by EFV-related compounds. Data for (<i>S</i>)-EFV are shown in the center. Δ<i>A</i> is the amplitude of spectral changes in the P450 difference spectra (insets). The results are presented as the mean ± SD of the measurements in the three spectral titrations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01383&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Mapping of the Allosteric Site(s) for Compound Binding</h3><div class="NLM_p">We first conducted in silico docking of the (<i>S</i>)- and (<i>R</i>)-isomers of <b>3</b>, the best CYP46A1 activator in vitro. Autodock, VINA, and Ledock were used, and none of the docking programs could fit these isomers to the allosteric site for (<i>S</i>)-EFV. The three programs did provide a consensus model for (<i>S</i>)-<b>3</b> and (<i>R</i>)-<b>3</b> binding to the so-called glutamate (Glu)-binding site, a region on the CYP46A1 proximal surface adjacent to the site EFV-binding (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a–c).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Glu activates CYP46A1 in vitro either alone or synergistically with (<i>S</i>)-EFV,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and we tested how CYP46A1 co-incubations with <span class="smallcaps smallerCapital">l</span>-Glu and <i>rac</i>-<b>3</b> or other compounds affected the enzyme activity under the conditions of the maximal P450 activation (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>d). <span class="smallcaps smallerCapital">l</span>-Glu did not synergistically activate CYP46A1 in the co-incubations with <i>rac</i><i>-</i><b>3</b>, (<i>S</i>)-<b>6</b>, or <i>rac-</i><b>7</b>, with the P450 activation becoming either lower (<i>rac</i><i>-</i><b>3</b>) or even abolished ((<i>S</i>)-<b>6</b> or <i>rac-</i><b>7</b>) relative to the P450 activity in the presence of either activator. Conversely, co-incubations with <span class="smallcaps smallerCapital">l</span>-Glu and (<i>S</i>)-<b>1</b>, <i>rac</i>-<b>2</b>, <i>rac</i>-<b>5</b>, <i>rac</i>-<b>8</b>, or <i>rac</i>-<b>9</b> synergistically activated CYP46A1 in vitro. These data suggested that <i>rac-</i><b>3</b> and (<i>S</i>)-<b>6</b> or <i>rac-</i><b>7</b> probably bind mainly to the allosteric site for Glu and compete with the neurotransmitter for this site, consistent with the computational predictions for (<i>S</i>)-<b>3</b> and (<i>R</i>)-<b>3</b>. In contrast, other EFV-related compounds likely bind to both EFV- and Glu-binding sites. Accordingly we then tested co-incubations of (<i>S</i>)-EFV with <i>rac</i><i>-</i><b>3</b>, (<i>S</i>)-<b>6</b>, or <i>rac-</i><b>7</b> and found a synergistic CYP46A1 activation (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>d). Thus we obtained support for the interaction of <i>rac</i><i>-</i><b>3</b>, (<i>S</i>)-<b>6</b>, and <i>rac-</i><b>7</b> mainly with the allosteric site for Glu.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/medium/jm9b01383_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Mapping of the CYP46A1 allosteric site for <i>rac</i>-<b>3</b>. (a–c) Computational models of (<i>S</i>)-EFV (black), <span class="smallcaps smallerCapital">l</span>-Glu (yellow), (<i>S</i>)-<b>3</b> (dark green), and (<i>R</i>)-<b>3</b> (light green) binding to the CYP46A1 surface. Docking experiments were carried out on PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Q9G">2Q9G</a>. Models for (<i>S</i>)-EFV and <span class="smallcaps smallerCapital">l</span>-Glu are taken from ref <a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a>, and those for (<i>S</i>)-<b>3</b> and (<i>R</i>)-<b>3</b> were generated in the present work. The heme group is in red. The nitrogen, oxygen, chlorine, and fluorine atoms are in blue, red, light green, and cyan, respectively. (d) Effect of <span class="smallcaps smallerCapital">l</span>-Glu (100 μM), (<i>S</i>)-EFV (20 μM), or EFV analog (20 μM) on the maximal extent of CYP46A1 activation. CYP46A1 activity is presented as nanomoles of 24-hydroxycholesterol (24HC) formed per nmole of CYP46A1 per min. Control incubations with no activator, <span class="smallcaps smallerCapital">l</span>-Glu only, and (<i>S</i>)-EFV only are shown as a white, yellow, and black bar, respectively. Incubations with an EFV-related compound only are shown as solid colored bars, and co-incubations with <span class="smallcaps smallerCapital">l</span>-Glu and (<i>S</i>)-EFV are shown as dashed (yellow and black dashes, respectively) colored bars. The results are presented as the mean ± SD of the measurements from the three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01383&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further map compound binding, we used the CYP46A1 mutants generated for this study as well as previously<a onclick="showRef(event, 'ref1 ref23'); return false;" href="javascript:void(0);" class="ref ref1 ref23">(1,23)</a> and assessed how the replacement of the amino acid residues specific for EFV binding site (R415A and F405A) and Glu binding site (K358R/L/A, F416A, and Y427F/A) as well as the loop region forming the common border between the two sites (K422A and R424A) affect maximal CYP46A1 activation by different EFV metabolites and derivatives. The P450 activation by <i>rac</i><i>-</i><b>3</b>, (<i>S</i>)-<b>6</b>, or <i>rac-</i><b>7</b> was not significantly affected by the smaller sized replacements within the EFV-binding site (R415A and F405A) but was largely reduced or abolished by the smaller sized replacements within the Glu-binding site (K358A, F416A, and Y427A) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a). The effect of the alanine substitutions of the border-forming Lys-422 and Arg-424 was differential, and activation pattern of the CYP46A1 mutants by <i>rac-</i><b>8</b> and <i>rac-</i><b>9</b> was different with only EFV-site but not the Glu-site smaller sized mutations mainly affecting the P450 activation, evidence for the preferential EFV-site binding (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b). Lastly, the activation of all of the smaller sized CYP46A1 mutants was altered by (<i>S</i>)-<b>1</b>, <i>rac</i>-<b>2</b>, and <i>rac-</i><b>5</b>, suggesting that these compounds bind to both EFV- and Glu-binding sites. Thus, depending on the structure, EFV-related compounds could bind either to both or mainly one of the allosteric sites and activate CYP46A1 in vitro with the extent of the P450 activation being compound-specific but not the allosteric site-specific (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/medium/jm9b01383_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mapping of the CYP46A1 allosteric site(s) for binding of EFV-related compounds. (a, b) Maximal activity of wild type (WT) CYP46A1 and the P450 mutants in the absence (white bars) or presence of different EFV-related compounds (20 μM, colored bars). CYP46A1 activity is presented as nanomoles of 24-hydroxycholesterol (24HC) formed per nmole of CYP46A1 per min. The results are presented as the mean ± SD of the measurements from the three independent experiments. (c–e). Some of the amino acid residues forming EFV binding site (c) and Glu binding site (d and e) as well as the border between the sites (c–e). The positions of (<i>S</i>)-EFV, (<i>S</i>)-<b>3</b>, and (<i>R</i>)-<b>3</b> within these sites are also shown. Docking experiments were carried out on PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Q9G">2Q9G</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01383&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Studies of a Model of (<i>S</i>)-EFV and <i>rac-</i><b>3</b> Binding to the CYP46A1 Active Site</h3><div class="NLM_p">These studies were carried out to gain insight into why there was no decrease in CYP46A1 activation and ultimately enzyme inhibition by <i>rac-</i><b>3</b> at higher metabolite concentrations as in the case with (<i>S</i>)-EFV (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b). Indeed, both (<i>S</i>)-EFV and <i>rac-</i><b>3</b> bind to the active site of substrate-free CYP46A1 and likely act as inhibitors by coordinating the P450 heme iron with the secondary amine group (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Further, only a 2-fold difference in the apparent spectral <i>K</i><sub>d</sub> of <i>rac-</i><b>3</b> and (<i>S</i>)-EFV for substrate-free CYP46A1 is not large enough to predict that there would be no competition between <i>rac-</i><b>3</b> and cholesterol for the CYP46A1 active site as likely in the case with (<i>S</i>)-EFV. We first determined the binding rates of (<i>S</i>)-EFV and <i>rac-</i><b>3</b> for substrate-free CYP46A1 at different compound concentrations as diagnostic for a model of compound binding: conformation-selection vs induced-fit<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> with the former discovered recently to be operative in several human P450 enzymes.<a onclick="showRef(event, 'ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39 ref40">(37−40)</a> Increasing compound concentrations increased the magnitude of the spectral changes with both (<i>S</i>)-EFV and <i>rac-</i><b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>a–d) but clearly decreased the rates of binding (<i>k</i><sub>observed</sub>) (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). Notably, for <i>rac-</i><b>3</b>, these rates were always lower (at least ∼7-fold) than those for (<i>S</i>)-EFV, and <i>rac-</i><b>3</b> showed essentially no spectral binding at 15–30 μM, the concentrations that still led to a measurable (<i>S</i>)-EFV binding. Similarly, when (<i>S</i>)-EFV and <i>rac-</i><b>3</b> were added to cholesterol-bound CYP46A1 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>e,f), the absorbance change for the type 2 spectral response was still observed for (<i>S</i>)-EFV at 50 μM but not <i>rac-</i><b>3</b> at 2 μM. A decrease in binding rates with increasing compound concentration indicates a conformation-selection model of binding.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> Collectively, the data obtained suggested that different CYP46A1 conformations are necessary for (<i>S</i>)-EFV and <i>rac-</i><b>3</b> binding to the P450 active site and that much less enzyme molecules exist in solution in the conformation favorable for <i>rac-</i><b>3</b>, thus preventing it from efficient competition with cholesterol for the CYP46A1 active site.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/medium/jm9b01383_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Binding of (<i>S</i>)-EFV and <i>rac</i>-<b>3</b> to CYP46A1. The P450 (4 μM) was mixed with varying concentrations of a compound, and spectra were collected and analyzed. (a, b) Mixing CYP46A1 with low (2 μM) and (c, d) high (50 μM or 60 μM) compound concentrations. (e, f) Mixing of 4 μM P450 46A1·4 μM cholesterol complex with 50 μM or 2 μM compound. The fits shown are single exponentials. At least four individual traces were collected and averaged.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01383&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/medium/jm9b01383_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Dependence of rates of binding to CYP46A1 as a function of compound concentration. Traces of Δ(<i>A</i><sub>437</sub> – <i>A</i><sub>416</sub>) (e.g., <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) were fit to single exponential plots. The error bars show the SD of the OLIS software fits. At least four separate reactions were averaged for each data point.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01383&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, we determined the apparent <i>k</i><sub>off</sub> rates for cholesterol, (<i>S</i>)-EFV and <i>rac-</i><b>3</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, <a href="/doi/suppl/10.1021/acs.jmedchem.9b01383/suppl_file/jm9b01383_si_001.pdf" class="ext-link">Figure S1</a>). Release of cholesterol (<i>k</i><sub>off</sub>) was very slow, 2 orders of magnitude slower than that of (<i>S</i>)- EFV and <i>rac-</i><b>3</b>, perhaps a reason why the apparent <i>K</i><sub>d</sub> of cholesterol for CYP46A1 was also much lower than those of (<i>S</i>)-EFV and <i>rac-</i><b>3</b> (9 nM vs 5 μM). Accordingly the calculated <i>k</i><sub>on</sub> rate of cholesterol was 1.7-fold lower than that for (<i>S</i>)-EFV but 1.9-fold higher than that for <i>rac-</i><b>3</b>, another advantage of (<i>S</i>)-EFV relative to <i>rac-</i><b>3</b> in terms of binding to the CYP46A1 active site. Thus, not only the predominant enzyme conformation but also the steady state <i>k</i><sub>on</sub> puts (<i>S</i>)-EFV at advantage,</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Compound Binding to CYP46A1<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>d</sub> for substrate-free CYP46A1 (M)</th><th class="colsep0 rowsep0" align="center">calculated <i>k</i><sub>on</sub><a class="ref internalNav" href="#t2fn1" aria-label="b">b</a> (M<sup>–1</sup> s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center">experimental <i>k</i><sub>off</sub> (s<sup>–1</sup>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cholesterol</td><td class="colsep0 rowsep0" align="left">9 × 10<sup>–9</sup> <a class="ref internalNav" href="#t2fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">1.3 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="left">0.012 ± 0.002</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-EFV</td><td class="colsep0 rowsep0" align="left">5 × 10<sup>–6</sup> <a class="ref internalNav" href="#t2fn3" aria-label="d">d</a> ± 0.4 × 10<sup>–6</sup></td><td class="colsep0 rowsep0" align="left">2.2 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="left">11.2 ± 0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>rac</i>-<b>3</b></td><td class="colsep0 rowsep0" align="left">5 × 10<sup>–6</sup> <a class="ref internalNav" href="#t2fn4" aria-label="e">e</a> ± 0.3 × 10<sup>–6</sup></td><td class="colsep0 rowsep0" align="left">0.7 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="left">3.6 ± 0.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup><sup>a</sup></sup><p class="last">Experimental data are presented as the mean ± SD of the measurements from the three independent experiments.</p></div><div class="footnote" id="t2fn1"><sup><sup>b</sup></sup><p class="last">Values calculated from <i>K</i><sub>d</sub> and <i>k</i><sub>off</sub> assuming <span class="NLM_inline-formula"><img class="imgWithoutFigViewer inline-formula-styles" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/medium/jm9b01383_m004.gif" alt="" id="_i10" /></img></span>.</p></div><div class="footnote" id="t2fn2"><sup><sup>c</sup></sup><p class="last">This value comes from an apparent <i>K</i><sub>d</sub> of 80 nM <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> after the correction for HPCD binding. See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for details.</p></div><div class="footnote" id="t2fn3"><sup><sup>d</sup></sup><p class="last">This is the <i>K</i><sub>d</sub> value for titrations at 24 °C <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> because the stopped-flow experiments were conducted at 23 °C.</p></div><div class="footnote" id="t2fn4"><sup><sup>e</sup></sup><p class="last">This is the <i>K</i><sub>d</sub> value for titrations at 24 °C determined in the present work in addition to the <i>K</i><sub>d</sub> value at 18 °C (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) as compared to <i>rac</i>-<b>3</b>, for the CYP46A1 active site binding and hence inhibition.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Discussion and Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81656" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81656" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The present work provides insight into the structure–activity relationships of (<i>S</i>)-EFV for CYP46A1 activation. Of the four functionalities tested (the N-1, 2-keto group, O-3, and cyclopropyl ring, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a), only one (the O-3) does not seem to be important for CYP46A1 activation as indicated by the concentration dependence curve for <i>rac</i>-<b>8</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>d). This curve was similar to that of (<i>S</i>)-EFV, consistent with compound binding to the same allosteric site as EFF (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b). Yet interaction with the CYP46A1 the active site was different as indicted by a type 1 spectral response in substrate-free CYP46A1 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). In addition, our studies revealed that introducing the hydroxyl group at C-7, C-8, or both C-8 and C-14 of EFV increased the maximal extent of CYP46A1 activation and eliminated the undesired CYP46A1 inhibition at higher compound concentrations (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b). All three hydroxylated compounds ((<i>S</i>)-<b>1</b>, <i>rac</i>-<b>1</b>, <i>rac</i>-<b>2</b>, and <i>rac</i>-<b>3</b>) appeared to bind similarly to the CYP46A1 active site (i.e., elicited a type 2 spectral response in substrate-free CYP46A1, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) and seemed to interact with either the allosteric site for Glu (<i>rac</i>-<b>3</b>) or both EFV and Glu ((<i>S</i>)-<b>1</b> and <i>rac</i>-<b>2</b>). As with <i>rac</i>-<b>8</b>, a reverse type 1 spectral response induced in cholesterol-bound CYP46A1 was a common feature of the hydroxylated compounds. However, only in the case of <i>rac</i>-<b>3</b> did this spectral response fit to a hyperbolic curve. It is thus possible that a reverse type 1 spectral response in cholesterol-bound CYP46A1 and a hyperbolic spectral fit are the features of a compound that does not inhibit the P450 at higher concentrations while activating CYP46A1 to the extent comparable with that of (<i>S</i>)-EFV (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Further studies are required to address this possibility.</div><div class="NLM_p">Notably the apparent <i>K</i><sub>d</sub> values for substrate-free CYP46A1 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) did not appear to be indicative of CYP46A1 inhibition in the concentration dependence curves, as was demonstrated by <i>rac</i>-<b>1</b>, <i>rac</i>-<b>2</b>, and <i>rac</i>-<b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b). To clarify the reason for a weak predictive power of an apparent <i>K</i><sub>d</sub> value, we capitalized on a recent discovery in the P450 field showing that the P450-compound interactions are complex and that conformational-selection is a dominant feature of many of these interactions for human P450s 2C6, 2D6, 3A4, 4A11, 17A1, and 21A2.<a onclick="showRef(event, 'ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39 ref40">(37−40)</a> By conducting the stopped-flow experiments, we ascertained that (<i>S</i>)-EFV and <i>rac</i>-<b>3</b> bind to substrate-free CYP46A1 in a mechanism involving conformational-selection, which is apparently more favorable to (<i>S</i>)-EFV than <i>rac</i>-<b>3</b>, a bulkier compound requiring more space in the P450 active site. In addition, a 3-fold lower <i>k</i><sub>on</sub> of <i>rac</i>-<b>3</b> than that of (<i>S</i>)-EFV when cholesterol release from the CYP46A1 active site (the <i>k</i><sub>off</sub>) is extremely slow (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) could be another reason for caution when considering the apparent <i>K</i><sub>d</sub> values.</div><div class="NLM_p">An important finding of the present work was that CYP46A1 could be activated by racemic mixtures, which is in contrast to HIV reverse transcriptase, which is inhibited only by the (<i>S</i>)-isomer of EFV.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> CYP46A1 activation and response to (<i>S</i>)-<b>1</b> and <i>rac</i>-<b>1</b> were similar but not identical (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), and molecular docking of (<i>S</i>)-<b>3</b> and (<i>R</i>)-<b>3</b> suggested the same binding site but a different binding mode (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>b,c). Thus, at least in some cases, using a racemate as compared to an expensive (<i>S</i>)-isomer could be more advantageous (besides lower compound cost) for activating CYP46A1 in vivo. First, we could still see the benefits of the enzyme activation while possibly minimizing the negative, non-CYP46A1 related effects<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42−44)</a> suggested by several cell culture studies, in which (<i>S</i>)-8-hydroxyEFV (as well as (<i>S</i>)-7-hydroxyEFV but to a lesser extent and not always) was shown to induce cell damage or death.<a onclick="showRef(event, 'ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47">(45−47)</a> However, these cell culture findings are not supported by a study in humans showing that neither plasma nor cerebrospinal fluid levels of (<i>S</i>)-8-hydroxyEFV are associated with central nervous system toxicity.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Also, the metabolite concentrations in the cell culture studies were designed to mimic the 600 mg/day EFV dose, which is >80-fold higher (∼8.5 (mg/kg of body weight)/day for a 70 kg person) than that (0.1 (mg/kg body weight)/day) given to mice. Second, CYP2B6 metabolizes (<i>S</i>)-EFV 10 times more efficiently in vitro than (<i>R</i>)-EFV and does not generate the (<i>R</i>) isomers of 7-hydroxyEFV (<b>2</b>), 7,8-dihydroxyEFV (<b>4</b>), and 8,14-dihydroxyEFV (<b>3</b>) from (<i>R</i>)-EFV.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Therefore the plasma half-life of racemic EFV or a hydroxylated EFV metabolite could be longer and hence requires a less frequent drug administration to activate CYP46A1. Lastly, potential toxic effects of the <i>R</i>-isomers of EFV metabolites have not been studied and may not be so detrimental as those suggested for the (<i>S</i>)-isomers.<a onclick="showRef(event, 'ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47">(45−47)</a> An in vivo investigation with racemic EFV and/or 8,14-dihydroxyEFV is required to evaluate potential benefits of the racemate use indicated by the current work in vitro.</div><div class="NLM_p">Of immediate clinical significance is our finding that EFV hydroxylations at positions 7, 8, and 14, which represent initial steps in EFV clearance by the liver,<a onclick="showRef(event, 'ref4 ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref4 ref25 ref26 ref27 ref28">(4,25−28)</a> enhance CYP46A1 activation at lower metabolite concentrations without inhibiting the enzyme at higher concentrations (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b). This finding raises a possibility that not only EFV but also its metabolites activate CYP46A1 in vivo. Indeed, all these compounds are present in the plasma of EFV-treated subjects: EFV at 2170–3350 ng/mL; 8-hydroxyEFV (<b>1</b>) at 315–2160 ng/mL; 7-hydroxyEFV (<b>2</b>) at 8.8–225 ng/mL; 8,14-dihydroxyEFV (<b>3</b>) at 10.2 ng/mL.<a onclick="showRef(event, 'ref4 ref49 ref50 ref51 ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref4 ref49 ref50 ref51 ref52 ref53 ref54">(4,49−54)</a> Also, the total polar surface areas of 38.3 Å<sup>2</sup> and 78.8 Å<sup>2</sup> for EFV and 8,14-dihydroxyEFV, respectively, and the predicted log <i>P</i> values of 4.53 and 3.17, respectively (calculated using the Molinspiration property calculation service), are within the desirable range for good CNS availability (<90–120 and 2–5).<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Consistent with these properties, EFV (13.9–19.5 ng/mL), 8-hydroxyEFV (<b>1</b>, 3.1–5.3 ng/mL), 7-hydroxyEFV (<b>2</b>, 0.63 ng/mL), and 8,14-dihydroxyEFV (<b>3</b>, 0.38–0.44 ng/mL) were detected in the cerebrospinal fluid, an established marker for free compound levels in the brain.<a onclick="showRef(event, 'ref4 ref29 ref49 ref50 ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref4 ref29 ref49 ref50 ref51 ref52 ref53">(4,29,49−53)</a> The detected compound levels in the cerebrospinal fluid were however low, probably because in the blood, EFV and EFV metabolites are ≥99.6% protein (albumin)-bound;<a onclick="showRef(event, 'ref4 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref4 ref50 ref51">(4,50,51)</a> hence only small drug amounts likely cross the blood–brain barrier.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Then once in the brain, EFV seems to readily accumulate in the tissue due to high propensity for protein binding as indicated by the experiments showing that EFV brain levels could exceed those in the plasma 4.6 times within 1 h of an intraperitoneal administration.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> In addition, EFV metabolites in the brain could be produced locally because EFV-metabolizing CYP2B6, CYP1A1, and CYP2C8 are not only expressed in the liver but also in the brain.<a onclick="showRef(event, 'ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref57 ref58 ref59">(57−59)</a> Thus, EFV metabolites could be present in the brain and activate CYP46A1 along with EFV, a possibility that would explain in part why only a small EFV dose (0.1 (mg /kg body weight)/day) is sufficient to activate CYP46A1 in mouse brain.</div><div class="NLM_p last">To conclude, structure–activity relationships of EFV for CYP46A1 activation were investigated and revealed that hydroxylations at C-7, -8, and -14 increase CYP46A1 activation at lower compound concentrations and decrease enzyme inhibition at higher compound concentrations. EFV N-1, 2-keto group, and the cyclopropyl ring were found to contribute to CYP46A1 activation, whereas the drug O-3 did not seem to be important. All of the investigated EFV metabolite and analogs decreased CYP46A1 inhibition at higher concentrations, possibly because their binding to the P450 active site involves the conformational selection mechanism. We also mapped the allosteric sites of compound binding on the CYP46A1 surface. The data obtained suggest the future direction of our work. This includes testing the following compounds, first in vitro and then, if justified, in vivo as potentially better CYP46A1 activators than (<i>S</i>)-EFV: (<i>S</i>)- and <i>rac</i>-7,8-dihydroxyEFV as well as (<i>S</i>)-8,14-dihydroxyEFV. Efforts are in progress for the generation of these compounds.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34386" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34386" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Materials</h3><div class="NLM_p last">(<i>S</i>)-EFV ((<i>S</i>)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2<i>H</i>-benzo[<i>d</i>][1,3]oxazin-2-one) and all EFV metabolites, as well as analogs, were purchased from Toronto Research Chemicals (Toronto, ON, Canada) and were >95% pure according to the manufacturer’s certificates of analysis (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01383/suppl_file/jm9b01383_si_001.pdf" class="ext-link">Figures S2–S11</a>). <sup>1</sup>H NMR and <sup>19</sup>F NMR spectra of these compounds conformed to their structures. <span class="smallcaps smallerCapital">l</span>-Glutamate was from MilliporeSigma (St. Louis, MO), and a 2 mM stock solution was prepared in water. Cholesterol was obtained from Steraloids (Newport, RI), and 24-hydroxy-[25,26,26,26,27,27,27-<sup>2</sup>H<sub>7</sub>]-cholesterol was from Medical Isotopes (Pelham, NH). Cholesterol was added from a 1 mM stock in 4.5%, w/v, aqueous 2-hydroxypropyl-β-cyclodextrin (HPCD), and deuterated 24-hydroxycholesterol was added from a 0.1 mM stock in methanol. Human truncated Δ(2–50)CYP46A1 with a four-histidine tag on the C terminus and rat cytochrome P450 oxidoreductase were expressed in <i>Escherichia coli</i> and purified as described.<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60,61)</a> The F405A Δ(2–50)CYP46A1 mutant was generated by using an in vitro QuikChange site-directed mutagenesis kit (Stratagene, San Diego, CA) according to the instructions. The correct generation of the desired mutation and absence of undesired mutations were confirmed by nucleotide sequencing of the entire CYP46A1 coding region as well as by the restriction analysis.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Enzyme Assays</h3><div class="NLM_p last">Incubations for the concentration dependence curves were carried out in 1 mL of 50 mM KP<sub>i</sub> buffer (pH 7.2) containing 100 mM NaCl, 40 μg/mL <span class="smallcaps smallerCapital">l</span>-α-1,2-dilauroyl-<i>sn</i>-glycero-3-phosphocholine, 0.5 μM purified Δ(2-50)CYP46A1, 1.0 μM cytochrome P450 oxidoreductase, 40 μM cholesterol, varying concentrations of a test compound (0–100 μM added from 0.5 to 5 mM methanol stocks to keep the 2% final methanol concentration), 2 units of catalase, and an NADPH-regenerating system (1 mM NADPH, 10 mM glucose 6-phosphate, and 2 units of glucose 6-phosphate dehydrogenase). Enzymatic reactions proceeded for 30 min at 37 °C, followed by sterol extraction with 5 mL of dichloromethane containing 1 nmol of 24-hydroxy-[25,26,26,26,27,27,27-<sup>2</sup>H<sub>7</sub>]-cholesterol, which served as an internal standard. Sterol extracts were then processed and analyzed by gas chromatography–mass spectrometry as described.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Incubations to determine for the maximal extent of CYP46A1 activation and the activation of the CY46A1 mutants were carried out similarly, except a fixed concentration (20 μM) of a test compound (added from a 5 mM stock in methanol) was used. Co-incubations with <span class="smallcaps smallerCapital">l</span>-Glu were with 100 μM neurotransmitter.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Spectral Titrations</h3><div class="NLM_p last">Spectral titrations were carried out at 18 °C as described,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> i.e., in 1 mL of 50 mM KP<sub>i</sub> buffer (pH 7.2) containing 100 mM NaCl and 0.4–0.5 μM Δ(2-50)CYP46A1, either substrate free or substrate-bound, i.e., in the presence of 20 μM cholesterol. Stock solutions of a 0.5–5 mM test compound in methanol or 0.5 mM cholesterol in 4.5% (<i>w</i>/<i>v</i>) aqueous HPCD were used. Data were fit by the GraphPad Prism software to either of the following equations:<span class="NLM_disp-formula"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/medium/jm9b01383_m001.gif" alt="" id="_i16" /></img></span><span class="NLM_disp-formula"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/medium/jm9b01383_m002.gif" alt="" id="_i17" /></img></span>or an allosteric sigmoidal curve, in which [E] is the enzyme concentration, Δ<i>A</i> is the spectral response at different compound concentrations [L], and Δ<i>A</i><sub>max</sub> is the maximal amplitude of the spectral response.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Computational Dockings</h3><div class="NLM_p last">The structures of (<i>S</i>)-<b>3</b> and (<i>R</i>)-<b>3</b> were optimized with density functional theory calculations at the B3LYP/6-31+G* level of theory using Gaussian 16.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> These architectures were then used as the input for docking experiments, using Autodock 4.2.6,<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Autodock VINA,<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> and Ledock.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Input files were generated using Autodock Tools 1.5.6<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> and converted using OpenBabel 2.3.1.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Docking experiments were carried out on PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Q9G">2Q9G</a>,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> with a search box centered on the <span class="smallcaps smallerCapital">l</span>-Glu binding pocket. The search box was similarly sized for all docking approaches (Autodock, 74 × 74 × 74, grid spacing 0.375 Å; Autodock VINA, 28 Å × 28 Å × 28 Å; Ledock, 28 Å × 28 Å × 28 Å). Visualization of docked compounds on the protein surface was carried out using PyMol.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Stopped-Flow Kinetics</h3><div class="NLM_p">Measurements were made in an OLIS RSM-1000 stopped-flow spectrophotometer (On-Line Instrument Systems, Bogart, GA) in the rapid-scanning mode, using a 20 mm × 4 mm cell, 16 mm × 0.2 mm Scandisk, 1.24 mm slits (8 nm bandpass), and 600 lines/500 nm gratings, operating at 23 °C. When the collection period was ≤4 s, data were collected at 1000 scans/s; when the collection time was >4 s, 62 scans/s were collected in the signal average mode. The wavelength range used was 330–570 nm. Measurements typically involved mixing one syringe containing 4 μM CYP46A1 in 50 mM KP<sub>i</sub> (pH 7.2), supplemented 100 mM NaCl, and another syringe containing a varying compound concentration in an equal volume of the same buffer. When CYP46A1 was premixed with equimolar cholesterol, the latter was added from a 2 mM stock in 4.5% (w/v) 2-hydroxypropyl-β-cyclodextrin. The data were saved as OLIS (.ols), and Excel files and converted to Δ<i>A</i><sub>max</sub> – Δ<i>A</i><sub>min</sub> plots. The resulting Excel files were corrected to Δ<i>A</i><sub><i>t</i> = 0</sub> > 0, saved as txt files, and imported into KinTek Explorer software version 8.0 (KinTek, Snowshoe, PA).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Analyses utilized an Apple iMac OSX 10.13.6 system.</div><div class="NLM_p last">The apparent rates of release (<i>k</i><sub>off</sub>) of cholesterol, (<i>S</i>)-EFV, and <i>rac-</i><b>3</b> from CYP46A1 were estimated by mixing a prebound complex with compound under study (4 μM CYP46A1 and 4 μM compound) with an excess of the inhibitor clotrimazole (40 μM), which binds tightly and has a different spectral complex.<a onclick="showRef(event, 'ref33 ref71'); return false;" href="javascript:void(0);" class="ref ref33 ref71">(33,71)</a> An increase in the Δ(A437-A416) absorbance was measured, and data from 8 to 12 plots were averaged. KinTek Explorer was used for data fitting. Since <span class="NLM_inline-formula"><img class="imgWithoutFigViewer inline-formula-styles" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/medium/jm9b01383_m003.gif" alt="" id="_i20" /></img></span>, the <i>k</i><sub>on</sub> rates were then calculated from the compound <i>K</i><sub>d</sub> values for substrate-free CYP46A1 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Cholesterol binds to both HPCD and CYP46A1; therefore the true <i>K</i><sub>d</sub> of cholesterol for CYP46A1 was calculated (9 nM) using KinTek Explorer and an apparent <i>K</i><sub>d</sub> of cholesterol for CYP46A1 (0.08 μM <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a>), the <i>K</i><sub>d</sub> of cholesterol for HPCD in 50 mM KP<sub>i</sub> buffer (pH 7.2) containing 100 mM NaCl at 24 °C (540 μM, determined in the present work as described<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a>), and the HPCD concentration (3.1 mM).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01383" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70024" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70024" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01383?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01383</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Figure S1 showing stopped-flow data for the <i>k</i><sub>off</sub> rate determination and Figures S2–S11 showing the certificates of analysis for EFV and EFV derivatives (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01383/suppl_file/jm9b01383_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01383/suppl_file/jm9b01383_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01383/suppl_file/jm9b01383_si_001.pdf">jm9b01383_si_001.pdf (12.65 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01383/suppl_file/jm9b01383_si_002.csv">jm9b01383_si_002.csv (0.74 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01383" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58252" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58252" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irina A. Pikuleva</span> - <span class="hlFld-Affiliation affiliation">Department of Ophthalmology
and Visual Sciences, Case Western Reserve
University, Cleveland, Ohio 44106, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9742-6232" title="Orcid link">http://orcid.org/0000-0001-9742-6232</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#472e26377f072426342269222332"><span class="__cf_email__" data-cfemail="bfd6decf87ffdcdeccda91dadbca">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Natalia Mast</span> - <span class="hlFld-Affiliation affiliation">Department of Ophthalmology
and Visual Sciences, Case Western Reserve
University, Cleveland, Ohio 44106, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Verwilst</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Korea University, Seoul 02841, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Clayton J. Wilkey</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, Vanderbilt University School
of Medicine, Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">F. Peter Guengerich</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, Vanderbilt University School
of Medicine, Nashville, Tennessee 37232, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7458-3048" title="Orcid link">http://orcid.org/0000-0002-7458-3048</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>N.M., P.V., C.J.W., and F.P.G. conducted experiments. N.M., P.V., F.P.G., and I.A.P. analyzed the data. N.M., P.V., F.P.G., and I.A.P wrote or contributed to the manuscript writing.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07676" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07676" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported in part by United States Public Health Service Grants R01 AG067552 (to I.A.P), P30 Core Grant EY011373, and Grant R01 GM118122 (to F.P.G.). The authors thank John Denker from the Molecular Biology and Genotyping Core of the Visual Sciences Research Center Core Facilities (supported by National Institutes of Health Grant P30 EY11373) for the generation of the CYP46A1 mutants.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">24HC</td><td class="NLM_def"><p class="first last">24-hydroxycholesterol</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">EFV</td><td class="NLM_def"><p class="first last">efavirenz</p></td></tr><tr><td class="NLM_term">Glu</td><td class="NLM_def"><p class="first last">glutamate</p></td></tr><tr><td class="NLM_term">HPCD</td><td class="NLM_def"><p class="first last">2-hydroxypropyl-β-cyclodextrin</p></td></tr><tr><td class="NLM_term"><i>rac</i></td><td class="NLM_def"><p class="first last">racemic</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75308" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75308" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 72 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, T. T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">In vitro cytochrome P450 46A1 (CYP46A1) activation by neuroactive compounds</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">12934</span>– <span class="NLM_lpage">12946</span>, <span class="refDoi"> DOI: 10.1074/jbc.M117.794909</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1074%2Fjbc.M117.794909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=28642370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1OkurzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=12934-12946&author=N.+Mastauthor=K.+W.+Andersonauthor=K.+M.+Johnsonauthor=T.+T.+N.+Phanauthor=F.+P.+Guengerichauthor=I.+A.+Pikuleva&title=In+vitro+cytochrome+P450+46A1+%28CYP46A1%29+activation+by+neuroactive+compounds&doi=10.1074%2Fjbc.M117.794909"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro cytochrome P450 46A1 (CYP46A1) activation by neuroactive compounds</span></div><div class="casAuthors">Mast, Natalia; Anderson, Kyle W.; Johnson, Kevin M.; Phan, Thanh T. N.; Guengerich, F. Peter; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">12934-12946</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cytochrome P 450 46A1 (CYP46A1, cholesterol 24-hydroxylase) is the enzyme responsible for the majority of cholesterol elimination from the brain.  Previously, we found that the anti-HIV drug efavirenz (EFV) can pharmacol. activate CYP46A1 in mice.  Herein, we investigated whether CYP46A1 could also be activated by endogenous compds., including major neurotransmitters.  In vitro expts. with purified recombinant CYP46A1 indicated that CYP46A1 is activated by L-glutamate (L-Glu), L-aspartate, γ-aminobutyric acid (GABA), and acetylcholine (Ach), with L-Glu eliciting the highest increase (3-fold) in CYP46A1-mediated cholesterol 24-hydroxylation.  We also found that L-Glu and other activating neurotransmitters bind to the same site on the CYP46A1 surface, which differs from the EFV-binding site.  The other principal differences between EFV and L-Glu in CYP46A1 activation include an apparent lack of L-Glu binding to the P 450 active site and different pathways of signal transduction from the allosteric site to the active site.  EFV and L-Glu similarly increased the CYP46A1 kcat, the rate of the "fast" phase of the enzyme redn. by the redox partner NADPH-cytochrome P 450 oxidoreductase, and the amt. of P 450 reduced.  Spectral titrns. with cholesterol, in the presence of EFV or L-Glu, suggest that water displacement from the heme iron can be affected in activator-bound CYP46A1.  Moreover, EFV and L-Glu synergistically activated CYP46A1.  Collectively, our in vitro data, along with those from previous cell culture and in vivo studies by others, suggest that L-Glu-induced CYP46A1 activation is of physiol. relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiFdaXT1EEJ7Vg90H21EOLACvtfcHk0ljyvMObYMoVpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1OkurzI&md5=45ec6757d8324c3f219a40cad3d9eac3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.794909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.794909%26sid%3Dliteratum%253Aachs%26aulast%3DMast%26aufirst%3DN.%26aulast%3DAnderson%26aufirst%3DK.%2BW.%26aulast%3DJohnson%26aufirst%3DK.%2BM.%26aulast%3DPhan%26aufirst%3DT.%2BT.%2BN.%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DIn%2520vitro%2520cytochrome%2520P450%252046A1%2520%2528CYP46A1%2529%2520activation%2520by%2520neuroactive%2520compounds%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D12934%26epage%3D12946%26doi%3D10.1074%2Fjbc.M117.794909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lund, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guileyardo, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D. W.</span></span> <span> </span><span class="NLM_article-title">cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">7238</span>– <span class="NLM_lpage">7243</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.13.7238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1073%2Fpnas.96.13.7238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10377398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADyaK1MXltVOrtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=7238-7243&author=E.+G.+Lundauthor=J.+M.+Guileyardoauthor=D.+W.+Russell&title=cDNA+cloning+of+cholesterol+24-hydroxylase%2C+a+mediator+of+cholesterol+homeostasis+in+the+brain&doi=10.1073%2Fpnas.96.13.7238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain</span></div><div class="casAuthors">Lund, Erik G.; Guileyardo, Joseph M.; Russell, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">7238-7243</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The turnover of cholesterol in the brain is thought to occur via conversion of excess cholesterol into 24S-hydroxycholesterol, an oxysterol that is readily secreted from the central nervous system into the plasma.  To gain mol. insight into this pathway of cholesterol metab., we used expression cloning to isolate cDNAs that encode murine and human cholesterol 24-hydroxylases.  DNA sequence anal. indicates that both proteins are localized to the endoplasmic reticulum, share 95% identity, and represent a new cytochrome P 450 subfamily (CYP46).  When transfected into cultured cells, the cDNAs produce an enzymic activity that converts cholesterol into 24S-hydroxycholesterol, and to a lesser extent, 25-hydroxycholesterol.  The cholesterol 24-hydroxylase gene contains 15 exons and is located on human chromosome 14q32.1.  Cholesterol 24-hydroxylase is expressed predominantly in the brain as judged by RNA and protein blotting.  In situ mRNA hybridization and immunohistochem. localize the expression of this P 450 to neurons in multiple subregions of the brain.  The concns. of 24S-hydroxycholesterol in serum are low in newborn mice, reach a peak between postnatal days 12 and 15, and thereafter decline to baseline levels.  In contrast, cholesterol 24-hydroxylase protein is first detected in the brain of mice at birth and continues to accumulate with age.  We conclude that the cloned cDNAs encode cholesterol 24-hydroxylases that synthesize oxysterols in neurons of the brain and that secretion of 24S-hydroxycholesterol from this tissue in the mouse is developmentally regulated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpnnVtKb72ibVg90H21EOLACvtfcHk0ljyvMObYMoVpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVOrtbg%253D&md5=b6c49f06202b7a55f87bc5e8c6c1ef2a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.13.7238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.13.7238%26sid%3Dliteratum%253Aachs%26aulast%3DLund%26aufirst%3DE.%2BG.%26aulast%3DGuileyardo%26aufirst%3DJ.%2BM.%26aulast%3DRussell%26aufirst%3DD.%2BW.%26atitle%3DcDNA%2520cloning%2520of%2520cholesterol%252024-hydroxylase%252C%2520a%2520mediator%2520of%2520cholesterol%2520homeostasis%2520in%2520the%2520brain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D7238%26epage%3D7243%26doi%3D10.1073%2Fpnas.96.13.7238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D. W.</span></span> <span> </span><span class="NLM_article-title">Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain</span>. <i>J. Comp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>507</i></span>,  <span class="NLM_fpage">1676</span>– <span class="NLM_lpage">1693</span>, <span class="refDoi"> DOI: 10.1002/cne.21605</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1002%2Fcne.21605" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=18241055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1OiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=507&publication_year=2008&pages=1676-1693&author=D.+M.+Ramirezauthor=S.+Anderssonauthor=D.+W.+Russell&title=Neuronal+expression+and+subcellular+localization+of+cholesterol+24-hydroxylase+in+the+mouse+brain&doi=10.1002%2Fcne.21605"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain</span></div><div class="casAuthors">Ramirez, Denise M. O.; Andersson, Stefan; Russell, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">507</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1676-1693</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Cholesterol 24-hydroxylase is a cytochrome P 450 (CYP46A1) that is selectively expressed in the brain and is responsible for the majority of cholesterol turnover in the central nervous system.  Mice deficient in 24-hydroxylase exhibit impaired learning and defective hippocampal long-term potentiation, suggesting that the metab. of cholesterol by this enzyme is required for learning and memory formation.  To det. where in the neuron cholesterol turnover was taking place, monoclonal antibodies directed against 24-hydroxylase were generated by immunization of mice with recombinant protein and used to detect the enzyme in brain homogenates, cultured neurons, and histol. sections.  24-Hydroxylase was localized to the endoplasmic reticulum and was distributed throughout the cell bodies and dendrites of multiple types of neurons; the enzyme was not detected in axon terminals or in the cells of 24-hydroxylase knockout mice.  24-Hydroxylase was highly expressed in pyramidal neurons of the hippocampus and cortex, in Purkinje cells of the cerebellum, and in hippocampal and cerebellar interneurons.  Within the retina, 24-hydroxylase was detected in ganglion cells and some but not all cells of the inner nuclear layer.  These findings reveal the microsomal localization of 24-hydroxylase and provide subcellular insight into cholesterol turnover in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFDMPBhTU1dLVg90H21EOLACvtfcHk0lgJCCh1WVf9CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1OiurY%253D&md5=e7e72c1f45ae87f6d2b5759ca9b34c79</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fcne.21605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcne.21605%26sid%3Dliteratum%253Aachs%26aulast%3DRamirez%26aufirst%3DD.%2BM.%26aulast%3DAndersson%26aufirst%3DS.%26aulast%3DRussell%26aufirst%3DD.%2BW.%26atitle%3DNeuronal%2520expression%2520and%2520subcellular%2520localization%2520of%2520cholesterol%252024-hydroxylase%2520in%2520the%2520mouse%2520brain%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D2008%26volume%3D507%26spage%3D1676%26epage%3D1693%26doi%3D10.1002%2Fcne.21605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avery, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanAusdall, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bumpus, N. N.</span></span> <span> </span><span class="NLM_article-title">Compartmentalization and antiviral effect of efavirenz metabolites in blood plasma, seminal plasma, and cerebrospinal fluid</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.049601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1124%2Fdmd.112.049601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=23166317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitlGisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=422-429&author=L.+B.+Averyauthor=J.+L.+VanAusdallauthor=C.+W.+Hendrixauthor=N.+N.+Bumpus&title=Compartmentalization+and+antiviral+effect+of+efavirenz+metabolites+in+blood+plasma%2C+seminal+plasma%2C+and+cerebrospinal+fluid&doi=10.1124%2Fdmd.112.049601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Compartmentalization and antiviral effect of efavirenz metabolites in blood plasma, seminal plasma, and cerebrospinal fluid</span></div><div class="casAuthors">Avery, Lindsay B.; Van Ausdall, Jennifer L.; Hendrix, Craig W.; Bumpus, Namandje N.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">422-429</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Efavirenz (EFV) is one of the most commonly prescribed antiretrovirals for use in the treatment of human immunodeficiency virus (HIV) infection.  EFV is extensively metabolized by cytochrome P 450 to a no. of oxygenated products; however, the pharmacol. activity and distribution of these metabolites in anat. compartments have yet to be explored.  The systemic distribution of EFV oxidative metabolites was examd. in blood plasma, seminal plasma, and cerebrospinal fluid from subjects on an EFV-based regimen.  The 8-hydroxy EFV metabolite was detected in blood plasma, seminal plasma, and cerebrospinal fluid, with median concns. of 314.5 ng/mL, 358.5 ng/mL, and 3.37 ng/mL, resp.  In contrast, 7-hydroxy and 8,14-hydroxy EFV were only detected in blood plasma and seminal plasma with median concns. of 8.84 ng/mL and 10.23 ng/mL, and 5.63 ng/mL and 5.43 ng/mL, resp.  Interestingly, protein-free concns. of metabolites were only detectable in seminal plasma, where a novel dihdyroxylated metabolite of EFV was also detected.  This accumulation of protein-free EFV metabolites was demonstrated to be the result of differential protein binding in seminal plasma compared with that of blood plasma.  In addn., the oxidative metabolites of EFV did not present with any significant pharmacol. activity toward HIV-1 as measured using an HIV green fluorescent protein single-round infectivity assay.  This study is the first to report the physiol. distribution of metabolites of an antiretroviral into biol. compartments that the virus is known to distribute and to examine their anti-HIV activity.  These data suggest that the male genital tract may be a novel compartment that should be considered in the evaluation of drug metabolite exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4Ssqy9xgKDbVg90H21EOLACvtfcHk0lgJCCh1WVf9CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitlGisLg%253D&md5=fcac32fd44f7a9508d2da56cb9b3405a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.049601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.049601%26sid%3Dliteratum%253Aachs%26aulast%3DAvery%26aufirst%3DL.%2BB.%26aulast%3DVanAusdall%26aufirst%3DJ.%2BL.%26aulast%3DHendrix%26aufirst%3DC.%2BW.%26aulast%3DBumpus%26aufirst%3DN.%2BN.%26atitle%3DCompartmentalization%2520and%2520antiviral%2520effect%2520of%2520efavirenz%2520metabolites%2520in%2520blood%2520plasma%252C%2520seminal%2520plasma%252C%2520and%2520cerebrospinal%2520fluid%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26spage%3D422%26epage%3D429%26doi%3D10.1124%2Fdmd.112.049601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bretillon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutjohann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widhe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bindl, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggertsen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diczfalusy, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björkhem, I.</span></span> <span> </span><span class="NLM_article-title">Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">840</span>– <span class="NLM_lpage">845</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10787445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtlKnsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=840-845&author=L.+Bretillonauthor=D.+Lutjohannauthor=L.+Stahleauthor=T.+Widheauthor=L.+Bindlauthor=G.+Eggertsenauthor=U.+Diczfalusyauthor=I.+Bj%C3%B6rkhem&title=Plasma+levels+of+24S-hydroxycholesterol+reflect+the+balance+between+cerebral+production+and+hepatic+metabolism+and+are+inversely+related+to+body+surface"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface</span></div><div class="casAuthors">Bretillon, Lionel; Lutjohann, Dieter; Stahle, Lars; Widhe, Torulf; Bindl, Lutz; Eggertsen, Gosta; Diczfalusy, Ulf; Bjorkhem, Ingemar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">840-845</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">Lipid Research, Inc.</span>)
        </div><div class="casAbstract">We have previously presented evidence that most of the 24S-hydroxycholesterol present in the circulation originates from the brain and that most of the elimination of this oxysterol occurs in the liver.  Plasma 24S-hydroxycholesterol levels decline by a factor of about 5 during the first decades of life.  The concn. of the enzyme cholesterol 24S-hydroxylase in the brain is, however, about const. from the first year of life, and reduced enzyme levels thus cannot explain the decreasing plasma levels during infancy.  In the present work we tested the hypothesis that the plasma levels of 24S-hydroxycholesterol may reflect the size of the brain relative to the capacity of the liver to eliminate the substance.  It is shown here that the age-dependent changes in abs. as well as cholesterol-related plasma level of 24S-hydroxycholesterol closely follow the changes in the ratio between estd. brain wt. and estd. liver vol.  The size of the brain is increased only about 50% whereas the size of the liver is increased by about 6-fold after the age of 1 yr.  Liver vol. is known to be highly correlated to body surface, and in accordance with this the abs. as well as the cholesterol-related plasma level of 24S-hydroxycholesterol was found to be highly inversely correlated to body surface in 77 healthy subjects of varying ages (r2 = 0.74).  Two chondrodystrophic dwarves with normal size of the brain but with markedly reduced body area had increased levels of 24S-hydroxycholesterol when related to age but normal levels when related to body surface.  It is concluded that the balance between cerebral prodn. and hepatic metab. is a crit. determinant for plasma levels of 24S-hydroxycholesterol at different ages and that endocrinol. factors are less important.  The results are discussed in relation to the possibility to use 24S-hydroxycholesterol in the circulation as a marker for cholesterol homeostasis in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOeVhunyKma7Vg90H21EOLACvtfcHk0lgJCCh1WVf9CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtlKnsbY%253D&md5=acd9b39bf0f154550339a202378f5850</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBretillon%26aufirst%3DL.%26aulast%3DLutjohann%26aufirst%3DD.%26aulast%3DStahle%26aufirst%3DL.%26aulast%3DWidhe%26aufirst%3DT.%26aulast%3DBindl%26aufirst%3DL.%26aulast%3DEggertsen%26aufirst%3DG.%26aulast%3DDiczfalusy%26aufirst%3DU.%26aulast%3DBj%25C3%25B6rkhem%26aufirst%3DI.%26atitle%3DPlasma%2520levels%2520of%252024S-hydroxycholesterol%2520reflect%2520the%2520balance%2520between%2520cerebral%2520production%2520and%2520hepatic%2520metabolism%2520and%2520are%2520inversely%2520related%2520to%2520body%2520surface%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2000%26volume%3D41%26spage%3D840%26epage%3D845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meaney, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diczfalusy, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björkhem, I.</span></span> <span> </span><span class="NLM_article-title">On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2130</span>– <span class="NLM_lpage">2135</span>, <span class="refDoi"> DOI: 10.1194/jlr.M200293-JLR200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1194%2Fjlr.M200293-JLR200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=12454275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD38XpslGjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=2130-2135&author=S.+Meaneyauthor=K.+Bodinauthor=U.+Diczfalusyauthor=I.+Bj%C3%B6rkhem&title=On+the+rate+of+translocation+in+vitro+and+kinetics+in+vivo+of+the+major+oxysterols+in+human+circulation%3A+critical+importance+of+the+position+of+the+oxygen+function&doi=10.1194%2Fjlr.M200293-JLR200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function</span></div><div class="casAuthors">Meaney, Steve; Bodin, Karl; Diczfalusy, Ulf; Bjorkhem, Ingemar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2130-2135</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">Lipid Research, Inc.</span>)
        </div><div class="casAbstract">Oxysterols possess powerful biol. activities.  Some of their effects on the regulation of key enzymes are similar to those of cholesterol, but are much more potent.  One of the crit. properties of oxysterols is their ability to pass lipophilic membranes at a high rate.  Transfer of unesterified 25-hydroxycholesterol from red blood cells to plasma has been reported to occur more than 1000 times faster than cholesterol.  Here the authors have measured the relative rate of such translocation of the three major oxysterols in human circulation: 27-hydroxycholesterol, 24S-hydroxycholesterol, and 4β-hydroxycholesterol.  The distance from the 3β-hydroxyl group to the addnl. hydroxyl group is the greatest possible in 27-hydroxycholesterol and the least possible in 4β-hydroxycholesterol.  The rate of exchange between erythrocytes and plasma was found to be high for 27-hydroxycholesterol and 24S-hydroxycholesterol, and hardly possible to measure for 4β-hydroxycholesterol and cholesterol.  When injected i.v. into humans, deuterium labeled 24- and 27-hydroxycholesterol caused an immediate high enrichment of the corresponding plasma sterols followed by a decay.  After injection of labeled 4β-hydroxycholesterol, the max. deuterium enrichment occurred after 2-3 h, when secretion of the oxysterol from the liver is likely to be the limiting factor.  When radiolabeled cholesterol was injected under the same conditions, max. appearance of label occurred after about 2 days.  The results illustrate the importance of the position of the addnl. oxygen in oxysterols and are discussed in relation to the rate of metab. and biol. effects of these oxysterols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosZDGbL-tNObVg90H21EOLACvtfcHk0lhvt7KFSO5aCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpslGjs7s%253D&md5=c60791c77396fa21c8e87760e71562e8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M200293-JLR200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M200293-JLR200%26sid%3Dliteratum%253Aachs%26aulast%3DMeaney%26aufirst%3DS.%26aulast%3DBodin%26aufirst%3DK.%26aulast%3DDiczfalusy%26aufirst%3DU.%26aulast%3DBj%25C3%25B6rkhem%26aufirst%3DI.%26atitle%3DOn%2520the%2520rate%2520of%2520translocation%2520in%2520vitro%2520and%2520kinetics%2520in%2520vivo%2520of%2520the%2520major%2520oxysterols%2520in%2520human%2520circulation%253A%2520critical%2520importance%2520of%2520the%2520position%2520of%2520the%2520oxygen%2520function%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2002%26volume%3D43%26spage%3D2130%26epage%3D2135%26doi%3D10.1194%2Fjlr.M200293-JLR200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lutjohann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breuer, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahlborg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nennesmo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siden, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diczfalusy, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björkhem, I.</span></span> <span> </span><span class="NLM_article-title">Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">9799</span>– <span class="NLM_lpage">9804</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.18.9799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1073%2Fpnas.93.18.9799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=8790411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A280%3ADyaK28zot1GntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=9799-9804&author=D.+Lutjohannauthor=O.+Breuerauthor=G.+Ahlborgauthor=I.+Nennesmoauthor=A.+Sidenauthor=U.+Diczfalusyauthor=I.+Bj%C3%B6rkhem&title=Cholesterol+homeostasis+in+human+brain%3A+evidence+for+an+age-dependent+flux+of+24S-hydroxycholesterol+from+the+brain+into+the+circulation&doi=10.1073%2Fpnas.93.18.9799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation</span></div><div class="casAuthors">Lutjohann D; Breuer O; Ahlborg G; Nennesmo I; Siden A; Diczfalusy U; Bjorkhem I</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">9799-804</span>
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">We have investigated whether side chain-hydroxylated cholesterol species are important for elimination of cholesterol from the brain.  Plasma concentrations of 24-hydroxycholesterol (24-OH-Chol) in the internal jugular vein and the brachial artery in healthy volunteers were consistent with a net flux of this steroid from the brain into the circulation, corresponding to elimination of approximately 4 mg cholesterol during a 24-h period in adults.  Results of experiments with rats exposed to 18O2 were also consistent with a flux of 24-OH-Chol from the brain into the circulation.  No other oxysterol measured showed a similar behavior as 24-OH-Chol.  These results and the finding that the concentration of 24-OH-Chol was 30- to 1500-fold higher in the brain than in any other organ except the adrenals indicate that the major part of 24-OH-Chol present in the circulation originates from the brain.  Both the 24-OH-Chol present in the brain and in the circulation were the 24S-stereoisomer.  In contrast to other oxysterols, levels of plasma 24-OH-Chol were found to be markedly dependent upon age.  The ratio between 24-OH-Chol and cholesterol in plasma was approximately 5 times higher during the first decade of life than during the sixth decade.  There was a high correlation between levels of 24-OH-Chol in plasma and cerebrospinal fluid.  It is suggested that the flux of 24-OH-Chol from the brain is important for cholesterol homeostasis in this organ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR6ftyKME6y3DDnmmyUf5qOfW6udTcc2eYQ7v9XIQPg_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28zot1GntQ%253D%253D&md5=98187a7ea536206759ec9e8f718c7f01</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.18.9799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.18.9799%26sid%3Dliteratum%253Aachs%26aulast%3DLutjohann%26aufirst%3DD.%26aulast%3DBreuer%26aufirst%3DO.%26aulast%3DAhlborg%26aufirst%3DG.%26aulast%3DNennesmo%26aufirst%3DI.%26aulast%3DSiden%26aufirst%3DA.%26aulast%3DDiczfalusy%26aufirst%3DU.%26aulast%3DBj%25C3%25B6rkhem%26aufirst%3DI.%26atitle%3DCholesterol%2520homeostasis%2520in%2520human%2520brain%253A%2520evidence%2520for%2520an%2520age-dependent%2520flux%2520of%252024S-hydroxycholesterol%2520from%2520the%2520brain%2520into%2520the%2520circulation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D9799%26epage%3D9804%26doi%3D10.1073%2Fpnas.93.18.9799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lund, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotti, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turley, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietschy, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D. W.</span></span> <span> </span><span class="NLM_article-title">Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">22980</span>– <span class="NLM_lpage">22988</span>, <span class="refDoi"> DOI: 10.1074/jbc.M303415200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1074%2Fjbc.M303415200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=12686551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksF2iu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=22980-22988&author=E.+G.+Lundauthor=C.+Xieauthor=T.+Kottiauthor=S.+D.+Turleyauthor=J.+M.+Dietschyauthor=D.+W.+Russell&title=Knockout+of+the+cholesterol+24-hydroxylase+gene+in+mice+reveals+a+brain-specific+mechanism+of+cholesterol+turnover&doi=10.1074%2Fjbc.M303415200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Knockout of the Cholesterol 24-Hydroxylase Gene in Mice Reveals a Brain-specific Mechanism of Cholesterol Turnover</span></div><div class="casAuthors">Lund, Erik G.; Xie, Chonglun; Kotti, Tiina; Turley, Stephen D.; Dietschy, John M.; Russell, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">22980-22988</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Most cholesterol turnover takes place in the liver and involves the conversion of cholesterol into sol. and readily excreted bile acids.  The synthesis of bile acids is limited to the liver, but several enzymes in the bile acid biosynthetic pathway are expressed in extra-hepatic tissues and there also may contribute to cholesterol turnover.  An example of the latter type of enzyme is cholesterol 24-hydroxylase, a cytochrome P 450 (CYP46A1) that is expressed at 100-fold higher levels in the brain than in the liver.  Cholesterol 24-hydroxylase catalyzes the synthesis of the oxysterol 24(S)-hydroxycholesterol.  To assess the relative contribution of the 24-hydroxylation pathway to cholesterol turnover, we performed balance studies in mice lacking the cholesterol 24-hydroxylase gene (Cyp46a1-/- mice).  Parameters of hepatic cholesterol and bile acid metab. in the mutant mice remained unchanged relative to wild type controls.  In contrast to the liver, the synthesis of new cholesterol was reduced by ∼40% in the brain, despite steady-state levels of cholesterol being similar in the knockout mice.  These data suggest that the synthesis of new cholesterol and the secretion of 24(S)-hydroxycholesterol are closely coupled and that at least 40% of cholesterol turnover in the brain is dependent on the action of cholesterol 24-hydroxylase.  We conclude that cholesterol 24-hydroxylase constitutes a major tissue-specific pathway for cholesterol turnover in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruKfgTcOsuPLVg90H21EOLACvtfcHk0lhvt7KFSO5aCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksF2iu7o%253D&md5=e056e83e101f38e41ff199bd016b64a3</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M303415200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M303415200%26sid%3Dliteratum%253Aachs%26aulast%3DLund%26aufirst%3DE.%2BG.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DKotti%26aufirst%3DT.%26aulast%3DTurley%26aufirst%3DS.%2BD.%26aulast%3DDietschy%26aufirst%3DJ.%2BM.%26aulast%3DRussell%26aufirst%3DD.%2BW.%26atitle%3DKnockout%2520of%2520the%2520cholesterol%252024-hydroxylase%2520gene%2520in%2520mice%2520reveals%2520a%2520brain-specific%2520mechanism%2520of%2520cholesterol%2520turnover%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D22980%26epage%3D22988%26doi%3D10.1074%2Fjbc.M303415200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kotti, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeiffer, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D. W.</span></span> <span> </span><span class="NLM_article-title">Brain cholesterol turnover required for geranylgeraniol production and learning in mice</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">3869</span>– <span class="NLM_lpage">3874</span>, <span class="refDoi"> DOI: 10.1073/pnas.0600316103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1073%2Fpnas.0600316103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=16505352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD28XivFymtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=3869-3874&author=T.+J.+Kottiauthor=D.+M.+Ramirezauthor=B.+E.+Pfeifferauthor=K.+M.+Huberauthor=D.+W.+Russell&title=Brain+cholesterol+turnover+required+for+geranylgeraniol+production+and+learning+in+mice&doi=10.1073%2Fpnas.0600316103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Brain cholesterol turnover required for geranylgeraniol production and learning in mice</span></div><div class="casAuthors">Kotti, Tiina J.; Ramirez, Denise M. O.; Pfeiffer, Brad E.; Huber, Kimberly M.; Russell, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3869-3874</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The mevalonate pathway produces cholesterol and nonsterol isoprenoids, such as geranylgeraniol.  In the brain, a fraction of cholesterol is metabolized in neurons by the enzyme cholesterol 24-hydroxylase, and this depletion activates the mevalonate pathway.  Brains from mice lacking 24-hydroxylase excrete cholesterol more slowly, and the tissue compensates by suppressing the mevalonate pathway.  Here we report that this suppression causes a defect in learning.  24-Hydroxylase knockout mice exhibit severe deficiencies in spatial, associative, and motor learning, and in hippocampal long-term potentiation (LTP).  Acute treatment of wild-type hippocampal slices with an inhibitor of the mevalonate pathway (a statin) also impairs LTP.  The effects of statin treatment and genetic elimination of 24-hydroxylase on LTP are reversed by a 20-min treatment with geranylgeraniol but not by cholesterol.  We conclude that cholesterol turnover in brain activates the mevalonate pathway and that a const. prodn. of geranylgeraniol in a small subset of neurons is required for LTP and learning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofEKiKgd7hXLVg90H21EOLACvtfcHk0ljBP2eXvemmyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivFymtr4%253D&md5=09611bad2c56d10c5d48be4c07caabb6</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0600316103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0600316103%26sid%3Dliteratum%253Aachs%26aulast%3DKotti%26aufirst%3DT.%2BJ.%26aulast%3DRamirez%26aufirst%3DD.%2BM.%26aulast%3DPfeiffer%26aufirst%3DB.%2BE.%26aulast%3DHuber%26aufirst%3DK.%2BM.%26aulast%3DRussell%26aufirst%3DD.%2BW.%26atitle%3DBrain%2520cholesterol%2520turnover%2520required%2520for%2520geranylgeraniol%2520production%2520and%2520learning%2520in%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D3869%26epage%3D3874%26doi%3D10.1073%2Fpnas.0600316103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maioli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heverin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismail, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puerta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafaati, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cedazo-Minguez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björkhem, I.</span></span> <span> </span><span class="NLM_article-title">Is it possible to improve memory function by upregulation of the cholesterol 24S-hydroxylase (CYP46A1) in the brain?</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e68534</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0068534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1371%2Fjournal.pone.0068534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=23874659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1SgsrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e68534&author=S.+Maioliauthor=A.+Bavnerauthor=Z.+Aliauthor=M.+Heverinauthor=M.+A.+Ismailauthor=E.+Puertaauthor=M.+Olinauthor=A.+Saeedauthor=M.+Shafaatiauthor=P.+Pariniauthor=A.+Cedazo-Minguezauthor=I.+Bj%C3%B6rkhem&title=Is+it+possible+to+improve+memory+function+by+upregulation+of+the+cholesterol+24S-hydroxylase+%28CYP46A1%29+in+the+brain%3F&doi=10.1371%2Fjournal.pone.0068534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Is it possible to improve memory function by upregulation of the cholesterol 24S-hydroxylase (CYP46A1) in the brain?</span></div><div class="casAuthors">Maioli, Silvia; Baavner, Ann; Ali, Zeina; Heverin, Maura; Ismail, Muhammad-Al-Mustafa; Puerta, Elena; Olin, Maria; Saeed, Ahmed; Shafaati, Marjan; Parini, Paolo; Cedazo-Minguez, Angel; Bjoerkhem, Ingemar</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e68534</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">We previously described a heterozygous mouse model overexpressing human HA-tagged 24S-hydroxylase (CYP46A1) utilizing a ubiquitous expression vector.  In this study, we generated homozygotes of these mice with circulating levels of 24OH 30-60 % higher than the heterozygotes.  Female homozygous CYP46A1 transgenic mice, aged 15 mo, showed an improvement in spatial memory in the Morris water maze test as compared to the wild type mice.  The levels of N-Methyl--Aspartate receptor 1, phosphorylated-N-Methyl--Aspartate receptor 2A, postsynaptic d. 95, synapsin-1 and synaphthophysin were significantly increased in the hippocampus of the CYP46A1 transgenic mice as compared to the controls.  The levels of lanosterol in the brain of the CYP46A1 transgenic mice were significantly increased, consistent with a higher synthesis of cholesterol.  Our results are discussed in relation to the hypothesis that the flux in the mevalonate pathway in the brain is of importance in cognitive functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCwJ94J9LAYbVg90H21EOLACvtfcHk0ljBP2eXvemmyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1SgsrzE&md5=f943f29f2ae6a096519041aa85737791</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0068534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0068534%26sid%3Dliteratum%253Aachs%26aulast%3DMaioli%26aufirst%3DS.%26aulast%3DBavner%26aufirst%3DA.%26aulast%3DAli%26aufirst%3DZ.%26aulast%3DHeverin%26aufirst%3DM.%26aulast%3DIsmail%26aufirst%3DM.%2BA.%26aulast%3DPuerta%26aufirst%3DE.%26aulast%3DOlin%26aufirst%3DM.%26aulast%3DSaeed%26aufirst%3DA.%26aulast%3DShafaati%26aufirst%3DM.%26aulast%3DParini%26aufirst%3DP.%26aulast%3DCedazo-Minguez%26aufirst%3DA.%26aulast%3DBj%25C3%25B6rkhem%26aufirst%3DI.%26atitle%3DIs%2520it%2520possible%2520to%2520improve%2520memory%2520function%2520by%2520upregulation%2520of%2520the%2520cholesterol%252024S-hydroxylase%2520%2528CYP46A1%2529%2520in%2520the%2520brain%253F%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De68534%26doi%3D10.1371%2Fjournal.pone.0068534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izumi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorumski, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mennerick, S.</span></span> <span> </span><span class="NLM_article-title">Endogenous 24<i>S</i>-hydroxycholesterol modulates NMDAR-mediated function in hippocampal slices</span>. <i>J. Neurophysiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">1263</span>– <span class="NLM_lpage">1272</span>, <span class="refDoi"> DOI: 10.1152/jn.00890.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1152%2Fjn.00890.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=26745248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A280%3ADC%252BC28rotlynsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2016&pages=1263-1272&author=M.+Y.+Sunauthor=Y.+Izumiauthor=A.+Benzauthor=C.+F.+Zorumskiauthor=S.+Mennerick&title=Endogenous+24S-hydroxycholesterol+modulates+NMDAR-mediated+function+in+hippocampal+slices&doi=10.1152%2Fjn.00890.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous 24S-hydroxycholesterol modulates NMDAR-mediated function in hippocampal slices</span></div><div class="casAuthors">Sun Min-Yu; Benz Ann; Izumi Yukitoshi; Zorumski Charles F; Mennerick Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurophysiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1263-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">N-methyl-D-aspartate receptors (NMDARs), a major subtype of glutamate receptors mediating excitatory transmission throughout the central nervous system (CNS), play critical roles in governing brain function and cognition.  Because NMDAR dysfunction contributes to the etiology of neurological and psychiatric disorders including stroke and schizophrenia, NMDAR modulators are potential drug candidates.  Our group recently demonstrated that the major brain cholesterol metabolite, 24S-hydroxycholesterol (24S-HC), positively modulates NMDARs when exogenously administered.  Here, we studied whether endogenous 24S-HC regulates NMDAR activity in hippocampal slices.  In CYP46A1(-/-) (knockout; KO) slices where endogenous 24S-HC is greatly reduced, NMDAR tone, measured as NMDAR-to-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) excitatory postsynaptic current (EPSC) ratio, was reduced.  This difference translated into more NMDAR-driven spiking in wild-type (WT) slices compared with KO slices.  Application of SGE-301, a 24S-HC analog, had comparable potentiating effects on NMDAR EPSCs in both WT and KO slices, suggesting that endogenous 24S-HC does not saturate its NMDAR modulatory site in ex vivo slices.  KO slices did not differ from WT slices in either spontaneous neurotransmission or in neuronal intrinsic excitability, and exhibited LTP indistinguishable from WT slices.  However, KO slices exhibited higher resistance to persistent NMDAR-dependent depression of synaptic transmission induced by oxygen-glucose deprivation (OGD), an effect restored by SGE-301.  Together, our results suggest that loss of positive NMDAR tone does not elicit compensatory changes in excitability or transmission, but it protects transmission against NMDAR-mediated dysfunction.  We expect that manipulating this endogenous NMDAR modulator may offer new treatment strategies for neuropsychiatric dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRUw9swP5_pTokFb3mqPUYDfW6udTcc2eZZ0R-762OlJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rotlynsQ%253D%253D&md5=165fff6180922d98bb138c4d0421923c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1152%2Fjn.00890.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fjn.00890.2015%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DM.%2BY.%26aulast%3DIzumi%26aufirst%3DY.%26aulast%3DBenz%26aufirst%3DA.%26aulast%3DZorumski%26aufirst%3DC.%2BF.%26aulast%3DMennerick%26aufirst%3DS.%26atitle%3DEndogenous%252024S-hydroxycholesterol%2520modulates%2520NMDAR-mediated%2520function%2520in%2520hippocampal%2520slices%26jtitle%3DJ.%2520Neurophysiol.%26date%3D2016%26volume%3D115%26spage%3D1263%26epage%3D1272%26doi%3D10.1152%2Fjn.00890.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linsenbardt, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emnett, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenman, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izumi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorumski, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mennerick, S.</span></span> <span> </span><span class="NLM_article-title">24(<i>S</i>)-Hydroxycholesterol as a modulator of neuronal signaling and survival</span>. <i>Neuroscientist</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1177/1073858414568122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1177%2F1073858414568122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=25628343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvVynurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=132-144&author=M.+Y.+Sunauthor=A.+J.+Linsenbardtauthor=C.+M.+Emnettauthor=L.+N.+Eisenmanauthor=Y.+Izumiauthor=C.+F.+Zorumskiauthor=S.+Mennerick&title=24%28S%29-Hydroxycholesterol+as+a+modulator+of+neuronal+signaling+and+survival&doi=10.1177%2F1073858414568122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">24(S)-hydroxycholesterol as a modulator of neuronal signaling and survival</span></div><div class="casAuthors">Sun, Min-Yu; Linsenbardt, Andrew J.; Emnett, Christine M.; Eisenman, Lawrence N.; Izumi, Yukitoshi; Zorumski, Charles F.; Mennerick, Steve</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscientist</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-144</span>CODEN:
                <span class="NLM_cas:coden">NROSFJ</span>;
        ISSN:<span class="NLM_cas:issn">1073-8584</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  The major cholesterol metabolite in brain, 24(S)-hydroxycholesterol (24S-HC), serves as a vehicle for cholesterol removal.  Its effects on neuronal function, however, have only recently begun to be investigated.  Here, we review that nascent work.  Our own studies have demonstrated that 24S-HC has potent pos. modulatory effects on N-methyldaspartate (NMDA) receptor (NMDAR) function.  This could have implications not only for brain plasticity but also for pathol. NMDAR overuse.  Other work has demonstrated effects of 24S-HC on neuronal survival and as a possible biomarker of neurodegenerative disease.  Depending on circumstances, both upregulation/mimicry of 24S-HC signaling and down-regulation/antagonism may have therapeutic potential.  We are interested in the possibility that synthetic analogs of 24S-HC with pos. effects at NMDARs may hold neurotherapeutic promise, given the role of NMDA receptor hypofunction in certain neuropsychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQdpyeroKwpbVg90H21EOLACvtfcHk0lhpzQwXDxgnrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvVynurs%253D&md5=491357d064d059a8ba61c4ed2c11f48a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1177%2F1073858414568122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1073858414568122%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DM.%2BY.%26aulast%3DLinsenbardt%26aufirst%3DA.%2BJ.%26aulast%3DEmnett%26aufirst%3DC.%2BM.%26aulast%3DEisenman%26aufirst%3DL.%2BN.%26aulast%3DIzumi%26aufirst%3DY.%26aulast%3DZorumski%26aufirst%3DC.%2BF.%26aulast%3DMennerick%26aufirst%3DS.%26atitle%3D24%2528S%2529-Hydroxycholesterol%2520as%2520a%2520modulator%2520of%2520neuronal%2520signaling%2520and%2520survival%26jtitle%3DNeuroscientist%26date%3D2016%26volume%3D22%26spage%3D132%26epage%3D144%26doi%3D10.1177%2F1073858414568122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petrov, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Cholesterol 24-hydroxylation by CYP46A1: benefits of modulation for brain diseases</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">635</span>– <span class="NLM_lpage">648</span>, <span class="refDoi"> DOI: 10.1007/s13311-019-00731-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1007%2Fs13311-019-00731-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=31001737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFGjsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=635-648&author=A.+M.+Petrovauthor=I.+A.+Pikuleva&title=Cholesterol+24-hydroxylation+by+CYP46A1%3A+benefits+of+modulation+for+brain+diseases&doi=10.1007%2Fs13311-019-00731-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases</span></div><div class="casAuthors">Petrov, Alexey M.; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">635-648</span>CODEN:
                <span class="NLM_cas:coden">NEURNV</span>;
        ISSN:<span class="NLM_cas:issn">1878-7479</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Cholesterol 24-hydroxylation is the major mechanism for cholesterol removal from the brain and the reaction catalyzed by cytochrome P 450 46A1 (CYP46A1), a CNS-specific enzyme.  This review describes CYP46A1 in the context of cholesterol homeostasis in the brain and summarizes available exptl. data on CYP46A1 assocn. with different neurol. diseases, including the mechanisms by which changes in the CYP46A1 activity in the brain could be beneficial for these diseases.  The modulation of CYP46A1 activity by genetic and pharmacol. means is also presented along with a brief synopsis of the two clin. trials that evaluate CYP46A1 as a therapeutic target for Alzheimer's disease as well as Dravet and Lennox-Gastaut syndromes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRhAkr3OF3v7Vg90H21EOLACvtfcHk0lhpzQwXDxgnrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFGjsL%252FL&md5=e4c31bedfd2b286f38304193a7255538</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs13311-019-00731-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-019-00731-6%26sid%3Dliteratum%253Aachs%26aulast%3DPetrov%26aufirst%3DA.%2BM.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DCholesterol%252024-hydroxylation%2520by%2520CYP46A1%253A%2520benefits%2520of%2520modulation%2520for%2520brain%2520diseases%26jtitle%3DNeurotherapeutics%26date%3D2019%26volume%3D16%26spage%3D635%26epage%3D648%26doi%3D10.1007%2Fs13311-019-00731-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hudry, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Dam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulik, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Deyn, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stet, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahouansou, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benraiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delacourte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bougneres, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubourg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartier, N.</span></span> <span> </span><span class="NLM_article-title">Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer’s disease</span>. <i>Mol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1038/mt.2009.175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1038%2Fmt.2009.175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=19654569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsVers78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=44-53&author=E.+Hudryauthor=D.+Van+Damauthor=W.+Kulikauthor=P.+P.+De+Deynauthor=F.+S.+Stetauthor=O.+Ahouansouauthor=A.+Benraissauthor=A.+Delacourteauthor=P.+Bougneresauthor=P.+Aubourgauthor=N.+Cartier&title=Adeno-associated+virus+gene+therapy+with+cholesterol+24-hydroxylase+reduces+the+amyloid+pathology+before+or+after+the+onset+of+amyloid+plaques+in+mouse+models+of+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fmt.2009.175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Adeno-associated Virus Gene Therapy With Cholesterol 24-Hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer's Disease</span></div><div class="casAuthors">Hudry, Eloise; Van Dam, Debby; Kulik, Wim; De Deyn, Peter P.; Stet, Femke S.; Ahouansou, Ornella; Benraiss, Abdellatif; Delacourte, Andre; Bougneres, Pierre; Aubourg, Patrick; Cartier, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-53</span>CODEN:
                <span class="NLM_cas:coden">MTOHCK</span>;
        ISSN:<span class="NLM_cas:issn">1525-0016</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The development of Alzheimer's disease (AD) is closely connected with cholesterol metab.  Cholesterol increases the prodn. and deposition of amyloid-β (Aβ) peptides that result in the formation of amyloid plaques, a hallmark of the pathol.  In the brain, cholesterol is synthesized in situ but cannot be degraded nor cross the blood-brain barrier.  The major exportable form of brain cholesterol is 24S-hydroxycholesterol, an oxysterol generated by the neuronal cholesterol 24-hydroxylase encoded by the CYP46A1 gene.  We report that the injection of adeno-assocd. vector (AAV) encoding CYP46A1 in the cortex and hippocampus of APP23 mice before the onset of amyloid deposits markedly reduces Aβ peptides, amyloid deposits and trimeric oligomers at 12 mo of age.  The Morris water maze (MWM) procedure also demonstrated improvement of spatial memory at 6 mo, before the onset of amyloid deposits.  AAV5-wtCYP46A1 vector injection in the cortex and hippocampus of amyloid precursor protein/presenilin 1 (APP/PS) mice after the onset of amyloid deposits also reduced markedly the no. of amyloid plaques in the hippocampus, and to a less extent in the cortex, 3 mo after the injection.  Our data demonstrate that neuronal overexpression of CYP46A1 before or after the onset of amyloid plaques significantly reduces Aβ pathol. in mouse models of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKfiqrwTlDnbVg90H21EOLACvtfcHk0lhpzQwXDxgnrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsVers78%253D&md5=ac2f0d1c7acce0b1d2464ac9a5ea2eb1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fmt.2009.175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmt.2009.175%26sid%3Dliteratum%253Aachs%26aulast%3DHudry%26aufirst%3DE.%26aulast%3DVan%2BDam%26aufirst%3DD.%26aulast%3DKulik%26aufirst%3DW.%26aulast%3DDe%2BDeyn%26aufirst%3DP.%2BP.%26aulast%3DStet%26aufirst%3DF.%2BS.%26aulast%3DAhouansou%26aufirst%3DO.%26aulast%3DBenraiss%26aufirst%3DA.%26aulast%3DDelacourte%26aufirst%3DA.%26aulast%3DBougneres%26aufirst%3DP.%26aulast%3DAubourg%26aufirst%3DP.%26aulast%3DCartier%26aufirst%3DN.%26atitle%3DAdeno-associated%2520virus%2520gene%2520therapy%2520with%2520cholesterol%252024-hydroxylase%2520reduces%2520the%2520amyloid%2520pathology%2520before%2520or%2520after%2520the%2520onset%2520of%2520amyloid%2520plaques%2520in%2520mouse%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520Ther.%26date%3D2010%26volume%3D18%26spage%3D44%26epage%3D53%26doi%3D10.1038%2Fmt.2009.175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burlot, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braudeau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaelsen-Preusse, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayciriex, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gautier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djelti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audrain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauphinot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Gomez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caillierez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laprevote, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bieche, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auzeil, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potier, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartier, N.</span></span> <span> </span><span class="NLM_article-title">Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5965</span>– <span class="NLM_lpage">5976</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddv268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1093%2Fhmg%2Fddv268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=26358780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitV2hs73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=5965-5976&author=M.+A.+Burlotauthor=J.+Braudeauauthor=K.+Michaelsen-Preusseauthor=B.+Potierauthor=S.+Ayciriexauthor=J.+Varinauthor=B.+Gautierauthor=F.+Djeltiauthor=M.+Audrainauthor=L.+Dauphinotauthor=F.+J.+Fernandez-Gomezauthor=R.+Caillierezauthor=O.+Laprevoteauthor=I.+Biecheauthor=N.+Auzeilauthor=M.+C.+Potierauthor=P.+Dutarauthor=M.+Korteauthor=L.+Bueeauthor=D.+Blumauthor=N.+Cartier&title=Cholesterol+24-hydroxylase+defect+is+implicated+in+memory+impairments+associated+with+Alzheimer-like+Tau+pathology&doi=10.1093%2Fhmg%2Fddv268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology</span></div><div class="casAuthors">Burlot, Marie-Anne; Braudeau, Jerome; Michaelsen-Preusse, Kristin; Potier, Brigitte; Ayciriex, Sophie; Varin, Jennifer; Gautier, Benoit; Djelti, Fathia; Audrain, Mickael; Dauphinot, Luce; Fernandez-Gomez, Francisco-Jose; Caillierez, Raphaelle; Laprevote, Olivier; Bieche, Ivan; Auzeil, Nicolas; Potier, Marie-Claude; Dutar, Patrick; Korte, Martin; Buee, Luc; Blum, David; Cartier, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5965-5976</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by both amyloid and Tau pathologies.  The amyloid component and altered cholesterol metab. are closely linked, but the relationship between Tau pathol. and cholesterol is currently unclear.  Brain cholesterol is synthesized in situ and cannot cross the blood-brain barrier: to be exported from the central nervous system into the blood circuit, excess cholesterol must be converted to 24S-hydroxycholesterol by the cholesterol 24-hydroxylase encoded by the CYP46A1 gene.  In AD patients, the concn. of 24S-hydroxycholesterol in the plasma and the cerebrospinal fluid are lower than in healthy controls.  The THY-Tau22 mouse is a model of AD-like Tau pathol. without amyloid pathol.  We used this model to investigate the potential assocn. between Tau pathol. and CYP46A1 modulation.  The amts. of CYP46A1 and 24S-hydroxycholesterol in the hippocampus were lower in THY-Tau22 than control mice.  We used an adeno-assocd. virus (AAV) gene transfer strategy to increase CYP46A1 expression in order to investigate the consequences on THY-Tau22 mouse phenotype.  Injection of the AAV-CYP46A1 vector into the hippocampus of THY-Tau22 mice led to CYP46A1 and 24S-hydroxycholesterol content normalization.  The cognitive deficits, impaired long-term depression and spine defects that characterize the THY-Tau22 model were completely rescued, whereas Tau hyperphosphorylation and assocd. gliosis were unaffected.  These results argue for a causal link between CYP46A1 protein content and memory impairments that result from Tau pathol.  Therefore, CYP46A1 may be a relevant therapeutic target for Tauopathies and esp. for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMcAVSrO3LsbVg90H21EOLACvtfcHk0lh1CwnEIH_2vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitV2hs73O&md5=51fb2ed6fa08a04b6006918804ab45dc</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddv268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddv268%26sid%3Dliteratum%253Aachs%26aulast%3DBurlot%26aufirst%3DM.%2BA.%26aulast%3DBraudeau%26aufirst%3DJ.%26aulast%3DMichaelsen-Preusse%26aufirst%3DK.%26aulast%3DPotier%26aufirst%3DB.%26aulast%3DAyciriex%26aufirst%3DS.%26aulast%3DVarin%26aufirst%3DJ.%26aulast%3DGautier%26aufirst%3DB.%26aulast%3DDjelti%26aufirst%3DF.%26aulast%3DAudrain%26aufirst%3DM.%26aulast%3DDauphinot%26aufirst%3DL.%26aulast%3DFernandez-Gomez%26aufirst%3DF.%2BJ.%26aulast%3DCaillierez%26aufirst%3DR.%26aulast%3DLaprevote%26aufirst%3DO.%26aulast%3DBieche%26aufirst%3DI.%26aulast%3DAuzeil%26aufirst%3DN.%26aulast%3DPotier%26aufirst%3DM.%2BC.%26aulast%3DDutar%26aufirst%3DP.%26aulast%3DKorte%26aufirst%3DM.%26aulast%3DBuee%26aufirst%3DL.%26aulast%3DBlum%26aufirst%3DD.%26aulast%3DCartier%26aufirst%3DN.%26atitle%3DCholesterol%252024-hydroxylase%2520defect%2520is%2520implicated%2520in%2520memory%2520impairments%2520associated%2520with%2520Alzheimer-like%2520Tau%2520pathology%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2015%26volume%3D24%26spage%3D5965%26epage%3D5976%26doi%3D10.1093%2Fhmg%2Fddv268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Djelti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braudeau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudry, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhenain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bieche, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chali, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayciriex, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auzeil, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langui, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potier, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laprevote, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidaud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duyckaerts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubourg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartier, N.</span></span> <span> </span><span class="NLM_article-title">CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer’s disease</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">2383</span>– <span class="NLM_lpage">2398</span>, <span class="refDoi"> DOI: 10.1093/brain/awv166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1093%2Fbrain%2Fawv166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=26141492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A280%3ADC%252BC2MbpvFGrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2015&pages=2383-2398&author=F.+Djeltiauthor=J.+Braudeauauthor=E.+Hudryauthor=M.+Dhenainauthor=J.+Varinauthor=I.+Biecheauthor=C.+Marquerauthor=F.+Chaliauthor=S.+Ayciriexauthor=N.+Auzeilauthor=S.+Alvesauthor=D.+Languiauthor=M.+C.+Potierauthor=O.+Laprevoteauthor=M.+Vidaudauthor=C.+Duyckaertsauthor=R.+Milesauthor=P.+Aubourgauthor=N.+Cartier&title=CYP46A1+inhibition%2C+brain+cholesterol+accumulation+and+neurodegeneration+pave+the+way+for+Alzheimer%E2%80%99s+disease&doi=10.1093%2Fbrain%2Fawv166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease</span></div><div class="casAuthors">Djelti Fathia; Braudeau Jerome; Hudry Eloise; Alves Sandro; Aubourg Patrick; Cartier Nathalie; Dhenain Marc; Varin Jennifer; Bieche Ivan; Vidaud Michel; Marquer Catherine; Chali Farah; Langui Dominique; Potier Marie-Claude; Duyckaerts Charles; Miles Richard; Ayciriex Sophie; Auzeil Nicolas; Laprevote Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">Pt 8</span>),
    <span class="NLM_cas:pages">2383-98</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Abnormalities in neuronal cholesterol homeostasis have been suspected or observed in several neurodegenerative disorders including Alzheimer's disease, Parkinson's disease and Huntington's disease.  However, it has not been demonstrated whether an increased abundance of cholesterol in neurons in vivo contributes to neurodegeneration.  To address this issue, we used RNA interference methodology to inhibit the expression of cholesterol 24-hydroxylase, encoded by the Cyp46a1 gene, in the hippocampus of normal mice.  Cholesterol 24-hydroxylase controls cholesterol efflux from the brain and thereby plays a major role in regulating brain cholesterol homeostasis.  We used an adeno-associated virus vector encoding short hairpin RNA directed against the mouse Cyp46a1 mRNA to decrease the expression of the Cyp46a1 gene in hippocampal neurons of normal mice.  This increased the cholesterol concentration in neurons, followed by cognitive deficits and hippocampal atrophy due to apoptotic neuronal death.  Prior to neuronal death, the recruitment of the amyloid protein precursor to lipid rafts was enhanced leading to the production of β-C-terminal fragment and amyloid-β peptides.  Abnormal phosphorylation of tau and endoplasmic reticulum stress were also observed.  In the APP23 mouse model of Alzheimer's disease, the abundance of amyloid-β peptides increased following inhibition of Cyp46a1 expression, and neuronal death was more widespread than in normal mice.  Altogether, these results suggest that increased amounts of neuronal cholesterol within the brain may contribute to inducing and/or aggravating Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQHu-SlLells6cY7HFp97qMfW6udTcc2eb87IwSCmDH-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbpvFGrtw%253D%253D&md5=e26f30e13e563cf2013a6d44df4d7331</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawv166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawv166%26sid%3Dliteratum%253Aachs%26aulast%3DDjelti%26aufirst%3DF.%26aulast%3DBraudeau%26aufirst%3DJ.%26aulast%3DHudry%26aufirst%3DE.%26aulast%3DDhenain%26aufirst%3DM.%26aulast%3DVarin%26aufirst%3DJ.%26aulast%3DBieche%26aufirst%3DI.%26aulast%3DMarquer%26aufirst%3DC.%26aulast%3DChali%26aufirst%3DF.%26aulast%3DAyciriex%26aufirst%3DS.%26aulast%3DAuzeil%26aufirst%3DN.%26aulast%3DAlves%26aufirst%3DS.%26aulast%3DLangui%26aufirst%3DD.%26aulast%3DPotier%26aufirst%3DM.%2BC.%26aulast%3DLaprevote%26aufirst%3DO.%26aulast%3DVidaud%26aufirst%3DM.%26aulast%3DDuyckaerts%26aufirst%3DC.%26aulast%3DMiles%26aufirst%3DR.%26aulast%3DAubourg%26aufirst%3DP.%26aulast%3DCartier%26aufirst%3DN.%26atitle%3DCYP46A1%2520inhibition%252C%2520brain%2520cholesterol%2520accumulation%2520and%2520neurodegeneration%2520pave%2520the%2520way%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%26date%3D2015%26volume%3D138%26spage%3D2383%26epage%3D2398%26doi%3D10.1093%2Fbrain%2Fawv166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chali, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djelti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eugene, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valderrama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubourg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duykaerts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, V.</span></span> <span> </span><span class="NLM_article-title">Inhibiting cholesterol degradation induces neuronal sclerosis and epileptic activity in mouse hippocampus</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1345</span>– <span class="NLM_lpage">1355</span>, <span class="refDoi"> DOI: 10.1111/ejn.12911</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1111%2Fejn.12911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=25847620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A280%3ADC%252BC2MjhsFeqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2015&pages=1345-1355&author=F.+Chaliauthor=F.+Djeltiauthor=E.+Eugeneauthor=M.+Valderramaauthor=C.+Marquerauthor=P.+Aubourgauthor=C.+Duykaertsauthor=R.+Milesauthor=N.+Cartierauthor=V.+Navarro&title=Inhibiting+cholesterol+degradation+induces+neuronal+sclerosis+and+epileptic+activity+in+mouse+hippocampus&doi=10.1111%2Fejn.12911"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting cholesterol degradation induces neuronal sclerosis and epileptic activity in mouse hippocampus</span></div><div class="casAuthors">Chali Farah; Eugene Emmanuel; Marquer Catherine; Duykaerts Charles; Miles Richard; Navarro Vincent; Djelti Fathia; Aubourg Patrick; Cartier Nathalie; Djelti Fathia; Aubourg Patrick; Cartier Nathalie; Valderrama Mario</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1345-55</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Elevations in neuronal cholesterol have been associated with several degenerative diseases.  An enhanced excitability and synchronous firing in surviving neurons are among the sequels of neuronal death in these diseases and also in some epileptic syndromes.  Here, we attempted to increase neuronal cholesterol levels, using a short hairpin RNA to suppress expression of the enzyme cytochrome P450 family 46, subfamily A, polypeptide 1 gene (CYP46A1).  This protein hydroxylates cholesterol and so facilitates transmembrane extrusion.  A short hairpin RNA CYP46A1construction coupled to the adeno-associated virus type 5 was injected focally and unilaterally into mouse hippocampus.  It was selectively expressed first in neurons of the cornu ammonis (hippocampus) (CA)3a region.  Cytoplasmic and membrane cholesterol increased, and the neuronal soma volume increased and then decreased before pyramidal cells died.  As CA3a pyramidal cells died, interictal electroencephalographic (EEG) events occurred during exploration and non-rapid eye movement sleep.  With time, neuronal death spread to involve pyramidal cells and interneurons of the CA1 region.  CA1 neuronal death was correlated with a delayed local expression of phosphorylated tau.  Astrocytes were activated throughout the hippocampus and microglial activation was specific to regions of neuronal death.  CA1 neuronal death was correlated with distinct aberrant EEG activity.  During exploratory behaviour and rapid eye movement sleep, EEG oscillations at 7-10 Hz (theta) could accelerate to 14-21 Hz (beta) waves.  They were accompanied by low-amplitude, high-frequency oscillations of peak power at ~300 Hz and a range of 250-350 Hz.  Although episodes of EEG acceleration were not correlated with changes in exploratory behaviour, they were followed in some animals by structured seizure-like discharges.  These data strengthen links between increased cholesterol, neuronal sclerosis and epileptic behaviour.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQkb2WpsKSRrkEksK8CslK8fW6udTcc2eZ0b3LdYjx8-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MjhsFeqtg%253D%253D&md5=a119c546ad384a1ce86f7c53e558f126</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fejn.12911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fejn.12911%26sid%3Dliteratum%253Aachs%26aulast%3DChali%26aufirst%3DF.%26aulast%3DDjelti%26aufirst%3DF.%26aulast%3DEugene%26aufirst%3DE.%26aulast%3DValderrama%26aufirst%3DM.%26aulast%3DMarquer%26aufirst%3DC.%26aulast%3DAubourg%26aufirst%3DP.%26aulast%3DDuykaerts%26aufirst%3DC.%26aulast%3DMiles%26aufirst%3DR.%26aulast%3DCartier%26aufirst%3DN.%26aulast%3DNavarro%26aufirst%3DV.%26atitle%3DInhibiting%2520cholesterol%2520degradation%2520induces%2520neuronal%2520sclerosis%2520and%2520epileptic%2520activity%2520in%2520mouse%2520hippocampus%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2015%26volume%3D41%26spage%3D1345%26epage%3D1355%26doi%3D10.1111%2Fejn.12911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boussicault, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamaziere, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planques, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heck, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moumne, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Despres, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pages, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piguet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubourg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caboche, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betuing, S.</span></span> <span> </span><span class="NLM_article-title">CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">953</span>– <span class="NLM_lpage">970</span>, <span class="refDoi"> DOI: 10.1093/brain/awv384</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1093%2Fbrain%2Fawv384" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=26912634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A280%3ADC%252BC28jktVOisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2016&pages=953-970&author=L.+Boussicaultauthor=S.+Alvesauthor=A.+Lamaziereauthor=A.+Planquesauthor=N.+Heckauthor=L.+Moumneauthor=G.+Despresauthor=S.+Bolteauthor=A.+Huauthor=C.+Pagesauthor=L.+Galvanauthor=F.+Piguetauthor=P.+Aubourgauthor=N.+Cartierauthor=J.+Cabocheauthor=S.+Betuing&title=CYP46A1%2C+the+rate-limiting+enzyme+for+cholesterol+degradation%2C+is+neuroprotective+in+Huntington%E2%80%99s+disease&doi=10.1093%2Fbrain%2Fawv384"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease</span></div><div class="casAuthors">Boussicault Lydie; Heck Nicolas; Moumne Lara; Pages Christiane; Caboche Jocelyne; Betuing Sandrine; Alves Sandro; Aubourg Patrick; Cartier Nathalie; Lamaziere Antonin; Despres Gaetan; Planques Anabelle; Bolte Susanne; Hu Amelie; Galvan Laurie; Piguet Francoise</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">Pt 3</span>),
    <span class="NLM_cas:pages">953-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Huntington's disease is an autosomal dominant neurodegenerative disease caused by abnormal polyglutamine expansion in huntingtin (Exp-HTT) leading to degeneration of striatal neurons.  Altered brain cholesterol homeostasis has been implicated in Huntington's disease, with increased accumulation of cholesterol in striatal neurons yet reduced levels of cholesterol metabolic precursors.  To elucidate these two seemingly opposing dysregulations, we investigated the expression of cholesterol 24-hydroxylase (CYP46A1), the neuronal-specific and rate-limiting enzyme for cholesterol conversion to 24S-hydroxycholesterol (24S-OHC).  CYP46A1 protein levels were decreased in the putamen, but not cerebral cortex samples, of post-mortem Huntington's disease patients when compared to controls.  Cyp46A1 mRNA and CYP46A1 protein levels were also decreased in the striatum of the R6/2 Huntington's disease mouse model and in SThdhQ111 cell lines.  In vivo, in a wild-type context, knocking down CYP46A1 expression in the striatum, via an adeno-associated virus-mediated delivery of selective shCYP46A1, reproduced the Huntington's disease phenotype, with spontaneous striatal neuron degeneration and motor deficits, as assessed by rotarod.  In vitro, CYP46A1 restoration protected SThdhQ111 and Exp-HTT-expressing striatal neurons in culture from cell death.  In the R6/2 Huntington's disease mouse model, adeno-associated virus-mediated delivery of CYP46A1 into the striatum decreased neuronal atrophy, decreased the number, intensity level and size of Exp-HTT aggregates and improved motor deficits, as assessed by rotarod and clasping behavioural tests.  Adeno-associated virus-CYP46A1 infection in R6/2 mice also restored levels of cholesterol and lanosterol and increased levels of desmosterol.  In vitro, lanosterol and desmosterol were found to protect striatal neurons expressing Exp-HTT from death.  We conclude that restoring CYP46A1 activity in the striatum promises a new therapeutic approach in Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpfLxj7fL7vZ0d-O_J5C0AfW6udTcc2eZ0b3LdYjx8-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jktVOisA%253D%253D&md5=116b6bc8d5b840696761c31cb79d8582</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawv384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawv384%26sid%3Dliteratum%253Aachs%26aulast%3DBoussicault%26aufirst%3DL.%26aulast%3DAlves%26aufirst%3DS.%26aulast%3DLamaziere%26aufirst%3DA.%26aulast%3DPlanques%26aufirst%3DA.%26aulast%3DHeck%26aufirst%3DN.%26aulast%3DMoumne%26aufirst%3DL.%26aulast%3DDespres%26aufirst%3DG.%26aulast%3DBolte%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DA.%26aulast%3DPages%26aufirst%3DC.%26aulast%3DGalvan%26aufirst%3DL.%26aulast%3DPiguet%26aufirst%3DF.%26aulast%3DAubourg%26aufirst%3DP.%26aulast%3DCartier%26aufirst%3DN.%26aulast%3DCaboche%26aufirst%3DJ.%26aulast%3DBetuing%26aufirst%3DS.%26atitle%3DCYP46A1%252C%2520the%2520rate-limiting%2520enzyme%2520for%2520cholesterol%2520degradation%252C%2520is%2520neuroprotective%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DBrain%26date%3D2016%26volume%3D139%26spage%3D953%26epage%3D970%26doi%3D10.1093%2Fbrain%2Fawv384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saadane, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trichonas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busik, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Retinal vascular abnormalities and microglia activation in mice with deficiency in cytochrome P450 46A1-mediated cholesterol removal</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>189</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">425</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2018.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1016%2Fj.ajpath.2018.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=30448403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFKiu7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2019&pages=405-425&author=A.+Saadaneauthor=N.+Mastauthor=G.+Trichonasauthor=D.+Chakrabortyauthor=S.+Hammerauthor=J.+V.+Busikauthor=M.+B.+Grantauthor=I.+A.+Pikuleva&title=Retinal+vascular+abnormalities+and+microglia+activation+in+mice+with+deficiency+in+cytochrome+P450+46A1-mediated+cholesterol+removal&doi=10.1016%2Fj.ajpath.2018.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Retinal Vascular Abnormalities and Microglia Activation in Mice with Deficiency in Cytochrome P450 46A1-Mediated Cholesterol Removal</span></div><div class="casAuthors">Saadane, Aicha; Mast, Natalia; Trichonas, George; Chakraborty, Dibyendu; Hammer, Sandra; Busik, Julia V.; Grant, Maria B.; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">189</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">405-425</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">CYP46A1 is the cytochrome P 450 enzyme that converts cholesterol to 24-hydroxycholesterol, a cholesterol elimination product and a potent liver X receptor (LXR) ligand.  We conducted retinal characterizations of Cyp46a1-/- mice that had normal fasting blood glucose levels but up to a 1.8-fold increase in retinal cholesterol.  The retina of Cyp46a1-/- mice exhibited venous beading and tortuosity, microglia/macrophage activation, and increased vascular permeability, features commonly assocd. with diabetic retinopathy.  The expression of Lxrα and Lxrβ was increased in both the whole Cyp46a1-/- retina and retinal macroglia/macrophages.  The LXR-target genes were affected as well, primarily in activated microglial cells and macrophages.  In the latter, the LXR-transactivated genes (Abca1, Abcg1, Apod, Apoe, Mylip, and Arg2) were up-regulated; similarly, there was an up-regulation of the LXR-transrepressed genes (Ccl2, Ptgs2, Cxcl1, Il1b, Il6, Nos2, and Tnfa).  For comparison, gene expression was investigated in bone marrow-derived macrophages from Cyp46a1-/- mice as well as retinal and bone marrow-derived macrophages from Cyp27a1-/- and Cyp27a1-/-Cyp46a1-/- mice.  CYP46A1 expression was detected in retinal endothelial cells, and this expression was increased in the proinflammatory environment.  Retinal Cyp46a1-/- phosphoproteome revealed altered phosphorylation of 30 different proteins, including tight junction protein zonula occludens 1 and aquaporin 4.  Collectively, the data obtained establish metabolic and regulatory significance of CYP46A1 for the retina and suggest pharmacol. activation of CYP46A1 as a potential therapeutic approach to dyslipidemia-induced retinal damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEWs9WiCVJMLVg90H21EOLACvtfcHk0ljxZHG8FtB5XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFKiu7vE&md5=2273491a130d8dc7a5000ab815549f7c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2018.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2018.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DSaadane%26aufirst%3DA.%26aulast%3DMast%26aufirst%3DN.%26aulast%3DTrichonas%26aufirst%3DG.%26aulast%3DChakraborty%26aufirst%3DD.%26aulast%3DHammer%26aufirst%3DS.%26aulast%3DBusik%26aufirst%3DJ.%2BV.%26aulast%3DGrant%26aufirst%3DM.%2BB.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DRetinal%2520vascular%2520abnormalities%2520and%2520microglia%2520activation%2520in%2520mice%2520with%2520deficiency%2520in%2520cytochrome%2520P450%252046A1-mediated%2520cholesterol%2520removal%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2019%26volume%3D189%26spage%3D405%26epage%3D425%26doi%3D10.1016%2Fj.ajpath.2018.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiseman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">3529</span>– <span class="NLM_lpage">3538</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.532846</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1074%2Fjbc.M113.532846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=24352658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitV2hur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=3529-3538&author=N.+Mastauthor=Y.+Liauthor=M.+Lingerauthor=M.+Clarkauthor=J.+Wisemanauthor=I.+A.+Pikuleva&title=Pharmacologic+stimulation+of+cytochrome+P450+46A1+and+cerebral+cholesterol+turnover+in+mice&doi=10.1074%2Fjbc.M113.532846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic Stimulation of Cytochrome P450 46A1 and Cerebral Cholesterol Turnover in Mice</span></div><div class="casAuthors">Mast, Natalia; Li, Yong; Linger, Marlin; Clark, Matthew; Wiseman, Jeffrey; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3529-3538</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cytochrome P 450 46A1 (CYP46A1) is a brain-specific cholesterol 24-hydroxylase responsible for the majority of cholesterol elimination from the brain.  Genetically increased CYP46A1 expression in mice leads to improved cognition and decreases manifestations of Alzheimer disease.  We found that four pharmaceuticals (efavirenz (EFV), acetaminophen, mirtazapine, and galantamine) prescribed for indications unrelated to cholesterol maintenance increased CYP46A1 activity in vitro.  We then evaluated the anti-HIV medication EFV for the mode of interaction with CYP46A1 and the effect on mice.  We propose a model for CYP46A1 activation by EFV and show that EFV enhanced CYP46A1 activity and cerebral cholesterol turnover in animals with no effect on the levels of brain cholesterol.  The doses of EFV administered to mice and required for the stimulation of their cerebral cholesterol turnover are a hundred times lower than those prescribed to HIV patients.  At such small doses, EFV may be devoid of adverse effects elicited by high drug concns.  CYP46A1 could be a novel therapeutic target and a tool to further investigate the physiol. and medical significance of cerebral cholesterol turnover.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprg1bnYJi8CbVg90H21EOLACvtfcHk0lghhLRxUe7SLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitV2hur4%253D&md5=e3a3b02fbfaaa3cec1ac9a6e8f9dc75e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.532846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.532846%26sid%3Dliteratum%253Aachs%26aulast%3DMast%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLinger%26aufirst%3DM.%26aulast%3DClark%26aufirst%3DM.%26aulast%3DWiseman%26aufirst%3DJ.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DPharmacologic%2520stimulation%2520of%2520cytochrome%2520P450%252046A1%2520and%2520cerebral%2520cholesterol%2520turnover%2520in%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D3529%26epage%3D3538%26doi%3D10.1074%2Fjbc.M113.532846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saadane, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valencia-Olvera, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constans, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxfield, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arakawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landreth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer’s disease</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">465</span>– <span class="NLM_lpage">476</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2017.06.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1016%2Fj.neuropharm.2017.06.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=28655608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVyntL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2017&pages=465-476&author=N.+Mastauthor=A.+Saadaneauthor=A.+Valencia-Olveraauthor=J.+Constansauthor=E.+Maxfieldauthor=H.+Arakawaauthor=Y.+Liauthor=G.+Landrethauthor=I.+A.+Pikuleva&title=Cholesterol-metabolizing+enzyme+cytochrome+P450+46A1+as+a+pharmacologic+target+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neuropharm.2017.06.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease</span></div><div class="casAuthors">Mast, Natalia; Saadane, Aicha; Valencia-Olvera, Ana; Constans, James; Maxfield, Erin; Arakawa, Hiroyuki; Li, Young; Landreth, Gary; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">465-476</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cytochrome P 450 46A1 (CYP46A1 or cholesterol 24-hydroxylase) controls cholesterol elimination from the brain and plays a role in higher order brain functions.  Genetically enhanced CYP46A1 expression in mouse models of Alzheimer's disease mitigates the manifestations of this disease.  We enhanced CYP46A1 activity pharmacol. by treating 5XFAD mice, a model of rapid amyloidogenesis, with a low dose of the anti-HIV medication efavirenz.  Efavirenz was administered from 1 to 9 mo of age, and mice were evaluated at specific time points.  At one month of age, cholesterol homeostasis was already disturbed in the brain of 5XFAD mice.  Nevertheless, efavirenz activated CYP46A1 and mouse cerebral cholesterol turnover during the first four months of administration.  This treatment time also reduced amyloid burden and microglia activation in the cortex and subiculum of 5XFAD mice as well as protein levels of amyloid precursor protein and the expression of several genes involved in inflammatory response.  However, mouse short-term memory and long-term spatial memory were impaired, whereas learning in the context-dependent fear test was improved.  Addnl. four months of drug administration (a total of eight months of treatment) improved long-term spatial memory in the treated as compared to the untreated mice, further decreased amyloid-β content in 5XFAD brain, and also decreased the mortality rate among male mice.  We propose a mechanistic model unifying the obsd. efavirenz effects.  We suggest that CYP46A1 activation by efavirenz could be a new anti-Alzheimer's disease treatment and a tool to study and identify normal and pathol. brain processes affected by cholesterol maintenance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmhSOTzpZZ6rVg90H21EOLACvtfcHk0lghhLRxUe7SLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVyntL7J&md5=3c4af0d8a17b48abf01d93c98e46f0fa</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2017.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2017.06.026%26sid%3Dliteratum%253Aachs%26aulast%3DMast%26aufirst%3DN.%26aulast%3DSaadane%26aufirst%3DA.%26aulast%3DValencia-Olvera%26aufirst%3DA.%26aulast%3DConstans%26aufirst%3DJ.%26aulast%3DMaxfield%26aufirst%3DE.%26aulast%3DArakawa%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLandreth%26aufirst%3DG.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DCholesterol-metabolizing%2520enzyme%2520cytochrome%2520P450%252046A1%2520as%2520a%2520pharmacologic%2520target%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D123%26spage%3D465%26epage%3D476%26doi%3D10.1016%2Fj.neuropharm.2017.06.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petrov, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxfield, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">CYP46A1 activation by efavirenz leads to behavioral Improvement without significant changes in amyloid plaque load in the brain of 5XFAD mice</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">724</span>, <span class="refDoi"> DOI: 10.1007/s13311-019-00737-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1007%2Fs13311-019-00737-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=31062296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFGjsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=710-724&author=A.+M.+Petrovauthor=M.+Lamauthor=N.+Mastauthor=J.+Moonauthor=Y.+Liauthor=E.+Maxfieldauthor=I.+A.+Pikuleva&title=CYP46A1+activation+by+efavirenz+leads+to+behavioral+Improvement+without+significant+changes+in+amyloid+plaque+load+in+the+brain+of+5XFAD+mice&doi=10.1007%2Fs13311-019-00737-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice</span></div><div class="casAuthors">Petrov, Alexey M.; Lam, Morrie; Mast, Natalia; Moon, Jean; Li, Yong; Maxfield, Erin; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">710-724</span>CODEN:
                <span class="NLM_cas:coden">NEURNV</span>;
        ISSN:<span class="NLM_cas:issn">1878-7479</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Efavirenz, the FDA-approved anti-retroviral medication, is evaluated in the clin. trial in patients with mild cognitive impairment or early dementia due to Alzheimer's disease.  Efavirenz is assessed for activation of cytochrome P 450 46A1 (CYP46A1), a CNS-specific enzyme that converts cholesterol to 24-hydroxycholesterol.  Cholesterol 24-hydroxylation is the major pathway for brain cholesterol removal, and a mechanism that controls brain cholesterol turnover.  The present study tested efavirenz on 5XFAD mice (an Alzheimer's model) at a very low daily dose of 0.1 mg/kg body wt.  Efavirenz treatment started from three months of age, after amyloid plague appearance, and continued for 6 mo.  This treatment led to CYP46A1 activation in the brain, enhancement of brain cholesterol turnover, behavioral improvements, redn. in microglia activation but increased astrocyte reactivity.  The levels of the sol. and insol. amyloid 40 and 42 peptides were unchanged while the no. and area of the dense core amyloid plaques were slightly decreased.  The measurements of the brain levels of several pre- and post-synaptic proteins (Munc13-1, PSD-95, gephyrin, synaptophysin, synapsin-1, and calbindin-D28k) suggested efavirenz effect at the synaptic level.  Efavirenz treatment in the present work seems to represent a model of behavioral and other improvements independent of the levels of the amyloid peptides and provides insight into potential outcomes of the future clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozKiLBY50Uq7Vg90H21EOLACvtfcHk0lghhLRxUe7SLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFGjsLbN&md5=80445eb9f29a113d3629f89e4f7747a0</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs13311-019-00737-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-019-00737-0%26sid%3Dliteratum%253Aachs%26aulast%3DPetrov%26aufirst%3DA.%2BM.%26aulast%3DLam%26aufirst%3DM.%26aulast%3DMast%26aufirst%3DN.%26aulast%3DMoon%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMaxfield%26aufirst%3DE.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DCYP46A1%2520activation%2520by%2520efavirenz%2520leads%2520to%2520behavioral%2520Improvement%2520without%2520significant%2520changes%2520in%2520amyloid%2520plaque%2520load%2520in%2520the%2520brain%2520of%25205XFAD%2520mice%26jtitle%3DNeurotherapeutics%26date%3D2019%26volume%3D16%26spage%3D710%26epage%3D724%26doi%3D10.1007%2Fs13311-019-00737-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudgens, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turko, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Mapping of the allosteric site in cholesterol hydroxylase CYP46A1 for efavirenz, a drug that stimulates enzyme activity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">11876</span>– <span class="NLM_lpage">11886</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.723577</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1074%2Fjbc.M116.723577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=27056331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC28Xoslahurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=11876-11886&author=K.+W.+Andersonauthor=N.+Mastauthor=J.+W.+Hudgensauthor=J.+B.+Linauthor=I.+V.+Turkoauthor=I.+A.+Pikuleva&title=Mapping+of+the+allosteric+site+in+cholesterol+hydroxylase+CYP46A1+for+efavirenz%2C+a+drug+that+stimulates+enzyme+activity&doi=10.1074%2Fjbc.M116.723577"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping of the Allosteric Site in Cholesterol Hydroxylase CYP46A1 for Efavirenz, a Drug That Stimulates Enzyme Activity</span></div><div class="casAuthors">Anderson, Kyle W.; Mast, Natalia; Hudgens, Jeffrey W.; Lin, Joseph B.; Turko, Illarion V.; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">11876-11886</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cytochrome P 450 46A1 (CYP46A1) is a microsomal enzyme and cholesterol 24-hydroxylase that controls cholesterol elimination from the brain.  This P 450 is also a potential target for Alzheimer disease because it can be activated pharmacol. by some marketed drugs, as exemplified by efavirenz, the anti-HIV medication.  Previously, we suggested that pharmaceuticals activate CYP46A1 allosterically through binding to a site on the cytosolic protein surface, which is different from the enzyme active site facing the membrane.  Here we identified this allosteric site for efavirenz on CYP46A1 by using a combination of hydrogen-deuterium exchange coupled to MS, computational modeling, site-directed mutagenesis, and anal. of the CYP46A1 crystal structure.  We also mapped the binding region for the CYP46A1 redox partner oxidoreductase and found that the allosteric and redox partner binding sites share a common border.  On the basis of the data obtained, we propose the mechanism of CYP46A1 allostery and the pathway for the signal transmission from the P 450 allosteric site to the active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-odvYrHl5arVg90H21EOLACvtfcHk0lgrEqucMTsg_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xoslahurw%253D&md5=21e195d95508c4b8870509cb10fe7868</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.723577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.723577%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DK.%2BW.%26aulast%3DMast%26aufirst%3DN.%26aulast%3DHudgens%26aufirst%3DJ.%2BW.%26aulast%3DLin%26aufirst%3DJ.%2BB.%26aulast%3DTurko%26aufirst%3DI.%2BV.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DMapping%2520of%2520the%2520allosteric%2520site%2520in%2520cholesterol%2520hydroxylase%2520CYP46A1%2520for%2520efavirenz%252C%2520a%2520drug%2520that%2520stimulates%2520enzyme%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D11876%26epage%3D11886%26doi%3D10.1074%2Fjbc.M116.723577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björkhem, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">9546</span>– <span class="NLM_lpage">9551</span>, <span class="refDoi"> DOI: 10.1073/pnas.0803717105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1073%2Fpnas.0803717105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=18621681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovVOjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=9546-9551&author=N.+Mastauthor=M.+A.+Whiteauthor=I.+Bj%C3%B6rkhemauthor=E.+F.+Johnsonauthor=C.+D.+Stoutauthor=I.+A.+Pikuleva&title=Crystal+structures+of+substrate-bound+and+substrate-free+cytochrome+P450+46A1%2C+the+principal+cholesterol+hydroxylase+in+the+brain&doi=10.1073%2Fpnas.0803717105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of substrate-bound and substrate-free cytochrome P 450 46A1, the principal cholesterol hydroxylase in the brain</span></div><div class="casAuthors">Mast, Natalia; White, Mark Andrew; Bjorkhem, Ingemar; Johnson, Eric F.; Stout, C. David; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">9546-9551</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">By converting cholesterol to (24S)-hydroxycholesterol, cytochrome P 450 46A1 (CYP46A1) initiates the major pathway for cholesterol removal from the brain.  Here, 2 crystal structures of CYP46A1 were detd.  The 1st was the 1.9-Å structure of CYP46A1 complexed with the high-affinity substrate, cholesterol 3-sulfate (CH-3S).  The 2nd structure was that of substrate-free CYP46A1 at 2.4 Å resoln.  CH-3S was bound in the productive orientation and occupied the entire length of the banana-shaped hydrophobic active site cavity.  A unique helix B'-C loop insertion (residues 116-120) contributed to positioning cholesterol for oxygenation catalyzed by CYP46A1.  A comparison with the substrate-free structure revealed substantial substrate-induced conformational changes in CYP46A1 and suggested that structurally distinct compds. could bind in the enzyme active site.  In vitro assays were performed to characterize the effect of different therapeutic agents on cholesterol hydroxylase activity of purified full-length recombinant CYP46A1, and several strong inhibitors and modest coactivators of CYP46A1 were identified.  Structural and biochem. data provide evidence that CYP46A1 activity could be altered by exposure to some therapeutic drugs and potentially other xenobiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphPUQVb_JcD7Vg90H21EOLACvtfcHk0lgrEqucMTsg_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovVOjtrw%253D&md5=14a967726d993afa01afd4776da206d2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0803717105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0803717105%26sid%3Dliteratum%253Aachs%26aulast%3DMast%26aufirst%3DN.%26aulast%3DWhite%26aufirst%3DM.%2BA.%26aulast%3DBj%25C3%25B6rkhem%26aufirst%3DI.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DStout%26aufirst%3DC.%2BD.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DCrystal%2520structures%2520of%2520substrate-bound%2520and%2520substrate-free%2520cytochrome%2520P450%252046A1%252C%2520the%2520principal%2520cholesterol%2520hydroxylase%2520in%2520the%2520brain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D9546%26epage%3D9551%26doi%3D10.1073%2Fpnas.0803717105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mutlib, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemeth, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markwalder, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seitz, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, D. D.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of efavirenz metabolites by liquid chromatography/mass spectrometry and high field NMR: species differences in the metabolism of efavirenz</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1319</span>– <span class="NLM_lpage">1333</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10534318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1319-1333&author=A.+E.+Mutlibauthor=H.+Chenauthor=G.+A.+Nemethauthor=J.+A.+Markwalderauthor=S.+P.+Seitzauthor=L.+S.+Ganauthor=D.+D.+Christ&title=Identification+and+characterization+of+efavirenz+metabolites+by+liquid+chromatography%2Fmass+spectrometry+and+high+field+NMR%3A+species+differences+in+the+metabolism+of+efavirenz"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of efavirenz metabolites by liquid chromatography/mass spectrometry and high field NMR: species differences in the metabolism of efavirenz</span></div><div class="casAuthors">Mutlib, A. E.; Chen, H.; Nemeth, G. A.; Markwalder, J. A.; Seitz, S. P.; Gan, L. S.; Christ, D. D.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1319-1333</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Efavirenz (Sustiva, Fig. 1) is a potent and specific inhibitor of HIV-1 reverse transcriptase approved for the treatment of HIV infection.  To examine the potential differences in the metab. among species, liq. chromatog./mass spectrometry profiles of efavirenz metabolites in urine of rats, guinea pigs, hamsters, cynomolgus monkeys, and humans were obtained and compared.  The metabolites of efavirenz were isolated, and structures were detd. unequivocally by mass spectral and NMR analyses.  Efavirenz was metabolized extensively by all the species as evidenced by the excretion of none or trace quantities of parent compd. in urine.  Significant species differences in the metab. of efavirenz were obsd.  The major metabolite excreted in the urine of all species was the O-glucuronide conjugate (M1) of the 8-hydroxylated metabolite.  Efavirenz was also metabolized by direct conjugation with glucuronic acid, forming the N-glucuronide (M2) in all five species.  The sulfate conjugate of 8-OH efavirenz (M3) was found in the urine of rats and cynomolgus monkeys but not in humans.  In addn. to the arom. ring-hydroxylated products, metabolites with a hydroxylated cyclopropane ring (at C14) were also isolated.  GSH-related products of efavirenz were identified in rats and guinea pigs.  The cysteinyl-glycine adduct (M10), formed from the GSH adduct (M9), was found in significant quantities in only rat and guinea pig urine and was not detected in other species.  In vitro metab. studies were conducted to show that the GSH adduct was produced from the cyclopropanol intermediate (M11) in the presence of only rat liver and kidney subcellular fractions and was not formed by similar prepns. from humans or cynomolgus monkeys.  These studies indicated the existence of a specific glutathione-S-transferase in rats capable of metabolizing the cyclopropanol metabolite (M11) to the GSH adduct, M9.  The biotransformation pathways of efavirenz in different species were proposed based on some of the in vitro results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVkQvIZDmcpLVg90H21EOLACvtfcHk0lgrEqucMTsg_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSht7g%253D&md5=cf23cb7f4ef9bb832ff80233e96cf852</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DNemeth%26aufirst%3DG.%2BA.%26aulast%3DMarkwalder%26aufirst%3DJ.%2BA.%26aulast%3DSeitz%26aufirst%3DS.%2BP.%26aulast%3DGan%26aufirst%3DL.%2BS.%26aulast%3DChrist%26aufirst%3DD.%2BD.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520efavirenz%2520metabolites%2520by%2520liquid%2520chromatography%252Fmass%2520spectrometry%2520and%2520high%2520field%2520NMR%253A%2520species%2520differences%2520in%2520the%2520metabolism%2520of%2520efavirenz%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26spage%3D1319%26epage%3D1333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorski, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flockhart, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desta, Z.</span></span> <span> </span><span class="NLM_article-title">The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>306</i></span>,  <span class="NLM_fpage">287</span>– <span class="NLM_lpage">300</span>, <span class="refDoi"> DOI: 10.1124/jpet.103.049601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1124%2Fjpet.103.049601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=12676886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvF2ksr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=287-300&author=B.+A.+Wardauthor=J.+C.+Gorskiauthor=D.+R.+Jonesauthor=S.+D.+Hallauthor=D.+A.+Flockhartauthor=Z.+Desta&title=The+cytochrome+P450+2B6+%28CYP2B6%29+is+the+main+catalyst+of+efavirenz+primary+and+secondary+metabolism%3A+implication+for+HIV%2FAIDS+therapy+and+utility+of+efavirenz+as+a+substrate+marker+of+CYP2B6+catalytic+activity&doi=10.1124%2Fjpet.103.049601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: Implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity</span></div><div class="casAuthors">Ward, Bryan A.; Gorski, J. Christopher; Jones, David R.; Hall, Stephen D.; Flockhart, David A.; Desta, Zeruesenay</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">287-300</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We used human liver microsomes (HLMs) and recombinant cytochromes P 450 (P450s) to identify the routes of efavirenz metab. and the P450s involved.  In HLMs, efavirenz undergoes primary oxidative hydroxylation to 8-hydroxyefavirenz (major) and 7-hydroxyefavirenz (minor) and secondary metab. to 8,14-dihydroxyefavirenz.  The formation of 8-hydroxyefavirenz in two HLMs showed sigmoidal kinetics (av. apparent Km, 20.2 μM; Vmax, 140 pmol/min/mg protein; and Hill coeff., 1.5), whereas that of 7-hydroxyefavirenz formation was characterized by hyperbolic kinetics (Km, 40.1 μM and Vmax, 20.5 pmol/min/mg protein).  In a panel of 10 P450s, CYP2B6 formed 8-hydroxyefavirenz and 8,14-dihydroxyefavirenz from efavirenz (10 μM) at the highest rate.  The Km value for the formation of 8-hydroxyefavirenz in CYP2B6 derived from hyperbolic Eq. 12.4 μM was close to that obtained in HLMs (Km, 20.2 μM).  None of the P450s tested showed activity toward 7-hydroxylation of efavirenz.  When 8-hydroxyefavirenz (2.5 μM) was used as a substrate, 8,14-dihydroxyefavirenz was formed by CYP2B6 at the highest rate, and its kinetics showed substrate inhibition (Ksi, ∼94 μM in HLMs and ∼234 μM in CYP2B6).  In a panel of 11 HLMs, 8-hydroxyefavirenz and 8,14-dihydroxyefavirenz formation rates from efavirenz (10 μM) correlated significantly with the activity of CYP2B6 and CYP3A.  N,N',N''-Triethylenethiophosphoramide (thioTEPA; 50 μM) inhibited the formation rates of 8-hydroxyefavirenz and 8,14-dihydroxyefavirenz from efavirenz (10 μM) by ≥60% in HLMs and CYP2B6, with Ki values < 4 μM.  In conclusion, CYP2B6 is the principal catalyst of efavirenz sequential hydroxylation.  Efavirenz systemic exposure is likely to be subject to interindividual variability in CYP2B6 activity and to drug interactions involving this isoform.  Efavirenz may be a valuable phenotyping tool to study the role of CYP2B6 in human drug metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdxH6M1qc21bVg90H21EOLACvtfcHk0li0mk1BKExWQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvF2ksr8%253D&md5=b08295185f3dd7c339a7744309002233</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.049601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.049601%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DB.%2BA.%26aulast%3DGorski%26aufirst%3DJ.%2BC.%26aulast%3DJones%26aufirst%3DD.%2BR.%26aulast%3DHall%26aufirst%3DS.%2BD.%26aulast%3DFlockhart%26aufirst%3DD.%2BA.%26aulast%3DDesta%26aufirst%3DZ.%26atitle%3DThe%2520cytochrome%2520P450%25202B6%2520%2528CYP2B6%2529%2520is%2520the%2520main%2520catalyst%2520of%2520efavirenz%2520primary%2520and%2520secondary%2520metabolism%253A%2520implication%2520for%2520HIV%252FAIDS%2520therapy%2520and%2520utility%2520of%2520efavirenz%2520as%2520a%2520substrate%2520marker%2520of%2520CYP2B6%2520catalytic%2520activity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D306%26spage%3D287%26epage%3D300%26doi%3D10.1124%2Fjpet.103.049601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bumpus, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenberg, P. F.</span></span> <span> </span><span class="NLM_article-title">Metabolism of efavirenz and 8-hydroxyefavirenz by P450 2B6 leads to inactivation by two distinct mechanisms</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>318</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">351</span>, <span class="refDoi"> DOI: 10.1124/jpet.106.102525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1124%2Fjpet.106.102525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=16611850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFymtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2006&pages=345-351&author=N.+N.+Bumpusauthor=U.+M.+Kentauthor=P.+F.+Hollenberg&title=Metabolism+of+efavirenz+and+8-hydroxyefavirenz+by+P450+2B6+leads+to+inactivation+by+two+distinct+mechanisms&doi=10.1124%2Fjpet.106.102525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of efavirenz and 8-hydroxyefavirenz by P450 2B6 leads to inactivation by two distinct mechanisms</span></div><div class="casAuthors">Bumpus, Namandje N.; Kent, Ute M.; Hollenberg, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">345-351</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Efavirenz is a non-nucleoside human immunodeficiency virus (HIV)-1 reverse transcriptase inhibitor used in combination therapy to treat HIV-1.  Efavirenz metab. is catalyzed primarily by the polymorphic enzyme P 450 2B6.  Metab. of efavirenz by P 450 2B6 and the naturally occurring P 450 2B6.4 mutant led to the formation of 8-hydroxyefavirenz.  Efavirenz inactivated the 7-ethoxy-4-(trifluoromethyl)coumarin activity of the wild-type P 450 2B6 enzyme in a time-, concn.-, and NADPH-dependent manner.  However, the P 450 2B6.4 variant was not inactivated by efavirenz.  The ability of efavirenz to inactivate both enzymes was investigated using cyclophosphamide and bupropion, two structurally unrelated substrates of P 450 2B6, as probes.  Preincubations with efavirenz decreased the ability of the wild-type enzyme to hydroxylate both substrates to similar extents but had no effect on the activities of the mutant enzyme.  Interestingly, the inactivation of the wild-type enzyme was completely reversible after 24 h of dialysis as detd. by heme, reduced CO spectra, and activity loss.  In contrast, 8-hydroxyefavirenz, a metabolite of efavirenz, was able to inactivate both enzymes irreversibly.  These data suggest that incubations of P 450 2B6 and P 450 2B6.4 with either the parent compd. efavirenz or the metabolite 8-hydroxyefavirenz in the reconstituted system result in the formation of two different reactive intermediates that lead to losses in enzymic activity by two different mechanisms, one reversible and one irreversible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2I3d_jfo2t7Vg90H21EOLACvtfcHk0li0mk1BKExWQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFymtL8%253D&md5=629c431f7c8f24139e5f83050b100c39</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.102525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.102525%26sid%3Dliteratum%253Aachs%26aulast%3DBumpus%26aufirst%3DN.%2BN.%26aulast%3DKent%26aufirst%3DU.%2BM.%26aulast%3DHollenberg%26aufirst%3DP.%2BF.%26atitle%3DMetabolism%2520of%2520efavirenz%2520and%25208-hydroxyefavirenz%2520by%2520P450%25202B6%2520leads%2520to%2520inactivation%2520by%2520two%2520distinct%2520mechanisms%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D318%26spage%3D345%26epage%3D351%26doi%3D10.1124%2Fjpet.106.102525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogburn, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desta, Z.</span></span> <span> </span><span class="NLM_article-title">Efavirenz primary and secondary metabolism in vitro and in vivo: identification of novel metabolic pathways and cytochrome P450 2A6 as the principal catalyst of efavirenz 7-hydroxylation</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1218</span>– <span class="NLM_lpage">1229</span>, <span class="refDoi"> DOI: 10.1124/dmd.109.031393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1124%2Fdmd.109.031393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=20335270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1Klsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1218-1229&author=E.+T.+Ogburnauthor=D.+R.+Jonesauthor=A.+R.+Mastersauthor=C.+Xuauthor=Y.+Guoauthor=Z.+Desta&title=Efavirenz+primary+and+secondary+metabolism+in+vitro+and+in+vivo%3A+identification+of+novel+metabolic+pathways+and+cytochrome+P450+2A6+as+the+principal+catalyst+of+efavirenz+7-hydroxylation&doi=10.1124%2Fdmd.109.031393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Efavirenz primary and secondary metabolism in vitro and in vivo: Identification of novel metabolic pathways and cytochrome P450 2A6 as the principal catalyst of efavirenz 7-hydroxylation</span></div><div class="casAuthors">Ogburn, Evan T.; Jones, David R.; Masters, Andrea R.; Xu, Cong; Guo, Yingying; Desta, Zeruesenay</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1218-1229</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Efavirenz primary and secondary metab. was investigated in vitro and in vivo.  In human liver microsome (HLM) samples, 7- and 8-hydroxyefavirenz accounted for 22.5% and 77.5% of the overall efavirenz metab., resp.  Kinetic, inhibition, and correlation analyses in HLM samples and expts. in expressed cytochrome P 450 show that CYP2A6 is the principal catalyst of efavirenz 7-hydroxylation.  Although CYP2B6 was the main enzyme catalyzing efavirenz 8-hydroxylation, CYP2A6 also seems to contribute.  Both 7- and 8-hydroxyefavirenz were further oxidized to novel dihydroxylated metabolite(s) primarily by CYP2B6.  These dihydroxylated metabolite(s) were not the same as 8,14-dihydroxyefavirenz, a metabolite that has been suggested to be directly formed via 14-hydroxylation of 8-hydroxyefavirenz, because 8,14-dihydroxyefavirenz was not detected in vitro when efavirenz, 7-, or 8-hydroxyefavirenz were used as substrates.  Efavirenz and its primary and secondary metabolites that were identified in vitro were quantified in plasma samples obtained from subjects taking a single 600 mg oral dose of efavirenz.  8,14-Dihydroxyefavirenz was detected and quantified in these plasma samples, suggesting that the glucuronide or the sulfate of 8-hydroxyefavirenz might undergo 14-hydroxylation in vivo.  In conclusion, efavirenz metab. is complex, involving unique and novel secondary metab.  Although efavirenz 8-hydroxylation by CYP2B6 remains the major clearance mechanism of efavirenz, CYP2A6-mediated 7-hydroxylation (and to some extent 8-hydroxylation) may also contribute.  Efavirenz may be a valuable dual phenotyping tool to study CYP2B6 and CYP2A6, and this should be further tested in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohnA4fuPyQVLVg90H21EOLACvtfcHk0lj1jYCwsEtTtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1Klsbc%253D&md5=e2a6478566ab5c233a57e13c5f1305a8</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.031393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.031393%26sid%3Dliteratum%253Aachs%26aulast%3DOgburn%26aufirst%3DE.%2BT.%26aulast%3DJones%26aufirst%3DD.%2BR.%26aulast%3DMasters%26aufirst%3DA.%2BR.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DDesta%26aufirst%3DZ.%26atitle%3DEfavirenz%2520primary%2520and%2520secondary%2520metabolism%2520in%2520vitro%2520and%2520in%2520vivo%253A%2520identification%2520of%2520novel%2520metabolic%2520pathways%2520and%2520cytochrome%2520P450%25202A6%2520as%2520the%2520principal%2520catalyst%2520of%2520efavirenz%25207-hydroxylation%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D1218%26epage%3D1229%26doi%3D10.1124%2Fdmd.109.031393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aouri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barcelo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ternon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavassini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anagnostopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yerly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hugues, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vernazza, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunthard, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buclin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telenti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decosterd, L. A.</span></span> <span> </span><span class="NLM_article-title">In vivo profiling and distribution of known and novel phase I and phase II metabolites of efavirenz in plasma, urine, and cerebrospinal fluid</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1124/dmd.115.065839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1124%2Fdmd.115.065839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=26553012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWnt7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=151-161&author=M.+Aouriauthor=C.+Barceloauthor=B.+Ternonauthor=M.+Cavassiniauthor=A.+Anagnostopoulosauthor=S.+Yerlyauthor=H.+Huguesauthor=P.+Vernazzaauthor=H.+F.+Gunthardauthor=T.+Buclinauthor=A.+Telentiauthor=M.+Rotgerauthor=L.+A.+Decosterd&title=In+vivo+profiling+and+distribution+of+known+and+novel+phase+I+and+phase+II+metabolites+of+efavirenz+in+plasma%2C+urine%2C+and+cerebrospinal+fluid&doi=10.1124%2Fdmd.115.065839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo profiling and distribution of known and novel phase I and phase II metabolites of efavirenz in plasma, urine, and cerebrospinal fluid</span></div><div class="casAuthors">Aouri, Manel; Barcelo, Catalina; Ternon, Beatrice; Cavassini, Matthias; Anagnostopoulos, Alexia; Yerly, Sabine; Hugues, Henry; Vernazza, Pietro; Gunthard, Huldrych F.; Buclin, Thierry; Telenti, Amalio; Rotger, Margalida; Decosterd, Laurent A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">151-161</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Efavirenz (EFV) is principally metabolized by CYP2B6 to 8-hydroxy-efavirenz (8OH-EFV) and to a lesser extent by CYP2A6 to 7-hydroxy-efavirenz (7OH-EFV).  So far, most metabolite profile analyses have been restricted to 8OH-EFV, 7OH-EFV, and EFV-N-glucuronide, even though these metabolites represent a minor percentage of EFV metabolites present in vivo.  We have performed a quant. phase I and II metabolite profile anal. by tandem mass spectrometry of plasma, cerebrospinal fluid (CSF), and urine samples in 71 human immunodeficiency virus patients taking efavirenz, prior to and after enzymic (glucuronidase and sulfatase) hydrolysis.  We have shown that phase II metabolites constitute the major part of the known circulating efavirenz species in humans.  The 8OH-EFV-glucuronide (gln) and 8OH-EFV-sulfate (identified for the first time) in humans were found to be 64- and 7-fold higher than the parent 8OH-EFV, resp.  In individuals (n = 67) genotyped for CYP2B6, 2A6, and CYP3A metabolic pathways, 8OH-EFV/EFV ratios in plasma were an index of CYP2B6 phenotypic activity (P < 0.0001), which was also reflected by phase II metabolites 8OH-EFV-glucuronide/EFV and 8OH-EFV-sulfate/EFV ratios.  Neither EFV nor 8OH-EFV, nor any other considered metabolites in plasma were assocd. with an increased risk of central nervous system (CNS) toxicity.  In CSF, 8OH-EFV levels were not influenced by CYP2B6 genotypes and did not predict CNS toxicity.  The phase II metabolites 8OH-EFV-gln, 8OH-EFV-sulfate, and 7OH-EFV-gln were present in CSF at 2- to 9-fold higher concns. than 8OH-EFV.  The potential contribution of known and previously unreported EFV metabolites in CSF to the neuropsychol. effects of efavirenz needs to be further examd. in larger cohort studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu_lSLGw2YqrVg90H21EOLACvtfcHk0lj1jYCwsEtTtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWnt7zN&md5=c8eb665e34c4274aa32a25291293ff29</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fdmd.115.065839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.115.065839%26sid%3Dliteratum%253Aachs%26aulast%3DAouri%26aufirst%3DM.%26aulast%3DBarcelo%26aufirst%3DC.%26aulast%3DTernon%26aufirst%3DB.%26aulast%3DCavassini%26aufirst%3DM.%26aulast%3DAnagnostopoulos%26aufirst%3DA.%26aulast%3DYerly%26aufirst%3DS.%26aulast%3DHugues%26aufirst%3DH.%26aulast%3DVernazza%26aufirst%3DP.%26aulast%3DGunthard%26aufirst%3DH.%2BF.%26aulast%3DBuclin%26aufirst%3DT.%26aulast%3DTelenti%26aufirst%3DA.%26aulast%3DRotger%26aufirst%3DM.%26aulast%3DDecosterd%26aufirst%3DL.%2BA.%26atitle%3DIn%2520vivo%2520profiling%2520and%2520distribution%2520of%2520known%2520and%2520novel%2520phase%2520I%2520and%2520phase%2520II%2520metabolites%2520of%2520efavirenz%2520in%2520plasma%252C%2520urine%252C%2520and%2520cerebrospinal%2520fluid%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2016%26volume%3D44%26spage%3D151%26epage%3D161%26doi%3D10.1124%2Fdmd.115.065839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Remmer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estabrook, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasame, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillette, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhulu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, O.</span></span> <span> </span><span class="NLM_article-title">Drug interaction with hepatic microsomal cytochrome</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1966</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">190</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=5905665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADyaF28XktVKmur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1966&pages=187-190&author=H.+Remmerauthor=J.+Schenkmanauthor=R.+W.+Estabrookauthor=H.+Sasameauthor=J.+Gilletteauthor=S.+Narasimhuluauthor=D.+Y.+Cooperauthor=O.+Rosenthal&title=Drug+interaction+with+hepatic+microsomal+cytochrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Drug interaction with hepatic microsomal cytochrome</span></div><div class="casAuthors">Remmer, H.; Schenkman, J.; Estabrook, R. W.; Sasame, H.; Gillette, J.; Narasimhulu, S.; Cooper, D. Y.; Rosenthal, O.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1966</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-90</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">The difference spectra of isolated rat liver microsomes to which substrates of drug-metabolizing enzymes were added were studied in order to det. whether spectral changes, indicative of substrate interaction, were present in hepatic as well as adrenal cortical microsomes.  Two types of spectral changes were observed.  Hexobarbitol (I), phenobarbital (II), aminopyrine, and amobarbital, either in the presence or absence of TPNH, caused spectral changes similar to those observed on the addn. of 17-hydroxyprogesterone to adrenal cortical microsomes.  The addn. of aniline or 2,4-dichloro-6-phenylphenoxyethylamine-HCl causes a second type of spectral change.  Pretreatment of rats with II enhanced the spectral changes observed with either I or II, while pretreatment with benzopyrene increased the amt. of cytochrome P-450 and the magnitude of the spectral change observed with aniline, but diminished the spectral change caused by I.  These diverse effects observed with various inducing agents may permit direct assessment of the differences occurring on modification of the hepatic microsomal oxidn. system during induction.  Apparently, these spectral changes are related to substrate interaction with a microsomal hemoprotein, presumably cytochrome P-450.  Possibly, substrate addn. either (a) modifies the molar absorptivity of the hemoprotein or modifies the hemoprotein ligand interaction or (b) converts an "activated" O form of cytochrome P-450 to its oxidized state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlBG1o68CpVrVg90H21EOLACvtfcHk0lj1jYCwsEtTtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF28XktVKmur4%253D&md5=db35443b586ad0335545504e2102bda1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRemmer%26aufirst%3DH.%26aulast%3DSchenkman%26aufirst%3DJ.%26aulast%3DEstabrook%26aufirst%3DR.%2BW.%26aulast%3DSasame%26aufirst%3DH.%26aulast%3DGillette%26aufirst%3DJ.%26aulast%3DNarasimhulu%26aufirst%3DS.%26aulast%3DCooper%26aufirst%3DD.%2BY.%26aulast%3DRosenthal%26aufirst%3DO.%26atitle%3DDrug%2520interaction%2520with%2520hepatic%2520microsomal%2520cytochrome%26jtitle%3DMol.%2520Pharmacol.%26date%3D1966%26volume%3D2%26spage%3D187%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schenkman, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remmer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estabrook, R. W.</span></span> <span> </span><span class="NLM_article-title">Spectral studies of drug interaction with hepatic microsomal cytochrome</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">123</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=4382749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADyaF2sXosVCjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1967&pages=113-123&author=J.+B.+Schenkmanauthor=H.+Remmerauthor=R.+W.+Estabrook&title=Spectral+studies+of+drug+interaction+with+hepatic+microsomal+cytochrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Spectral studies of drug interaction with hepatic microsomal cytochrome</span></div><div class="casAuthors">Schenkman, John B.; Remmer, Herbert; Estabrook, Ronald W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-23</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Two types of spectral changes are described as resulting from substrate interaction with a hepatic microsomal cytochrome; the magnitude of these spectral changes is dependent on protein concn. and substrate concn. as well as the substrate employed.  In 2 of the 3 types of substrates examd. the concn. of substrate necessary to evoke half-max. enzyme activity was similar to the concn. of the same substrate necessary for half-max. spectral changes.  The addn. of NADPH, a corequirement for the microsomal mixed function oxidase, causes a modification of both types of spectral changes, without altering substrate affinity.  Three possible hypotheses are advanced, based upon the exptl. observations, to explain the two types of spectral changes observed.  24 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoInUTNOrGCNbVg90H21EOLACvtfcHk0ljVygNOxUuyeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXosVCjtQ%253D%253D&md5=8f1a923fb13a3c6bbeed43c6d0e80e5e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchenkman%26aufirst%3DJ.%2BB.%26aulast%3DRemmer%26aufirst%3DH.%26aulast%3DEstabrook%26aufirst%3DR.%2BW.%26atitle%3DSpectral%2520studies%2520of%2520drug%2520interaction%2520with%2520hepatic%2520microsomal%2520cytochrome%26jtitle%3DMol.%2520Pharmacol.%26date%3D1967%26volume%3D3%26spage%3D113%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mailman, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, E.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P-450 difference spectra: effect of chemical structure on Type II spectra in mouse hepatic microsomes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=4152826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADyaE2cXltFGit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1974&pages=301-308&author=R.+B.+Mailmanauthor=A.+P.+Kulkarniauthor=R.+C.+Bakerauthor=E.+Hodgson&title=Cytochrome+P-450+difference+spectra%3A+effect+of+chemical+structure+on+Type+II+spectra+in+mouse+hepatic+microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P-450 difference spectra.  Effect of chemical structure on type II spectra in mouse hepatic microsomes</span></div><div class="casAuthors">Mailman, Richard B.; Kulkarni, A. P.; Baker, Rodney C.; Hodgson, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">301-8</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    </div><div class="casAbstract">The difference spectra of oxidized cytochrome P 450 [9035-51-2] in liver microsomes showed two types of perturbations when treated with different potential ligands, and the effects of many compds. indicated the structural features assocd. with induction of the type II spectrum (max. 425-35 nm,min. 390-410 nm).  Binding of this type was correlated with the presence of a N atom in which sp2 or sp3 nonbonded electrons were sterically accessible, and the spectral size was either reduced or eliminated as substituents were placed close to this N.  A modified type II binding, i.e., a bathochromic shift, was caused by other nucleophilic atoms with relatively free steric access.  Minor structural changes in the compds. could affect both the size and type of spectrum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIZGXS6ExPGbVg90H21EOLACvtfcHk0ljVygNOxUuyeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXltFGit7w%253D&md5=cdd08b26dbf310f2ecb303089eff8ec7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMailman%26aufirst%3DR.%2BB.%26aulast%3DKulkarni%26aufirst%3DA.%2BP.%26aulast%3DBaker%26aufirst%3DR.%2BC.%26aulast%3DHodgson%26aufirst%3DE.%26atitle%3DCytochrome%2520P-450%2520difference%2520spectra%253A%2520effect%2520of%2520chemical%2520structure%2520on%2520Type%2520II%2520spectra%2520in%2520mouse%2520hepatic%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1974%26volume%3D2%26spage%3D301%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charvet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, C. D.</span></span> <span> </span><span class="NLM_article-title">Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">31783</span>– <span class="NLM_lpage">31795</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.143313</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1074%2Fjbc.M110.143313" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=20667828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=31783-31795&author=N.+Mastauthor=C.+Charvetauthor=I.+A.+Pikulevaauthor=C.+D.+Stout&title=Structural+basis+of+drug+binding+to+CYP46A1%2C+an+enzyme+that+controls+cholesterol+turnover+in+the+brain&doi=10.1074%2Fjbc.M110.143313"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Drug Binding to CYP46A1, an Enzyme That Controls Cholesterol Turnover in the Brain</span></div><div class="casAuthors">Mast, Natalia; Charvet, Casey; Pikuleva, Irina A.; Stout, C. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">31783-31795</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cytochrome P 450 46A1 (CYP46A1) initiates the major pathway of cholesterol elimination from the brain and thereby controls cholesterol turnover in this organ.  We detd. x-ray crystal structures of CYP46A1 in complex with four structurally distinct pharmaceuticals; antidepressant tranylcypromine (2.15 Å), anticonvulsant thioperamide (1.65 Å), antifungal voriconazole (2.35 Å), and antifungal clotrimazole (2.50 Å).  All four drugs are nitrogen-contg. compds. that have nanomolar affinity for CYP46A1 in vitro yet differ in size, shape, hydrophobicity, and type of the nitrogen ligand.  Structures of the co-complexes demonstrate that each drug binds in a single orientation to the active site with tranylcypromine, thioperamide, and voriconazole coordinating the heme iron via their nitrogen atoms and clotrimazole being at a 4 Å distance from the heme iron.  We show here that clotrimazole is also a substrate for CYP46A1.  High affinity for CYP46A1 is detd. by a set of specific interactions, some of which were further investigated by soln. studies using structural analogs of the drugs and the T306A CYP46A1 mutant.  Collectively, our results reveal how diverse inhibitors can be accommodated in the CYP46A1 active site and provide an explanation for the obsd. differences in the drug-induced spectral response.  Co-complexes with tranylcypromine, thioperamide, and voriconazole represent the first structural characterization of the drug binding to a P 450 enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq9TvdcFkRG7Vg90H21EOLACvtfcHk0ljVygNOxUuyeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7zI&md5=3ce22203cf3b9ffde9ff0b0b9c1ccdc4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.143313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.143313%26sid%3Dliteratum%253Aachs%26aulast%3DMast%26aufirst%3DN.%26aulast%3DCharvet%26aufirst%3DC.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26aulast%3DStout%26aufirst%3DC.%2BD.%26atitle%3DStructural%2520basis%2520of%2520drug%2520binding%2520to%2520CYP46A1%252C%2520an%2520enzyme%2520that%2520controls%2520cholesterol%2520turnover%2520in%2520the%2520brain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D31783%26epage%3D31795%26doi%3D10.1074%2Fjbc.M110.143313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nebert, D. W.</span></span> <span> </span><span class="NLM_article-title">Correlation of Type I, Type II, and Reverse Type I difference spectra with absolute changes in spin state of hepatic microsomal cytochrome P-450 iron from five mammalian species</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>253</i></span>,  <span class="NLM_fpage">1048</span>– <span class="NLM_lpage">1058</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=203579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADyaE1cXhtFKlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1978&pages=1048-1058&author=K.+Kumakiauthor=M.+Satoauthor=H.+Konauthor=D.+W.+Nebert&title=Correlation+of+Type+I%2C+Type+II%2C+and+Reverse+Type+I+difference+spectra+with+absolute+changes+in+spin+state+of+hepatic+microsomal+cytochrome+P-450+iron+from+five+mammalian+species"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation of type I, type II, and reverse type I difference spectra with absolute changes in spin state of hepatic microsomal cytochrome P-450 iron from five mammalian species</span></div><div class="casAuthors">Kumaki, Kenji; Sato, Mitsuo; Kon, Hideo; Nebert, Daniel W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1048-58</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The spin state of cytochrome P-450 ferric iron in vivo and in vitro was examd. in freshly prepd. liver microsomes from rabbit, guinea pig, hamster, mouse, and rat by low temp. EPR spectroscopy and compared with room temp. difference spectral changes.  The in vivo spin state in intact freshly prepd. microsomes reflects the environment of the P-450 iron itself in the vicinity of the heme protein, which may include bound endogenous compds., whereas the in vitro spin state reflects binding of added exogenous compds. to the iron (or binding in the vicinity of the heme iron).  A method is proposed for detg. the percentage of high spin P-450 iron in vivo per total P-450 content, by knowing the gy ≃ 8.0/gy ≃ 2.24 ratio of EPR signal heights.  This method gives a good approxn. among all 5 mammalian species examd. and during various in vivo treatments with inducers of certain forms of P-450 and during in vitro addns. of chems.  The EPR data with a series of compds. of increasing ligand field strengths added in vitro are consistent with the hypothesis that the 6th coordination site for in vivo low spin P-450 ferric iron is an O atom from an adjacent amino acid residue or a water mol.  The greater the amt. of high spin P-450 iron in vivo at the start of the expt., the lesser the peak-to-trough spectral height produced by pure type I substrates added in vitro, and the greater the peak-to-trough spectral height produced by pure reverse type I or type II compds. added in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn_iUhKUBdKbVg90H21EOLACvtfcHk0ljVygNOxUuyeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhtFKlt7s%253D&md5=90532e27840af9cd3c6bce9cc35edd0b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumaki%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DKon%26aufirst%3DH.%26aulast%3DNebert%26aufirst%3DD.%2BW.%26atitle%3DCorrelation%2520of%2520Type%2520I%252C%2520Type%2520II%252C%2520and%2520Reverse%2520Type%2520I%2520difference%2520spectra%2520with%2520absolute%2520changes%2520in%2520spin%2520state%2520of%2520hepatic%2520microsomal%2520cytochrome%2520P-450%2520iron%2520from%2520five%2520mammalian%2520species%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1978%26volume%3D253%26spage%3D1048%26epage%3D1058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vogt, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Cera, E.</span></span> <span> </span><span class="NLM_article-title">Conformational selection or induced fit? A critical appraisal of the kinetic mechanism</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5894</span>– <span class="NLM_lpage">5902</span>, <span class="refDoi"> DOI: 10.1021/bi3006913</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi3006913" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVKltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=5894-5902&author=A.+D.+Vogtauthor=E.+Di+Cera&title=Conformational+selection+or+induced+fit%3F+A+critical+appraisal+of+the+kinetic+mechanism&doi=10.1021%2Fbi3006913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational selection or induced fit? A critical appraisal of the kinetic mechanism</span></div><div class="casAuthors">Vogt, Austin D.; Di Cera, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">5894-5902</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">For almost 5 decades, 2 competing mechanisms of ligand recognition, conformational selection and induced fit, have dominated the interpretation of ligand binding in biol. macromols.  When binding-dissocn. events are fast compared to conformational transitions, the rate of approach to equil., kobs, becomes diagnostic of conformational selection or induced fit based on whether it decreases or increases, resp., with the ligand concn. [L].  However, this simple conclusion based on the rapid equil. approxn. is not valid in general.  Here, the authors show that conformational selection is assocd. with a rich repertoire of kinetic properties, with kobs decreasing or increasing with [L] depending on the relative magnitude of the rate of ligand dissocn., koff, and the rate of conformational isomerization, kr.  The authors prove that, even for the simplest 2-step mechanism of ligand binding, a decrease in kobs with [L] is unequivocal evidence of conformational selection, but an increase in kobs with [L] is not unequivocal evidence of induced fit.  Ligand binding to glucokinase, thrombin, and its precursor, prethrombin-2, are used as relevant examples.  It is concluded that conformational selection as a mechanism for ligand binding to its target may be far more common than currently believed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdButaqMoNzLVg90H21EOLACvtfcHk0liBlamIt252lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVKltbo%253D&md5=0f7c66027467c390967075c3be8e5254</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fbi3006913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi3006913%26sid%3Dliteratum%253Aachs%26aulast%3DVogt%26aufirst%3DA.%2BD.%26aulast%3DDi%2BCera%26aufirst%3DE.%26atitle%3DConformational%2520selection%2520or%2520induced%2520fit%253F%2520A%2520critical%2520appraisal%2520of%2520the%2520kinetic%2520mechanism%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D5894%26epage%3D5902%26doi%3D10.1021%2Fbi3006913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gianni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemth, P.</span></span> <span> </span><span class="NLM_article-title">Distinguishing induced fit from conformational selection</span>. <i>Biophys. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>189</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">39s</span>, <span class="refDoi"> DOI: 10.1016/j.bpc.2014.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1016%2Fj.bpc.2014.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=24747333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvVWltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2014&pages=33-39s&author=S.+Gianniauthor=J.+Doganauthor=P.+Jemth&title=Distinguishing+induced+fit+from+conformational+selection&doi=10.1016%2Fj.bpc.2014.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Distinguishing induced fit from conformational selection</span></div><div class="casAuthors">Gianni, Stefano; Dogan, Jakob; Jemth, Per</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">189</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">33-39</span>CODEN:
                <span class="NLM_cas:coden">BICIAZ</span>;
        ISSN:<span class="NLM_cas:issn">0301-4622</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The interactions between proteins and ligands often involve a conformational change in the protein.  This conformational change can occur before (conformational selection) or after (induced fit) the assocn. with ligand.  It is often very difficult to distinguish induced fit from conformational selection when hyperbolic binding kinetics are obsd.  In light of a recent paper in this journal (Vogt et al., Biophys. Chem., 186, 2014, 13-21) and the current interest in binding mechanisms emerging from obsd. sampling of distinct conformations in protein domains, as well as from the field of intrinsically disordered proteins, we here describe a kinetic method that, at least in some cases, unequivocally distinguishes induced fit from conformational selection.  The method relies on measuring the obsd. rate const. λ for binding and varying both the protein and the ligand in sep. expts.  Whereas induced fit always yields a hyperbolic dependence of increasing λ values, the conformational selection mechanism gives rise to distinct kinetics when the ligand and protein (displaying the conformational change) concn. is varied in sep. expts.  We provide examples from the literature and discuss the limitations of the approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBGtc2RoRf-7Vg90H21EOLACvtfcHk0liBlamIt252lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvVWltb0%253D&md5=ecbe065454d8d9315638b5960b800c38</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bpc.2014.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bpc.2014.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DGianni%26aufirst%3DS.%26aulast%3DDogan%26aufirst%3DJ.%26aulast%3DJemth%26aufirst%3DP.%26atitle%3DDistinguishing%2520induced%2520fit%2520from%2520conformational%2520selection%26jtitle%3DBiophys.%2520Chem.%26date%3D2014%26volume%3D189%26spage%3D33%26epage%3D39s%26doi%3D10.1016%2Fj.bpc.2014.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span> <span> </span><span class="NLM_article-title">Kinetic processivity of the two-step oxidations of progesterone and pregnenolone to androgens by human cytochrome P450 17A1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">13168</span>– <span class="NLM_lpage">13185</span>, <span class="refDoi"> DOI: 10.1074/jbc.M117.794917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1074%2Fjbc.M117.794917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=28684414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlWhur%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=13168-13185&author=E.+Gonzalezauthor=F.+P.+Guengerich&title=Kinetic+processivity+of+the+two-step+oxidations+of+progesterone+and+pregnenolone+to+androgens+by+human+cytochrome+P450+17A1&doi=10.1074%2Fjbc.M117.794917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic processivity of the two-step oxidations of progesterone and pregnenolone to androgens by human cytochrome P450 17A1</span></div><div class="casAuthors">Gonzalez, Eric; Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">13168-13185</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cytochrome P 450 (P 450, CYP) 17A1 plays a crit. role in steroid metab., catalyzing both the 17α-hydroxylation of pregnenolone and progesterone and the subsequent 17α,20-lyase reactions to form dehydroepiandrosterone (DHEA) and androstenedione (Andro), resp., crit. for generating glucocorticoids and androgens.  Human P 450 17A1 reaction rates examd. are enhanced by the accessory protein cytochrome b5 (b5), but the exact role of b5 in P 450 17A1-catalyzed reactions is unclear as are several details of these reactions.  Here, we examd. in detail the processivity of the 17α-hydroxylation and lyase steps.  B5 did not enhance reaction rates by decreasing the koff rates of any of the steroids.  Steroid binding to P 450 17A1 was more complex than a simple two-state system.  Pre-steady-state expts. indicated lag phases for Andro prodn. from progesterone and for DHEA from pregnenolone, indicating a distributive character of the enzyme.  However, we obsd. processivity in pregnenolone/DHEA pulse-chase expts.  (S)-Orteronel was three times more inhibitory toward the conversion of 17α-hydroxypregnenolone to DHEA than toward the 17α-hydroxylation of pregnenolone.  IC50 values for (S)-orteronel were identical for blocking DHEA formation from pregnenolone and for 17α-hydroxylation, suggestive of processivity.  Global kinetic modeling helped assign sets of rate consts. for individual or groups of reactions, indicating that human P 450 17A1 is an inherently distributive enzyme but that some processivity is present, i.e. some of the 17α-OH pregnenolone formed from pregnenolone did not dissoc. from P 450 17A1 before conversion to DHEA.  Our results also suggest multiple conformations of P 450 17A1, as previously proposed on the basis of NMR spectroscopy and X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY30m86m4cjbVg90H21EOLACvtfcHk0liBlamIt252lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlWhur%252FF&md5=938001edf69216fccd3c170ded30d58a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.794917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.794917%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%26aufirst%3DE.%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DKinetic%2520processivity%2520of%2520the%2520two-step%2520oxidations%2520of%2520progesterone%2520and%2520pregnenolone%2520to%2520androgens%2520by%2520human%2520cytochrome%2520P450%252017A1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D13168%26epage%3D13185%26doi%3D10.1074%2Fjbc.M117.794917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkey, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddish, M. J.</span></span> <span> </span><span class="NLM_article-title">Conformational selection dominates binding of steroids to human cytochrome P450 17A1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">10028</span>– <span class="NLM_lpage">10041</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA119.008860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1074%2Fjbc.RA119.008860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=31072872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A280%3ADC%252BB3M7ktF2hsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=10028-10041&author=F.+P.+Guengerichauthor=C.+J.+Wilkeyauthor=S.+M.+Glassauthor=M.+J.+Reddish&title=Conformational+selection+dominates+binding+of+steroids+to+human+cytochrome+P450+17A1&doi=10.1074%2Fjbc.RA119.008860"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational selection dominates binding of steroids to human cytochrome P450 17A1</span></div><div class="casAuthors">Guengerich F Peter; Wilkey Clayton J; Glass Sarah M; Reddish Michael J</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of biological chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10028-10041</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cytochrome P450 (P450, CYP) enzymes are the major catalysts involved in the oxidation of steroids as well as many other compounds.  Their versatility has been explained in part by flexibility of the proteins and complexity of the binding mechanisms.  However, whether these proteins bind their substrates via induced fit or conformational selection is not understood.  P450 17A1 has a major role in steroidogenesis, catalyzing the two-step oxidations of progesterone and pregnenolone to androstenedione and dehydroepiandrosterone, respectively, via 17α-hydroxy (OH) intermediates.  We examined the interaction of P450 17A1 with its steroid substrates by analyzing progress curves (UV-visible spectroscopy), revealing that the rates of binding of any of these substrates decreased with increasing substrate concentration, a hallmark of conformational selection.  Further, when the concentration of 17α-OH pregnenolone was held constant and the P450 concentration increased, the binding rate increased, and such opposite patterns are also diagnostic of conformational selection.  Kinetic simulation modeling was also more consistent with conformational selection than with an induced-fit mechanism.  Cytochrome b5 partially enhances P450 17A1 lyase activity by altering the P450 17A1 conformation but did not measurably alter the binding of 17α-OH pregnenolone or 17α-OH progesterone, as judged by the apparent Kd and binding kinetics.  The P450 17A1 inhibitor abiraterone also bound to P450 17A1 in a multistep manner, and modeling indicated that the selective inhibition of the two P450 17A1 steps by the drug orteronel can be rationalized only by a multiple-conformation model.  In conclusion, P450 17A1 binds its steroid substrates via conformational selection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuPFZGSPoZE3qj_yg7twvpfW6udTcc2eYD5Wu5oL89b7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7ktF2hsA%253D%253D&md5=3a45e860f5ca51c1023354b885010b00</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA119.008860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA119.008860%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26aulast%3DWilkey%26aufirst%3DC.%2BJ.%26aulast%3DGlass%26aufirst%3DS.%2BM.%26aulast%3DReddish%26aufirst%3DM.%2BJ.%26atitle%3DConformational%2520selection%2520dominates%2520binding%2520of%2520steroids%2520to%2520human%2520cytochrome%2520P450%252017A1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26spage%3D10028%26epage%3D10041%26doi%3D10.1074%2Fjbc.RA119.008860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkey, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, T. T. N.</span></span> <span> </span><span class="NLM_article-title">Human cytochrome P450 enzymes bind drugs and other substrates mainly through conformational-selection modes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">10928</span>– <span class="NLM_lpage">10941</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA119.009305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1074%2Fjbc.RA119.009305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=31147443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A280%3ADC%252BB3M3hs1WhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=10928-10941&author=F.+P.+Guengerichauthor=C.+J.+Wilkeyauthor=T.+T.+N.+Phan&title=Human+cytochrome+P450+enzymes+bind+drugs+and+other+substrates+mainly+through+conformational-selection+modes&doi=10.1074%2Fjbc.RA119.009305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Human cytochrome P450 enzymes bind drugs and other substrates mainly through conformational-selection modes</span></div><div class="casAuthors">Guengerich F Peter; Wilkey Clayton J; Phan Thanh T N</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of biological chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">10928-10941</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cytochrome P450 (P450) enzymes are major catalysts involved in the oxidations of most drugs, steroids, carcinogens, fat-soluble vitamins, and natural products.  The binding of substrates to some of the 57 human P450s and other mammalian P450s is more complex than a two-state system and has been proposed to involve mechanisms such as multiple ligand occupancy, induced-fit, and conformational-selection.  Here, we used kinetic analysis of binding with multiple concentrations of substrates and computational modeling of these data to discern possible binding modes of several human P450s.  We observed that P450 2D6 binds its ligand rolapitant in a mechanism involving conformational-selection.  P450 4A11 bound the substrate lauric acid via conformational-selection, as did P450 2C8 with palmitic acid.  Binding of the steroid progesterone to P450 21A2 was also best described by a conformational-selection model.  Hexyl isonicotinate binding to P450 2E1 could be described by either a conformational-selection or an induced-fit model.  Simulation of the binding of the ligands midazolam, bromocriptine, testosterone, and ketoconazole to P450 3A4 was consistent with an induced-fit or a conformational-selection model, but the concentration dependence of binding rates for varying both P450 3A4 and midazolam concentrations revealed discordance in the parameters, indicative of conformational-selection.  Binding of the P450s 2C8, 2D6, 3A4, 4A11, and 21A2 was best described by conformational-selection, and P450 2E1 appeared to fit either mode.  These findings highlight the complexity of human P450-substrate interactions and that conformational-selection is a dominant feature of many of these interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaT5SunVS7rLZpSb_XWfMrfW6udTcc2eYD5Wu5oL89b7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3hs1WhsA%253D%253D&md5=cf1b5d5c34e4a3bb0a6681618087d35a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA119.009305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA119.009305%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26aulast%3DWilkey%26aufirst%3DC.%2BJ.%26aulast%3DPhan%26aufirst%3DT.%2BT.%2BN.%26atitle%3DHuman%2520cytochrome%2520P450%2520enzymes%2520bind%2520drugs%2520and%2520other%2520substrates%2520mainly%2520through%2520conformational-selection%2520modes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26spage%3D10928%26epage%3D10941%26doi%3D10.1074%2Fjbc.RA119.009305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddish, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span> <span> </span><span class="NLM_article-title">Human cytochrome P450 11B2 produces aldosterone by a processive mechanism due to the lactol form of the intermediate 18-hydroxycorticosterone</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">12975</span>– <span class="NLM_lpage">12991</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA119.009830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1074%2Fjbc.RA119.009830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=31296661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntlyntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=12975-12991&author=M.+J.+Reddishauthor=F.+P.+Guengerich&title=Human+cytochrome+P450+11B2+produces+aldosterone+by+a+processive+mechanism+due+to+the+lactol+form+of+the+intermediate+18-hydroxycorticosterone&doi=10.1074%2Fjbc.RA119.009830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Human cytochrome P450 11B2 produces aldosterone by a processive mechanism due to the lactol form of the intermediate 18-hydroxycorticosterone</span></div><div class="casAuthors">Reddish, Michael J.; Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">12975-12991</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human cytochrome P 450 11B2 catalyzes the formation of aldosterone, the major endogenous human mineralocorticoid.  Aldosterone is important for the regulation of electrolyte homeostasis.  Mutations and overexpression of P 450 11B2 (also known as aldosterone synthase) can lead to hypertension, congestive heart failure, and diabetic nephropathy.  The enzyme is therefore a target for drug development to manage these various disorders.  P 450 11B2 catalyzes aldosterone formation from 11-deoxycorticosterone through three distinct oxidn. steps.  It is currently unknown to which degree these reactions happen in sequence without the intermediate products dissocg. from the enzyme (i.e. processively) or whether these reactions happen solely distributively, in which the intermediate products must first dissoc. and then rebind to the enzyme before subsequent oxidn.  We present here a comprehensive investigation of processivity in P 450 11B2-catalyzed reactions using steady-state, pre-steady-state, pulse-chase, equil.-binding titrns., and stopped-flow binding studies.  We utilized the data obtained to develop a kinetic model for P 450 11B2 and tested this model by enzyme kinetics simulations.  We found that although aldosterone is produced processively, the enzyme preferentially utilizes a distributive mechanism that ends with the prodn. of 18-OH corticosterone.  This seemingly contradictory observation could be resolved by considering the ability of the intermediate product 18-OH corticosterone to exist as a lactol form, with the equil. favoring the ring-closed lactol configuration.  In summary, our refined model for P 450 11B2 catalysis indicates isomerization of the intermediate to a lactol can explain why P 450 11B2 must produce aldosterone through a processive mechanism despite favoring a distributive mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9bIHofma1mLVg90H21EOLACvtfcHk0lhKLumlwbrh3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntlyntA%253D%253D&md5=83e9ab1eaf06b943c30f327a5c400e99</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA119.009830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA119.009830%26sid%3Dliteratum%253Aachs%26aulast%3DReddish%26aufirst%3DM.%2BJ.%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DHuman%2520cytochrome%2520P450%252011B2%2520produces%2520aldosterone%2520by%2520a%2520processive%2520mechanism%2520due%2520to%2520the%2520lactol%2520form%2520of%2520the%2520intermediate%252018-hydroxycorticosterone%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26spage%3D12975%26epage%3D12991%26doi%3D10.1074%2Fjbc.RA119.009830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britcher, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lumma, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyle, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huff, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. S.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2602</span>– <span class="NLM_lpage">2605</span>, <span class="refDoi"> DOI: 10.1128/AAC.39.12.2602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1128%2FAAC.39.12.2602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=8592986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADyaK2MXps1Orsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1995&pages=2602-2605&author=S.+D.+Youngauthor=S.+F.+Britcherauthor=L.+O.+Tranauthor=L.+S.+Payneauthor=W.+C.+Lummaauthor=T.+A.+Lyleauthor=J.+R.+Huffauthor=P.+S.+Andersonauthor=D.+B.+Olsenauthor=S.+S.+Carroll&title=L-743%2C+726+%28DMP-266%29%3A+a+novel%2C+highly+potent+nonnucleoside+inhibitor+of+the+human+immunodeficiency+virus+type+1+reverse+transcriptase&doi=10.1128%2FAAC.39.12.2602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">L-743,726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase</span></div><div class="casAuthors">Young, Steven D.; Britcher, Susan F.; Tran, Lee O.; Payne, Linda S.; Lumma, William C.; Lyle, Terry A.; Huff, Joel R.; Anderson, Paul S.; Olsen, David B.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2602-5</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The clin. benefit of the human immunodeficiency virus type 1 (HIV-1) nonnucleoside reverse transcriptase (RT) inhibitors (NNRTIs) is limited by the rapid selection of inhibitor-resistant viral variants.  However, it may be possible to enhance the clin. utility of this inhibitor class by deriving compds. that express both high levels of antiviral activity and an augmented pharmacokinetic profile.  Accordingly, we developed a new class of NNRTIs, the 1,4-dihydro-2H-3,1-benzoxazin-2-ones.  L-743,726 (DMP-266), a member of this class, was chosen for clin. evaluation because of its in vitro properties.  The compd. was a potent inhibitor of the wild-type HIV-1 RT (Ki = 2.93 nM) and exhibited a 95% inhibitor concn. of 1.5 nM for the inhibition of HIV-1 replicative spread in cell culture.  In addn., L-743,726 was found to be capable of inhibiting, with 95% inhibitor concns. of ≤1.5 μM, a panel of NNRTI-resistant mutant viruses, each of which expressed a single RT amino acid substitution.  Derivation of virus with notably reduced susceptibility to the inhibitor required prolonged cell culture selection and was mediated by a combination of at least two RT amino acid substitutions.  Studies of L-743,726 in rats, monkeys, and a chimpanzee demonstrated the compd.'s potential for good oral bioavailability and pharmacokinetics in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOICv4Hf4CarVg90H21EOLACvtfcHk0lh4-j1gIF6T0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXps1Orsrc%253D&md5=c37f9d3d472a21a0078e69082f5f45e4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1128%2FAAC.39.12.2602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.39.12.2602%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DS.%2BD.%26aulast%3DBritcher%26aufirst%3DS.%2BF.%26aulast%3DTran%26aufirst%3DL.%2BO.%26aulast%3DPayne%26aufirst%3DL.%2BS.%26aulast%3DLumma%26aufirst%3DW.%2BC.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DAnderson%26aufirst%3DP.%2BS.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26atitle%3DL-743%252C%2520726%2520%2528DMP-266%2529%253A%2520a%2520novel%252C%2520highly%2520potent%2520nonnucleoside%2520inhibitor%2520of%2520the%2520human%2520immunodeficiency%2520virus%2520type%25201%2520reverse%2520transcriptase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1995%26volume%3D39%26spage%3D2602%26epage%3D2605%26doi%3D10.1128%2FAAC.39.12.2602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Apostolova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blas-Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galindo, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esplugues, J. V.</span></span> <span> </span><span class="NLM_article-title">Efavirenz: What is known about the cellular mechanisms responsible for its adverse effects</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>812</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2017.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1016%2Fj.ejphar.2017.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=28690189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtF2hsL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=812&publication_year=2017&pages=163-173&author=N.+Apostolovaauthor=A.+Blas-Garciaauthor=M.+J.+Galindoauthor=J.+V.+Esplugues&title=Efavirenz%3A+What+is+known+about+the+cellular+mechanisms+responsible+for+its+adverse+effects&doi=10.1016%2Fj.ejphar.2017.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Efavirenz: What is known about the cellular mechanisms responsible for its adverse effects</span></div><div class="casAuthors">Apostolova, Nadezda; Blas-Garcia, Ana; Galindo, Maria J.; Esplugues, Juan V.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">812</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">163-173</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The HIV infection remains an important health problem worldwide.  However, due to the efficacy of combined antiretroviral therapy (cART), it has ceased to be a mortal condition, becoming a chronic disease instead.  Efavirenz, the most prescribed non-nucleoside analog reverse transcriptase inhibitor (NNRTI), has been a key component of cART since its commercialization in 1998.  Though still a drug of choice in many countries, its primacy has been challenged by the arrival of newer antiretroviral agents with better toxicity profiles and treatment adherence.  The major side effects related to EFV have been widely described in clin. studies, however the mechanisms that participate in their pathogenesis remain largely ununderstood.  This review provides an insight into the cellular and mol. mechanisms responsible for the development of the most significant undesired effects induced by efavirenz, both short- and long-term, revealed by in vitro and in vivo exptl. pharmacol. research.  Growing evidence implicates the drug in energy metab., mitochondrial function, and other cellular processes involved in stress responses including oxidative stress, inflammation and autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb5l6cCQUj5LVg90H21EOLACvtfcHk0lh4-j1gIF6T0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtF2hsL7O&md5=56e877278ccb81be99c1aad7ae9b953b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2017.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2017.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DApostolova%26aufirst%3DN.%26aulast%3DBlas-Garcia%26aufirst%3DA.%26aulast%3DGalindo%26aufirst%3DM.%2BJ.%26aulast%3DEsplugues%26aufirst%3DJ.%2BV.%26atitle%3DEfavirenz%253A%2520What%2520is%2520known%2520about%2520the%2520cellular%2520mechanisms%2520responsible%2520for%2520its%2520adverse%2520effects%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D812%26spage%3D163%26epage%3D173%26doi%3D10.1016%2Fj.ejphar.2017.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Apostolova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funes, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blas-Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galindo, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esplugues, J. V.</span></span> <span> </span><span class="NLM_article-title">Efavirenz and the CNS: what we already know and questions that need to be answered</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">2693</span>– <span class="NLM_lpage">2708</span>, <span class="refDoi"> DOI: 10.1093/jac/dkv183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1093%2Fjac%2Fdkv183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=26203180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslartbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2015&pages=2693-2708&author=N.+Apostolovaauthor=H.+A.+Funesauthor=A.+Blas-Garciaauthor=M.+J.+Galindoauthor=A.+Alvarezauthor=J.+V.+Esplugues&title=Efavirenz+and+the+CNS%3A+what+we+already+know+and+questions+that+need+to+be+answered&doi=10.1093%2Fjac%2Fdkv183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Efavirenz and the CNS: what we already know and questions that need to be answered</span></div><div class="casAuthors">Apostolova, Nadezda; Funes, Haryes A.; Blas-Garcia, Ana; Galindo, Maria J.; Alvarez, Angeles; Esplugues, Juan V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2693-2708</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  The NNRTI efavirenz has long been one of the most frequently employed antiretroviral drugs in the multidrug regimens used to treat HIV infection, in accordance with its well-demonstrated antiretroviral efficacy and favorable pharmacokinetics.  However, growing concern about its adverse effects has sometimes led to efavirenz being replaced by other drugs in the initial treatment selection or to switching of therapy to efavirenz-free regimens in experienced patients.  Neurol. and neuropsychiatric reactions are the manifestations most frequently experienced by efavirenz-treated patients and range from transitory effects, such as nightmares, dizziness, insomnia, nervousness and lack of concn., to more severe symptoms including depression, suicidal ideation or even psychosis.  In addn., efavirenz has recently been assocd. with mild/moderate neurocognitive impairment, which is of specific relevance given that half of the patients receiving ART eventually suffer some form of HIV-assocd. neurocognitive disorder.  The mechanisms responsible for efavirenz-induced neurotoxicity are unclear, although growing evidence points to disturbances in brain mitochondrial function and bioenergetics.  This review offers a comprehensive overview of the current evidence on the interaction that efavirenz displays with the CNS, including the penetration and concn. of the drug in the brain.  The authors discuss the prevalence, types and specificities of its side effects and recently uncovered cellular mechanisms that may be involved in their development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ6L7H98mW9bVg90H21EOLACvtfcHk0lh4-j1gIF6T0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslartbbI&md5=a4f4eb06f650302f3c1befe6c270ee8e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkv183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkv183%26sid%3Dliteratum%253Aachs%26aulast%3DApostolova%26aufirst%3DN.%26aulast%3DFunes%26aufirst%3DH.%2BA.%26aulast%3DBlas-Garcia%26aufirst%3DA.%26aulast%3DGalindo%26aufirst%3DM.%2BJ.%26aulast%3DAlvarez%26aufirst%3DA.%26aulast%3DEsplugues%26aufirst%3DJ.%2BV.%26atitle%3DEfavirenz%2520and%2520the%2520CNS%253A%2520what%2520we%2520already%2520know%2520and%2520questions%2520that%2520need%2520to%2520be%2520answered%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2015%26volume%3D70%26spage%3D2693%26epage%3D2708%26doi%3D10.1093%2Fjac%2Fdkv183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalwadi, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozuna, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viljoen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schetz, J. A.</span></span> <span> </span><span class="NLM_article-title">Adverse neuropsychiatric events and recreational use of efavirenz and other HIV-1 antiretroviral drugs</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">684</span>– <span class="NLM_lpage">711</span>, <span class="refDoi"> DOI: 10.1124/pr.117.013706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1124%2Fpr.117.013706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=29945900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvVKnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2018&pages=684-711&author=D.+A.+Dalwadiauthor=L.+Ozunaauthor=B.+H.+Harveyauthor=M.+Viljoenauthor=J.+A.+Schetz&title=Adverse+neuropsychiatric+events+and+recreational+use+of+efavirenz+and+other+HIV-1+antiretroviral+drugs&doi=10.1124%2Fpr.117.013706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Adverse neuropsychiatric events and recreational use of efavirenz and other HIV-1 antiretroviral drugs</span></div><div class="casAuthors">Dalwadi, Dhwanil A.; Ozuna, Luis; Harvey, Brian H.; Viljoen, Michelle; Schetz, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">684-711</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Efavirenz is a highly effective HIV-1 antiretrovira drug.  Efavirenz-based treatment is generally well-tolerated in children, although some experience persistent concn. problems, as well as sleep disturbances, psychotic reactions, and seizures.  In an effort to link basic with clin. research, parameters assocd. with efavirenz brain exposure are discussed, and factors that increase efavirenz levels are explored in depth as they are expected to contribute to NPAE risk.  These include the role of modifiable and nonmodifiable risk factors such as diet, wt., and drug-drug interactions and sex, age, and ethnicity/pharmacogenetics.  In addn. to NPAEs, this review explores what is known about antiretroviral (ARV) drugs being used for recreational purposes.  Although multiple ARV drugs are covered, special attention is devoted to efavirenz given that the majority of reports of NPAEs and illicit use of ARV drugs concern efavirenz.  The evolving mol. mechanistic basis of NPAEs and abuse of efavirenz point to a complex and polymodal receptor pharmacol.  Animal studies to date primarily point to a serotonergic mechanism of action.  Recently emerging assocns. between HIV-assocd. neurocognitive disorder and efavirenz use, and possible contributions of the mitochondrial-immune-inflammatory-redox cascade are explored in the context of the signaling mechanisms that appear to be involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNBRRK9ByIr7Vg90H21EOLACvtfcHk0ljD3qwLWv1wDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvVKnsbg%253D&md5=7af51e02e8c22e647490db003e68d3e8</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1124%2Fpr.117.013706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.117.013706%26sid%3Dliteratum%253Aachs%26aulast%3DDalwadi%26aufirst%3DD.%2BA.%26aulast%3DOzuna%26aufirst%3DL.%26aulast%3DHarvey%26aufirst%3DB.%2BH.%26aulast%3DViljoen%26aufirst%3DM.%26aulast%3DSchetz%26aufirst%3DJ.%2BA.%26atitle%3DAdverse%2520neuropsychiatric%2520events%2520and%2520recreational%2520use%2520of%2520efavirenz%2520and%2520other%2520HIV-1%2520antiretroviral%2520drugs%26jtitle%3DPharmacol.%2520Rev.%26date%3D2018%26volume%3D70%26spage%3D684%26epage%3D711%26doi%3D10.1124%2Fpr.117.013706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bumpus, N. N.</span></span> <span> </span><span class="NLM_article-title">Efavirenz and 8-hydroxyefavirenz induce cell death via a JNK- and BimEL-dependent mechanism in primary human hepatocytes</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>257</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2011.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1016%2Fj.taap.2011.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=21958719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2mtLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=2011&pages=227-234&author=N.+N.+Bumpus&title=Efavirenz+and+8-hydroxyefavirenz+induce+cell+death+via+a+JNK-+and+BimEL-dependent+mechanism+in+primary+human+hepatocytes&doi=10.1016%2Fj.taap.2011.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Efavirenz and 8-hydroxyefavirenz induce cell death via a JNK- and BimEL-dependent mechanism in primary human hepatocytes</span></div><div class="casAuthors">Bumpus, Namandje N.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">257</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">227-234</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Chronic use of efavirenz (EFV) has been linked to incidences of hepatotoxicity in patients receiving EFV to treat HIV-1.  While recent studies have demonstrated that EFV stimulates hepatic cell death a role for the metabolites of efavirenz in this process has yet to be examd.  In the present study, incubation of primary human hepatocytes with synthetic 8-hydroxyEFV (8-OHEFV), which is the primary metabolite of EFV, resulted in cell death, caspase-3 activation and reactive oxygen species formation.  The metabolite exerted these effects at earlier time points and using lower concns. than were required for the parent compd.  In addn., pharmacol. inhibition of cytochrome P 450-dependent metab. of EFV using 1-aminobenzotriazole markedly decreased reactive oxygen species formation and cell death.  Treatment of primary human hepatocytes with EFV and 8-OHEFV also stimulated phosphorylation of c-Jun N-terminal kinase (JNK) as well as phosphorylation of the JNK substrate c-Jun.  Further, the mRNA and protein expression of an isoform of Bim (Bcl-2 interacting mediator of cell death) denoted as BimEL, which is proapoptotic and has been shown to be modulated by JNK, was increased.  Inhibition of JNK using SP600125 prevented the EFV- and 8-OHEFV-mediated cell death.  Silencing of Bim using siRNA transfected into hepatocytes also prevented cell death resulting from 8-OHEFV-treatment.  These data suggest that the oxidative metabolite 8-OHEFV is a more potent inducer of hepatic cell death than the parent compd. EFV.  Further, activation of the JNK signaling pathway and BimEL mRNA expression appear to be required for EFV- and 8-OHEFV-mediated hepatocyte death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq1qgK17j9W7Vg90H21EOLACvtfcHk0ljD3qwLWv1wDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2mtLnO&md5=bee59d25f4f081b5e4f07ad5193126c5</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2011.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2011.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DBumpus%26aufirst%3DN.%2BN.%26atitle%3DEfavirenz%2520and%25208-hydroxyefavirenz%2520induce%2520cell%2520death%2520via%2520a%2520JNK-%2520and%2520BimEL-dependent%2520mechanism%2520in%2520primary%2520human%2520hepatocytes%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2011%26volume%3D257%26spage%3D227%26epage%3D234%26doi%3D10.1016%2Fj.taap.2011.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tovar-Y-Romo, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bumpus, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomerantz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacktor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McArthur, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haughey, N. J.</span></span> <span> </span><span class="NLM_article-title">Dendritic spine injury induced by the 8-hydroxy metabolite of efavirenz</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>343</i></span>,  <span class="NLM_fpage">696</span>– <span class="NLM_lpage">703</span>, <span class="refDoi"> DOI: 10.1124/jpet.112.195701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1124%2Fjpet.112.195701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=22984227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslyjs7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2012&pages=696-703&author=L.+B.+Tovar-Y-Romoauthor=N.+N.+Bumpusauthor=D.+Pomerantzauthor=L.+B.+Averyauthor=N.+Sacktorauthor=J.+C.+McArthurauthor=N.+J.+Haughey&title=Dendritic+spine+injury+induced+by+the+8-hydroxy+metabolite+of+efavirenz&doi=10.1124%2Fjpet.112.195701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Dendritic spine injury induced by the 8-hydroxy metabolite of efavirenz</span></div><div class="casAuthors">Tovar-y-Romo, Luis B.; Bumpus, Namandje N.; Pomerantz, Daniel; Avery, Lindsay B.; Sacktor, Ned; McArthur, Justin C.; Haughey, Norman J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">696-703</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Despite combination antiretroviral therapies (cARTs), a significant proportion of HIV-infected patients develop HIV-assocd. neurocognitive disorders (HAND).  Ongoing viral replication in the central nervous system (CNS) caused by poor brain penetration of cART may contribute to HAND.  However, it has also been proposed that the toxic effects of long-term cART may contribute to HAND.  A better understanding of the neurotoxic potential of cART is critically needed in light of the use of CNS-penetrating cARTs to contend with the virus reservoir in the brain.  The efavirenz (EFV) metabolites 7-hydroxyefavirenz (7-OH-EFV) and 8-hydroxyefavirenz (8-OH-EFV) were synthesized and purified, and their chem. structures were confirmed by mass spectrometry and NMR.  The effects of EFV, 7-OH-EFV, and 8-OH-EFV on calcium, dendritic spine morphol., and survival were detd. in primary neurons.  EFV, 7-OH-EFV, and 8-OH-EFV each induced neuronal damage in a dose-dependent manner.  However, 8-OH-EFV was at least an order of magnitude more toxic than EFV or 7-OH-EFV, inducing considerable damage to dendritic spines at a 10 nM concn.  The 8-OH-EFV metabolite evoked calcium flux in neurons, which was mediated primarily by L-type voltage-operated calcium channels (VOCCs).  Blockade of L-type VOCCs protected dendritic spines from 8-OH-EFV-induced damage.  Concns. of EFV and 8-OH-EFV in the cerebral spinal fluid of HIV-infected subjects taking EFV were within the range that damaged neurons in culture.  These findings demonstrate that the 8-OH metabolite of EFV is a potent neurotoxin and highlight the importance of directly detg. the effects of antiretroviral drugs and drug metabolites on neurons and other brain cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4SOdUynFJ5LVg90H21EOLACvtfcHk0ljD3qwLWv1wDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslyjs7zP&md5=f3e404f2c06de376abf274c191925aca</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.195701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.195701%26sid%3Dliteratum%253Aachs%26aulast%3DTovar-Y-Romo%26aufirst%3DL.%2BB.%26aulast%3DBumpus%26aufirst%3DN.%2BN.%26aulast%3DPomerantz%26aufirst%3DD.%26aulast%3DAvery%26aufirst%3DL.%2BB.%26aulast%3DSacktor%26aufirst%3DN.%26aulast%3DMcArthur%26aufirst%3DJ.%2BC.%26aulast%3DHaughey%26aufirst%3DN.%2BJ.%26atitle%3DDendritic%2520spine%2520injury%2520induced%2520by%2520the%25208-hydroxy%2520metabolite%2520of%2520efavirenz%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D343%26spage%3D696%26epage%3D703%26doi%3D10.1124%2Fjpet.112.195701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brandmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehls, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dringen, R.</span></span> <span> </span><span class="NLM_article-title">8-Hydroxy-efavirenz, the primary metabolite of the antiretroviral drug Efavirenz, stimulates the glycolytic flux in cultured rat astrocytes</span>. <i>Neurochem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2524</span>– <span class="NLM_lpage">2534</span>, <span class="refDoi"> DOI: 10.1007/s11064-013-1165-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1007%2Fs11064-013-1165-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=24091996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKjtrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=2524-2534&author=M.+Brandmannauthor=U.+Nehlsauthor=R.+Dringen&title=8-Hydroxy-efavirenz%2C+the+primary+metabolite+of+the+antiretroviral+drug+Efavirenz%2C+stimulates+the+glycolytic+flux+in+cultured+rat+astrocytes&doi=10.1007%2Fs11064-013-1165-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">8-Hydroxy-efavirenz, the Primary Metabolite of the Antiretroviral Drug Efavirenz, Stimulates the Glycolytic Flux in Cultured Rat Astrocytes</span></div><div class="casAuthors">Brandmann, Maria; Nehls, Uwe; Dringen, Ralf</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2524-2534</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In active antiretroviral therapy antiretroviral drugs are employed for the restoration of a functional immune system in patients suffering from the acquired immunodeficiency syndrome.  However, potential adverse effects of such compds. to brain cells are discussed in connection with the development of neurocognitive impairments in patients.  To investigate potential effects of antiretroviral drugs on cell viability and the glycolytic flux of brain cells, astrocyte-rich primary cultures were exposed to various antiretroviral compds., including the non-nucleoside reverse transcriptase inhibitor efavirenz.  In a concn. of 10μM, neither efavirenz nor any of the other investigated antiretroviral compds. acutely compromised the cell viability nor altered glucose consumption or lactate prodn.  In contrast, the primary metabolite of efavirenz, 8-hydroxy-efavirenz, stimulated the glycolytic flux in viable astrocytes in a time- and concn.-dependent manner with half-maximal and maximal effects at concns. of 5 and 10μM, resp.  The stimulation of glycolytic flux by 8-hydroxy-efavirenz was not additive to that obtained for astrocytes that were treated with the respiratory chain inhibitor rotenone and was abolished by removal of extracellular 8-hydroxy-efavirenz.  In a concn. of 10μM, 8-hydroxy-efavirenz and efavirenz did not affect mitochondrial respiration, while both compds. lowered in a concn. of 60μM significantly the oxygen consumption by mitochondria that had been isolated form cultured astrocytes, suggesting that the stimulation of glycolytic flux by 8-hydroxy-efavirenz is not caused by direct inhibition of respiration.  The obsd. alteration of astrocytic glucose metab. by 8-hydroxy-efavirenz could contribute to the adverse neurol. side effects reported for patients that are chronically treated with efavirenz-contg. medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpndDlmo7_ic7Vg90H21EOLACvtfcHk0ljD3qwLWv1wDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKjtrvO&md5=a3de597ea9bbf59e6ab0ac340c0ae59e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs11064-013-1165-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-013-1165-2%26sid%3Dliteratum%253Aachs%26aulast%3DBrandmann%26aufirst%3DM.%26aulast%3DNehls%26aufirst%3DU.%26aulast%3DDringen%26aufirst%3DR.%26atitle%3D8-Hydroxy-efavirenz%252C%2520the%2520primary%2520metabolite%2520of%2520the%2520antiretroviral%2520drug%2520Efavirenz%252C%2520stimulates%2520the%2520glycolytic%2520flux%2520in%2520cultured%2520rat%2520astrocytes%26jtitle%3DNeurochem.%2520Res.%26date%3D2013%26volume%3D38%26spage%3D2524%26epage%3D2534%26doi%3D10.1007%2Fs11064-013-1165-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neiner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharasch, E. D.</span></span> <span> </span><span class="NLM_article-title">Efavirenz metabolism: influence of polymorphic CYP2B6 variants and stereochemistry</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1195</span>– <span class="NLM_lpage">1205</span>, <span class="refDoi"> DOI: 10.1124/dmd.119.086348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1124%2Fdmd.119.086348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=31324697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVOmtbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2019&pages=1195-1205&author=P.+F.+Wangauthor=A.+Neinerauthor=E.+D.+Kharasch&title=Efavirenz+metabolism%3A+influence+of+polymorphic+CYP2B6+variants+and+stereochemistry&doi=10.1124%2Fdmd.119.086348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Efavirenz metabolism: influence of polymorphic CYP2B6 variants and stereochemistry</span></div><div class="casAuthors">Wang, Pan-Fen; Neiner, Alicia; Kharasch, Evan D.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1195-1205</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Efavirenz (more specifically the S-enantiomer) is a cornerstone antiretroviral therapy for treatment of HIV infection.  The major primary metabolite is S-8-hydroxyefavirenz, which does not have antiretroviral activity but is neurotoxic.  Cytochrome P 450 2B6 (CYP2B6) is the major enzyme catalyzing S-8-hydroxyefavirenz formation.  CYP2B6 genetics and drug interactions are major determinants of clin. efavirenz disposition and dose adjustment.  In addn., as a prototypic CYP2B6 substrate, S-efavirenz and analogs can inform on the structure, activity, catalytic mechanisms, and stereoselectivity of CYP2B6.  Metab. of R-efavirenz by CYP2B6 remains unexplored.  This investigation assessed S-efavirenz metab. by clin. relevant CYP2B6 genetic variants.  This investigation also evaluated R-efavirenz hydroxylation by wild-type CYP2B6.1 and CYP2B6 variants.  S-Efavirenz 8-hydroxylation by wild-type CYP2B6.1 and variants exhibited pos. cooperativity and apparent cooperative substrate inhibition.  On the basis of Clmax values, relative activities for S-efavirenz 8-hydroxylation were in the order CYP2B6.4 > CYP2B6.1 ≈ CYP2B6.5 ≈ CYP2B6.17 > CYP2B6.6 ≈ CYP2B6.7 ≈ CYP2B6.9 ≈ CYP2B6.19 ≈ CYP2B6.26; CYP2B6.16 and CYP2B6.18 showed minimal activity.  Rates of R-efavirenz metab. were approx. 1/10 those of S-efavirenz for wild-type CYP2B6.1 and variants.  On the basis of Clmax values, there was 14-fold enantioselectivity (S > R-efavirenz) for wild-type CYP2B6.1, and 5- to 22-fold differences for other CYP2B6 variants.  These results show that both CYP2B6 516G > T (CYP2B6*6 and CYP2B6*9) and 983T > C (CYP2B6*16 and CYP2B6*18) polymorphisms cause canonical diminishment or losS-of-function variants for S-efavirenz 8-hydroxylation, provide a mechanistic basis for known clin. pharmacogenetic differences in efavirenz disposition, and may predict addnl. clin. important variant alleles.  Efavirenz is the most stereoselective CYP2B6 drug substrate yet identified and may be a useful probe for the CYP2B6 active site and catalytic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3WodX_xkejrVg90H21EOLACvtfcHk0li80BmU-4tfGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVOmtbzM&md5=2da30d2ed544db1715ec545836d3db02</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1124%2Fdmd.119.086348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.119.086348%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%2BF.%26aulast%3DNeiner%26aufirst%3DA.%26aulast%3DKharasch%26aufirst%3DE.%2BD.%26atitle%3DEfavirenz%2520metabolism%253A%2520influence%2520of%2520polymorphic%2520CYP2B6%2520variants%2520and%2520stereochemistry%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2019%26volume%3D47%26spage%3D1195%26epage%3D1205%26doi%3D10.1124%2Fdmd.119.086348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Best, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koopmans, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letendre, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capparelli, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifford, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collier, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelman, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mbeo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCutchan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haubrich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, I.</span></span>; <span class="NLM_contrib-group">Charter Group.</span> <span> </span><span class="NLM_article-title">Efavirenz concentrations in CSF exceed IC50 for wild-type HIV</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">354</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1093/jac/dkq434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1093%2Fjac%2Fdkq434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=21098541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsFaisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2011&pages=354-357&author=B.+M.+Bestauthor=P.+P.+Koopmansauthor=S.+L.+Letendreauthor=E.+V.+Capparelliauthor=S.+S.+Rossiauthor=D.+B.+Cliffordauthor=A.+C.+Collierauthor=B.+B.+Gelmanauthor=G.+Mbeoauthor=J.+A.+McCutchanauthor=D.+M.+Simpsonauthor=R.+Haubrichauthor=R.+Ellisauthor=I.+Grantauthor=Charter+Group.&title=Efavirenz+concentrations+in+CSF+exceed+IC50+for+wild-type+HIV&doi=10.1093%2Fjac%2Fdkq434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Efavirenz concentrations in CSF exceed IC50 for wild-type HIV</span></div><div class="casAuthors">Best, Brookie M.; Koopmans, Peter P.; Letendre, Scott L.; Capparelli, Edmund V.; Rossi, Steven S.; Clifford, David B.; Collier, Ann C.; Gelman, Benjamin B.; Mbeo, Gilbert; McCutchan, J. Allen; Simpson, David M.; Haubrich, Richard; Ellis, Ronald; Grant, Igor; Grant, Igor; McCutchan, J. Allen; Ellis, Ronald J.; Marcotte, Thomas D.; Franklin, Donald; Ellis, Ronald J.; McCutchan, J. Allen; Alexander, Terry; Letendre, Scott; Capparelli, Edmund; Heaton, Robert K.; Atkinson, J. Hampton; Woods, Steven Paul; Dawson, Matthew; Wong, Joseph K.; Fennema-Notestine, Christine; Taylor, Michael J.; Theilmann, Rebecca; Gamst, Anthony C.; Cushman, Clint; Abramson, Ian; Vaida, Florin; Marcotte, Thomas D.; von Jaeger, Rodney; McArthur, Justin; Smith, Mary; Morgello, Susan; Simpson, David; Mintz, Letty; McCutchan, J. Allen; Toperoff, Will; Collier, Ann; Marra, Christina; Jones, Trudy; Gelman, Benjamin; Head, Eleanor; Clifford, David; Al-Lozi, Muhammad; Teshome, Mengesha</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">354-357</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">HIV-assocd. neurocognitive disorders remain common despite use of potent antiretroviral therapy (ART).  Ongoing viral replication due to poor distribution of antivirals into the CNS may increase risk for HIV-assocd. neurocognitive disorders.  This study's objective was to det. penetration of a commonly prescribed antiretroviral drug, efavirenz, into CSF.  CHARTER is an ongoing, North American, multicenter, observational study to det. the effects of ART on HIV-assocd. neurol. disease.  Single random blood plasma and CSF samples were drawn within 1 h of each other from subjects taking efavirenz between Sept. 2003 and July 2007.  Samples were assayed by HPLC or HPLC/mass spectrometry with detection limits of 39 ng/mL (plasma) and <0.1 ng/mL (CSF).  Eighty participants (age 44 years; 79 kg; 20 females) had samples drawn 12.5 h post-dose.  The median efavirenz concns. after a median of 7 mo [interquartile range (IQR) 2-17] of therapy were 2145 ng/mL in plasma (IQR 1384-4423) and 13.9 ng/mL in CSF (IQR 4.1-21.2).  The CSF/plasma concn. ratio from paired samples drawn within 1 h of each other was 0.005 (IQR 0.0026-0.0076; n = 69).  The CSF/IC50 ratio was 26 (IQR 8-41) using the published IC50 for wild-type HIV (0.51 ng/mL).  Two CSF samples had concns. below the efavirenz IC50 for wild-type HIV.  Efavirenz concns. in the CSF are only 0.5% of plasma concns. but exceed the wild-type IC50 in nearly all individuals.  Since CSF drug concns. reflect those in brain interstitial fluids, efavirenz reaches therapeutic concns. in brain tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSJFkOSQw5LrVg90H21EOLACvtfcHk0li80BmU-4tfGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsFaisQ%253D%253D&md5=a16eb97e47a1fed373bcc8f31ebd2938</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkq434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkq434%26sid%3Dliteratum%253Aachs%26aulast%3DBest%26aufirst%3DB.%2BM.%26aulast%3DKoopmans%26aufirst%3DP.%2BP.%26aulast%3DLetendre%26aufirst%3DS.%2BL.%26aulast%3DCapparelli%26aufirst%3DE.%2BV.%26aulast%3DRossi%26aufirst%3DS.%2BS.%26aulast%3DClifford%26aufirst%3DD.%2BB.%26aulast%3DCollier%26aufirst%3DA.%2BC.%26aulast%3DGelman%26aufirst%3DB.%2BB.%26aulast%3DMbeo%26aufirst%3DG.%26aulast%3DMcCutchan%26aufirst%3DJ.%2BA.%26aulast%3DSimpson%26aufirst%3DD.%2BM.%26aulast%3DHaubrich%26aufirst%3DR.%26aulast%3DEllis%26aufirst%3DR.%26aulast%3DGrant%26aufirst%3DI.%26aulast%3D%26atitle%3DEfavirenz%2520concentrations%2520in%2520CSF%2520exceed%2520IC50%2520for%2520wild-type%2520HIV%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2011%26volume%3D66%26spage%3D354%26epage%3D357%26doi%3D10.1093%2Fjac%2Fdkq434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avery, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakshi, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, C. W.</span></span> <span> </span><span class="NLM_article-title">The male genital tract is not a pharmacological sanctuary from efavirenz</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1038/clpt.2011.99</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1038%2Fclpt.2011.99" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=21633344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvVaks7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2011&pages=151-156&author=L.+B.+Averyauthor=R.+P.+Bakshiauthor=Y.+J.+Caoauthor=C.+W.+Hendrix&title=The+male+genital+tract+is+not+a+pharmacological+sanctuary+from+efavirenz&doi=10.1038%2Fclpt.2011.99"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The Male Genital Tract Is Not a Pharmacological Sanctuary From Efavirenz</span></div><div class="casAuthors">Avery, L. B.; Bakshi, R. P.; Cao, Y. J.; Hendrix, C. W.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">151-156</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Many antiretroviral (ARV) drugs have large blood plasma-to-seminal plasma (BP/SP) concn. ratios.  Concern exists that these drugs do not adequately penetrate the male genital tract (MGT), resulting in the MGT becoming a "pharmacol. sanctuary" from these agents, with ineffective MGT concns. despite effective blood concns.  Efavirenz (EFV) is the most highly protein-bound ARV drug, with >99% binding in blood plasma and the largest BP/SP total EFV concn. ratio, reportedly ranging from 11 to 33.  To evaluate protein binding as an explanation for the differences between the drug concns. in blood and semen, we developed a novel ultrafiltration method, cor. for the duration of centrifugation, to measure protein binding in the two matrixes.  In six subjects, protein-free EFV concns. were the same in blood and semen; the median (interquartile range (IQR)) protein-free EFV SP/BP ratio was 1.21 (0.99-1.35); EFV protein binding was 99.82% (99.79-99.86) in BP and 95.26% (93.24-96.67) in SP.  This shows that the MGT is not a sanctuary from EFV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjRn_27qMLKLVg90H21EOLACvtfcHk0li80BmU-4tfGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvVaks7Y%253D&md5=d80016bd7474396e968b6fd19f02a7e0</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2011.99&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2011.99%26sid%3Dliteratum%253Aachs%26aulast%3DAvery%26aufirst%3DL.%2BB.%26aulast%3DBakshi%26aufirst%3DR.%2BP.%26aulast%3DCao%26aufirst%3DY.%2BJ.%26aulast%3DHendrix%26aufirst%3DC.%2BW.%26atitle%3DThe%2520male%2520genital%2520tract%2520is%2520not%2520a%2520pharmacological%2520sanctuary%2520from%2520efavirenz%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2011%26volume%3D90%26spage%3D151%26epage%3D156%26doi%3D10.1038%2Fclpt.2011.99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avery, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacktor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McArthur, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, C. W.</span></span> <span> </span><span class="NLM_article-title">Protein-free efavirenz concentrations in cerebrospinal fluid and blood plasma are equivalent: applying the law of mass action to predict protein-free drug concentration</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1409</span>– <span class="NLM_lpage">1414</span>, <span class="refDoi"> DOI: 10.1128/AAC.02329-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1128%2FAAC.02329-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=23295919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2htLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=1409-1414&author=L.+B.+Averyauthor=N.+Sacktorauthor=J.+C.+McArthurauthor=C.+W.+Hendrix&title=Protein-free+efavirenz+concentrations+in+cerebrospinal+fluid+and+blood+plasma+are+equivalent%3A+applying+the+law+of+mass+action+to+predict+protein-free+drug+concentration&doi=10.1128%2FAAC.02329-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Protein-free efavirenz concentrations in cerebrospinal fluid and blood plasma are equivalent: applying the law of mass action to predict protein-free drug concentration</span></div><div class="casAuthors">Avery, L. B.; Sacktor, N.; McArthur, J. C.; Hendrix, C. W.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1409-1414</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Efavirenz (EFV) is one of the most commonly prescribed antiretroviral drugs (ARVs) for the treatment of HIV.  Highly protein-bound drugs, like EFV, have limited central nervous system (CNS) penetration when measured using total drug concn. gradients between blood plasma (BP) and cerebrospinal fluid (CSF).  However, the more relevant pharmacol. active protein-free drug concns. are rarely assessed directly in clin. studies.  Using paired BP and CSF samples obtained from 13 subjects on an EFV-contg. regimen, both the protein-free and total concns. of EFV were detd.  Despite a median (interquartile range [IQR]) total EFV BP/CSF concn. ratio of 134 (116 to 198), the protein-free EFV BP/CSF concn. ratio was 1.20 (0.97 to 2.12).  EFV median (IQR) protein binding was 99.78% (99.74 to 99.80%) in BP and 76.19% (74.47 to 77.15%) in CSF.  In addn., using the law of mass action and an in vitro-derived EFV-human serum albumin dissocn. const., we have demonstrated that the predicted median (IQR) protein-free concn. in BP, 4.59 ng/mL (4.02 to 9.44 ng/mL), compared well to that obsd. in BP, 4.77 ng/mL (3.68 to 6.75 ng/mL).  Similar results were also obsd. in CSF and seminal plasma.  This method provides a useful predictive tool for estg. protein binding in varied anat. compartments.  Our results of equiv. protein-free EFV concns. in BP and CSF do not support prior concerns of the CNS as a pharmacol. sanctuary from EFV.  As CSF penetration of ARVs may increase our understanding of HIV-assocd. neurol. dysfunction and antiretroviral effect, assessment of protein-free CSF concns. of other highly protein-bound ARVs is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou0Cqn80c2hLVg90H21EOLACvtfcHk0ljTbbzhPw3soQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2htLY%253D&md5=d615662548b7ad218435ba8894f03f6d</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1128%2FAAC.02329-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02329-12%26sid%3Dliteratum%253Aachs%26aulast%3DAvery%26aufirst%3DL.%2BB.%26aulast%3DSacktor%26aufirst%3DN.%26aulast%3DMcArthur%26aufirst%3DJ.%2BC.%26aulast%3DHendrix%26aufirst%3DC.%2BW.%26atitle%3DProtein-free%2520efavirenz%2520concentrations%2520in%2520cerebrospinal%2520fluid%2520and%2520blood%2520plasma%2520are%2520equivalent%253A%2520applying%2520the%2520law%2520of%2520mass%2520action%2520to%2520predict%2520protein-free%2520drug%2520concentration%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D1409%26epage%3D1414%26doi%3D10.1128%2FAAC.02329-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winston, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Else, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jessen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avihingsanon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chetchotisakd, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emery, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puls, R.</span></span>; <span class="NLM_contrib-group">ENCORE Cerebrospinal Fluid (CSF) Substudy Team.</span> <span> </span><span class="NLM_article-title">Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trial</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1026</span>– <span class="NLM_lpage">1032</span>, <span class="refDoi"> DOI: 10.1093/cid/ciu976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1093%2Fcid%2Fciu976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=25501988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVKksLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2015&pages=1026-1032&author=A.+Winstonauthor=J.+Aminauthor=A.+Clarkeauthor=L.+Elseauthor=A.+Amaraauthor=A.+Owenauthor=T.+Barberauthor=H.+Jessenauthor=A.+Avihingsanonauthor=P.+Chetchotisakdauthor=S.+Khooauthor=D.+A.+Cooperauthor=S.+Emeryauthor=R.+Pulsauthor=ENCORE+Cerebrospinal+Fluid+%28CSF%29+Substudy+Team.&title=Cerebrospinal+fluid+exposure+of+efavirenz+and+its+major+metabolites+when+dosed+at+400+mg+and+600+mg+once+daily%3A+a+randomized+controlled+trial&doi=10.1093%2Fcid%2Fciu976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trial</span></div><div class="casAuthors">Winston, Alan; Amin, Janaki; Clarke, Amanda; Else, Laura; Amara, Alieu; Owen, Andrew; Barber, Tristan; Jessen, Heiko; Avinghsanon, Anchalee; Chetchotisakd, Ploenchan; Khoo, Saye; Cooper, David A.; Emery, Sean; Puls, Rebekah</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1026-1032</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: The optimal penetration of antiretroviral agents into the central nervous system may be a balance between providing adequate drug exposure to inhibit human immunodeficiency virus (HIV) replication while avoiding concns. assocd. with neuronal toxicities.  Methods: Cerebrospinal fluid (CSF) exposure of efavirenz and the metabolites 7-hydroxy (7OH) and 8-hydroxy (8OH) efavirenz were assessed after at least 12 wk of therapy in HIV-infected subjects randomized to commence antiretroviral regimens contg. efavirenz at either 400 mg or 600 mg once daily.  Results: Of 28 subjects (14 and 14 on efavirenz 400 mg and 600 mg, resp.), CSF HIV RNA was undetectable in all.  Geometric mean CSF efavirenz, 7OH-, and 8OH-efavirenz concns. (with 90% confidence intervals [CIs]) for the 400-mg and 600-mg dosing groups were 16.5 (13-21) and 19.5 (15-25) ng/mL; 0.6 (.4-.9) and 0.6 (.4-1) ng/mL; and 5.1 (4.0-6.4) and 3.1 (2.1-4.4) ng/mL, resp.  Efavirenz concn. in CSF was >0.51 ng/mL (proposed CSF 50% maximal inhibitory concn. for wild-type virus) in all subjects, and 8OH-efavirenz concn. in CSF was >3.3 ng/mL (a proposed toxicity threshold) in 11 of 14 and 7 of 14 subjects randomized to the 400 mg and 600 mg doses of efavirenz, resp.  Whereas CSF efavirenz concn. was significantly assocd. with plasma concn. (P < .001) and cytochrome P 450 2B6 genotype (CSF efavirenz GG to GT/TT geometric mean ratio, 0.56 [90% CI, .42-.74]), CSF 8OH-efavirenz concn. was not (P = .242 for assocn. and CSF 8OH-efavirenz GG to GT/TT geometric mean ratio, 1.52 [90% CI, .97-2.36]).  Conclusions: With both doses of efavirenz studied, CSF concns. were considered adequate to inhibit HIV replication, although concns. of 8OH-efavirenz were greater than those reportedly assocd. with neuronal toxicity.  CSF exposure of 8OH-efavirenz was not dependent on plasma exposure and, as we postulate, may be subject to saturable pharmacokinetic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-pV1WlwiwALVg90H21EOLACvtfcHk0ljTbbzhPw3soQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVKksLnO&md5=52a3100a789324429a0fe4ff4612f848</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fciu976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fciu976%26sid%3Dliteratum%253Aachs%26aulast%3DWinston%26aufirst%3DA.%26aulast%3DAmin%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DA.%26aulast%3DElse%26aufirst%3DL.%26aulast%3DAmara%26aufirst%3DA.%26aulast%3DOwen%26aufirst%3DA.%26aulast%3DBarber%26aufirst%3DT.%26aulast%3DJessen%26aufirst%3DH.%26aulast%3DAvihingsanon%26aufirst%3DA.%26aulast%3DChetchotisakd%26aufirst%3DP.%26aulast%3DKhoo%26aufirst%3DS.%26aulast%3DCooper%26aufirst%3DD.%2BA.%26aulast%3DEmery%26aufirst%3DS.%26aulast%3DPuls%26aufirst%3DR.%26aulast%3D%26atitle%3DCerebrospinal%2520fluid%2520exposure%2520of%2520efavirenz%2520and%2520its%2520major%2520metabolites%2520when%2520dosed%2520at%2520400%2520mg%2520and%2520600%2520mg%2520once%2520daily%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2015%26volume%3D60%26spage%3D1026%26epage%3D1032%26doi%3D10.1093%2Fcid%2Fciu976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nightingale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winston, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Else, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ustianowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Back, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirmohamed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torok, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoo, S.</span></span> <span> </span><span class="NLM_article-title">Efavirenz and metabolites in cerebrospinal fluid: relationship with CYP2B6 c.516G—>T genotype and perturbed blood-brain barrier due to tuberculous meningitis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4511</span>– <span class="NLM_lpage">4518</span>, <span class="refDoi"> DOI: 10.1128/AAC.00280-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1128%2FAAC.00280-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=27161633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2nsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=4511-4518&author=S.+Nightingaleauthor=T.+T.+Chauauthor=M.+Fisherauthor=M.+Nelsonauthor=A.+Winstonauthor=L.+Elseauthor=D.+F.+Carrauthor=S.+Taylorauthor=A.+Ustianowskiauthor=D.+Backauthor=M.+Pirmohamedauthor=T.+Solomonauthor=J.+Farrarauthor=M.+E.+Torokauthor=S.+Khoo&title=Efavirenz+and+metabolites+in+cerebrospinal+fluid%3A+relationship+with+CYP2B6+c.516G%E2%80%94%3ET+genotype+and+perturbed+blood-brain+barrier+due+to+tuberculous+meningitis&doi=10.1128%2FAAC.00280-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Efavirenz and metabolites in cerebrospinal fluid: relationship with CYP2B6 c.516G→T genotype and perturbed blood-brain barrier due to tuberculous meningitis</span></div><div class="casAuthors">Nightingale, Sam; Chau, Tran Thi Hong; Fisher, Martin; Nelson, Mark; Winston, Alan; Else, Laura; Carr, Daniel F.; Taylor, Steven; Ustianowski, Andrew; Back, David; Pirmohamed, Munir; Solomon, Tom; Farrar, Jeremy; Toerok, M. Estee; Khoo, Saye</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4511-4518</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Efavirenz (EFZ) has been assocd. with neuropsychiatric side effects.  Recently, the 8-hydroxy-EFZ (8OH-EFZ) metabolite has been shown to be a potent neurotoxin in vitro, inducing neuronal damage at concns. of 3.3 ng/mL.  EFZ induced similar neuronal damage at concns. of 31.6 ng/mL.  We investigated the effect of genotype and blood-brain barrier integrity on EFZ metabolite concns. in cerebrospinal fluid (CSF).  We measured CSF drug concns. in subjects from two sep. study populations: 47 subjects with tuberculous meningitis (TBM) coinfection in Vietnam receiving 800 mg EFZ with std. antituberculous treatment and 25 subjects from the PARTITION study in the United Kingdom without central nervous system infection receiving 600 mg EFZ.  EFZ and metabolite concns. in CSF and plasma were measured and compared with ests. of effectiveness and neurotoxicity from available published in vitro and in vivo data.  The effect of the CYP2B6 c.516G→T genotype (GG genotype, fast EFV metabolizer status; GT genotype, intermediate EFV metabolizer status; TT genotype, slow EFV metabolizer status) was examd.  The mean CSF concns. of EFZ and 8OH-EFZ in the TBM group were 60.3 and 39.3 ng/mL, resp., and those in the no-TBM group were 15.0 and 5.9 ng/mL, resp.  Plasma EFZ and 8OHEFZ concns. were similar between the two groups.  CSF EFZ concns. were above the in vitro toxic concn. in 76% of samples (GG genotype, 61%; GT genotype, 90%; TT genotype, 100%) in the TBM group and 13% of samples (GG genotype, 0%; GT genotype, 18%; TT genotype, 50%) in the no-TBM group.  CSF 8OH-EFZ concns. were above the in vitro toxic concn. in 98% of the TBM group and 87% of the no-TBM group; levels were independent of genotype but correlated with the CSF/plasma albumin ratio.  Potentially neurotoxic concns. of 8OH-EFZ are frequently obsd. in CSF independently of the CYP2B6 genotype, particularly in those with impaired blood-brain barrier integrity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq86zTKlLIKN7Vg90H21EOLACvtfcHk0lhlWXRllRwqyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2nsbnN&md5=d176f206071bd863c100eefb477396c6</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1128%2FAAC.00280-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00280-16%26sid%3Dliteratum%253Aachs%26aulast%3DNightingale%26aufirst%3DS.%26aulast%3DChau%26aufirst%3DT.%2BT.%26aulast%3DFisher%26aufirst%3DM.%26aulast%3DNelson%26aufirst%3DM.%26aulast%3DWinston%26aufirst%3DA.%26aulast%3DElse%26aufirst%3DL.%26aulast%3DCarr%26aufirst%3DD.%2BF.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DUstianowski%26aufirst%3DA.%26aulast%3DBack%26aufirst%3DD.%26aulast%3DPirmohamed%26aufirst%3DM.%26aulast%3DSolomon%26aufirst%3DT.%26aulast%3DFarrar%26aufirst%3DJ.%26aulast%3DTorok%26aufirst%3DM.%2BE.%26aulast%3DKhoo%26aufirst%3DS.%26atitle%3DEfavirenz%2520and%2520metabolites%2520in%2520cerebrospinal%2520fluid%253A%2520relationship%2520with%2520CYP2B6%2520c.516G%25E2%2580%2594%253ET%2520genotype%2520and%2520perturbed%2520blood-brain%2520barrier%2520due%2520to%2520tuberculous%2520meningitis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D4511%26epage%3D4518%26doi%3D10.1128%2FAAC.00280-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ngaimisi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugusi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minzi, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedel, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janabi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugusi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haefeli, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burhenne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aklillu, E.</span></span> <span> </span><span class="NLM_article-title">Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patients</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">676</span>– <span class="NLM_lpage">684</span>, <span class="refDoi"> DOI: 10.1038/clpt.2010.172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1038%2Fclpt.2010.172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=20881953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlWmurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2010&pages=676-684&author=E.+Ngaimisiauthor=S.+Mugusiauthor=O.+M.+Minziauthor=P.+Sasiauthor=K.+D.+Riedelauthor=A.+Sudaauthor=N.+Uedaauthor=M.+Janabiauthor=F.+Mugusiauthor=W.+E.+Haefeliauthor=J.+Burhenneauthor=E.+Aklillu&title=Long-term+efavirenz+autoinduction+and+its+effect+on+plasma+exposure+in+HIV+patients&doi=10.1038%2Fclpt.2010.172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patients</span></div><div class="casAuthors">Ngaimisi, E.; Mugusi, S.; Minzi, O. M.; Sasi, P.; Riedel, K.-D.; Suda, A.; Ueda, N.; Janabi, M.; Mugusi, F.; Haefeli, W. E.; Burhenne, J.; Aklillu, E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">676-684</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We investigated the influence of gender and pharmacogenetic variations on long-term efavirenz autoinduction and disposition among patients with HIV in Tanzania (N = 129).  Plasma concns. (at 16 h) of efavirenz and 8-hydroxyefavirenz were quantified at weeks 4 and 16 of therapy.  Genotyping was performed to identify cytochrome P 450 (CYP) 2B6*6, CYP3A5*3, *6, and *7, and ABCB1-3435 C/T genotypes.  There were redns. in the median efavirenz concn. (Wilcoxon matched-pair test P < 0.001) and efavirenz/8-hydroxyefavirenz ratio (P < 0.001) by 19 and 32%, resp., at week 16 as compared with week 4.  The proportion of patients with efavirenz concn. <1 μg/mL at week 16 was higher by 67, 25, and 5% in CYP2B6*1/*1, *1/*6, and *6/*6 genotypes, resp.  The defined therapeutic range based on obsd. plasma concns. is affected by the time point of sampling and the CYP2B6 genotype.  The effect of efavirenz autoinduction on reducing plasma exposure continues up to week 16 and predominantly affects CYP2B6 extensive metabolizers.  Among CYP2B6 slow metabolizers, the presence of a CYP3A5 genotype allele is assocd. with greater effects of efavirenz autoinduction on plasma concns. of the drug.  The cumulative induction may influence the long-term antiretroviral therapy outcome, particularly in CYP2B6*1 carriers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQJQEn9W8anbVg90H21EOLACvtfcHk0lhlWXRllRwqyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlWmurjI&md5=055c36fd0226217fbe57b00f25b04583</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2010.172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2010.172%26sid%3Dliteratum%253Aachs%26aulast%3DNgaimisi%26aufirst%3DE.%26aulast%3DMugusi%26aufirst%3DS.%26aulast%3DMinzi%26aufirst%3DO.%2BM.%26aulast%3DSasi%26aufirst%3DP.%26aulast%3DRiedel%26aufirst%3DK.%2BD.%26aulast%3DSuda%26aufirst%3DA.%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DJanabi%26aufirst%3DM.%26aulast%3DMugusi%26aufirst%3DF.%26aulast%3DHaefeli%26aufirst%3DW.%2BE.%26aulast%3DBurhenne%26aufirst%3DJ.%26aulast%3DAklillu%26aufirst%3DE.%26atitle%3DLong-term%2520efavirenz%2520autoinduction%2520and%2520its%2520effect%2520on%2520plasma%2520exposure%2520in%2520HIV%2520patients%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2010%26volume%3D88%26spage%3D676%26epage%3D684%26doi%3D10.1038%2Fclpt.2010.172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span> <span> </span><span class="NLM_article-title">Structure-brain exposure relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">7559</span>– <span class="NLM_lpage">7583</span>, <span class="refDoi"> DOI: 10.1021/jm060642i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure-brain+exposure+relationships&doi=10.1021%2Fjm060642i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-brain exposure relationships</span></div><div class="casAuthors">Hitchcock, Stephen A.; Pennington, Lewis D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7559-7583</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the use of structure modification to influence blood-brain barrier penetration by modulating either passive diffusion or active transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3V-TERRGy07Vg90H21EOLACvtfcHk0lhlWXRllRwqyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK&md5=97dff583ffae6d0ef66512ffbee38c34</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure-brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583%26doi%3D10.1021%2Fjm060642i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dirson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hindlet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">German-Fattal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gimenez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farinotti, R.</span></span> <span> </span><span class="NLM_article-title">Efavirenz does not interact with the ABCB1 transporter at the blood-brain barrier</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1525</span>– <span class="NLM_lpage">1532</span>, <span class="refDoi"> DOI: 10.1007/s11095-006-0279-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1007%2Fs11095-006-0279-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=16779703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFOmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2006&pages=1525-1532&author=G.+Dirsonauthor=C.+Fernandezauthor=P.+Hindletauthor=F.+Rouxauthor=M.+German-Fattalauthor=F.+Gimenezauthor=R.+Farinotti&title=Efavirenz+does+not+interact+with+the+ABCB1+transporter+at+the+blood-brain+barrier&doi=10.1007%2Fs11095-006-0279-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Efavirenz does not interact with the ABCB1 transporter at the blood-brain barrier</span></div><div class="casAuthors">Dirson, Gregoire; Fernandez, Christine; Hindlet, Patrick; Roux, Francoise; German-Fattal, Michele; Gimenez, Francois; Farinotti, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1525-1532</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">This work characterizes the interactions between efavirenz (EFV) and P-glycoprotein (P-gp/ABCB1) at the blood-brain barrier (BBB) and predicts the possible consequences on the brain uptake of coadministered P-gp substrates.  The uptake of EFV was measured in whole brains of rat and mdr1a-/- and mdr1a+/+ mice, and in GPNT cells (rat brain endothelial cell line) with and without P-gp inhibitors (PSC833, S9788, Quinidine).  The effect of a single dose or multiple doses of EFV on the P-gp functionality was evaluated in vivo and in vitro by measuring the brain and cell uptake of digoxin, completed by the anal. of the P-gp expression at the rat BBB after repeated administrations of EFV.  Inhibition of P-gp did not alter the uptake of EFV in rat brain and GPNT cells.  The EFV brain/plasma ratio in mdr1a-/- mice, lacking the expression of P-gp, was not different from that in mdr1a+/+ mice.  Moreover, a single dose of EFV did not modify the uptake of digoxin in rat brain and GPNT cells.  Finally, the 3-day exposure of GPNT cells to EFV did not have any effect on the uptake of digoxin.  Similarly, the 7-day treatment with EFV did not change the uptake of digoxin in rat brain nor the expression of P-gp at the BBB.  EFV is strongly distributed in the brain, but is neither a substrate nor an inhibitor of the P-gp at the blood-brain barrier.  On the other hand, EFV did not induce P-gp, allowing to sustain the brain accumulation of assocd. P-gp substrates such as protease inhibitors.  These findings make EFV suitable for combinations circumventing the brain HIV-1 residency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTZ_KOTO18LrVg90H21EOLACvtfcHk0lgqtzSyGaAkiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFOmtbc%253D&md5=cf726428f5b0f5a72db84205db4d6c7c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1007%2Fs11095-006-0279-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-006-0279-5%26sid%3Dliteratum%253Aachs%26aulast%3DDirson%26aufirst%3DG.%26aulast%3DFernandez%26aufirst%3DC.%26aulast%3DHindlet%26aufirst%3DP.%26aulast%3DRoux%26aufirst%3DF.%26aulast%3DGerman-Fattal%26aufirst%3DM.%26aulast%3DGimenez%26aufirst%3DF.%26aulast%3DFarinotti%26aufirst%3DR.%26atitle%3DEfavirenz%2520does%2520not%2520interact%2520with%2520the%2520ABCB1%2520transporter%2520at%2520the%2520blood-brain%2520barrier%26jtitle%3DPharm.%2520Res.%26date%3D2006%26volume%3D23%26spage%3D1525%26epage%3D1532%26doi%3D10.1007%2Fs11095-006-0279-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miksys, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyndale, R. F.</span></span> <span> </span><span class="NLM_article-title">Drug-metabolizing cytochrome P450s in the brain</span>. <i>J. Psychiatry Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">406</span>– <span class="NLM_lpage">415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=12491573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A280%3ADC%252BD38jivFKjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=406-415&author=S.+L.+Miksysauthor=R.+F.+Tyndale&title=Drug-metabolizing+cytochrome+P450s+in+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-metabolizing cytochrome P450s in the brain</span></div><div class="casAuthors">Miksys Sharon L; Tyndale Rachel F</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatry & neuroscience : JPN</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">406-15</span>
        ISSN:<span class="NLM_cas:issn">1180-4882</span>.
    </div><div class="casAbstract">Most CYP subfamilies have been identified in brain, but there is much more information available on the distribution and metabolic activity of CYP subfamilies in brain of rodents than in humans, and what we do know still lags far behind our knowledge of hepatic CYPs.  With the constant acquisition of data on the genetics, molecular structure and metabolic capacity of brain CYPs, we are increasingly able to investigate their role in the brain and the possible consequences of altered local metabolism.  However, at this stage, the contribution of brain CYPs to local metabolism of drugs, toxins and endogenous compounds is still speculative, as is the role for these CYPs in modulating brain function and in the development of brain diseases.  Much investigative work remains to be done to firmly establish the links between the presence of CYPs in brain, their function in this highly heterogeneous and complex organ and the consequences on overall brain function and health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQBOEzlWYddxtts4TFFB11gfW6udTcc2eZAMphRpb7mUrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38jivFKjsA%253D%253D&md5=0e3a0f568b9e61a3aecda38ae05aeb52</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiksys%26aufirst%3DS.%2BL.%26aulast%3DTyndale%26aufirst%3DR.%2BF.%26atitle%3DDrug-metabolizing%2520cytochrome%2520P450s%2520in%2520the%2520brain%26jtitle%3DJ.%2520Psychiatry%2520Neurosci.%26date%3D2002%26volume%3D27%26spage%3D406%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McFadyen, M. C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melvin, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, G. I.</span></span> <span> </span><span class="NLM_article-title">Regional distribution of individual forms of cytochrome P450 mRNA in normal adult human brain</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">825</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.1016/S0006-2952(97)00516-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1016%2FS0006-2952%2897%2900516-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=9586955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADyaK1cXitVKgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1998&pages=825-830&author=M.+C.+E.+McFadyenauthor=W.+T.+Melvinauthor=G.+I.+Murray&title=Regional+distribution+of+individual+forms+of+cytochrome+P450+mRNA+in+normal+adult+human+brain&doi=10.1016%2FS0006-2952%2897%2900516-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Regional distribution of individual forms of cytochrome P450 mRNA in normal adult human brain</span></div><div class="casAuthors">Mcfadyen, Morag C. E.; Melvin, William T.; Murray, Graeme I.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">825-830</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Cytochrome P 450 (CYP) isoforms represent a large family of hemoproteins which play a major role in the oxidative metab. of a wide range of xenobiotics and some endogenous compds.  Here, the presence of individual members of the CYP1, CYP2 and CYP3 P 450 families was investigated by reverse transcriptase-PCR in different regions of normal human brain consisting of frontal and temporal cortices, midbrain, cerebellum, pons, and medulla.  All cytochrome P 450 isoforms were identified in specific regions of brain with CYP1A1 and CYP2C being the most frequently expressed forms.  Sequencing identified the CYP2C PCR product as CYP2C8.  This study indicated that individual P 450 mRNAs are present in human brain and are found in specific brain regions.  The distribution of individual P 450 isoforms in different regions of the human brain is likely to be highly important in detg. the response of the brain to toxic foreign compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr20U11D82RrVg90H21EOLACvtfcHk0lgqtzSyGaAkiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitVKgsr8%253D&md5=07d7737abd7e31a594f7f7f9af9e2991</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2897%2900516-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252897%252900516-9%26sid%3Dliteratum%253Aachs%26aulast%3DMcFadyen%26aufirst%3DM.%2BC.%2BE.%26aulast%3DMelvin%26aufirst%3DW.%2BT.%26aulast%3DMurray%26aufirst%3DG.%2BI.%26atitle%3DRegional%2520distribution%2520of%2520individual%2520forms%2520of%2520cytochrome%2520P450%2520mRNA%2520in%2520normal%2520adult%2520human%2520brain%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1998%26volume%3D55%26spage%3D825%26epage%3D830%26doi%3D10.1016%2FS0006-2952%2897%2900516-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klose, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaisdell, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, J. A.</span></span> <span> </span><span class="NLM_article-title">Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs</span>. <i>J. Biochem. Mol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">295</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1099-0461(1999)13:6<289::AID-JBT1>3.0.CO;2-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1002%2F%28SICI%291099-0461%281999%2913%3A6%3C289%3A%3AAID-JBT1%3E3.0.CO%3B2-N" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10487415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADyaK1MXlvVWisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=289-295&author=T.+S.+Kloseauthor=J.+A.+Blaisdellauthor=J.+A.+Goldstein&title=Gene+structure+of+CYP2C8+and+extrahepatic+distribution+of+the+human+CYP2Cs&doi=10.1002%2F%28SICI%291099-0461%281999%2913%3A6%3C289%3A%3AAID-JBT1%3E3.0.CO%3B2-N"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs</span></div><div class="casAuthors">Klose, Theresa S.; Blaisdell, Joyce A.; Goldstein, Joyce A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemical and Molecular Toxicology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">289-295</span>CODEN:
                <span class="NLM_cas:coden">JBMTFQ</span>;
        ISSN:<span class="NLM_cas:issn">1095-6670</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Extrahepatic tissue distribution of the mRNAs for the four human CYP2Cs (2C8, 2C9, 2C18, and 2C19) was examd. in kidney, testes, adrenal gland, prostate, brain, uterus, mammary gland, ovary, lung, and duodenum.  CYP2C mRNAs were detected by RT-PCR using specific primers for each individual CYP2C.  CYP2C8 mRNA was detected in the kidney, adrenal gland, brain, uterus, mammary gland, ovary, and duodenum.  CYP2C9 mRNA was detected in the kidney, testes, adrenal gland, prostate, ovary, and duodenum.  CYP2C18 mRNA was found only in the brain, uterus, mammary gland, kidney, and duodenum and CYP2C19 mRNA was found only in the duodenum.  Immunoblot anal. of small intestinal microsomes detected both 2C9 and 2C19 proteins.  In addn., genomic clones for CYP2C8 were sequenced, and long-distance PCR was performed to det. the complete gene structure.  CYP2C8 spanned a 31 kb region.  Comparative anal. of the 2.4 kb upstream region of CYP2C8 with CYP2C9 revealed two previously unidentified transcription factors sites, C/EBP and HPF-1, and the latter might be involved in hepatic expression.  Although CYP2C8 has been shown to be phenobarbital inducible, neither a barbiturate-responsive regulatory sequence (a Barbie box) nor a phenobarbital-responsive enhancer module (PBREM) was found within the upstream region analyzed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9boqLhgNEGLVg90H21EOLACvtfcHk0lgqtzSyGaAkiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvVWisbc%253D&md5=dee35e42b32864a1de8e63da144493c6</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291099-0461%281999%2913%3A6%3C289%3A%3AAID-JBT1%3E3.0.CO%3B2-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291099-0461%25281999%252913%253A6%253C289%253A%253AAID-JBT1%253E3.0.CO%253B2-N%26sid%3Dliteratum%253Aachs%26aulast%3DKlose%26aufirst%3DT.%2BS.%26aulast%3DBlaisdell%26aufirst%3DJ.%2BA.%26aulast%3DGoldstein%26aufirst%3DJ.%2BA.%26atitle%3DGene%2520structure%2520of%2520CYP2C8%2520and%2520extrahepatic%2520distribution%2520of%2520the%2520human%2520CYP2Cs%26jtitle%3DJ.%2520Biochem.%2520Mol.%2520Toxicol.%26date%3D1999%26volume%3D13%26spage%3D289%26epage%3D295%26doi%3D10.1002%2F%28SICI%291099-0461%281999%2913%3A6%3C289%3A%3AAID-JBT1%3E3.0.CO%3B2-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björkhem, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Use of complementary cation and anion heavy-atom salt derivatives to solve the structure of cytochrome P450 46A1</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">495</span>, <span class="refDoi"> DOI: 10.1107/S0907444908004046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1107%2FS0907444908004046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=18453684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlagtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=487-495&author=M.+A.+Whiteauthor=N.+Mastauthor=I.+Bj%C3%B6rkhemauthor=E.+F.+Johnsonauthor=C.+D.+Stoutauthor=I.+A.+Pikuleva&title=Use+of+complementary+cation+and+anion+heavy-atom+salt+derivatives+to+solve+the+structure+of+cytochrome+P450+46A1&doi=10.1107%2FS0907444908004046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Use of complementary cation and anion heavy-atom salt derivatives to solve the structure of cytochrome P 450 46A1</span></div><div class="casAuthors">White, Mark Andrew; Mast, Natalia; Bjorkhem, Ingemar; Johnson, Eric F.; Stout, C. David; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">487-495</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Human cytochrome P 450 46A1 (CYP46A1) is one of the key enzymes in cholesterol homeostasis in the brain.  Here, the crystn. and heavy-atom structure soln. of an active truncated CYP46A1 in complex with the high-affinity substrate analog cholesterol 3-sulfate (CH-3S) is reported.  The 2.6 Å structure of CYP46A1-CH-3S was solved using both anion and cation heavy-atom salts.  In addn. to the native anomalous signal from the heme Fe, an NaI anion halide salt deriv. and a complementary CsCl alkali-metal cation salt deriv. were used.  The general implications of the use of halide and alkali-metal quick soaks are discussed.  The importance of using isoionic strength buffers, the titrn. of heavy-atom salts into different ionic species, and the role of concn. were considered.  It was obsd. that cation/anion-binding sites would occasionally overlap, which could neg. impact upon mixed RbBr soaks used for multiple anomalous scatterer MAD (MMAD).  The use of complementary cation and anion heavy-atom salt derivs. is a convenient and powerful tool for MIR(AS) structure soln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKdGXukX3OtLVg90H21EOLACvtfcHk0lgMOegdl9Q5jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlagtrY%253D&md5=7db15bbf5f39f17751ea6f167850aeb6</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1107%2FS0907444908004046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444908004046%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DM.%2BA.%26aulast%3DMast%26aufirst%3DN.%26aulast%3DBj%25C3%25B6rkhem%26aufirst%3DI.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DStout%26aufirst%3DC.%2BD.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DUse%2520of%2520complementary%2520cation%2520and%2520anion%2520heavy-atom%2520salt%2520derivatives%2520to%2520solve%2520the%2520structure%2520of%2520cytochrome%2520P450%252046A1%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2008%26volume%3D64%26spage%3D487%26epage%3D495%26doi%3D10.1107%2FS0907444908004046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teiber, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokones, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenberg, P. F.</span></span> <span> </span><span class="NLM_article-title">Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activities</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">324</span>– <span class="NLM_lpage">332</span>, <span class="refDoi"> DOI: 10.1006/abbi.1997.0534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1006%2Fabbi.1997.0534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=9473308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADyaK1cXhtVWgsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=1998&pages=324-332&author=I.+H.+Hannaauthor=J.+F.+Teiberauthor=K.+L.+Kokonesauthor=P.+F.+Hollenberg&title=Role+of+the+alanine+at+position+363+of+cytochrome+P450+2B2+in+influencing+the+NADPH-+and+hydroperoxide-supported+activities&doi=10.1006%2Fabbi.1997.0534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activities</span></div><div class="casAuthors">Hanna, Imad H.; Teiber, John F.; Kokones, Kristin L.; Hollenberg, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">324-332</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Escherichia coli was used to express the two closely related cytochromes P 450 2B1 and 2B2 and two mutants of 2B2 in which residues Gly-303 and Ala-363 were replaced by Ser and Val, resp.  The expressed proteins were partially purified and assayed for benzphetamine and n-octylamine (NOA) binding and 7-ethoxy-4-trifluoromethylcoumarin O-deethylation (EOD), benzphetamine N-demethylation (BND) and 7,12-dimethylbenz[a]anthracene (DMBA) hydroxylation activities in the presence and absence of cytochrome b5.  The Kd values for benzphetamine and NOA obtained for the wild-type enzymes were similar to reported values.  The Ala-363 → Val mutant (A363V) of 2B2 exhibited Kd values for both ligands that were more similar to 2B1 than to 2B2.  The EOD and BND activities of the A363V mutant were 10- and 3.8-fold those exhibited by 2B2, resp.  With DMBA, the A363V mutation led to a 6-fold increase in the hydroxylation activity at the 7-Me substituent while the hydroxylation activity at the 12-Me substituent was slightly suppressed.  The 7-hydroxymethyl:12-hydroxymethyl product ratio obtained with the A363V mutant (1.3) was much closer to the ratio obtained with 2B1 (1.9) than to that obtained with 2B2 (0.17).  Conversely, the Gly-303 → Ser substitution did not influence the characteristics of the 2B2-catalyzed metab. of DMBA to the same magnitude.  When cumene hydroperoxide (CHP) was used to support the EOD activities of the proteins, 2B2 exhibited a 2- to 20-fold greater activity than 2B1 or either of the mutants.  Examn. of the CHP-derived products of the EOD reactions revealed the formation of mainly 2-phenyl-2-propanol due to the heterolytic cleavage of CHP.  However, only the 2B1 EOD-reaction mixt. also contained the P 450-mediated CHP-isomerization products 2-phenyl-1,2-propanediol and 2-(p-hydroxyphenyl)-2-propanol.  The formation of these products with 2B1 but not 2B2 may explain why 2B1 is not as efficient as 2B2 or 2B2-G303S in carrying out the CHP-supported reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOjX6BJ2y4pbVg90H21EOLACvtfcHk0lgMOegdl9Q5jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtVWgsb8%253D&md5=62ba12f8077fd4efbde00af52193bb22</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1997.0534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1997.0534%26sid%3Dliteratum%253Aachs%26aulast%3DHanna%26aufirst%3DI.%2BH.%26aulast%3DTeiber%26aufirst%3DJ.%2BF.%26aulast%3DKokones%26aufirst%3DK.%2BL.%26aulast%3DHollenberg%26aufirst%3DP.%2BF.%26atitle%3DRole%2520of%2520the%2520alanine%2520at%2520position%2520363%2520of%2520cytochrome%2520P450%25202B2%2520in%2520influencing%2520the%2520NADPH-%2520and%2520hydroperoxide-supported%2520activities%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1998%26volume%3D350%26spage%3D324%26epage%3D332%26doi%3D10.1006%2Fabbi.1997.0534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reem, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bederman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiPatre, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björkhem, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Cholestenoic acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism with that in the brain</span>. <i>Invest. Ophthalmol. Visual Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">594</span>– <span class="NLM_lpage">603</span>, <span class="refDoi"> DOI: 10.1167/iovs.10-6021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1167%2Fiovs.10-6021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=20881306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVShtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=594-603&author=N.+Mastauthor=R.+Reemauthor=I.+Bedermanauthor=S.+Huangauthor=P.+L.+DiPatreauthor=I.+Bj%C3%B6rkhemauthor=I.+A.+Pikuleva&title=Cholestenoic+acid+is+an+important+elimination+product+of+cholesterol+in+the+retina%3A+comparison+of+retinal+cholesterol+metabolism+with+that+in+the+brain&doi=10.1167%2Fiovs.10-6021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Cholestenoic acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism with that in the brain</span></div><div class="casAuthors">Mast, Natalia; Reem, Rachel; Bederman, Ilya; Huang, Suber; DiPatre, Pier Luigi; Bjorkhem, Ingemar; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Investigative Ophthalmology & Visual Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">594-603</span>CODEN:
                <span class="NLM_cas:coden">IOVSDA</span>;
        ISSN:<span class="NLM_cas:issn">1552-5783</span>.
    
            (<span class="NLM_cas:orgname">Association for Research in Vision and Ophthalmology</span>)
        </div><div class="casAbstract">PURPOSE. Accumulating evidence indicates a link between cholesterol and age-related macular degeneration.  Yet, little is known about cholesterol elimination from the retina and retinal pigment epithelium (RPE), the two layers that are damaged in this blinding disease.  Several different pathways of enzymic cholesterol removal exist in extraocular tissues.  The authors tested whether metabolites from these pathways could also be quantified in the bovine and human retina and RPE.  For comparison, they measured cholesterol oxidn. products in two regions of the bovine and human brain and in the bovine liver and adrenal glands.  METHODS. Sterol quantification was carried out by isotope diln. gas chromatog.-mass spectrometry.  Bovine tissues were used first to optimize anal. procedures and to investigate postmortem changes in oxysterol concns.  Then human specimens were analyzed for oxysterol concns.  RESULTS. Qual., oxysterol profiles were similar in the bovine and human tissues.  In the human retina and RPE, the authors could not detect 27-hydroxycholesterol but unexpectedly found that its oxidn. product, 5-cholestenoic acid, is the most abundant oxysterol, varying up to threefold in different persons.  24S-Hydroxysterol and pregnenolone were also present in the retina, but at much lower quantities and without significant interindividual variability.  In the brain, the predominant oxysterol was 24S-hydroxycholesterol.  CONCLUSIONS. The oxysterol profile of the retina suggests that all known pathways of cholesterol elimination in extraocular organs are operative in the retina and that they likely vary depending on specific cell type.  However, overall oxidn. to 5-cholestenoic acid appears to be the predominant mechanism for cholesterol elimination from this organ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI2VlOcUrzmLVg90H21EOLACvtfcHk0lgMOegdl9Q5jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVShtro%253D&md5=e6125af623bff666cec1cc6c37076164</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1167%2Fiovs.10-6021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.10-6021%26sid%3Dliteratum%253Aachs%26aulast%3DMast%26aufirst%3DN.%26aulast%3DReem%26aufirst%3DR.%26aulast%3DBederman%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DDiPatre%26aufirst%3DP.%2BL.%26aulast%3DBj%25C3%25B6rkhem%26aufirst%3DI.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DCholestenoic%2520acid%2520is%2520an%2520important%2520elimination%2520product%2520of%2520cholesterol%2520in%2520the%2520retina%253A%2520comparison%2520of%2520retinal%2520cholesterol%2520metabolism%2520with%2520that%2520in%2520the%2520brain%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2011%26volume%3D52%26spage%3D594%26epage%3D603%26doi%3D10.1167%2Fiovs.10-6021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Binding of a cyano- and fluoro-containing drug bicalutamide to cytochrome P450 46A1: unusual features and spectral response</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">4613</span>– <span class="NLM_lpage">4624</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.438754</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1074%2Fjbc.M112.438754" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=23288837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1ajtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=4613-4624&author=N.+Mastauthor=W.+Zhengauthor=C.+D.+Stoutauthor=I.+A.+Pikuleva&title=Binding+of+a+cyano-+and+fluoro-containing+drug+bicalutamide+to+cytochrome+P450+46A1%3A+unusual+features+and+spectral+response&doi=10.1074%2Fjbc.M112.438754"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of a Cyano- and Fluoro-containing Drug Bicalutamide to Cytochrome P450 46A1</span></div><div class="casAuthors">Mast, Natalia; Zheng, Wenchao; Stout, C. David; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4613-4624</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cytochrome P 450 46A1 (CYP46A1) is the cholesterol 24-hydroxylase initiating the major pathways of cholesterol removal from the brain, and bicalutamide (BIC) is a drug of choice for the treatment of progressive androgen-dependent prostate cancer.  We evaluated the interactions of BIC with CYP46A1 by x-ray crystallog. and by conducting soln. and mutagenesis studies.  Because BIC is administered to patients as a racemic mixt. of the S and R isomers, we studied all three, racemic BIC as well as the S and R isomers.  Co-crystn. of CYP46A1 with racemic BIC led to structure detns. at 2.1 Å resoln. with the drug complexes exhibiting novel properties.  Both BIC isomers bind to the CYP46A1 active site in very similar single orientation and adopt an energetically unfavorable folded conformation.  This folded BIC conformation is correlated with drug-induced localized shifts of amino acid side chains in CYP46A1 and unusual interactions in the CYP46A1-BIC complex.  One of these interactions involves a water mol. that is coordinated to the P 450 heme iron and also hydrogen-bonded to the BIC nitrile.  Due to polarization of the water in this environment, the heme elicits previously unreported types of P 450 spectral responses.  We also obsd. that access to the P 450 active site was affected by differential recognition of S vs. R isomers at the CYP46A1 surface arising from BIC conformational polymorphism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopKoqOyJxaTbVg90H21EOLACvtfcHk0lgJt65aYPjnSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1ajtr0%253D&md5=084918e90d085e1dc4fc8831d7f4ba46</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.438754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.438754%26sid%3Dliteratum%253Aachs%26aulast%3DMast%26aufirst%3DN.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DStout%26aufirst%3DC.%2BD.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DBinding%2520of%2520a%2520cyano-%2520and%2520fluoro-containing%2520drug%2520bicalutamide%2520to%2520cytochrome%2520P450%252046A1%253A%2520unusual%2520features%2520and%2520spectral%2520response%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D4613%26epage%3D4624%26doi%3D10.1074%2Fjbc.M112.438754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frisch, M. J.</span>; <span class="NLM_string-name">Trucks, G. W.</span>; <span class="NLM_string-name">Schlegel, H. B.</span>; <span class="NLM_string-name">Scuseria, G. E.</span>; <span class="NLM_string-name">Robb, M. A.</span>; <span class="NLM_string-name">Cheeseman, J. R.</span>; <span class="NLM_string-name">Scalmani, G.</span>; <span class="NLM_string-name">Barone, V.</span>; <span class="NLM_string-name">Petersson, G. A.</span>; <span class="NLM_string-name">Nakatsuji, H.</span>; <span class="NLM_string-name">Li, X.</span>; <span class="NLM_string-name">Caricato, M.</span>; <span class="NLM_string-name">Marenich, A. V.</span>; <span class="NLM_string-name">Bloino, J.</span>; <span class="NLM_string-name">Janesko, B. G.</span>; <span class="NLM_string-name">Gomperts, R.</span>; <span class="NLM_string-name">Mennucci, B.</span>; <span class="NLM_string-name">Hratchian, H. P.</span>; <span class="NLM_string-name">Ortiz, J. V.</span>; <span class="NLM_string-name">Izmaylov, A. F.</span>; <span class="NLM_string-name">Sonnenberg, J. L.</span>; <span class="NLM_string-name">Williams</span>; ; <span class="NLM_string-name">Ding, F.</span>; <span class="NLM_string-name">Lipparini, F.</span>; <span class="NLM_string-name">Egidi, F.</span>; <span class="NLM_string-name">Goings, J.</span>; <span class="NLM_string-name">Peng, B.</span>; <span class="NLM_string-name">Petrone, A.</span>; <span class="NLM_string-name">Henderson, T.</span>; <span class="NLM_string-name">Ranasinghe, D.</span>; <span class="NLM_string-name">Zakrzewski, V. G.</span>; <span class="NLM_string-name">Gao, J.</span>; <span class="NLM_string-name">Rega, N.</span>; <span class="NLM_string-name">Zheng, G.</span>; <span class="NLM_string-name">Liang, W.</span>; <span class="NLM_string-name">Hada, M.</span>; <span class="NLM_string-name">Ehara, M.</span>; <span class="NLM_string-name">Toyota, K.</span>; <span class="NLM_string-name">Fukuda, R.</span>; <span class="NLM_string-name">Hasegawa, J.</span>; <span class="NLM_string-name">Ishida, M.</span>; <span class="NLM_string-name">Nakajima, T.</span>; <span class="NLM_string-name">Honda, Y.</span>; <span class="NLM_string-name">Kitao, O.</span>; <span class="NLM_string-name">Nakai, H.</span>; <span class="NLM_string-name">Vreven, T.</span>; <span class="NLM_string-name">Throssell, K.</span>; <span class="NLM_string-name">Montgomery, J. A.,  Jr.</span>; <span class="NLM_string-name">Peralta, J. E.</span>; <span class="NLM_string-name">Ogliaro, F.</span>; <span class="NLM_string-name">Bearpark, M. J.</span>; <span class="NLM_string-name">Heyd, J. J.</span>; <span class="NLM_string-name">Brothers, E. N.</span>; <span class="NLM_string-name">Kudin, K. N.</span>; <span class="NLM_string-name">Staroverov, V. N.</span>; <span class="NLM_string-name">Keith, T. A.</span>; <span class="NLM_string-name">Kobayashi, R.</span>; <span class="NLM_string-name">Normand, J.</span>; <span class="NLM_string-name">Raghavachari, K.</span>; <span class="NLM_string-name">Rendell, A. P.</span>; <span class="NLM_string-name">Burant, J. C.</span>; <span class="NLM_string-name">Iyengar, S. S.</span>; <span class="NLM_string-name">Tomasi, J.</span>; <span class="NLM_string-name">Cossi, M.</span>; <span class="NLM_string-name">Millam, J. M.</span>; <span class="NLM_string-name">Klene, M.</span>; <span class="NLM_string-name">Adamo, C.</span>; <span class="NLM_string-name">Cammi, R.</span>; <span class="NLM_string-name">Ochterski, J. W.</span>; <span class="NLM_string-name">Martin, R. L.</span>; <span class="NLM_string-name">Morokuma, K.</span>; <span class="NLM_string-name">Farkas, O.</span>; <span class="NLM_string-name">Foresman, J. B.</span>; <span class="NLM_string-name">Fox, D. J.</span></span> <i>Gaussian 16</i>, revision <span class="NLM_edition">A.03</span>; <span class="NLM_publisher-name">Gaussian, Inc.</span>: <span class="NLM_publisher-loc">Wallingford, CT</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+J.+Frisch&author=G.+W.+Trucks&author=H.+B.+Schlegel&author=G.+E.+Scuseria&author=M.+A.+Robb&author=J.+R.+Cheeseman&author=G.+Scalmani&author=V.+Barone&author=G.+A.+Petersson&author=H.+Nakatsuji&author=X.+Li&author=M.+Caricato&author=A.+V.+Marenich&author=J.+Bloino&author=B.+G.+Janesko&author=R.+Gomperts&author=B.+Mennucci&author=H.+P.+Hratchian&author=J.+V.+Ortiz&author=A.+F.+Izmaylov&author=J.+L.+Sonnenberg&author=+Williams&author=F.+Ding&author=F.+Lipparini&author=F.+Egidi&author=J.+Goings&author=B.+Peng&author=A.+Petrone&author=T.+Henderson&author=D.+Ranasinghe&author=V.+G.+Zakrzewski&author=J.+Gao&author=N.+Rega&author=G.+Zheng&author=W.+Liang&author=M.+Hada&author=M.+Ehara&author=K.+Toyota&author=R.+Fukuda&author=J.+Hasegawa&author=M.+Ishida&author=T.+Nakajima&author=Y.+Honda&author=O.+Kitao&author=H.+Nakai&author=T.+Vreven&author=K.+Throssell&author=J.+A.+Montgomery&author=J.+E.+Peralta&author=F.+Ogliaro&author=M.+J.+Bearpark&author=J.+J.+Heyd&author=E.+N.+Brothers&author=K.+N.+Kudin&author=V.+N.+Staroverov&author=T.+A.+Keith&author=R.+Kobayashi&author=J.+Normand&author=K.+Raghavachari&author=A.+P.+Rendell&author=J.+C.+Burant&author=S.+S.+Iyengar&author=J.+Tomasi&author=M.+Cossi&author=J.+M.+Millam&author=M.+Klene&author=C.+Adamo&author=R.+Cammi&author=J.+W.+Ochterski&author=R.+L.+Martin&author=K.+Morokuma&author=O.+Farkas&author=J.+B.+Foresman&author=D.+J.+Fox&title=Gaussian+16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DFrisch%26aufirst%3DM.%2BJ.%26jtitle%3DGaussian%252016%26pub%3DGaussian%252C%2520Inc%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belew, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2785</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDockTools4%3A+automated+docking+with+selective+receptor+flexibility&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0lgJt65aYPjnSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520automated%2520docking%2520with%2520selective%2520receptor%2520flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trott, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2009&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span> <span> </span><span class="NLM_article-title">Enriching screening libraries with bioactive fragment space</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3594</span>– <span class="NLM_lpage">3597</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1016%2Fj.bmcl.2016.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=27311891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvF2qur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3594-3597&author=N.+Zhangauthor=H.+Zhao&title=Enriching+screening+libraries+with+bioactive+fragment+space&doi=10.1016%2Fj.bmcl.2016.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Enriching screening libraries with bioactive fragment space</span></div><div class="casAuthors">Zhang, Na; Zhao, Hongtao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3594-3597</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">By deconvoluting 238,073 bioactive mols. in the ChEMBL library into extended Murcko ring systems, we identified a set of 2245 ring systems present in at least 10 mols.  These ring systems belong to 2221 clusters by ECFP4 fingerprints with a min. intracluster similarity of 0.8.  Their overlap with ring systems in com. libraries was further quantified.  Our findings suggest that success of a small fragment library is driven by the convergence of effective coverage of bioactive ring systems (e.g., 10% coverage by 1000 fragments vs. 40% by 2 million HTS compds.), high enrichment of bioactive ring systems, and low mol. complexity enhancing the probability of a match with the protein targets.  Reconciling with the previous studies, bioactive ring systems are underrepresented in screening libraries.  As such, we propose a library of virtual fragments with key functionalities via fragmentation of bioactive mols.  Its utility is exemplified by a prospective application on protein kinase CK2, resulting in the discovery of a series of novel inhibitors with the most potent compd. having an IC50 of 0.5 μM and a ligand efficiency of 0.41 kcal/mol per heavy atom.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4bxc8wtSc1bVg90H21EOLACvtfcHk0lhdf2KMTTzy4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvF2qur8%253D&md5=d4a071d6ca7785c654b08964659eed22</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DH.%26atitle%3DEnriching%2520screening%2520libraries%2520with%2520bioactive%2520fragment%2520space%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3594%26epage%3D3597%26doi%3D10.1016%2Fj.bmcl.2016.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span> <span> </span><span class="NLM_article-title">Python: a programming language for software integration and development</span>. <i>J. Mol. Graphics Modell.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10660911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtV2rsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=57-61&author=M.+F.+Sanner&title=Python%3A+a+programming+language+for+software+integration+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Python: a programming language for software integration and development</span></div><div class="casAuthors">Sanner, M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-61</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The use of interpreted languages in biocomputing has been investigated to create a programmable, dynamic environment in which components can be tied together at a high level.  This work has demonstrated the benefits of such an approach and the features of the interpreted language that are key to successful component integration.  This involved Python, an interpreted, interactive, object-oriented programming language.  It provides high-level data structures such as list and associative arrays, dynamic typing and dynamic binding, modules, classes, exceptions, automatic memory management and others.  Python has been found to be instrumental in the mol. modeling research environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaCFXA1JC8X7Vg90H21EOLACvtfcHk0lhdf2KMTTzy4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtV2rsA%253D%253D&md5=3bf94934548080055dda54f68468c656</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanner%26aufirst%3DM.%2BF.%26atitle%3DPython%253A%2520a%2520programming%2520language%2520for%2520software%2520integration%2520and%2520development%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D1999%26volume%3D17%26spage%3D57%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Boyle, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banck, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandermeersch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchison, G. R.</span></span> <span> </span><span class="NLM_article-title">Open Babel: An open chemical toolbox</span>. <i>J. Cheminf.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">33</span>, <span class="refDoi"> DOI: 10.1186/1758-2946-3-33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1186%2F1758-2946-3-33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=21982300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVWjurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=33&author=N.+M.+O%E2%80%99Boyleauthor=M.+Banckauthor=C.+A.+Jamesauthor=C.+Morleyauthor=T.+Vandermeerschauthor=G.+R.+Hutchison&title=Open+Babel%3A+An+open+chemical+toolbox&doi=10.1186%2F1758-2946-3-33"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Open Babel: an open chemical toolbox</span></div><div class="casAuthors">O'Boyle, Noel M.; Banck, Michael; James, Craig A.; Morley, Chris; Vandermeersch, Tim; Hutchison, Geoffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cheminformatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">33</span>CODEN:
                <span class="NLM_cas:coden">JCOHB3</span>;
        ISSN:<span class="NLM_cas:issn">1758-2946</span>.
    
            (<span class="NLM_cas:orgname">Chemistry Central Ltd.</span>)
        </div><div class="casAbstract">Background: A frequent problem in computational modeling is the interconversion of chem. structures between different formats.  While std. interchange formats exist (for example, Chem. Markup Language) and de facto stds. have arisen (for example, SMILES format), the need to interconvert formats is a continuing problem due to the multitude of different application areas for chem. data, differences in the data stored by different formats (0D vs. 3D, for example), and competition between software along with a lack of vendor-neutral formats.  Results: We discuss, for the first time, Open Babel, an open-source chem. toolbox that speaks the many languages of chem. data.  Open Babel version 2.3 interconverts over 110 formats.  The need to represent such a wide variety of chem. and mol. data requires a library that implements a wide range of cheminformatics algorithms, from partial charge assignment and aromaticity detection, to bond order perception and canonicalization.  We detail the implementation of Open Babel, describe key advances in the 2.3 release, and outline a variety of uses both in terms of software products and scientific research, including applications far beyond simple format interconversion.  Conclusions: Open Babel presents a soln. to the proliferation of multiple chem. file formats.  In addn., it provides a variety of useful utilities from conformer searching and 2D depiction, to filtering, batch conversion, and substructure and similarity searching.  For developers, it can be used as a programming library to handle chem. data in areas such as org. chem., drug design, materials science, and computational chem.  It is freely available under an open-source license.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfQ1lvaS5767Vg90H21EOLACvtfcHk0lg_R0xsd8hLPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVWjurbF&md5=74e4f19b7f87417f916d57f7abcfb761</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1186%2F1758-2946-3-33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1758-2946-3-33%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DN.%2BM.%26aulast%3DBanck%26aufirst%3DM.%26aulast%3DJames%26aufirst%3DC.%2BA.%26aulast%3DMorley%26aufirst%3DC.%26aulast%3DVandermeersch%26aufirst%3DT.%26aulast%3DHutchison%26aufirst%3DG.%2BR.%26atitle%3DOpen%2520Babel%253A%2520An%2520open%2520chemical%2520toolbox%26jtitle%3DJ.%2520Cheminf.%26date%3D2011%26volume%3D3%26spage%3D33%26doi%3D10.1186%2F1758-2946-3-33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blom, T.</span></span> <span> </span><span class="NLM_article-title">Global kinetic explorer: a new computer program for dynamic simulation and fitting of kinetic data</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>387</i></span>,  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2008.12.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1016%2Fj.ab.2008.12.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=19154726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFKjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2009&pages=20-29&author=K.+A.+Johnsonauthor=Z.+B.+Simpsonauthor=T.+Blom&title=Global+kinetic+explorer%3A+a+new+computer+program+for+dynamic+simulation+and+fitting+of+kinetic+data&doi=10.1016%2Fj.ab.2008.12.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Global Kinetic Explorer: A new computer program for dynamic simulation and fitting of kinetic data</span></div><div class="casAuthors">Johnson, Kenneth A.; Simpson, Zachary B.; Blom, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-29</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We describe a new dynamic kinetic simulation program that allows multiple data sets to be fit simultaneously to a single model based on numerical integration of the rate equations describing the reaction mechanism.  Unlike other programs that allow fitting based on numerical integration of rate equations, in the dynamic simulation rate consts., output factors, and starting concns. of reactants can be scrolled while observing the change in the shape of the simulated reaction curves.  Fast dynamic simulation facilitates the exploration of initial parameters that serve as the starting point for nonlinear regression in fitting data and facilitates exploration of the relationships between individual consts. and observable reactions.  The exploration of parameter space by dynamic simulation provides a powerful tool for learning kinetics and for evaluating the extent to which parameters are constrained by the data.  This feature is crit. to avoid overly complex models that are not supported by the data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTFFZnhMRb-rVg90H21EOLACvtfcHk0lg_R0xsd8hLPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFKjt7c%253D&md5=1d0227c91a334f47edae70f5a89478ff</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2008.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2008.12.024%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DK.%2BA.%26aulast%3DSimpson%26aufirst%3DZ.%2BB.%26aulast%3DBlom%26aufirst%3DT.%26atitle%3DGlobal%2520kinetic%2520explorer%253A%2520a%2520new%2520computer%2520program%2520for%2520dynamic%2520simulation%2520and%2520fitting%2520of%2520kinetic%2520data%26jtitle%3DAnal.%2520Biochem.%26date%3D2009%26volume%3D387%26spage%3D20%26epage%3D29%26doi%3D10.1016%2Fj.ab.2008.12.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Antifungal azoles: structural insights into undesired tight binding to cholesterol-metabolizing CYP46A1</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1124/mol.113.085902</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1124%2Fmol.113.085902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=23604141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVajsbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=86-94&author=N.+Mastauthor=W.+Zhengauthor=C.+D.+Stoutauthor=I.+A.+Pikuleva&title=Antifungal+azoles%3A+structural+insights+into+undesired+tight+binding+to+cholesterol-metabolizing+CYP46A1&doi=10.1124%2Fmol.113.085902"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Antifungal azoles: structural insights into undesired tight binding to cholesterol-metabolizing CYP46A1</span></div><div class="casAuthors">Mast, Natalia; Zheng, Wenchao; Stout, C. David; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">86-94</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Although there are currently three generations of antifungal azoles on the market, even the third-generation agents show undesirable interactions with human cytochrome P 450 (P 450) enzymes.  CYP46A1 is a cholesterol-metabolizing P 450 in the brain that tightly binds a no. of structurally distinct azoles.  Previously, we detd. the crystal structures of CYP46A1 in complex with voriconazole and clotrimazole, and in the present work we cocrystd. the P 450 with posaconazole at 2.5 Å resoln.  This long antifungal drug coordinates the P 450 heme iron with the nitrogen atom of its terminal azole ring and adopts a linear configuration occupying the whole length of the substrate access channel and extending beyond the protein surface.  Numerous drug-protein interactions det. the submicromolar Kd of posaconazole for CYP46A1.  We compared the crystal structure of posaconazole-bound CYP46A1 with those of the P 450 in complex with other drugs, including the antifungal voriconazole and clotrimazole.  We also analyzed the accommodation of posaconazole in the active site of the target enzymes, CYPs 51, from several pathogenic species.  These and the soln. studies with different marketed azoles, collectively, allowed us to identify the determinants of tight azole binding to CYP46A1 and generate an overall picture of azole binding to this important P 450.  The data obtained suggest that development of CYP51-specific antifungal agents will continue to be a challenge.  Therefore, structural understanding of the azole binding not only to CYPs 51 from the pathogenic species but also to different human P450s is required to deal efficiently with this challenge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRLxgeEtx4YbVg90H21EOLACvtfcHk0lg_R0xsd8hLPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVajsbjL&md5=6b5af98bb32f9a5f3be0e84248a82941</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.085902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.085902%26sid%3Dliteratum%253Aachs%26aulast%3DMast%26aufirst%3DN.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DStout%26aufirst%3DC.%2BD.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DAntifungal%2520azoles%253A%2520structural%2520insights%2520into%2520undesired%2520tight%2520binding%2520to%2520cholesterol-metabolizing%2520CYP46A1%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26spage%3D86%26epage%3D94%26doi%3D10.1124%2Fmol.113.085902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björkhem, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Cholesterol binding to cytochrome P450 7A1, a key enzyme in bile acid biosynthrsis</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">3259</span>– <span class="NLM_lpage">3271</span>, <span class="refDoi"> DOI: 10.1021/bi047566a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi047566a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFehtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=3259-3271&author=N.+Mastauthor=S.+E.+Grahamauthor=U.+Anderssonauthor=I.+Bj%C3%B6rkhemauthor=C.+Hillauthor=J.+Petersonauthor=I.+A.+Pikuleva&title=Cholesterol+binding+to+cytochrome+P450+7A1%2C+a+key+enzyme+in+bile+acid+biosynthrsis&doi=10.1021%2Fbi047566a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Cholesterol Binding to Cytochrome P450 7A1, a Key Enzyme in Bile Acid Biosynthesis</span></div><div class="casAuthors">Mast, Natalia; Graham, Sandra E.; Andersson, Ulla; Bjorkhem, Ingemar; Hill, Courtney; Peterson, Julian; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3259-3271</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The conversion of cholesterol to 7α-hydroxycholesterol catalyzed by cytochrome P 450 7A1 (CYP7A1) initiates the major pathway for cholesterol elimination in mammals.  In the present work we focused on identification of determinants of the CYP7A1 substrate specificity inside the active site using a homol. model with a novel P 450-fold, site-directed mutagenesis, and substrate-binding and kinetic studies.  Forty-one mutants, encompassing twenty-six amino acid residues, were generated and characterized, and of these, seven residues appear to det. cholesterol binding in the active site.  In addn., four cholesterol derivs. were used as active site probes in the wild type and the seven mutant enzymes, and the spectral binding consts. and products were analyzed.  It was concluded that Asn288 in the I helix plays a key role in the P 450-cholesterol contacts by hydrogen bonding to the steroid 3β-hydroxyl, while Val280 and Ala284 are beside and the Trp283 is above the steroid nucleus orienting the cholesterol mol.  Leu360 and Ala358 between the K helix and the β1-4 strand and Leu485 in the β4 sheet-turn appear to define the size of the active site over the heme pyrrole ring A, thus limiting the orientation and size of the substrate at the steroid A ring.  Addnl., the A358V mutant was found to form two new products, one being 7β-hydroxycholesterol.  Our data indicate that a tight fit of cholesterol in the enzyme active site is in part responsible for the high efficiency of cholesterol turnover by CYP7A1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRO2XJUx4RXbVg90H21EOLACvtfcHk0lh92cYPVoyumg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFehtLY%253D&md5=e0198a07b011f0062a8c7aef2f67ded1</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fbi047566a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi047566a%26sid%3Dliteratum%253Aachs%26aulast%3DMast%26aufirst%3DN.%26aulast%3DGraham%26aufirst%3DS.%2BE.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DBj%25C3%25B6rkhem%26aufirst%3DI.%26aulast%3DHill%26aufirst%3DC.%26aulast%3DPeterson%26aufirst%3DJ.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DCholesterol%2520binding%2520to%2520cytochrome%2520P450%25207A1%252C%2520a%2520key%2520enzyme%2520in%2520bile%2520acid%2520biosynthrsis%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D3259%26epage%3D3271%26doi%3D10.1021%2Fbi047566a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">F. Peter Guengerich, Stella A. Child, Ian R. Barckhausen, <span class="NLM_string-name hlFld-ContribAuthor">Margo H. Goldfarb</span>. </span><span class="cited-content_cbyCitation_article-title">Kinetic Evidence for an Induced-Fit Mechanism in the Binding of the Substrate Camphor by Cytochrome P450cam. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2021,</strong> <em>11 </em>
                                    (2)
                                     , 639-649. <a href="https://doi.org/10.1021/acscatal.0c04455" title="DOI URL">https://doi.org/10.1021/acscatal.0c04455</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c04455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c04455%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DKinetic%252BEvidence%252Bfor%252Ban%252BInduced-Fit%252BMechanism%252Bin%252Bthe%252BBinding%252Bof%252Bthe%252BSubstrate%252BCamphor%252Bby%252BCytochrome%252BP450cam%26aulast%3DGuengerich%26aufirst%3DF.%2BPeter%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14102020%26date%3D12122020%26date%3D29122020%26volume%3D11%26issue%3D2%26spage%3D639%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Johan E. van Lier</span>. </span><span class="cited-content_cbyCitation_article-title">New Therapeutic Targets for Brain Function and Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (12)
                                     , 6474-6476. <a href="https://doi.org/10.1021/acs.jmedchem.9b01947" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01947</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01947%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252BTherapeutic%252BTargets%252Bfor%252BBrain%252BFunction%252Band%252BDisease%26aulast%3Dvan%2BLier%26aufirst%3DJohan%2BE.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D25112019%26date%3D17122019%26volume%3D63%26issue%3D12%26spage%3D6474%26epage%3D6476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Libo  Zhang</span>, <span class="hlFld-ContribAuthor ">Dumei  Ma</span>, <span class="hlFld-ContribAuthor ">Yingwu  Yin</span>, <span class="hlFld-ContribAuthor ">Qian  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Using Small Molecules to Enhance P450 OleT Enzyme Activity in Situ. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>27 </em>
                                    (35)
                                     , 8940-8945. <a href="https://doi.org/10.1002/chem.202100680" title="DOI URL">https://doi.org/10.1002/chem.202100680</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202100680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202100680%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DUsing%252BSmall%252BMolecules%252Bto%252BEnhance%252BP450%252BOleT%252BEnzyme%252BActivity%252Bin%252BSitu%26aulast%3DZhang%26aufirst%3DLibo%26date%3D2021%26date%3D2021%26volume%3D27%26issue%3D35%26spage%3D8940%26epage%3D8945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alejandro O.  Sodero</span>. </span><span class="cited-content_cbyCitation_article-title">24S‐hydroxycholesterol: Cellular effects and variations in brain diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neurochemistry</span><span> <strong>2021,</strong> <em>157 </em>
                                    (4)
                                     , 899-918. <a href="https://doi.org/10.1111/jnc.15228" title="DOI URL">https://doi.org/10.1111/jnc.15228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jnc.15228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjnc.15228%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neurochemistry%26atitle%3D24S%2525E2%252580%252590hydroxycholesterol%25253A%252BCellular%252Beffects%252Band%252Bvariations%252Bin%252Bbrain%252Bdiseases%26aulast%3DSodero%26aufirst%3DAlejandro%2BO.%26date%3D2021%26date%3D2020%26volume%3D157%26issue%3D4%26spage%3D899%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F. Peter  Guengerich</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Metabolism: Cytochrome P450. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-820472-6.99996-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-820472-6.99996-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-820472-6.99996-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-820472-6.99996-1%26sid%3Dliteratum%253Aachs%26atitle%3DDrug%252BMetabolism%25253A%252BCytochrome%252BP450%26aulast%3DGuengerich%26aufirst%3DF.%2BPeter%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BBiomedical%252BSciences%26date%3D2021%26volume%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toshiya  Nishi</span>, <span class="hlFld-ContribAuthor ">Shinichi  Kondo</span>, <span class="hlFld-ContribAuthor ">Maki  Miyamoto</span>, <span class="hlFld-ContribAuthor ">Sayuri  Watanabe</span>, <span class="hlFld-ContribAuthor ">Shigeo  Hasegawa</span>, <span class="hlFld-ContribAuthor ">Shigeru  Kondo</span>, <span class="hlFld-ContribAuthor ">Jason  Yano</span>, <span class="hlFld-ContribAuthor ">Etsurou  Watanabe</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Ishi</span>, <span class="hlFld-ContribAuthor ">Masato  Yoshikawa</span>, <span class="hlFld-ContribAuthor ">Haruhi Kamisaki  Ando</span>, <span class="hlFld-ContribAuthor ">William  Farnaby</span>, <span class="hlFld-ContribAuthor ">Shinji  Fujimoto</span>, <span class="hlFld-ContribAuthor ">Eiji  Sunahara</span>, <span class="hlFld-ContribAuthor ">Momoko  Ohori</span>, <span class="hlFld-ContribAuthor ">Matthew J.  During</span>, <span class="hlFld-ContribAuthor ">Takanobu  Kuroita</span>, <span class="hlFld-ContribAuthor ">Tatsuki  Koike</span>. </span><span class="cited-content_cbyCitation_article-title">Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-74036-6" title="DOI URL">https://doi.org/10.1038/s41598-020-74036-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-74036-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-74036-6%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DSoticlestat%25252C%252Ba%252Bnovel%252Bcholesterol%252B24-hydroxylase%252Binhibitor%252Bshows%252Ba%252Btherapeutic%252Bpotential%252Bfor%252Bneural%252Bhyperexcitation%252Bin%252Bmice%26aulast%3DNishi%26aufirst%3DToshiya%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Enrico  Di Cera</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanisms of ligand binding. </span><span class="cited-content_cbyCitation_journal-name">Biophysics Reviews</span><span> <strong>2020,</strong> <em>1 </em>
                                    (1)
                                     , 011303. <a href="https://doi.org/10.1063/5.0020997" title="DOI URL">https://doi.org/10.1063/5.0020997</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1063/5.0020997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1063%2F5.0020997%26sid%3Dliteratum%253Aachs%26jtitle%3DBiophysics%2520Reviews%26atitle%3DMechanisms%252Bof%252Bligand%252Bbinding%26aulast%3DDi%2BCera%26aufirst%3DEnrico%26date%3D2020%26volume%3D1%26issue%3D1%26spage%3D011303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen  Chen</span>, <span class="hlFld-ContribAuthor ">Jiahui  Chen</span>, <span class="hlFld-ContribAuthor ">Natalia  Mast</span>, <span class="hlFld-ContribAuthor ">Jian  Rong</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Deng</span>, <span class="hlFld-ContribAuthor ">Tuo  Shao</span>, <span class="hlFld-ContribAuthor ">Hualong  Fu</span>, <span class="hlFld-ContribAuthor ">Qingzhen  Yu</span>, <span class="hlFld-ContribAuthor ">Jiyun  Sun</span>, <span class="hlFld-ContribAuthor ">Yihan  Shao</span>, <span class="hlFld-ContribAuthor ">Lee  Josephson</span>, <span class="hlFld-ContribAuthor ">Thomas Lee  Collier</span>, <span class="hlFld-ContribAuthor ">Irina  Pikuleva</span>, <span class="hlFld-ContribAuthor ">Steven H.  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and pharmacokinetic study of a 11C-labeled cholesterol 24-hydroxylase inhibitor using ‘in-loop’ [11C]CO2 fixation method. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (9)
                                     , 127068. <a href="https://doi.org/10.1016/j.bmcl.2020.127068" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127068</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127068%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bpharmacokinetic%252Bstudy%252Bof%252Ba%252B11C-labeled%252Bcholesterol%252B24-hydroxylase%252Binhibitor%252Busing%252B%2525E2%252580%252598in-loop%2525E2%252580%252599%252B%25255B11C%25255DCO2%252Bfixation%252Bmethod%26aulast%3DChen%26aufirst%3DZhen%26date%3D2020%26volume%3D30%26issue%3D9%26spage%3D127068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Filip  Miljković</span>, <span class="hlFld-ContribAuthor ">Rui  Xiong</span>, <span class="hlFld-ContribAuthor ">Dakshinamurthy  Sivakumar</span>, <span class="hlFld-ContribAuthor ">Christopher Alan  Brown</span>. </span><span class="cited-content_cbyCitation_article-title">Members of our Early Career Panel highlight key research articles on the theme of drug repurposing. </span><span class="cited-content_cbyCitation_journal-name">Future Drug Discovery</span><span> <strong>2020,</strong> <em>2 </em>
                                    (2)
                                     , FDD39. <a href="https://doi.org/10.4155/fdd-2020-0009" title="DOI URL">https://doi.org/10.4155/fdd-2020-0009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fdd-2020-0009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffdd-2020-0009%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Drug%2520Discovery%26atitle%3DMembers%252Bof%252Bour%252BEarly%252BCareer%252BPanel%252Bhighlight%252Bkey%252Bresearch%252Barticles%252Bon%252Bthe%252Btheme%252Bof%252Bdrug%252Brepurposing%26aulast%3DMiljkovi%25C4%2587%26aufirst%3DFilip%26date%3D2020%26volume%3D2%26issue%3D2%26spage%3DFDD39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F. Peter  Guengerich</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Metabolism: Cytochrome P450. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-820472-6.00001-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-820472-6.00001-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-820472-6.00001-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-820472-6.00001-3%26sid%3Dliteratum%253Aachs%26atitle%3DDrug%252BMetabolism%25253A%252BCytochrome%252BP450%26aulast%3DGuengerich%26aufirst%3DF.%2BPeter%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/medium/jm9b01383_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01383&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/medium/jm9b01383_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. EFV metabolites and analogs. (a, c) Chemical structures of EFV, its metabolites, and analogs studied in the present work. Structural divergence from EFV is highlighted in either red font or circles. EFV metabolism by the cytochrome P450 enzymes is also shown and taken with permission from ref <a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a>. (b, d) Dependence of CYP46A1 activity in vitro on the concentration of (<i>S</i>)-EFV or an EFV-related compound. CYP46A1 activity (the rate of cholesterol 24-hydroxylation) is presented as nanomoles of 24-hydroxycholesterol (24HC) formed per nmole of CYP46A1 per min. The range of the tested compound concentrations is based on our previous study,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> in which 100 μM (<i>S</i>)-EFV almost completely inhibited CYP46A1. The results are the mean ± SD of the measurements from the three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01383&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/medium/jm9b01383_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Spectral responses induced in substrate-free CYP46A1 by EFV-related compounds. Data for (<i>S</i>)-EFV are shown in the center. Δ<i>A</i> is the amplitude of spectral changes in the P450 difference spectra (insets). The results are presented as the mean ± SD of the measurements in the three spectral titrations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01383&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/medium/jm9b01383_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Spectral responses induced in cholesterol-bound CYP46A1 by EFV-related compounds. Data for (<i>S</i>)-EFV are shown in the center. Δ<i>A</i> is the amplitude of spectral changes in the P450 difference spectra (insets). The results are presented as the mean ± SD of the measurements in the three spectral titrations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01383&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/medium/jm9b01383_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Mapping of the CYP46A1 allosteric site for <i>rac</i>-<b>3</b>. (a–c) Computational models of (<i>S</i>)-EFV (black), <span class="smallcaps smallerCapital">l</span>-Glu (yellow), (<i>S</i>)-<b>3</b> (dark green), and (<i>R</i>)-<b>3</b> (light green) binding to the CYP46A1 surface. Docking experiments were carried out on PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Q9G">2Q9G</a>. Models for (<i>S</i>)-EFV and <span class="smallcaps smallerCapital">l</span>-Glu are taken from ref <a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a>, and those for (<i>S</i>)-<b>3</b> and (<i>R</i>)-<b>3</b> were generated in the present work. The heme group is in red. The nitrogen, oxygen, chlorine, and fluorine atoms are in blue, red, light green, and cyan, respectively. (d) Effect of <span class="smallcaps smallerCapital">l</span>-Glu (100 μM), (<i>S</i>)-EFV (20 μM), or EFV analog (20 μM) on the maximal extent of CYP46A1 activation. CYP46A1 activity is presented as nanomoles of 24-hydroxycholesterol (24HC) formed per nmole of CYP46A1 per min. Control incubations with no activator, <span class="smallcaps smallerCapital">l</span>-Glu only, and (<i>S</i>)-EFV only are shown as a white, yellow, and black bar, respectively. Incubations with an EFV-related compound only are shown as solid colored bars, and co-incubations with <span class="smallcaps smallerCapital">l</span>-Glu and (<i>S</i>)-EFV are shown as dashed (yellow and black dashes, respectively) colored bars. The results are presented as the mean ± SD of the measurements from the three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01383&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/medium/jm9b01383_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mapping of the CYP46A1 allosteric site(s) for binding of EFV-related compounds. (a, b) Maximal activity of wild type (WT) CYP46A1 and the P450 mutants in the absence (white bars) or presence of different EFV-related compounds (20 μM, colored bars). CYP46A1 activity is presented as nanomoles of 24-hydroxycholesterol (24HC) formed per nmole of CYP46A1 per min. The results are presented as the mean ± SD of the measurements from the three independent experiments. (c–e). Some of the amino acid residues forming EFV binding site (c) and Glu binding site (d and e) as well as the border between the sites (c–e). The positions of (<i>S</i>)-EFV, (<i>S</i>)-<b>3</b>, and (<i>R</i>)-<b>3</b> within these sites are also shown. Docking experiments were carried out on PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Q9G">2Q9G</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01383&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/medium/jm9b01383_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Binding of (<i>S</i>)-EFV and <i>rac</i>-<b>3</b> to CYP46A1. The P450 (4 μM) was mixed with varying concentrations of a compound, and spectra were collected and analyzed. (a, b) Mixing CYP46A1 with low (2 μM) and (c, d) high (50 μM or 60 μM) compound concentrations. (e, f) Mixing of 4 μM P450 46A1·4 μM cholesterol complex with 50 μM or 2 μM compound. The fits shown are single exponentials. At least four individual traces were collected and averaged.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01383&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/medium/jm9b01383_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Dependence of rates of binding to CYP46A1 as a function of compound concentration. Traces of Δ(<i>A</i><sub>437</sub> – <i>A</i><sub>416</sub>) (e.g., <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) were fit to single exponential plots. The error bars show the SD of the OLIS software fits. At least four separate reactions were averaged for each data point.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-12/acs.jmedchem.9b01383/20200618/images/large/jm9b01383_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01383&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63307" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63307" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 72 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, T. T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">In vitro cytochrome P450 46A1 (CYP46A1) activation by neuroactive compounds</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">12934</span>– <span class="NLM_lpage">12946</span>, <span class="refDoi"> DOI: 10.1074/jbc.M117.794909</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1074%2Fjbc.M117.794909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=28642370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1OkurzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=12934-12946&author=N.+Mastauthor=K.+W.+Andersonauthor=K.+M.+Johnsonauthor=T.+T.+N.+Phanauthor=F.+P.+Guengerichauthor=I.+A.+Pikuleva&title=In+vitro+cytochrome+P450+46A1+%28CYP46A1%29+activation+by+neuroactive+compounds&doi=10.1074%2Fjbc.M117.794909"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro cytochrome P450 46A1 (CYP46A1) activation by neuroactive compounds</span></div><div class="casAuthors">Mast, Natalia; Anderson, Kyle W.; Johnson, Kevin M.; Phan, Thanh T. N.; Guengerich, F. Peter; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">12934-12946</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cytochrome P 450 46A1 (CYP46A1, cholesterol 24-hydroxylase) is the enzyme responsible for the majority of cholesterol elimination from the brain.  Previously, we found that the anti-HIV drug efavirenz (EFV) can pharmacol. activate CYP46A1 in mice.  Herein, we investigated whether CYP46A1 could also be activated by endogenous compds., including major neurotransmitters.  In vitro expts. with purified recombinant CYP46A1 indicated that CYP46A1 is activated by L-glutamate (L-Glu), L-aspartate, γ-aminobutyric acid (GABA), and acetylcholine (Ach), with L-Glu eliciting the highest increase (3-fold) in CYP46A1-mediated cholesterol 24-hydroxylation.  We also found that L-Glu and other activating neurotransmitters bind to the same site on the CYP46A1 surface, which differs from the EFV-binding site.  The other principal differences between EFV and L-Glu in CYP46A1 activation include an apparent lack of L-Glu binding to the P 450 active site and different pathways of signal transduction from the allosteric site to the active site.  EFV and L-Glu similarly increased the CYP46A1 kcat, the rate of the "fast" phase of the enzyme redn. by the redox partner NADPH-cytochrome P 450 oxidoreductase, and the amt. of P 450 reduced.  Spectral titrns. with cholesterol, in the presence of EFV or L-Glu, suggest that water displacement from the heme iron can be affected in activator-bound CYP46A1.  Moreover, EFV and L-Glu synergistically activated CYP46A1.  Collectively, our in vitro data, along with those from previous cell culture and in vivo studies by others, suggest that L-Glu-induced CYP46A1 activation is of physiol. relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiFdaXT1EEJ7Vg90H21EOLACvtfcHk0ligcKYv7bjJ_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1OkurzI&md5=45ec6757d8324c3f219a40cad3d9eac3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.794909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.794909%26sid%3Dliteratum%253Aachs%26aulast%3DMast%26aufirst%3DN.%26aulast%3DAnderson%26aufirst%3DK.%2BW.%26aulast%3DJohnson%26aufirst%3DK.%2BM.%26aulast%3DPhan%26aufirst%3DT.%2BT.%2BN.%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DIn%2520vitro%2520cytochrome%2520P450%252046A1%2520%2528CYP46A1%2529%2520activation%2520by%2520neuroactive%2520compounds%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D12934%26epage%3D12946%26doi%3D10.1074%2Fjbc.M117.794909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lund, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guileyardo, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D. W.</span></span> <span> </span><span class="NLM_article-title">cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">7238</span>– <span class="NLM_lpage">7243</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.13.7238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1073%2Fpnas.96.13.7238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10377398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADyaK1MXltVOrtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=7238-7243&author=E.+G.+Lundauthor=J.+M.+Guileyardoauthor=D.+W.+Russell&title=cDNA+cloning+of+cholesterol+24-hydroxylase%2C+a+mediator+of+cholesterol+homeostasis+in+the+brain&doi=10.1073%2Fpnas.96.13.7238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain</span></div><div class="casAuthors">Lund, Erik G.; Guileyardo, Joseph M.; Russell, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">7238-7243</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The turnover of cholesterol in the brain is thought to occur via conversion of excess cholesterol into 24S-hydroxycholesterol, an oxysterol that is readily secreted from the central nervous system into the plasma.  To gain mol. insight into this pathway of cholesterol metab., we used expression cloning to isolate cDNAs that encode murine and human cholesterol 24-hydroxylases.  DNA sequence anal. indicates that both proteins are localized to the endoplasmic reticulum, share 95% identity, and represent a new cytochrome P 450 subfamily (CYP46).  When transfected into cultured cells, the cDNAs produce an enzymic activity that converts cholesterol into 24S-hydroxycholesterol, and to a lesser extent, 25-hydroxycholesterol.  The cholesterol 24-hydroxylase gene contains 15 exons and is located on human chromosome 14q32.1.  Cholesterol 24-hydroxylase is expressed predominantly in the brain as judged by RNA and protein blotting.  In situ mRNA hybridization and immunohistochem. localize the expression of this P 450 to neurons in multiple subregions of the brain.  The concns. of 24S-hydroxycholesterol in serum are low in newborn mice, reach a peak between postnatal days 12 and 15, and thereafter decline to baseline levels.  In contrast, cholesterol 24-hydroxylase protein is first detected in the brain of mice at birth and continues to accumulate with age.  We conclude that the cloned cDNAs encode cholesterol 24-hydroxylases that synthesize oxysterols in neurons of the brain and that secretion of 24S-hydroxycholesterol from this tissue in the mouse is developmentally regulated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpnnVtKb72ibVg90H21EOLACvtfcHk0ligcKYv7bjJ_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVOrtbg%253D&md5=b6c49f06202b7a55f87bc5e8c6c1ef2a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.13.7238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.13.7238%26sid%3Dliteratum%253Aachs%26aulast%3DLund%26aufirst%3DE.%2BG.%26aulast%3DGuileyardo%26aufirst%3DJ.%2BM.%26aulast%3DRussell%26aufirst%3DD.%2BW.%26atitle%3DcDNA%2520cloning%2520of%2520cholesterol%252024-hydroxylase%252C%2520a%2520mediator%2520of%2520cholesterol%2520homeostasis%2520in%2520the%2520brain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D7238%26epage%3D7243%26doi%3D10.1073%2Fpnas.96.13.7238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D. W.</span></span> <span> </span><span class="NLM_article-title">Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain</span>. <i>J. Comp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>507</i></span>,  <span class="NLM_fpage">1676</span>– <span class="NLM_lpage">1693</span>, <span class="refDoi"> DOI: 10.1002/cne.21605</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1002%2Fcne.21605" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=18241055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1OiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=507&publication_year=2008&pages=1676-1693&author=D.+M.+Ramirezauthor=S.+Anderssonauthor=D.+W.+Russell&title=Neuronal+expression+and+subcellular+localization+of+cholesterol+24-hydroxylase+in+the+mouse+brain&doi=10.1002%2Fcne.21605"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain</span></div><div class="casAuthors">Ramirez, Denise M. O.; Andersson, Stefan; Russell, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">507</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1676-1693</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Cholesterol 24-hydroxylase is a cytochrome P 450 (CYP46A1) that is selectively expressed in the brain and is responsible for the majority of cholesterol turnover in the central nervous system.  Mice deficient in 24-hydroxylase exhibit impaired learning and defective hippocampal long-term potentiation, suggesting that the metab. of cholesterol by this enzyme is required for learning and memory formation.  To det. where in the neuron cholesterol turnover was taking place, monoclonal antibodies directed against 24-hydroxylase were generated by immunization of mice with recombinant protein and used to detect the enzyme in brain homogenates, cultured neurons, and histol. sections.  24-Hydroxylase was localized to the endoplasmic reticulum and was distributed throughout the cell bodies and dendrites of multiple types of neurons; the enzyme was not detected in axon terminals or in the cells of 24-hydroxylase knockout mice.  24-Hydroxylase was highly expressed in pyramidal neurons of the hippocampus and cortex, in Purkinje cells of the cerebellum, and in hippocampal and cerebellar interneurons.  Within the retina, 24-hydroxylase was detected in ganglion cells and some but not all cells of the inner nuclear layer.  These findings reveal the microsomal localization of 24-hydroxylase and provide subcellular insight into cholesterol turnover in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFDMPBhTU1dLVg90H21EOLACvtfcHk0ligcKYv7bjJ_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1OiurY%253D&md5=e7e72c1f45ae87f6d2b5759ca9b34c79</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fcne.21605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcne.21605%26sid%3Dliteratum%253Aachs%26aulast%3DRamirez%26aufirst%3DD.%2BM.%26aulast%3DAndersson%26aufirst%3DS.%26aulast%3DRussell%26aufirst%3DD.%2BW.%26atitle%3DNeuronal%2520expression%2520and%2520subcellular%2520localization%2520of%2520cholesterol%252024-hydroxylase%2520in%2520the%2520mouse%2520brain%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D2008%26volume%3D507%26spage%3D1676%26epage%3D1693%26doi%3D10.1002%2Fcne.21605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avery, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanAusdall, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bumpus, N. N.</span></span> <span> </span><span class="NLM_article-title">Compartmentalization and antiviral effect of efavirenz metabolites in blood plasma, seminal plasma, and cerebrospinal fluid</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.049601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1124%2Fdmd.112.049601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=23166317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitlGisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=422-429&author=L.+B.+Averyauthor=J.+L.+VanAusdallauthor=C.+W.+Hendrixauthor=N.+N.+Bumpus&title=Compartmentalization+and+antiviral+effect+of+efavirenz+metabolites+in+blood+plasma%2C+seminal+plasma%2C+and+cerebrospinal+fluid&doi=10.1124%2Fdmd.112.049601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Compartmentalization and antiviral effect of efavirenz metabolites in blood plasma, seminal plasma, and cerebrospinal fluid</span></div><div class="casAuthors">Avery, Lindsay B.; Van Ausdall, Jennifer L.; Hendrix, Craig W.; Bumpus, Namandje N.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">422-429</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Efavirenz (EFV) is one of the most commonly prescribed antiretrovirals for use in the treatment of human immunodeficiency virus (HIV) infection.  EFV is extensively metabolized by cytochrome P 450 to a no. of oxygenated products; however, the pharmacol. activity and distribution of these metabolites in anat. compartments have yet to be explored.  The systemic distribution of EFV oxidative metabolites was examd. in blood plasma, seminal plasma, and cerebrospinal fluid from subjects on an EFV-based regimen.  The 8-hydroxy EFV metabolite was detected in blood plasma, seminal plasma, and cerebrospinal fluid, with median concns. of 314.5 ng/mL, 358.5 ng/mL, and 3.37 ng/mL, resp.  In contrast, 7-hydroxy and 8,14-hydroxy EFV were only detected in blood plasma and seminal plasma with median concns. of 8.84 ng/mL and 10.23 ng/mL, and 5.63 ng/mL and 5.43 ng/mL, resp.  Interestingly, protein-free concns. of metabolites were only detectable in seminal plasma, where a novel dihdyroxylated metabolite of EFV was also detected.  This accumulation of protein-free EFV metabolites was demonstrated to be the result of differential protein binding in seminal plasma compared with that of blood plasma.  In addn., the oxidative metabolites of EFV did not present with any significant pharmacol. activity toward HIV-1 as measured using an HIV green fluorescent protein single-round infectivity assay.  This study is the first to report the physiol. distribution of metabolites of an antiretroviral into biol. compartments that the virus is known to distribute and to examine their anti-HIV activity.  These data suggest that the male genital tract may be a novel compartment that should be considered in the evaluation of drug metabolite exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4Ssqy9xgKDbVg90H21EOLACvtfcHk0lh9J950vbDxLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitlGisLg%253D&md5=fcac32fd44f7a9508d2da56cb9b3405a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.049601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.049601%26sid%3Dliteratum%253Aachs%26aulast%3DAvery%26aufirst%3DL.%2BB.%26aulast%3DVanAusdall%26aufirst%3DJ.%2BL.%26aulast%3DHendrix%26aufirst%3DC.%2BW.%26aulast%3DBumpus%26aufirst%3DN.%2BN.%26atitle%3DCompartmentalization%2520and%2520antiviral%2520effect%2520of%2520efavirenz%2520metabolites%2520in%2520blood%2520plasma%252C%2520seminal%2520plasma%252C%2520and%2520cerebrospinal%2520fluid%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26spage%3D422%26epage%3D429%26doi%3D10.1124%2Fdmd.112.049601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bretillon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutjohann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widhe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bindl, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggertsen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diczfalusy, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björkhem, I.</span></span> <span> </span><span class="NLM_article-title">Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">840</span>– <span class="NLM_lpage">845</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10787445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtlKnsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=840-845&author=L.+Bretillonauthor=D.+Lutjohannauthor=L.+Stahleauthor=T.+Widheauthor=L.+Bindlauthor=G.+Eggertsenauthor=U.+Diczfalusyauthor=I.+Bj%C3%B6rkhem&title=Plasma+levels+of+24S-hydroxycholesterol+reflect+the+balance+between+cerebral+production+and+hepatic+metabolism+and+are+inversely+related+to+body+surface"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface</span></div><div class="casAuthors">Bretillon, Lionel; Lutjohann, Dieter; Stahle, Lars; Widhe, Torulf; Bindl, Lutz; Eggertsen, Gosta; Diczfalusy, Ulf; Bjorkhem, Ingemar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">840-845</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">Lipid Research, Inc.</span>)
        </div><div class="casAbstract">We have previously presented evidence that most of the 24S-hydroxycholesterol present in the circulation originates from the brain and that most of the elimination of this oxysterol occurs in the liver.  Plasma 24S-hydroxycholesterol levels decline by a factor of about 5 during the first decades of life.  The concn. of the enzyme cholesterol 24S-hydroxylase in the brain is, however, about const. from the first year of life, and reduced enzyme levels thus cannot explain the decreasing plasma levels during infancy.  In the present work we tested the hypothesis that the plasma levels of 24S-hydroxycholesterol may reflect the size of the brain relative to the capacity of the liver to eliminate the substance.  It is shown here that the age-dependent changes in abs. as well as cholesterol-related plasma level of 24S-hydroxycholesterol closely follow the changes in the ratio between estd. brain wt. and estd. liver vol.  The size of the brain is increased only about 50% whereas the size of the liver is increased by about 6-fold after the age of 1 yr.  Liver vol. is known to be highly correlated to body surface, and in accordance with this the abs. as well as the cholesterol-related plasma level of 24S-hydroxycholesterol was found to be highly inversely correlated to body surface in 77 healthy subjects of varying ages (r2 = 0.74).  Two chondrodystrophic dwarves with normal size of the brain but with markedly reduced body area had increased levels of 24S-hydroxycholesterol when related to age but normal levels when related to body surface.  It is concluded that the balance between cerebral prodn. and hepatic metab. is a crit. determinant for plasma levels of 24S-hydroxycholesterol at different ages and that endocrinol. factors are less important.  The results are discussed in relation to the possibility to use 24S-hydroxycholesterol in the circulation as a marker for cholesterol homeostasis in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOeVhunyKma7Vg90H21EOLACvtfcHk0lh9J950vbDxLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtlKnsbY%253D&md5=acd9b39bf0f154550339a202378f5850</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBretillon%26aufirst%3DL.%26aulast%3DLutjohann%26aufirst%3DD.%26aulast%3DStahle%26aufirst%3DL.%26aulast%3DWidhe%26aufirst%3DT.%26aulast%3DBindl%26aufirst%3DL.%26aulast%3DEggertsen%26aufirst%3DG.%26aulast%3DDiczfalusy%26aufirst%3DU.%26aulast%3DBj%25C3%25B6rkhem%26aufirst%3DI.%26atitle%3DPlasma%2520levels%2520of%252024S-hydroxycholesterol%2520reflect%2520the%2520balance%2520between%2520cerebral%2520production%2520and%2520hepatic%2520metabolism%2520and%2520are%2520inversely%2520related%2520to%2520body%2520surface%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2000%26volume%3D41%26spage%3D840%26epage%3D845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meaney, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diczfalusy, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björkhem, I.</span></span> <span> </span><span class="NLM_article-title">On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2130</span>– <span class="NLM_lpage">2135</span>, <span class="refDoi"> DOI: 10.1194/jlr.M200293-JLR200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1194%2Fjlr.M200293-JLR200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=12454275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD38XpslGjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=2130-2135&author=S.+Meaneyauthor=K.+Bodinauthor=U.+Diczfalusyauthor=I.+Bj%C3%B6rkhem&title=On+the+rate+of+translocation+in+vitro+and+kinetics+in+vivo+of+the+major+oxysterols+in+human+circulation%3A+critical+importance+of+the+position+of+the+oxygen+function&doi=10.1194%2Fjlr.M200293-JLR200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function</span></div><div class="casAuthors">Meaney, Steve; Bodin, Karl; Diczfalusy, Ulf; Bjorkhem, Ingemar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2130-2135</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">Lipid Research, Inc.</span>)
        </div><div class="casAbstract">Oxysterols possess powerful biol. activities.  Some of their effects on the regulation of key enzymes are similar to those of cholesterol, but are much more potent.  One of the crit. properties of oxysterols is their ability to pass lipophilic membranes at a high rate.  Transfer of unesterified 25-hydroxycholesterol from red blood cells to plasma has been reported to occur more than 1000 times faster than cholesterol.  Here the authors have measured the relative rate of such translocation of the three major oxysterols in human circulation: 27-hydroxycholesterol, 24S-hydroxycholesterol, and 4β-hydroxycholesterol.  The distance from the 3β-hydroxyl group to the addnl. hydroxyl group is the greatest possible in 27-hydroxycholesterol and the least possible in 4β-hydroxycholesterol.  The rate of exchange between erythrocytes and plasma was found to be high for 27-hydroxycholesterol and 24S-hydroxycholesterol, and hardly possible to measure for 4β-hydroxycholesterol and cholesterol.  When injected i.v. into humans, deuterium labeled 24- and 27-hydroxycholesterol caused an immediate high enrichment of the corresponding plasma sterols followed by a decay.  After injection of labeled 4β-hydroxycholesterol, the max. deuterium enrichment occurred after 2-3 h, when secretion of the oxysterol from the liver is likely to be the limiting factor.  When radiolabeled cholesterol was injected under the same conditions, max. appearance of label occurred after about 2 days.  The results illustrate the importance of the position of the addnl. oxygen in oxysterols and are discussed in relation to the rate of metab. and biol. effects of these oxysterols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosZDGbL-tNObVg90H21EOLACvtfcHk0lh9J950vbDxLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpslGjs7s%253D&md5=c60791c77396fa21c8e87760e71562e8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M200293-JLR200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M200293-JLR200%26sid%3Dliteratum%253Aachs%26aulast%3DMeaney%26aufirst%3DS.%26aulast%3DBodin%26aufirst%3DK.%26aulast%3DDiczfalusy%26aufirst%3DU.%26aulast%3DBj%25C3%25B6rkhem%26aufirst%3DI.%26atitle%3DOn%2520the%2520rate%2520of%2520translocation%2520in%2520vitro%2520and%2520kinetics%2520in%2520vivo%2520of%2520the%2520major%2520oxysterols%2520in%2520human%2520circulation%253A%2520critical%2520importance%2520of%2520the%2520position%2520of%2520the%2520oxygen%2520function%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2002%26volume%3D43%26spage%3D2130%26epage%3D2135%26doi%3D10.1194%2Fjlr.M200293-JLR200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lutjohann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breuer, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahlborg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nennesmo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siden, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diczfalusy, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björkhem, I.</span></span> <span> </span><span class="NLM_article-title">Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">9799</span>– <span class="NLM_lpage">9804</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.18.9799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1073%2Fpnas.93.18.9799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=8790411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A280%3ADyaK28zot1GntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=9799-9804&author=D.+Lutjohannauthor=O.+Breuerauthor=G.+Ahlborgauthor=I.+Nennesmoauthor=A.+Sidenauthor=U.+Diczfalusyauthor=I.+Bj%C3%B6rkhem&title=Cholesterol+homeostasis+in+human+brain%3A+evidence+for+an+age-dependent+flux+of+24S-hydroxycholesterol+from+the+brain+into+the+circulation&doi=10.1073%2Fpnas.93.18.9799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation</span></div><div class="casAuthors">Lutjohann D; Breuer O; Ahlborg G; Nennesmo I; Siden A; Diczfalusy U; Bjorkhem I</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">9799-804</span>
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">We have investigated whether side chain-hydroxylated cholesterol species are important for elimination of cholesterol from the brain.  Plasma concentrations of 24-hydroxycholesterol (24-OH-Chol) in the internal jugular vein and the brachial artery in healthy volunteers were consistent with a net flux of this steroid from the brain into the circulation, corresponding to elimination of approximately 4 mg cholesterol during a 24-h period in adults.  Results of experiments with rats exposed to 18O2 were also consistent with a flux of 24-OH-Chol from the brain into the circulation.  No other oxysterol measured showed a similar behavior as 24-OH-Chol.  These results and the finding that the concentration of 24-OH-Chol was 30- to 1500-fold higher in the brain than in any other organ except the adrenals indicate that the major part of 24-OH-Chol present in the circulation originates from the brain.  Both the 24-OH-Chol present in the brain and in the circulation were the 24S-stereoisomer.  In contrast to other oxysterols, levels of plasma 24-OH-Chol were found to be markedly dependent upon age.  The ratio between 24-OH-Chol and cholesterol in plasma was approximately 5 times higher during the first decade of life than during the sixth decade.  There was a high correlation between levels of 24-OH-Chol in plasma and cerebrospinal fluid.  It is suggested that the flux of 24-OH-Chol from the brain is important for cholesterol homeostasis in this organ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR6ftyKME6y3DDnmmyUf5qOfW6udTcc2ebZMzcd-OGNNbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28zot1GntQ%253D%253D&md5=98187a7ea536206759ec9e8f718c7f01</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.18.9799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.18.9799%26sid%3Dliteratum%253Aachs%26aulast%3DLutjohann%26aufirst%3DD.%26aulast%3DBreuer%26aufirst%3DO.%26aulast%3DAhlborg%26aufirst%3DG.%26aulast%3DNennesmo%26aufirst%3DI.%26aulast%3DSiden%26aufirst%3DA.%26aulast%3DDiczfalusy%26aufirst%3DU.%26aulast%3DBj%25C3%25B6rkhem%26aufirst%3DI.%26atitle%3DCholesterol%2520homeostasis%2520in%2520human%2520brain%253A%2520evidence%2520for%2520an%2520age-dependent%2520flux%2520of%252024S-hydroxycholesterol%2520from%2520the%2520brain%2520into%2520the%2520circulation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D9799%26epage%3D9804%26doi%3D10.1073%2Fpnas.93.18.9799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lund, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotti, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turley, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietschy, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D. W.</span></span> <span> </span><span class="NLM_article-title">Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">22980</span>– <span class="NLM_lpage">22988</span>, <span class="refDoi"> DOI: 10.1074/jbc.M303415200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1074%2Fjbc.M303415200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=12686551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksF2iu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=22980-22988&author=E.+G.+Lundauthor=C.+Xieauthor=T.+Kottiauthor=S.+D.+Turleyauthor=J.+M.+Dietschyauthor=D.+W.+Russell&title=Knockout+of+the+cholesterol+24-hydroxylase+gene+in+mice+reveals+a+brain-specific+mechanism+of+cholesterol+turnover&doi=10.1074%2Fjbc.M303415200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Knockout of the Cholesterol 24-Hydroxylase Gene in Mice Reveals a Brain-specific Mechanism of Cholesterol Turnover</span></div><div class="casAuthors">Lund, Erik G.; Xie, Chonglun; Kotti, Tiina; Turley, Stephen D.; Dietschy, John M.; Russell, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">22980-22988</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Most cholesterol turnover takes place in the liver and involves the conversion of cholesterol into sol. and readily excreted bile acids.  The synthesis of bile acids is limited to the liver, but several enzymes in the bile acid biosynthetic pathway are expressed in extra-hepatic tissues and there also may contribute to cholesterol turnover.  An example of the latter type of enzyme is cholesterol 24-hydroxylase, a cytochrome P 450 (CYP46A1) that is expressed at 100-fold higher levels in the brain than in the liver.  Cholesterol 24-hydroxylase catalyzes the synthesis of the oxysterol 24(S)-hydroxycholesterol.  To assess the relative contribution of the 24-hydroxylation pathway to cholesterol turnover, we performed balance studies in mice lacking the cholesterol 24-hydroxylase gene (Cyp46a1-/- mice).  Parameters of hepatic cholesterol and bile acid metab. in the mutant mice remained unchanged relative to wild type controls.  In contrast to the liver, the synthesis of new cholesterol was reduced by ∼40% in the brain, despite steady-state levels of cholesterol being similar in the knockout mice.  These data suggest that the synthesis of new cholesterol and the secretion of 24(S)-hydroxycholesterol are closely coupled and that at least 40% of cholesterol turnover in the brain is dependent on the action of cholesterol 24-hydroxylase.  We conclude that cholesterol 24-hydroxylase constitutes a major tissue-specific pathway for cholesterol turnover in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruKfgTcOsuPLVg90H21EOLACvtfcHk0liIpX6Z2_UXGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksF2iu7o%253D&md5=e056e83e101f38e41ff199bd016b64a3</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M303415200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M303415200%26sid%3Dliteratum%253Aachs%26aulast%3DLund%26aufirst%3DE.%2BG.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DKotti%26aufirst%3DT.%26aulast%3DTurley%26aufirst%3DS.%2BD.%26aulast%3DDietschy%26aufirst%3DJ.%2BM.%26aulast%3DRussell%26aufirst%3DD.%2BW.%26atitle%3DKnockout%2520of%2520the%2520cholesterol%252024-hydroxylase%2520gene%2520in%2520mice%2520reveals%2520a%2520brain-specific%2520mechanism%2520of%2520cholesterol%2520turnover%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D22980%26epage%3D22988%26doi%3D10.1074%2Fjbc.M303415200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kotti, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeiffer, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D. W.</span></span> <span> </span><span class="NLM_article-title">Brain cholesterol turnover required for geranylgeraniol production and learning in mice</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">3869</span>– <span class="NLM_lpage">3874</span>, <span class="refDoi"> DOI: 10.1073/pnas.0600316103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1073%2Fpnas.0600316103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=16505352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD28XivFymtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=3869-3874&author=T.+J.+Kottiauthor=D.+M.+Ramirezauthor=B.+E.+Pfeifferauthor=K.+M.+Huberauthor=D.+W.+Russell&title=Brain+cholesterol+turnover+required+for+geranylgeraniol+production+and+learning+in+mice&doi=10.1073%2Fpnas.0600316103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Brain cholesterol turnover required for geranylgeraniol production and learning in mice</span></div><div class="casAuthors">Kotti, Tiina J.; Ramirez, Denise M. O.; Pfeiffer, Brad E.; Huber, Kimberly M.; Russell, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3869-3874</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The mevalonate pathway produces cholesterol and nonsterol isoprenoids, such as geranylgeraniol.  In the brain, a fraction of cholesterol is metabolized in neurons by the enzyme cholesterol 24-hydroxylase, and this depletion activates the mevalonate pathway.  Brains from mice lacking 24-hydroxylase excrete cholesterol more slowly, and the tissue compensates by suppressing the mevalonate pathway.  Here we report that this suppression causes a defect in learning.  24-Hydroxylase knockout mice exhibit severe deficiencies in spatial, associative, and motor learning, and in hippocampal long-term potentiation (LTP).  Acute treatment of wild-type hippocampal slices with an inhibitor of the mevalonate pathway (a statin) also impairs LTP.  The effects of statin treatment and genetic elimination of 24-hydroxylase on LTP are reversed by a 20-min treatment with geranylgeraniol but not by cholesterol.  We conclude that cholesterol turnover in brain activates the mevalonate pathway and that a const. prodn. of geranylgeraniol in a small subset of neurons is required for LTP and learning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofEKiKgd7hXLVg90H21EOLACvtfcHk0liIpX6Z2_UXGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivFymtr4%253D&md5=09611bad2c56d10c5d48be4c07caabb6</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0600316103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0600316103%26sid%3Dliteratum%253Aachs%26aulast%3DKotti%26aufirst%3DT.%2BJ.%26aulast%3DRamirez%26aufirst%3DD.%2BM.%26aulast%3DPfeiffer%26aufirst%3DB.%2BE.%26aulast%3DHuber%26aufirst%3DK.%2BM.%26aulast%3DRussell%26aufirst%3DD.%2BW.%26atitle%3DBrain%2520cholesterol%2520turnover%2520required%2520for%2520geranylgeraniol%2520production%2520and%2520learning%2520in%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D3869%26epage%3D3874%26doi%3D10.1073%2Fpnas.0600316103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maioli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heverin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismail, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puerta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafaati, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cedazo-Minguez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björkhem, I.</span></span> <span> </span><span class="NLM_article-title">Is it possible to improve memory function by upregulation of the cholesterol 24S-hydroxylase (CYP46A1) in the brain?</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e68534</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0068534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1371%2Fjournal.pone.0068534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=23874659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1SgsrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e68534&author=S.+Maioliauthor=A.+Bavnerauthor=Z.+Aliauthor=M.+Heverinauthor=M.+A.+Ismailauthor=E.+Puertaauthor=M.+Olinauthor=A.+Saeedauthor=M.+Shafaatiauthor=P.+Pariniauthor=A.+Cedazo-Minguezauthor=I.+Bj%C3%B6rkhem&title=Is+it+possible+to+improve+memory+function+by+upregulation+of+the+cholesterol+24S-hydroxylase+%28CYP46A1%29+in+the+brain%3F&doi=10.1371%2Fjournal.pone.0068534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Is it possible to improve memory function by upregulation of the cholesterol 24S-hydroxylase (CYP46A1) in the brain?</span></div><div class="casAuthors">Maioli, Silvia; Baavner, Ann; Ali, Zeina; Heverin, Maura; Ismail, Muhammad-Al-Mustafa; Puerta, Elena; Olin, Maria; Saeed, Ahmed; Shafaati, Marjan; Parini, Paolo; Cedazo-Minguez, Angel; Bjoerkhem, Ingemar</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e68534</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">We previously described a heterozygous mouse model overexpressing human HA-tagged 24S-hydroxylase (CYP46A1) utilizing a ubiquitous expression vector.  In this study, we generated homozygotes of these mice with circulating levels of 24OH 30-60 % higher than the heterozygotes.  Female homozygous CYP46A1 transgenic mice, aged 15 mo, showed an improvement in spatial memory in the Morris water maze test as compared to the wild type mice.  The levels of N-Methyl--Aspartate receptor 1, phosphorylated-N-Methyl--Aspartate receptor 2A, postsynaptic d. 95, synapsin-1 and synaphthophysin were significantly increased in the hippocampus of the CYP46A1 transgenic mice as compared to the controls.  The levels of lanosterol in the brain of the CYP46A1 transgenic mice were significantly increased, consistent with a higher synthesis of cholesterol.  Our results are discussed in relation to the hypothesis that the flux in the mevalonate pathway in the brain is of importance in cognitive functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCwJ94J9LAYbVg90H21EOLACvtfcHk0lg-0AnkS4iM7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1SgsrzE&md5=f943f29f2ae6a096519041aa85737791</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0068534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0068534%26sid%3Dliteratum%253Aachs%26aulast%3DMaioli%26aufirst%3DS.%26aulast%3DBavner%26aufirst%3DA.%26aulast%3DAli%26aufirst%3DZ.%26aulast%3DHeverin%26aufirst%3DM.%26aulast%3DIsmail%26aufirst%3DM.%2BA.%26aulast%3DPuerta%26aufirst%3DE.%26aulast%3DOlin%26aufirst%3DM.%26aulast%3DSaeed%26aufirst%3DA.%26aulast%3DShafaati%26aufirst%3DM.%26aulast%3DParini%26aufirst%3DP.%26aulast%3DCedazo-Minguez%26aufirst%3DA.%26aulast%3DBj%25C3%25B6rkhem%26aufirst%3DI.%26atitle%3DIs%2520it%2520possible%2520to%2520improve%2520memory%2520function%2520by%2520upregulation%2520of%2520the%2520cholesterol%252024S-hydroxylase%2520%2528CYP46A1%2529%2520in%2520the%2520brain%253F%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De68534%26doi%3D10.1371%2Fjournal.pone.0068534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izumi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorumski, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mennerick, S.</span></span> <span> </span><span class="NLM_article-title">Endogenous 24<i>S</i>-hydroxycholesterol modulates NMDAR-mediated function in hippocampal slices</span>. <i>J. Neurophysiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">1263</span>– <span class="NLM_lpage">1272</span>, <span class="refDoi"> DOI: 10.1152/jn.00890.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1152%2Fjn.00890.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=26745248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A280%3ADC%252BC28rotlynsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2016&pages=1263-1272&author=M.+Y.+Sunauthor=Y.+Izumiauthor=A.+Benzauthor=C.+F.+Zorumskiauthor=S.+Mennerick&title=Endogenous+24S-hydroxycholesterol+modulates+NMDAR-mediated+function+in+hippocampal+slices&doi=10.1152%2Fjn.00890.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous 24S-hydroxycholesterol modulates NMDAR-mediated function in hippocampal slices</span></div><div class="casAuthors">Sun Min-Yu; Benz Ann; Izumi Yukitoshi; Zorumski Charles F; Mennerick Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurophysiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1263-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">N-methyl-D-aspartate receptors (NMDARs), a major subtype of glutamate receptors mediating excitatory transmission throughout the central nervous system (CNS), play critical roles in governing brain function and cognition.  Because NMDAR dysfunction contributes to the etiology of neurological and psychiatric disorders including stroke and schizophrenia, NMDAR modulators are potential drug candidates.  Our group recently demonstrated that the major brain cholesterol metabolite, 24S-hydroxycholesterol (24S-HC), positively modulates NMDARs when exogenously administered.  Here, we studied whether endogenous 24S-HC regulates NMDAR activity in hippocampal slices.  In CYP46A1(-/-) (knockout; KO) slices where endogenous 24S-HC is greatly reduced, NMDAR tone, measured as NMDAR-to-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) excitatory postsynaptic current (EPSC) ratio, was reduced.  This difference translated into more NMDAR-driven spiking in wild-type (WT) slices compared with KO slices.  Application of SGE-301, a 24S-HC analog, had comparable potentiating effects on NMDAR EPSCs in both WT and KO slices, suggesting that endogenous 24S-HC does not saturate its NMDAR modulatory site in ex vivo slices.  KO slices did not differ from WT slices in either spontaneous neurotransmission or in neuronal intrinsic excitability, and exhibited LTP indistinguishable from WT slices.  However, KO slices exhibited higher resistance to persistent NMDAR-dependent depression of synaptic transmission induced by oxygen-glucose deprivation (OGD), an effect restored by SGE-301.  Together, our results suggest that loss of positive NMDAR tone does not elicit compensatory changes in excitability or transmission, but it protects transmission against NMDAR-mediated dysfunction.  We expect that manipulating this endogenous NMDAR modulator may offer new treatment strategies for neuropsychiatric dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRUw9swP5_pTokFb3mqPUYDfW6udTcc2eb9u1nakl6oBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rotlynsQ%253D%253D&md5=165fff6180922d98bb138c4d0421923c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1152%2Fjn.00890.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fjn.00890.2015%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DM.%2BY.%26aulast%3DIzumi%26aufirst%3DY.%26aulast%3DBenz%26aufirst%3DA.%26aulast%3DZorumski%26aufirst%3DC.%2BF.%26aulast%3DMennerick%26aufirst%3DS.%26atitle%3DEndogenous%252024S-hydroxycholesterol%2520modulates%2520NMDAR-mediated%2520function%2520in%2520hippocampal%2520slices%26jtitle%3DJ.%2520Neurophysiol.%26date%3D2016%26volume%3D115%26spage%3D1263%26epage%3D1272%26doi%3D10.1152%2Fjn.00890.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linsenbardt, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emnett, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenman, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izumi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorumski, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mennerick, S.</span></span> <span> </span><span class="NLM_article-title">24(<i>S</i>)-Hydroxycholesterol as a modulator of neuronal signaling and survival</span>. <i>Neuroscientist</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1177/1073858414568122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1177%2F1073858414568122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=25628343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvVynurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=132-144&author=M.+Y.+Sunauthor=A.+J.+Linsenbardtauthor=C.+M.+Emnettauthor=L.+N.+Eisenmanauthor=Y.+Izumiauthor=C.+F.+Zorumskiauthor=S.+Mennerick&title=24%28S%29-Hydroxycholesterol+as+a+modulator+of+neuronal+signaling+and+survival&doi=10.1177%2F1073858414568122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">24(S)-hydroxycholesterol as a modulator of neuronal signaling and survival</span></div><div class="casAuthors">Sun, Min-Yu; Linsenbardt, Andrew J.; Emnett, Christine M.; Eisenman, Lawrence N.; Izumi, Yukitoshi; Zorumski, Charles F.; Mennerick, Steve</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscientist</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-144</span>CODEN:
                <span class="NLM_cas:coden">NROSFJ</span>;
        ISSN:<span class="NLM_cas:issn">1073-8584</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  The major cholesterol metabolite in brain, 24(S)-hydroxycholesterol (24S-HC), serves as a vehicle for cholesterol removal.  Its effects on neuronal function, however, have only recently begun to be investigated.  Here, we review that nascent work.  Our own studies have demonstrated that 24S-HC has potent pos. modulatory effects on N-methyldaspartate (NMDA) receptor (NMDAR) function.  This could have implications not only for brain plasticity but also for pathol. NMDAR overuse.  Other work has demonstrated effects of 24S-HC on neuronal survival and as a possible biomarker of neurodegenerative disease.  Depending on circumstances, both upregulation/mimicry of 24S-HC signaling and down-regulation/antagonism may have therapeutic potential.  We are interested in the possibility that synthetic analogs of 24S-HC with pos. effects at NMDARs may hold neurotherapeutic promise, given the role of NMDA receptor hypofunction in certain neuropsychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQdpyeroKwpbVg90H21EOLACvtfcHk0lg-0AnkS4iM7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvVynurs%253D&md5=491357d064d059a8ba61c4ed2c11f48a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1177%2F1073858414568122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1073858414568122%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DM.%2BY.%26aulast%3DLinsenbardt%26aufirst%3DA.%2BJ.%26aulast%3DEmnett%26aufirst%3DC.%2BM.%26aulast%3DEisenman%26aufirst%3DL.%2BN.%26aulast%3DIzumi%26aufirst%3DY.%26aulast%3DZorumski%26aufirst%3DC.%2BF.%26aulast%3DMennerick%26aufirst%3DS.%26atitle%3D24%2528S%2529-Hydroxycholesterol%2520as%2520a%2520modulator%2520of%2520neuronal%2520signaling%2520and%2520survival%26jtitle%3DNeuroscientist%26date%3D2016%26volume%3D22%26spage%3D132%26epage%3D144%26doi%3D10.1177%2F1073858414568122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petrov, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Cholesterol 24-hydroxylation by CYP46A1: benefits of modulation for brain diseases</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">635</span>– <span class="NLM_lpage">648</span>, <span class="refDoi"> DOI: 10.1007/s13311-019-00731-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1007%2Fs13311-019-00731-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=31001737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFGjsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=635-648&author=A.+M.+Petrovauthor=I.+A.+Pikuleva&title=Cholesterol+24-hydroxylation+by+CYP46A1%3A+benefits+of+modulation+for+brain+diseases&doi=10.1007%2Fs13311-019-00731-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases</span></div><div class="casAuthors">Petrov, Alexey M.; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">635-648</span>CODEN:
                <span class="NLM_cas:coden">NEURNV</span>;
        ISSN:<span class="NLM_cas:issn">1878-7479</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Cholesterol 24-hydroxylation is the major mechanism for cholesterol removal from the brain and the reaction catalyzed by cytochrome P 450 46A1 (CYP46A1), a CNS-specific enzyme.  This review describes CYP46A1 in the context of cholesterol homeostasis in the brain and summarizes available exptl. data on CYP46A1 assocn. with different neurol. diseases, including the mechanisms by which changes in the CYP46A1 activity in the brain could be beneficial for these diseases.  The modulation of CYP46A1 activity by genetic and pharmacol. means is also presented along with a brief synopsis of the two clin. trials that evaluate CYP46A1 as a therapeutic target for Alzheimer's disease as well as Dravet and Lennox-Gastaut syndromes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRhAkr3OF3v7Vg90H21EOLACvtfcHk0lgWY8ngxHa7ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFGjsL%252FL&md5=e4c31bedfd2b286f38304193a7255538</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs13311-019-00731-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-019-00731-6%26sid%3Dliteratum%253Aachs%26aulast%3DPetrov%26aufirst%3DA.%2BM.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DCholesterol%252024-hydroxylation%2520by%2520CYP46A1%253A%2520benefits%2520of%2520modulation%2520for%2520brain%2520diseases%26jtitle%3DNeurotherapeutics%26date%3D2019%26volume%3D16%26spage%3D635%26epage%3D648%26doi%3D10.1007%2Fs13311-019-00731-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hudry, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Dam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulik, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Deyn, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stet, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahouansou, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benraiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delacourte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bougneres, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubourg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartier, N.</span></span> <span> </span><span class="NLM_article-title">Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer’s disease</span>. <i>Mol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1038/mt.2009.175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1038%2Fmt.2009.175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=19654569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsVers78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=44-53&author=E.+Hudryauthor=D.+Van+Damauthor=W.+Kulikauthor=P.+P.+De+Deynauthor=F.+S.+Stetauthor=O.+Ahouansouauthor=A.+Benraissauthor=A.+Delacourteauthor=P.+Bougneresauthor=P.+Aubourgauthor=N.+Cartier&title=Adeno-associated+virus+gene+therapy+with+cholesterol+24-hydroxylase+reduces+the+amyloid+pathology+before+or+after+the+onset+of+amyloid+plaques+in+mouse+models+of+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fmt.2009.175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Adeno-associated Virus Gene Therapy With Cholesterol 24-Hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer's Disease</span></div><div class="casAuthors">Hudry, Eloise; Van Dam, Debby; Kulik, Wim; De Deyn, Peter P.; Stet, Femke S.; Ahouansou, Ornella; Benraiss, Abdellatif; Delacourte, Andre; Bougneres, Pierre; Aubourg, Patrick; Cartier, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-53</span>CODEN:
                <span class="NLM_cas:coden">MTOHCK</span>;
        ISSN:<span class="NLM_cas:issn">1525-0016</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The development of Alzheimer's disease (AD) is closely connected with cholesterol metab.  Cholesterol increases the prodn. and deposition of amyloid-β (Aβ) peptides that result in the formation of amyloid plaques, a hallmark of the pathol.  In the brain, cholesterol is synthesized in situ but cannot be degraded nor cross the blood-brain barrier.  The major exportable form of brain cholesterol is 24S-hydroxycholesterol, an oxysterol generated by the neuronal cholesterol 24-hydroxylase encoded by the CYP46A1 gene.  We report that the injection of adeno-assocd. vector (AAV) encoding CYP46A1 in the cortex and hippocampus of APP23 mice before the onset of amyloid deposits markedly reduces Aβ peptides, amyloid deposits and trimeric oligomers at 12 mo of age.  The Morris water maze (MWM) procedure also demonstrated improvement of spatial memory at 6 mo, before the onset of amyloid deposits.  AAV5-wtCYP46A1 vector injection in the cortex and hippocampus of amyloid precursor protein/presenilin 1 (APP/PS) mice after the onset of amyloid deposits also reduced markedly the no. of amyloid plaques in the hippocampus, and to a less extent in the cortex, 3 mo after the injection.  Our data demonstrate that neuronal overexpression of CYP46A1 before or after the onset of amyloid plaques significantly reduces Aβ pathol. in mouse models of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKfiqrwTlDnbVg90H21EOLACvtfcHk0lgWY8ngxHa7ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsVers78%253D&md5=ac2f0d1c7acce0b1d2464ac9a5ea2eb1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fmt.2009.175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmt.2009.175%26sid%3Dliteratum%253Aachs%26aulast%3DHudry%26aufirst%3DE.%26aulast%3DVan%2BDam%26aufirst%3DD.%26aulast%3DKulik%26aufirst%3DW.%26aulast%3DDe%2BDeyn%26aufirst%3DP.%2BP.%26aulast%3DStet%26aufirst%3DF.%2BS.%26aulast%3DAhouansou%26aufirst%3DO.%26aulast%3DBenraiss%26aufirst%3DA.%26aulast%3DDelacourte%26aufirst%3DA.%26aulast%3DBougneres%26aufirst%3DP.%26aulast%3DAubourg%26aufirst%3DP.%26aulast%3DCartier%26aufirst%3DN.%26atitle%3DAdeno-associated%2520virus%2520gene%2520therapy%2520with%2520cholesterol%252024-hydroxylase%2520reduces%2520the%2520amyloid%2520pathology%2520before%2520or%2520after%2520the%2520onset%2520of%2520amyloid%2520plaques%2520in%2520mouse%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520Ther.%26date%3D2010%26volume%3D18%26spage%3D44%26epage%3D53%26doi%3D10.1038%2Fmt.2009.175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burlot, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braudeau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaelsen-Preusse, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayciriex, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gautier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djelti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audrain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauphinot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Gomez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caillierez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laprevote, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bieche, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auzeil, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potier, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartier, N.</span></span> <span> </span><span class="NLM_article-title">Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5965</span>– <span class="NLM_lpage">5976</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddv268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1093%2Fhmg%2Fddv268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=26358780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitV2hs73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=5965-5976&author=M.+A.+Burlotauthor=J.+Braudeauauthor=K.+Michaelsen-Preusseauthor=B.+Potierauthor=S.+Ayciriexauthor=J.+Varinauthor=B.+Gautierauthor=F.+Djeltiauthor=M.+Audrainauthor=L.+Dauphinotauthor=F.+J.+Fernandez-Gomezauthor=R.+Caillierezauthor=O.+Laprevoteauthor=I.+Biecheauthor=N.+Auzeilauthor=M.+C.+Potierauthor=P.+Dutarauthor=M.+Korteauthor=L.+Bueeauthor=D.+Blumauthor=N.+Cartier&title=Cholesterol+24-hydroxylase+defect+is+implicated+in+memory+impairments+associated+with+Alzheimer-like+Tau+pathology&doi=10.1093%2Fhmg%2Fddv268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology</span></div><div class="casAuthors">Burlot, Marie-Anne; Braudeau, Jerome; Michaelsen-Preusse, Kristin; Potier, Brigitte; Ayciriex, Sophie; Varin, Jennifer; Gautier, Benoit; Djelti, Fathia; Audrain, Mickael; Dauphinot, Luce; Fernandez-Gomez, Francisco-Jose; Caillierez, Raphaelle; Laprevote, Olivier; Bieche, Ivan; Auzeil, Nicolas; Potier, Marie-Claude; Dutar, Patrick; Korte, Martin; Buee, Luc; Blum, David; Cartier, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5965-5976</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by both amyloid and Tau pathologies.  The amyloid component and altered cholesterol metab. are closely linked, but the relationship between Tau pathol. and cholesterol is currently unclear.  Brain cholesterol is synthesized in situ and cannot cross the blood-brain barrier: to be exported from the central nervous system into the blood circuit, excess cholesterol must be converted to 24S-hydroxycholesterol by the cholesterol 24-hydroxylase encoded by the CYP46A1 gene.  In AD patients, the concn. of 24S-hydroxycholesterol in the plasma and the cerebrospinal fluid are lower than in healthy controls.  The THY-Tau22 mouse is a model of AD-like Tau pathol. without amyloid pathol.  We used this model to investigate the potential assocn. between Tau pathol. and CYP46A1 modulation.  The amts. of CYP46A1 and 24S-hydroxycholesterol in the hippocampus were lower in THY-Tau22 than control mice.  We used an adeno-assocd. virus (AAV) gene transfer strategy to increase CYP46A1 expression in order to investigate the consequences on THY-Tau22 mouse phenotype.  Injection of the AAV-CYP46A1 vector into the hippocampus of THY-Tau22 mice led to CYP46A1 and 24S-hydroxycholesterol content normalization.  The cognitive deficits, impaired long-term depression and spine defects that characterize the THY-Tau22 model were completely rescued, whereas Tau hyperphosphorylation and assocd. gliosis were unaffected.  These results argue for a causal link between CYP46A1 protein content and memory impairments that result from Tau pathol.  Therefore, CYP46A1 may be a relevant therapeutic target for Tauopathies and esp. for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMcAVSrO3LsbVg90H21EOLACvtfcHk0ljyo3wicSgOxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitV2hs73O&md5=51fb2ed6fa08a04b6006918804ab45dc</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddv268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddv268%26sid%3Dliteratum%253Aachs%26aulast%3DBurlot%26aufirst%3DM.%2BA.%26aulast%3DBraudeau%26aufirst%3DJ.%26aulast%3DMichaelsen-Preusse%26aufirst%3DK.%26aulast%3DPotier%26aufirst%3DB.%26aulast%3DAyciriex%26aufirst%3DS.%26aulast%3DVarin%26aufirst%3DJ.%26aulast%3DGautier%26aufirst%3DB.%26aulast%3DDjelti%26aufirst%3DF.%26aulast%3DAudrain%26aufirst%3DM.%26aulast%3DDauphinot%26aufirst%3DL.%26aulast%3DFernandez-Gomez%26aufirst%3DF.%2BJ.%26aulast%3DCaillierez%26aufirst%3DR.%26aulast%3DLaprevote%26aufirst%3DO.%26aulast%3DBieche%26aufirst%3DI.%26aulast%3DAuzeil%26aufirst%3DN.%26aulast%3DPotier%26aufirst%3DM.%2BC.%26aulast%3DDutar%26aufirst%3DP.%26aulast%3DKorte%26aufirst%3DM.%26aulast%3DBuee%26aufirst%3DL.%26aulast%3DBlum%26aufirst%3DD.%26aulast%3DCartier%26aufirst%3DN.%26atitle%3DCholesterol%252024-hydroxylase%2520defect%2520is%2520implicated%2520in%2520memory%2520impairments%2520associated%2520with%2520Alzheimer-like%2520Tau%2520pathology%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2015%26volume%3D24%26spage%3D5965%26epage%3D5976%26doi%3D10.1093%2Fhmg%2Fddv268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Djelti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braudeau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudry, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhenain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bieche, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chali, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayciriex, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auzeil, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langui, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potier, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laprevote, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidaud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duyckaerts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubourg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartier, N.</span></span> <span> </span><span class="NLM_article-title">CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer’s disease</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">2383</span>– <span class="NLM_lpage">2398</span>, <span class="refDoi"> DOI: 10.1093/brain/awv166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1093%2Fbrain%2Fawv166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=26141492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A280%3ADC%252BC2MbpvFGrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2015&pages=2383-2398&author=F.+Djeltiauthor=J.+Braudeauauthor=E.+Hudryauthor=M.+Dhenainauthor=J.+Varinauthor=I.+Biecheauthor=C.+Marquerauthor=F.+Chaliauthor=S.+Ayciriexauthor=N.+Auzeilauthor=S.+Alvesauthor=D.+Languiauthor=M.+C.+Potierauthor=O.+Laprevoteauthor=M.+Vidaudauthor=C.+Duyckaertsauthor=R.+Milesauthor=P.+Aubourgauthor=N.+Cartier&title=CYP46A1+inhibition%2C+brain+cholesterol+accumulation+and+neurodegeneration+pave+the+way+for+Alzheimer%E2%80%99s+disease&doi=10.1093%2Fbrain%2Fawv166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease</span></div><div class="casAuthors">Djelti Fathia; Braudeau Jerome; Hudry Eloise; Alves Sandro; Aubourg Patrick; Cartier Nathalie; Dhenain Marc; Varin Jennifer; Bieche Ivan; Vidaud Michel; Marquer Catherine; Chali Farah; Langui Dominique; Potier Marie-Claude; Duyckaerts Charles; Miles Richard; Ayciriex Sophie; Auzeil Nicolas; Laprevote Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">Pt 8</span>),
    <span class="NLM_cas:pages">2383-98</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Abnormalities in neuronal cholesterol homeostasis have been suspected or observed in several neurodegenerative disorders including Alzheimer's disease, Parkinson's disease and Huntington's disease.  However, it has not been demonstrated whether an increased abundance of cholesterol in neurons in vivo contributes to neurodegeneration.  To address this issue, we used RNA interference methodology to inhibit the expression of cholesterol 24-hydroxylase, encoded by the Cyp46a1 gene, in the hippocampus of normal mice.  Cholesterol 24-hydroxylase controls cholesterol efflux from the brain and thereby plays a major role in regulating brain cholesterol homeostasis.  We used an adeno-associated virus vector encoding short hairpin RNA directed against the mouse Cyp46a1 mRNA to decrease the expression of the Cyp46a1 gene in hippocampal neurons of normal mice.  This increased the cholesterol concentration in neurons, followed by cognitive deficits and hippocampal atrophy due to apoptotic neuronal death.  Prior to neuronal death, the recruitment of the amyloid protein precursor to lipid rafts was enhanced leading to the production of β-C-terminal fragment and amyloid-β peptides.  Abnormal phosphorylation of tau and endoplasmic reticulum stress were also observed.  In the APP23 mouse model of Alzheimer's disease, the abundance of amyloid-β peptides increased following inhibition of Cyp46a1 expression, and neuronal death was more widespread than in normal mice.  Altogether, these results suggest that increased amounts of neuronal cholesterol within the brain may contribute to inducing and/or aggravating Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQHu-SlLells6cY7HFp97qMfW6udTcc2eZYxdG6hhyxYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbpvFGrtw%253D%253D&md5=e26f30e13e563cf2013a6d44df4d7331</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawv166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawv166%26sid%3Dliteratum%253Aachs%26aulast%3DDjelti%26aufirst%3DF.%26aulast%3DBraudeau%26aufirst%3DJ.%26aulast%3DHudry%26aufirst%3DE.%26aulast%3DDhenain%26aufirst%3DM.%26aulast%3DVarin%26aufirst%3DJ.%26aulast%3DBieche%26aufirst%3DI.%26aulast%3DMarquer%26aufirst%3DC.%26aulast%3DChali%26aufirst%3DF.%26aulast%3DAyciriex%26aufirst%3DS.%26aulast%3DAuzeil%26aufirst%3DN.%26aulast%3DAlves%26aufirst%3DS.%26aulast%3DLangui%26aufirst%3DD.%26aulast%3DPotier%26aufirst%3DM.%2BC.%26aulast%3DLaprevote%26aufirst%3DO.%26aulast%3DVidaud%26aufirst%3DM.%26aulast%3DDuyckaerts%26aufirst%3DC.%26aulast%3DMiles%26aufirst%3DR.%26aulast%3DAubourg%26aufirst%3DP.%26aulast%3DCartier%26aufirst%3DN.%26atitle%3DCYP46A1%2520inhibition%252C%2520brain%2520cholesterol%2520accumulation%2520and%2520neurodegeneration%2520pave%2520the%2520way%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%26date%3D2015%26volume%3D138%26spage%3D2383%26epage%3D2398%26doi%3D10.1093%2Fbrain%2Fawv166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chali, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djelti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eugene, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valderrama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubourg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duykaerts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, V.</span></span> <span> </span><span class="NLM_article-title">Inhibiting cholesterol degradation induces neuronal sclerosis and epileptic activity in mouse hippocampus</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1345</span>– <span class="NLM_lpage">1355</span>, <span class="refDoi"> DOI: 10.1111/ejn.12911</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1111%2Fejn.12911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=25847620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A280%3ADC%252BC2MjhsFeqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2015&pages=1345-1355&author=F.+Chaliauthor=F.+Djeltiauthor=E.+Eugeneauthor=M.+Valderramaauthor=C.+Marquerauthor=P.+Aubourgauthor=C.+Duykaertsauthor=R.+Milesauthor=N.+Cartierauthor=V.+Navarro&title=Inhibiting+cholesterol+degradation+induces+neuronal+sclerosis+and+epileptic+activity+in+mouse+hippocampus&doi=10.1111%2Fejn.12911"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting cholesterol degradation induces neuronal sclerosis and epileptic activity in mouse hippocampus</span></div><div class="casAuthors">Chali Farah; Eugene Emmanuel; Marquer Catherine; Duykaerts Charles; Miles Richard; Navarro Vincent; Djelti Fathia; Aubourg Patrick; Cartier Nathalie; Djelti Fathia; Aubourg Patrick; Cartier Nathalie; Valderrama Mario</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1345-55</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Elevations in neuronal cholesterol have been associated with several degenerative diseases.  An enhanced excitability and synchronous firing in surviving neurons are among the sequels of neuronal death in these diseases and also in some epileptic syndromes.  Here, we attempted to increase neuronal cholesterol levels, using a short hairpin RNA to suppress expression of the enzyme cytochrome P450 family 46, subfamily A, polypeptide 1 gene (CYP46A1).  This protein hydroxylates cholesterol and so facilitates transmembrane extrusion.  A short hairpin RNA CYP46A1construction coupled to the adeno-associated virus type 5 was injected focally and unilaterally into mouse hippocampus.  It was selectively expressed first in neurons of the cornu ammonis (hippocampus) (CA)3a region.  Cytoplasmic and membrane cholesterol increased, and the neuronal soma volume increased and then decreased before pyramidal cells died.  As CA3a pyramidal cells died, interictal electroencephalographic (EEG) events occurred during exploration and non-rapid eye movement sleep.  With time, neuronal death spread to involve pyramidal cells and interneurons of the CA1 region.  CA1 neuronal death was correlated with a delayed local expression of phosphorylated tau.  Astrocytes were activated throughout the hippocampus and microglial activation was specific to regions of neuronal death.  CA1 neuronal death was correlated with distinct aberrant EEG activity.  During exploratory behaviour and rapid eye movement sleep, EEG oscillations at 7-10 Hz (theta) could accelerate to 14-21 Hz (beta) waves.  They were accompanied by low-amplitude, high-frequency oscillations of peak power at ~300 Hz and a range of 250-350 Hz.  Although episodes of EEG acceleration were not correlated with changes in exploratory behaviour, they were followed in some animals by structured seizure-like discharges.  These data strengthen links between increased cholesterol, neuronal sclerosis and epileptic behaviour.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQkb2WpsKSRrkEksK8CslK8fW6udTcc2eZYxdG6hhyxYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MjhsFeqtg%253D%253D&md5=a119c546ad384a1ce86f7c53e558f126</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fejn.12911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fejn.12911%26sid%3Dliteratum%253Aachs%26aulast%3DChali%26aufirst%3DF.%26aulast%3DDjelti%26aufirst%3DF.%26aulast%3DEugene%26aufirst%3DE.%26aulast%3DValderrama%26aufirst%3DM.%26aulast%3DMarquer%26aufirst%3DC.%26aulast%3DAubourg%26aufirst%3DP.%26aulast%3DDuykaerts%26aufirst%3DC.%26aulast%3DMiles%26aufirst%3DR.%26aulast%3DCartier%26aufirst%3DN.%26aulast%3DNavarro%26aufirst%3DV.%26atitle%3DInhibiting%2520cholesterol%2520degradation%2520induces%2520neuronal%2520sclerosis%2520and%2520epileptic%2520activity%2520in%2520mouse%2520hippocampus%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2015%26volume%3D41%26spage%3D1345%26epage%3D1355%26doi%3D10.1111%2Fejn.12911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boussicault, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamaziere, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planques, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heck, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moumne, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Despres, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pages, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piguet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubourg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caboche, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betuing, S.</span></span> <span> </span><span class="NLM_article-title">CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">953</span>– <span class="NLM_lpage">970</span>, <span class="refDoi"> DOI: 10.1093/brain/awv384</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1093%2Fbrain%2Fawv384" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=26912634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A280%3ADC%252BC28jktVOisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2016&pages=953-970&author=L.+Boussicaultauthor=S.+Alvesauthor=A.+Lamaziereauthor=A.+Planquesauthor=N.+Heckauthor=L.+Moumneauthor=G.+Despresauthor=S.+Bolteauthor=A.+Huauthor=C.+Pagesauthor=L.+Galvanauthor=F.+Piguetauthor=P.+Aubourgauthor=N.+Cartierauthor=J.+Cabocheauthor=S.+Betuing&title=CYP46A1%2C+the+rate-limiting+enzyme+for+cholesterol+degradation%2C+is+neuroprotective+in+Huntington%E2%80%99s+disease&doi=10.1093%2Fbrain%2Fawv384"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease</span></div><div class="casAuthors">Boussicault Lydie; Heck Nicolas; Moumne Lara; Pages Christiane; Caboche Jocelyne; Betuing Sandrine; Alves Sandro; Aubourg Patrick; Cartier Nathalie; Lamaziere Antonin; Despres Gaetan; Planques Anabelle; Bolte Susanne; Hu Amelie; Galvan Laurie; Piguet Francoise</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">Pt 3</span>),
    <span class="NLM_cas:pages">953-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Huntington's disease is an autosomal dominant neurodegenerative disease caused by abnormal polyglutamine expansion in huntingtin (Exp-HTT) leading to degeneration of striatal neurons.  Altered brain cholesterol homeostasis has been implicated in Huntington's disease, with increased accumulation of cholesterol in striatal neurons yet reduced levels of cholesterol metabolic precursors.  To elucidate these two seemingly opposing dysregulations, we investigated the expression of cholesterol 24-hydroxylase (CYP46A1), the neuronal-specific and rate-limiting enzyme for cholesterol conversion to 24S-hydroxycholesterol (24S-OHC).  CYP46A1 protein levels were decreased in the putamen, but not cerebral cortex samples, of post-mortem Huntington's disease patients when compared to controls.  Cyp46A1 mRNA and CYP46A1 protein levels were also decreased in the striatum of the R6/2 Huntington's disease mouse model and in SThdhQ111 cell lines.  In vivo, in a wild-type context, knocking down CYP46A1 expression in the striatum, via an adeno-associated virus-mediated delivery of selective shCYP46A1, reproduced the Huntington's disease phenotype, with spontaneous striatal neuron degeneration and motor deficits, as assessed by rotarod.  In vitro, CYP46A1 restoration protected SThdhQ111 and Exp-HTT-expressing striatal neurons in culture from cell death.  In the R6/2 Huntington's disease mouse model, adeno-associated virus-mediated delivery of CYP46A1 into the striatum decreased neuronal atrophy, decreased the number, intensity level and size of Exp-HTT aggregates and improved motor deficits, as assessed by rotarod and clasping behavioural tests.  Adeno-associated virus-CYP46A1 infection in R6/2 mice also restored levels of cholesterol and lanosterol and increased levels of desmosterol.  In vitro, lanosterol and desmosterol were found to protect striatal neurons expressing Exp-HTT from death.  We conclude that restoring CYP46A1 activity in the striatum promises a new therapeutic approach in Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpfLxj7fL7vZ0d-O_J5C0AfW6udTcc2eYXuIK28HPhILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jktVOisA%253D%253D&md5=116b6bc8d5b840696761c31cb79d8582</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawv384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawv384%26sid%3Dliteratum%253Aachs%26aulast%3DBoussicault%26aufirst%3DL.%26aulast%3DAlves%26aufirst%3DS.%26aulast%3DLamaziere%26aufirst%3DA.%26aulast%3DPlanques%26aufirst%3DA.%26aulast%3DHeck%26aufirst%3DN.%26aulast%3DMoumne%26aufirst%3DL.%26aulast%3DDespres%26aufirst%3DG.%26aulast%3DBolte%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DA.%26aulast%3DPages%26aufirst%3DC.%26aulast%3DGalvan%26aufirst%3DL.%26aulast%3DPiguet%26aufirst%3DF.%26aulast%3DAubourg%26aufirst%3DP.%26aulast%3DCartier%26aufirst%3DN.%26aulast%3DCaboche%26aufirst%3DJ.%26aulast%3DBetuing%26aufirst%3DS.%26atitle%3DCYP46A1%252C%2520the%2520rate-limiting%2520enzyme%2520for%2520cholesterol%2520degradation%252C%2520is%2520neuroprotective%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DBrain%26date%3D2016%26volume%3D139%26spage%3D953%26epage%3D970%26doi%3D10.1093%2Fbrain%2Fawv384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saadane, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trichonas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busik, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Retinal vascular abnormalities and microglia activation in mice with deficiency in cytochrome P450 46A1-mediated cholesterol removal</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>189</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">425</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2018.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1016%2Fj.ajpath.2018.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=30448403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFKiu7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2019&pages=405-425&author=A.+Saadaneauthor=N.+Mastauthor=G.+Trichonasauthor=D.+Chakrabortyauthor=S.+Hammerauthor=J.+V.+Busikauthor=M.+B.+Grantauthor=I.+A.+Pikuleva&title=Retinal+vascular+abnormalities+and+microglia+activation+in+mice+with+deficiency+in+cytochrome+P450+46A1-mediated+cholesterol+removal&doi=10.1016%2Fj.ajpath.2018.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Retinal Vascular Abnormalities and Microglia Activation in Mice with Deficiency in Cytochrome P450 46A1-Mediated Cholesterol Removal</span></div><div class="casAuthors">Saadane, Aicha; Mast, Natalia; Trichonas, George; Chakraborty, Dibyendu; Hammer, Sandra; Busik, Julia V.; Grant, Maria B.; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">189</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">405-425</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">CYP46A1 is the cytochrome P 450 enzyme that converts cholesterol to 24-hydroxycholesterol, a cholesterol elimination product and a potent liver X receptor (LXR) ligand.  We conducted retinal characterizations of Cyp46a1-/- mice that had normal fasting blood glucose levels but up to a 1.8-fold increase in retinal cholesterol.  The retina of Cyp46a1-/- mice exhibited venous beading and tortuosity, microglia/macrophage activation, and increased vascular permeability, features commonly assocd. with diabetic retinopathy.  The expression of Lxrα and Lxrβ was increased in both the whole Cyp46a1-/- retina and retinal macroglia/macrophages.  The LXR-target genes were affected as well, primarily in activated microglial cells and macrophages.  In the latter, the LXR-transactivated genes (Abca1, Abcg1, Apod, Apoe, Mylip, and Arg2) were up-regulated; similarly, there was an up-regulation of the LXR-transrepressed genes (Ccl2, Ptgs2, Cxcl1, Il1b, Il6, Nos2, and Tnfa).  For comparison, gene expression was investigated in bone marrow-derived macrophages from Cyp46a1-/- mice as well as retinal and bone marrow-derived macrophages from Cyp27a1-/- and Cyp27a1-/-Cyp46a1-/- mice.  CYP46A1 expression was detected in retinal endothelial cells, and this expression was increased in the proinflammatory environment.  Retinal Cyp46a1-/- phosphoproteome revealed altered phosphorylation of 30 different proteins, including tight junction protein zonula occludens 1 and aquaporin 4.  Collectively, the data obtained establish metabolic and regulatory significance of CYP46A1 for the retina and suggest pharmacol. activation of CYP46A1 as a potential therapeutic approach to dyslipidemia-induced retinal damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEWs9WiCVJMLVg90H21EOLACvtfcHk0lj6jo1MumjxXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFKiu7vE&md5=2273491a130d8dc7a5000ab815549f7c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2018.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2018.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DSaadane%26aufirst%3DA.%26aulast%3DMast%26aufirst%3DN.%26aulast%3DTrichonas%26aufirst%3DG.%26aulast%3DChakraborty%26aufirst%3DD.%26aulast%3DHammer%26aufirst%3DS.%26aulast%3DBusik%26aufirst%3DJ.%2BV.%26aulast%3DGrant%26aufirst%3DM.%2BB.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DRetinal%2520vascular%2520abnormalities%2520and%2520microglia%2520activation%2520in%2520mice%2520with%2520deficiency%2520in%2520cytochrome%2520P450%252046A1-mediated%2520cholesterol%2520removal%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2019%26volume%3D189%26spage%3D405%26epage%3D425%26doi%3D10.1016%2Fj.ajpath.2018.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiseman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">3529</span>– <span class="NLM_lpage">3538</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.532846</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1074%2Fjbc.M113.532846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=24352658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitV2hur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=3529-3538&author=N.+Mastauthor=Y.+Liauthor=M.+Lingerauthor=M.+Clarkauthor=J.+Wisemanauthor=I.+A.+Pikuleva&title=Pharmacologic+stimulation+of+cytochrome+P450+46A1+and+cerebral+cholesterol+turnover+in+mice&doi=10.1074%2Fjbc.M113.532846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic Stimulation of Cytochrome P450 46A1 and Cerebral Cholesterol Turnover in Mice</span></div><div class="casAuthors">Mast, Natalia; Li, Yong; Linger, Marlin; Clark, Matthew; Wiseman, Jeffrey; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3529-3538</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cytochrome P 450 46A1 (CYP46A1) is a brain-specific cholesterol 24-hydroxylase responsible for the majority of cholesterol elimination from the brain.  Genetically increased CYP46A1 expression in mice leads to improved cognition and decreases manifestations of Alzheimer disease.  We found that four pharmaceuticals (efavirenz (EFV), acetaminophen, mirtazapine, and galantamine) prescribed for indications unrelated to cholesterol maintenance increased CYP46A1 activity in vitro.  We then evaluated the anti-HIV medication EFV for the mode of interaction with CYP46A1 and the effect on mice.  We propose a model for CYP46A1 activation by EFV and show that EFV enhanced CYP46A1 activity and cerebral cholesterol turnover in animals with no effect on the levels of brain cholesterol.  The doses of EFV administered to mice and required for the stimulation of their cerebral cholesterol turnover are a hundred times lower than those prescribed to HIV patients.  At such small doses, EFV may be devoid of adverse effects elicited by high drug concns.  CYP46A1 could be a novel therapeutic target and a tool to further investigate the physiol. and medical significance of cerebral cholesterol turnover.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprg1bnYJi8CbVg90H21EOLACvtfcHk0lj6jo1MumjxXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitV2hur4%253D&md5=e3a3b02fbfaaa3cec1ac9a6e8f9dc75e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.532846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.532846%26sid%3Dliteratum%253Aachs%26aulast%3DMast%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLinger%26aufirst%3DM.%26aulast%3DClark%26aufirst%3DM.%26aulast%3DWiseman%26aufirst%3DJ.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DPharmacologic%2520stimulation%2520of%2520cytochrome%2520P450%252046A1%2520and%2520cerebral%2520cholesterol%2520turnover%2520in%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D3529%26epage%3D3538%26doi%3D10.1074%2Fjbc.M113.532846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saadane, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valencia-Olvera, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constans, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxfield, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arakawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landreth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer’s disease</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">465</span>– <span class="NLM_lpage">476</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2017.06.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1016%2Fj.neuropharm.2017.06.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=28655608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVyntL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2017&pages=465-476&author=N.+Mastauthor=A.+Saadaneauthor=A.+Valencia-Olveraauthor=J.+Constansauthor=E.+Maxfieldauthor=H.+Arakawaauthor=Y.+Liauthor=G.+Landrethauthor=I.+A.+Pikuleva&title=Cholesterol-metabolizing+enzyme+cytochrome+P450+46A1+as+a+pharmacologic+target+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neuropharm.2017.06.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease</span></div><div class="casAuthors">Mast, Natalia; Saadane, Aicha; Valencia-Olvera, Ana; Constans, James; Maxfield, Erin; Arakawa, Hiroyuki; Li, Young; Landreth, Gary; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">465-476</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cytochrome P 450 46A1 (CYP46A1 or cholesterol 24-hydroxylase) controls cholesterol elimination from the brain and plays a role in higher order brain functions.  Genetically enhanced CYP46A1 expression in mouse models of Alzheimer's disease mitigates the manifestations of this disease.  We enhanced CYP46A1 activity pharmacol. by treating 5XFAD mice, a model of rapid amyloidogenesis, with a low dose of the anti-HIV medication efavirenz.  Efavirenz was administered from 1 to 9 mo of age, and mice were evaluated at specific time points.  At one month of age, cholesterol homeostasis was already disturbed in the brain of 5XFAD mice.  Nevertheless, efavirenz activated CYP46A1 and mouse cerebral cholesterol turnover during the first four months of administration.  This treatment time also reduced amyloid burden and microglia activation in the cortex and subiculum of 5XFAD mice as well as protein levels of amyloid precursor protein and the expression of several genes involved in inflammatory response.  However, mouse short-term memory and long-term spatial memory were impaired, whereas learning in the context-dependent fear test was improved.  Addnl. four months of drug administration (a total of eight months of treatment) improved long-term spatial memory in the treated as compared to the untreated mice, further decreased amyloid-β content in 5XFAD brain, and also decreased the mortality rate among male mice.  We propose a mechanistic model unifying the obsd. efavirenz effects.  We suggest that CYP46A1 activation by efavirenz could be a new anti-Alzheimer's disease treatment and a tool to study and identify normal and pathol. brain processes affected by cholesterol maintenance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmhSOTzpZZ6rVg90H21EOLACvtfcHk0lhEyZ2RtW56NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVyntL7J&md5=3c4af0d8a17b48abf01d93c98e46f0fa</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2017.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2017.06.026%26sid%3Dliteratum%253Aachs%26aulast%3DMast%26aufirst%3DN.%26aulast%3DSaadane%26aufirst%3DA.%26aulast%3DValencia-Olvera%26aufirst%3DA.%26aulast%3DConstans%26aufirst%3DJ.%26aulast%3DMaxfield%26aufirst%3DE.%26aulast%3DArakawa%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLandreth%26aufirst%3DG.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DCholesterol-metabolizing%2520enzyme%2520cytochrome%2520P450%252046A1%2520as%2520a%2520pharmacologic%2520target%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D123%26spage%3D465%26epage%3D476%26doi%3D10.1016%2Fj.neuropharm.2017.06.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petrov, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxfield, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">CYP46A1 activation by efavirenz leads to behavioral Improvement without significant changes in amyloid plaque load in the brain of 5XFAD mice</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">724</span>, <span class="refDoi"> DOI: 10.1007/s13311-019-00737-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1007%2Fs13311-019-00737-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=31062296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFGjsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=710-724&author=A.+M.+Petrovauthor=M.+Lamauthor=N.+Mastauthor=J.+Moonauthor=Y.+Liauthor=E.+Maxfieldauthor=I.+A.+Pikuleva&title=CYP46A1+activation+by+efavirenz+leads+to+behavioral+Improvement+without+significant+changes+in+amyloid+plaque+load+in+the+brain+of+5XFAD+mice&doi=10.1007%2Fs13311-019-00737-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice</span></div><div class="casAuthors">Petrov, Alexey M.; Lam, Morrie; Mast, Natalia; Moon, Jean; Li, Yong; Maxfield, Erin; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">710-724</span>CODEN:
                <span class="NLM_cas:coden">NEURNV</span>;
        ISSN:<span class="NLM_cas:issn">1878-7479</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Efavirenz, the FDA-approved anti-retroviral medication, is evaluated in the clin. trial in patients with mild cognitive impairment or early dementia due to Alzheimer's disease.  Efavirenz is assessed for activation of cytochrome P 450 46A1 (CYP46A1), a CNS-specific enzyme that converts cholesterol to 24-hydroxycholesterol.  Cholesterol 24-hydroxylation is the major pathway for brain cholesterol removal, and a mechanism that controls brain cholesterol turnover.  The present study tested efavirenz on 5XFAD mice (an Alzheimer's model) at a very low daily dose of 0.1 mg/kg body wt.  Efavirenz treatment started from three months of age, after amyloid plague appearance, and continued for 6 mo.  This treatment led to CYP46A1 activation in the brain, enhancement of brain cholesterol turnover, behavioral improvements, redn. in microglia activation but increased astrocyte reactivity.  The levels of the sol. and insol. amyloid 40 and 42 peptides were unchanged while the no. and area of the dense core amyloid plaques were slightly decreased.  The measurements of the brain levels of several pre- and post-synaptic proteins (Munc13-1, PSD-95, gephyrin, synaptophysin, synapsin-1, and calbindin-D28k) suggested efavirenz effect at the synaptic level.  Efavirenz treatment in the present work seems to represent a model of behavioral and other improvements independent of the levels of the amyloid peptides and provides insight into potential outcomes of the future clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozKiLBY50Uq7Vg90H21EOLACvtfcHk0lhEyZ2RtW56NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFGjsLbN&md5=80445eb9f29a113d3629f89e4f7747a0</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs13311-019-00737-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-019-00737-0%26sid%3Dliteratum%253Aachs%26aulast%3DPetrov%26aufirst%3DA.%2BM.%26aulast%3DLam%26aufirst%3DM.%26aulast%3DMast%26aufirst%3DN.%26aulast%3DMoon%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMaxfield%26aufirst%3DE.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DCYP46A1%2520activation%2520by%2520efavirenz%2520leads%2520to%2520behavioral%2520Improvement%2520without%2520significant%2520changes%2520in%2520amyloid%2520plaque%2520load%2520in%2520the%2520brain%2520of%25205XFAD%2520mice%26jtitle%3DNeurotherapeutics%26date%3D2019%26volume%3D16%26spage%3D710%26epage%3D724%26doi%3D10.1007%2Fs13311-019-00737-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudgens, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turko, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Mapping of the allosteric site in cholesterol hydroxylase CYP46A1 for efavirenz, a drug that stimulates enzyme activity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">11876</span>– <span class="NLM_lpage">11886</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.723577</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1074%2Fjbc.M116.723577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=27056331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC28Xoslahurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=11876-11886&author=K.+W.+Andersonauthor=N.+Mastauthor=J.+W.+Hudgensauthor=J.+B.+Linauthor=I.+V.+Turkoauthor=I.+A.+Pikuleva&title=Mapping+of+the+allosteric+site+in+cholesterol+hydroxylase+CYP46A1+for+efavirenz%2C+a+drug+that+stimulates+enzyme+activity&doi=10.1074%2Fjbc.M116.723577"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping of the Allosteric Site in Cholesterol Hydroxylase CYP46A1 for Efavirenz, a Drug That Stimulates Enzyme Activity</span></div><div class="casAuthors">Anderson, Kyle W.; Mast, Natalia; Hudgens, Jeffrey W.; Lin, Joseph B.; Turko, Illarion V.; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">11876-11886</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cytochrome P 450 46A1 (CYP46A1) is a microsomal enzyme and cholesterol 24-hydroxylase that controls cholesterol elimination from the brain.  This P 450 is also a potential target for Alzheimer disease because it can be activated pharmacol. by some marketed drugs, as exemplified by efavirenz, the anti-HIV medication.  Previously, we suggested that pharmaceuticals activate CYP46A1 allosterically through binding to a site on the cytosolic protein surface, which is different from the enzyme active site facing the membrane.  Here we identified this allosteric site for efavirenz on CYP46A1 by using a combination of hydrogen-deuterium exchange coupled to MS, computational modeling, site-directed mutagenesis, and anal. of the CYP46A1 crystal structure.  We also mapped the binding region for the CYP46A1 redox partner oxidoreductase and found that the allosteric and redox partner binding sites share a common border.  On the basis of the data obtained, we propose the mechanism of CYP46A1 allostery and the pathway for the signal transmission from the P 450 allosteric site to the active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-odvYrHl5arVg90H21EOLACvtfcHk0lhEyZ2RtW56NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xoslahurw%253D&md5=21e195d95508c4b8870509cb10fe7868</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.723577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.723577%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DK.%2BW.%26aulast%3DMast%26aufirst%3DN.%26aulast%3DHudgens%26aufirst%3DJ.%2BW.%26aulast%3DLin%26aufirst%3DJ.%2BB.%26aulast%3DTurko%26aufirst%3DI.%2BV.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DMapping%2520of%2520the%2520allosteric%2520site%2520in%2520cholesterol%2520hydroxylase%2520CYP46A1%2520for%2520efavirenz%252C%2520a%2520drug%2520that%2520stimulates%2520enzyme%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D11876%26epage%3D11886%26doi%3D10.1074%2Fjbc.M116.723577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björkhem, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">9546</span>– <span class="NLM_lpage">9551</span>, <span class="refDoi"> DOI: 10.1073/pnas.0803717105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1073%2Fpnas.0803717105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=18621681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovVOjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=9546-9551&author=N.+Mastauthor=M.+A.+Whiteauthor=I.+Bj%C3%B6rkhemauthor=E.+F.+Johnsonauthor=C.+D.+Stoutauthor=I.+A.+Pikuleva&title=Crystal+structures+of+substrate-bound+and+substrate-free+cytochrome+P450+46A1%2C+the+principal+cholesterol+hydroxylase+in+the+brain&doi=10.1073%2Fpnas.0803717105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of substrate-bound and substrate-free cytochrome P 450 46A1, the principal cholesterol hydroxylase in the brain</span></div><div class="casAuthors">Mast, Natalia; White, Mark Andrew; Bjorkhem, Ingemar; Johnson, Eric F.; Stout, C. David; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">9546-9551</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">By converting cholesterol to (24S)-hydroxycholesterol, cytochrome P 450 46A1 (CYP46A1) initiates the major pathway for cholesterol removal from the brain.  Here, 2 crystal structures of CYP46A1 were detd.  The 1st was the 1.9-Å structure of CYP46A1 complexed with the high-affinity substrate, cholesterol 3-sulfate (CH-3S).  The 2nd structure was that of substrate-free CYP46A1 at 2.4 Å resoln.  CH-3S was bound in the productive orientation and occupied the entire length of the banana-shaped hydrophobic active site cavity.  A unique helix B'-C loop insertion (residues 116-120) contributed to positioning cholesterol for oxygenation catalyzed by CYP46A1.  A comparison with the substrate-free structure revealed substantial substrate-induced conformational changes in CYP46A1 and suggested that structurally distinct compds. could bind in the enzyme active site.  In vitro assays were performed to characterize the effect of different therapeutic agents on cholesterol hydroxylase activity of purified full-length recombinant CYP46A1, and several strong inhibitors and modest coactivators of CYP46A1 were identified.  Structural and biochem. data provide evidence that CYP46A1 activity could be altered by exposure to some therapeutic drugs and potentially other xenobiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphPUQVb_JcD7Vg90H21EOLACvtfcHk0lgMYKMdMgWTgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovVOjtrw%253D&md5=14a967726d993afa01afd4776da206d2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0803717105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0803717105%26sid%3Dliteratum%253Aachs%26aulast%3DMast%26aufirst%3DN.%26aulast%3DWhite%26aufirst%3DM.%2BA.%26aulast%3DBj%25C3%25B6rkhem%26aufirst%3DI.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DStout%26aufirst%3DC.%2BD.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DCrystal%2520structures%2520of%2520substrate-bound%2520and%2520substrate-free%2520cytochrome%2520P450%252046A1%252C%2520the%2520principal%2520cholesterol%2520hydroxylase%2520in%2520the%2520brain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D9546%26epage%3D9551%26doi%3D10.1073%2Fpnas.0803717105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mutlib, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemeth, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markwalder, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seitz, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, D. D.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of efavirenz metabolites by liquid chromatography/mass spectrometry and high field NMR: species differences in the metabolism of efavirenz</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1319</span>– <span class="NLM_lpage">1333</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10534318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1319-1333&author=A.+E.+Mutlibauthor=H.+Chenauthor=G.+A.+Nemethauthor=J.+A.+Markwalderauthor=S.+P.+Seitzauthor=L.+S.+Ganauthor=D.+D.+Christ&title=Identification+and+characterization+of+efavirenz+metabolites+by+liquid+chromatography%2Fmass+spectrometry+and+high+field+NMR%3A+species+differences+in+the+metabolism+of+efavirenz"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of efavirenz metabolites by liquid chromatography/mass spectrometry and high field NMR: species differences in the metabolism of efavirenz</span></div><div class="casAuthors">Mutlib, A. E.; Chen, H.; Nemeth, G. A.; Markwalder, J. A.; Seitz, S. P.; Gan, L. S.; Christ, D. D.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1319-1333</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Efavirenz (Sustiva, Fig. 1) is a potent and specific inhibitor of HIV-1 reverse transcriptase approved for the treatment of HIV infection.  To examine the potential differences in the metab. among species, liq. chromatog./mass spectrometry profiles of efavirenz metabolites in urine of rats, guinea pigs, hamsters, cynomolgus monkeys, and humans were obtained and compared.  The metabolites of efavirenz were isolated, and structures were detd. unequivocally by mass spectral and NMR analyses.  Efavirenz was metabolized extensively by all the species as evidenced by the excretion of none or trace quantities of parent compd. in urine.  Significant species differences in the metab. of efavirenz were obsd.  The major metabolite excreted in the urine of all species was the O-glucuronide conjugate (M1) of the 8-hydroxylated metabolite.  Efavirenz was also metabolized by direct conjugation with glucuronic acid, forming the N-glucuronide (M2) in all five species.  The sulfate conjugate of 8-OH efavirenz (M3) was found in the urine of rats and cynomolgus monkeys but not in humans.  In addn. to the arom. ring-hydroxylated products, metabolites with a hydroxylated cyclopropane ring (at C14) were also isolated.  GSH-related products of efavirenz were identified in rats and guinea pigs.  The cysteinyl-glycine adduct (M10), formed from the GSH adduct (M9), was found in significant quantities in only rat and guinea pig urine and was not detected in other species.  In vitro metab. studies were conducted to show that the GSH adduct was produced from the cyclopropanol intermediate (M11) in the presence of only rat liver and kidney subcellular fractions and was not formed by similar prepns. from humans or cynomolgus monkeys.  These studies indicated the existence of a specific glutathione-S-transferase in rats capable of metabolizing the cyclopropanol metabolite (M11) to the GSH adduct, M9.  The biotransformation pathways of efavirenz in different species were proposed based on some of the in vitro results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVkQvIZDmcpLVg90H21EOLACvtfcHk0lgMYKMdMgWTgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSht7g%253D&md5=cf23cb7f4ef9bb832ff80233e96cf852</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DNemeth%26aufirst%3DG.%2BA.%26aulast%3DMarkwalder%26aufirst%3DJ.%2BA.%26aulast%3DSeitz%26aufirst%3DS.%2BP.%26aulast%3DGan%26aufirst%3DL.%2BS.%26aulast%3DChrist%26aufirst%3DD.%2BD.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520efavirenz%2520metabolites%2520by%2520liquid%2520chromatography%252Fmass%2520spectrometry%2520and%2520high%2520field%2520NMR%253A%2520species%2520differences%2520in%2520the%2520metabolism%2520of%2520efavirenz%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26spage%3D1319%26epage%3D1333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorski, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flockhart, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desta, Z.</span></span> <span> </span><span class="NLM_article-title">The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>306</i></span>,  <span class="NLM_fpage">287</span>– <span class="NLM_lpage">300</span>, <span class="refDoi"> DOI: 10.1124/jpet.103.049601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1124%2Fjpet.103.049601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=12676886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvF2ksr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=287-300&author=B.+A.+Wardauthor=J.+C.+Gorskiauthor=D.+R.+Jonesauthor=S.+D.+Hallauthor=D.+A.+Flockhartauthor=Z.+Desta&title=The+cytochrome+P450+2B6+%28CYP2B6%29+is+the+main+catalyst+of+efavirenz+primary+and+secondary+metabolism%3A+implication+for+HIV%2FAIDS+therapy+and+utility+of+efavirenz+as+a+substrate+marker+of+CYP2B6+catalytic+activity&doi=10.1124%2Fjpet.103.049601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: Implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity</span></div><div class="casAuthors">Ward, Bryan A.; Gorski, J. Christopher; Jones, David R.; Hall, Stephen D.; Flockhart, David A.; Desta, Zeruesenay</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">287-300</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We used human liver microsomes (HLMs) and recombinant cytochromes P 450 (P450s) to identify the routes of efavirenz metab. and the P450s involved.  In HLMs, efavirenz undergoes primary oxidative hydroxylation to 8-hydroxyefavirenz (major) and 7-hydroxyefavirenz (minor) and secondary metab. to 8,14-dihydroxyefavirenz.  The formation of 8-hydroxyefavirenz in two HLMs showed sigmoidal kinetics (av. apparent Km, 20.2 μM; Vmax, 140 pmol/min/mg protein; and Hill coeff., 1.5), whereas that of 7-hydroxyefavirenz formation was characterized by hyperbolic kinetics (Km, 40.1 μM and Vmax, 20.5 pmol/min/mg protein).  In a panel of 10 P450s, CYP2B6 formed 8-hydroxyefavirenz and 8,14-dihydroxyefavirenz from efavirenz (10 μM) at the highest rate.  The Km value for the formation of 8-hydroxyefavirenz in CYP2B6 derived from hyperbolic Eq. 12.4 μM was close to that obtained in HLMs (Km, 20.2 μM).  None of the P450s tested showed activity toward 7-hydroxylation of efavirenz.  When 8-hydroxyefavirenz (2.5 μM) was used as a substrate, 8,14-dihydroxyefavirenz was formed by CYP2B6 at the highest rate, and its kinetics showed substrate inhibition (Ksi, ∼94 μM in HLMs and ∼234 μM in CYP2B6).  In a panel of 11 HLMs, 8-hydroxyefavirenz and 8,14-dihydroxyefavirenz formation rates from efavirenz (10 μM) correlated significantly with the activity of CYP2B6 and CYP3A.  N,N',N''-Triethylenethiophosphoramide (thioTEPA; 50 μM) inhibited the formation rates of 8-hydroxyefavirenz and 8,14-dihydroxyefavirenz from efavirenz (10 μM) by ≥60% in HLMs and CYP2B6, with Ki values < 4 μM.  In conclusion, CYP2B6 is the principal catalyst of efavirenz sequential hydroxylation.  Efavirenz systemic exposure is likely to be subject to interindividual variability in CYP2B6 activity and to drug interactions involving this isoform.  Efavirenz may be a valuable phenotyping tool to study the role of CYP2B6 in human drug metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdxH6M1qc21bVg90H21EOLACvtfcHk0lgMYKMdMgWTgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvF2ksr8%253D&md5=b08295185f3dd7c339a7744309002233</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.049601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.049601%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DB.%2BA.%26aulast%3DGorski%26aufirst%3DJ.%2BC.%26aulast%3DJones%26aufirst%3DD.%2BR.%26aulast%3DHall%26aufirst%3DS.%2BD.%26aulast%3DFlockhart%26aufirst%3DD.%2BA.%26aulast%3DDesta%26aufirst%3DZ.%26atitle%3DThe%2520cytochrome%2520P450%25202B6%2520%2528CYP2B6%2529%2520is%2520the%2520main%2520catalyst%2520of%2520efavirenz%2520primary%2520and%2520secondary%2520metabolism%253A%2520implication%2520for%2520HIV%252FAIDS%2520therapy%2520and%2520utility%2520of%2520efavirenz%2520as%2520a%2520substrate%2520marker%2520of%2520CYP2B6%2520catalytic%2520activity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D306%26spage%3D287%26epage%3D300%26doi%3D10.1124%2Fjpet.103.049601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bumpus, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenberg, P. F.</span></span> <span> </span><span class="NLM_article-title">Metabolism of efavirenz and 8-hydroxyefavirenz by P450 2B6 leads to inactivation by two distinct mechanisms</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>318</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">351</span>, <span class="refDoi"> DOI: 10.1124/jpet.106.102525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1124%2Fjpet.106.102525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=16611850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFymtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2006&pages=345-351&author=N.+N.+Bumpusauthor=U.+M.+Kentauthor=P.+F.+Hollenberg&title=Metabolism+of+efavirenz+and+8-hydroxyefavirenz+by+P450+2B6+leads+to+inactivation+by+two+distinct+mechanisms&doi=10.1124%2Fjpet.106.102525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of efavirenz and 8-hydroxyefavirenz by P450 2B6 leads to inactivation by two distinct mechanisms</span></div><div class="casAuthors">Bumpus, Namandje N.; Kent, Ute M.; Hollenberg, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">345-351</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Efavirenz is a non-nucleoside human immunodeficiency virus (HIV)-1 reverse transcriptase inhibitor used in combination therapy to treat HIV-1.  Efavirenz metab. is catalyzed primarily by the polymorphic enzyme P 450 2B6.  Metab. of efavirenz by P 450 2B6 and the naturally occurring P 450 2B6.4 mutant led to the formation of 8-hydroxyefavirenz.  Efavirenz inactivated the 7-ethoxy-4-(trifluoromethyl)coumarin activity of the wild-type P 450 2B6 enzyme in a time-, concn.-, and NADPH-dependent manner.  However, the P 450 2B6.4 variant was not inactivated by efavirenz.  The ability of efavirenz to inactivate both enzymes was investigated using cyclophosphamide and bupropion, two structurally unrelated substrates of P 450 2B6, as probes.  Preincubations with efavirenz decreased the ability of the wild-type enzyme to hydroxylate both substrates to similar extents but had no effect on the activities of the mutant enzyme.  Interestingly, the inactivation of the wild-type enzyme was completely reversible after 24 h of dialysis as detd. by heme, reduced CO spectra, and activity loss.  In contrast, 8-hydroxyefavirenz, a metabolite of efavirenz, was able to inactivate both enzymes irreversibly.  These data suggest that incubations of P 450 2B6 and P 450 2B6.4 with either the parent compd. efavirenz or the metabolite 8-hydroxyefavirenz in the reconstituted system result in the formation of two different reactive intermediates that lead to losses in enzymic activity by two different mechanisms, one reversible and one irreversible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2I3d_jfo2t7Vg90H21EOLACvtfcHk0lgfPC0ws9fn3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFymtL8%253D&md5=629c431f7c8f24139e5f83050b100c39</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.102525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.102525%26sid%3Dliteratum%253Aachs%26aulast%3DBumpus%26aufirst%3DN.%2BN.%26aulast%3DKent%26aufirst%3DU.%2BM.%26aulast%3DHollenberg%26aufirst%3DP.%2BF.%26atitle%3DMetabolism%2520of%2520efavirenz%2520and%25208-hydroxyefavirenz%2520by%2520P450%25202B6%2520leads%2520to%2520inactivation%2520by%2520two%2520distinct%2520mechanisms%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D318%26spage%3D345%26epage%3D351%26doi%3D10.1124%2Fjpet.106.102525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogburn, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desta, Z.</span></span> <span> </span><span class="NLM_article-title">Efavirenz primary and secondary metabolism in vitro and in vivo: identification of novel metabolic pathways and cytochrome P450 2A6 as the principal catalyst of efavirenz 7-hydroxylation</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1218</span>– <span class="NLM_lpage">1229</span>, <span class="refDoi"> DOI: 10.1124/dmd.109.031393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1124%2Fdmd.109.031393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=20335270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1Klsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1218-1229&author=E.+T.+Ogburnauthor=D.+R.+Jonesauthor=A.+R.+Mastersauthor=C.+Xuauthor=Y.+Guoauthor=Z.+Desta&title=Efavirenz+primary+and+secondary+metabolism+in+vitro+and+in+vivo%3A+identification+of+novel+metabolic+pathways+and+cytochrome+P450+2A6+as+the+principal+catalyst+of+efavirenz+7-hydroxylation&doi=10.1124%2Fdmd.109.031393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Efavirenz primary and secondary metabolism in vitro and in vivo: Identification of novel metabolic pathways and cytochrome P450 2A6 as the principal catalyst of efavirenz 7-hydroxylation</span></div><div class="casAuthors">Ogburn, Evan T.; Jones, David R.; Masters, Andrea R.; Xu, Cong; Guo, Yingying; Desta, Zeruesenay</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1218-1229</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Efavirenz primary and secondary metab. was investigated in vitro and in vivo.  In human liver microsome (HLM) samples, 7- and 8-hydroxyefavirenz accounted for 22.5% and 77.5% of the overall efavirenz metab., resp.  Kinetic, inhibition, and correlation analyses in HLM samples and expts. in expressed cytochrome P 450 show that CYP2A6 is the principal catalyst of efavirenz 7-hydroxylation.  Although CYP2B6 was the main enzyme catalyzing efavirenz 8-hydroxylation, CYP2A6 also seems to contribute.  Both 7- and 8-hydroxyefavirenz were further oxidized to novel dihydroxylated metabolite(s) primarily by CYP2B6.  These dihydroxylated metabolite(s) were not the same as 8,14-dihydroxyefavirenz, a metabolite that has been suggested to be directly formed via 14-hydroxylation of 8-hydroxyefavirenz, because 8,14-dihydroxyefavirenz was not detected in vitro when efavirenz, 7-, or 8-hydroxyefavirenz were used as substrates.  Efavirenz and its primary and secondary metabolites that were identified in vitro were quantified in plasma samples obtained from subjects taking a single 600 mg oral dose of efavirenz.  8,14-Dihydroxyefavirenz was detected and quantified in these plasma samples, suggesting that the glucuronide or the sulfate of 8-hydroxyefavirenz might undergo 14-hydroxylation in vivo.  In conclusion, efavirenz metab. is complex, involving unique and novel secondary metab.  Although efavirenz 8-hydroxylation by CYP2B6 remains the major clearance mechanism of efavirenz, CYP2A6-mediated 7-hydroxylation (and to some extent 8-hydroxylation) may also contribute.  Efavirenz may be a valuable dual phenotyping tool to study CYP2B6 and CYP2A6, and this should be further tested in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohnA4fuPyQVLVg90H21EOLACvtfcHk0lgfPC0ws9fn3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1Klsbc%253D&md5=e2a6478566ab5c233a57e13c5f1305a8</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.031393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.031393%26sid%3Dliteratum%253Aachs%26aulast%3DOgburn%26aufirst%3DE.%2BT.%26aulast%3DJones%26aufirst%3DD.%2BR.%26aulast%3DMasters%26aufirst%3DA.%2BR.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DDesta%26aufirst%3DZ.%26atitle%3DEfavirenz%2520primary%2520and%2520secondary%2520metabolism%2520in%2520vitro%2520and%2520in%2520vivo%253A%2520identification%2520of%2520novel%2520metabolic%2520pathways%2520and%2520cytochrome%2520P450%25202A6%2520as%2520the%2520principal%2520catalyst%2520of%2520efavirenz%25207-hydroxylation%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D1218%26epage%3D1229%26doi%3D10.1124%2Fdmd.109.031393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aouri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barcelo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ternon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavassini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anagnostopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yerly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hugues, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vernazza, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunthard, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buclin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telenti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decosterd, L. A.</span></span> <span> </span><span class="NLM_article-title">In vivo profiling and distribution of known and novel phase I and phase II metabolites of efavirenz in plasma, urine, and cerebrospinal fluid</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1124/dmd.115.065839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1124%2Fdmd.115.065839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=26553012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWnt7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=151-161&author=M.+Aouriauthor=C.+Barceloauthor=B.+Ternonauthor=M.+Cavassiniauthor=A.+Anagnostopoulosauthor=S.+Yerlyauthor=H.+Huguesauthor=P.+Vernazzaauthor=H.+F.+Gunthardauthor=T.+Buclinauthor=A.+Telentiauthor=M.+Rotgerauthor=L.+A.+Decosterd&title=In+vivo+profiling+and+distribution+of+known+and+novel+phase+I+and+phase+II+metabolites+of+efavirenz+in+plasma%2C+urine%2C+and+cerebrospinal+fluid&doi=10.1124%2Fdmd.115.065839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo profiling and distribution of known and novel phase I and phase II metabolites of efavirenz in plasma, urine, and cerebrospinal fluid</span></div><div class="casAuthors">Aouri, Manel; Barcelo, Catalina; Ternon, Beatrice; Cavassini, Matthias; Anagnostopoulos, Alexia; Yerly, Sabine; Hugues, Henry; Vernazza, Pietro; Gunthard, Huldrych F.; Buclin, Thierry; Telenti, Amalio; Rotger, Margalida; Decosterd, Laurent A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">151-161</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Efavirenz (EFV) is principally metabolized by CYP2B6 to 8-hydroxy-efavirenz (8OH-EFV) and to a lesser extent by CYP2A6 to 7-hydroxy-efavirenz (7OH-EFV).  So far, most metabolite profile analyses have been restricted to 8OH-EFV, 7OH-EFV, and EFV-N-glucuronide, even though these metabolites represent a minor percentage of EFV metabolites present in vivo.  We have performed a quant. phase I and II metabolite profile anal. by tandem mass spectrometry of plasma, cerebrospinal fluid (CSF), and urine samples in 71 human immunodeficiency virus patients taking efavirenz, prior to and after enzymic (glucuronidase and sulfatase) hydrolysis.  We have shown that phase II metabolites constitute the major part of the known circulating efavirenz species in humans.  The 8OH-EFV-glucuronide (gln) and 8OH-EFV-sulfate (identified for the first time) in humans were found to be 64- and 7-fold higher than the parent 8OH-EFV, resp.  In individuals (n = 67) genotyped for CYP2B6, 2A6, and CYP3A metabolic pathways, 8OH-EFV/EFV ratios in plasma were an index of CYP2B6 phenotypic activity (P < 0.0001), which was also reflected by phase II metabolites 8OH-EFV-glucuronide/EFV and 8OH-EFV-sulfate/EFV ratios.  Neither EFV nor 8OH-EFV, nor any other considered metabolites in plasma were assocd. with an increased risk of central nervous system (CNS) toxicity.  In CSF, 8OH-EFV levels were not influenced by CYP2B6 genotypes and did not predict CNS toxicity.  The phase II metabolites 8OH-EFV-gln, 8OH-EFV-sulfate, and 7OH-EFV-gln were present in CSF at 2- to 9-fold higher concns. than 8OH-EFV.  The potential contribution of known and previously unreported EFV metabolites in CSF to the neuropsychol. effects of efavirenz needs to be further examd. in larger cohort studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu_lSLGw2YqrVg90H21EOLACvtfcHk0lgfPC0ws9fn3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWnt7zN&md5=c8eb665e34c4274aa32a25291293ff29</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fdmd.115.065839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.115.065839%26sid%3Dliteratum%253Aachs%26aulast%3DAouri%26aufirst%3DM.%26aulast%3DBarcelo%26aufirst%3DC.%26aulast%3DTernon%26aufirst%3DB.%26aulast%3DCavassini%26aufirst%3DM.%26aulast%3DAnagnostopoulos%26aufirst%3DA.%26aulast%3DYerly%26aufirst%3DS.%26aulast%3DHugues%26aufirst%3DH.%26aulast%3DVernazza%26aufirst%3DP.%26aulast%3DGunthard%26aufirst%3DH.%2BF.%26aulast%3DBuclin%26aufirst%3DT.%26aulast%3DTelenti%26aufirst%3DA.%26aulast%3DRotger%26aufirst%3DM.%26aulast%3DDecosterd%26aufirst%3DL.%2BA.%26atitle%3DIn%2520vivo%2520profiling%2520and%2520distribution%2520of%2520known%2520and%2520novel%2520phase%2520I%2520and%2520phase%2520II%2520metabolites%2520of%2520efavirenz%2520in%2520plasma%252C%2520urine%252C%2520and%2520cerebrospinal%2520fluid%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2016%26volume%3D44%26spage%3D151%26epage%3D161%26doi%3D10.1124%2Fdmd.115.065839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Remmer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estabrook, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasame, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillette, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhulu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, O.</span></span> <span> </span><span class="NLM_article-title">Drug interaction with hepatic microsomal cytochrome</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1966</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">190</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=5905665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADyaF28XktVKmur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1966&pages=187-190&author=H.+Remmerauthor=J.+Schenkmanauthor=R.+W.+Estabrookauthor=H.+Sasameauthor=J.+Gilletteauthor=S.+Narasimhuluauthor=D.+Y.+Cooperauthor=O.+Rosenthal&title=Drug+interaction+with+hepatic+microsomal+cytochrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Drug interaction with hepatic microsomal cytochrome</span></div><div class="casAuthors">Remmer, H.; Schenkman, J.; Estabrook, R. W.; Sasame, H.; Gillette, J.; Narasimhulu, S.; Cooper, D. Y.; Rosenthal, O.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1966</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-90</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">The difference spectra of isolated rat liver microsomes to which substrates of drug-metabolizing enzymes were added were studied in order to det. whether spectral changes, indicative of substrate interaction, were present in hepatic as well as adrenal cortical microsomes.  Two types of spectral changes were observed.  Hexobarbitol (I), phenobarbital (II), aminopyrine, and amobarbital, either in the presence or absence of TPNH, caused spectral changes similar to those observed on the addn. of 17-hydroxyprogesterone to adrenal cortical microsomes.  The addn. of aniline or 2,4-dichloro-6-phenylphenoxyethylamine-HCl causes a second type of spectral change.  Pretreatment of rats with II enhanced the spectral changes observed with either I or II, while pretreatment with benzopyrene increased the amt. of cytochrome P-450 and the magnitude of the spectral change observed with aniline, but diminished the spectral change caused by I.  These diverse effects observed with various inducing agents may permit direct assessment of the differences occurring on modification of the hepatic microsomal oxidn. system during induction.  Apparently, these spectral changes are related to substrate interaction with a microsomal hemoprotein, presumably cytochrome P-450.  Possibly, substrate addn. either (a) modifies the molar absorptivity of the hemoprotein or modifies the hemoprotein ligand interaction or (b) converts an "activated" O form of cytochrome P-450 to its oxidized state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlBG1o68CpVrVg90H21EOLACvtfcHk0ljHrMTeVuOLCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF28XktVKmur4%253D&md5=db35443b586ad0335545504e2102bda1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRemmer%26aufirst%3DH.%26aulast%3DSchenkman%26aufirst%3DJ.%26aulast%3DEstabrook%26aufirst%3DR.%2BW.%26aulast%3DSasame%26aufirst%3DH.%26aulast%3DGillette%26aufirst%3DJ.%26aulast%3DNarasimhulu%26aufirst%3DS.%26aulast%3DCooper%26aufirst%3DD.%2BY.%26aulast%3DRosenthal%26aufirst%3DO.%26atitle%3DDrug%2520interaction%2520with%2520hepatic%2520microsomal%2520cytochrome%26jtitle%3DMol.%2520Pharmacol.%26date%3D1966%26volume%3D2%26spage%3D187%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schenkman, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remmer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estabrook, R. W.</span></span> <span> </span><span class="NLM_article-title">Spectral studies of drug interaction with hepatic microsomal cytochrome</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">123</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=4382749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADyaF2sXosVCjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1967&pages=113-123&author=J.+B.+Schenkmanauthor=H.+Remmerauthor=R.+W.+Estabrook&title=Spectral+studies+of+drug+interaction+with+hepatic+microsomal+cytochrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Spectral studies of drug interaction with hepatic microsomal cytochrome</span></div><div class="casAuthors">Schenkman, John B.; Remmer, Herbert; Estabrook, Ronald W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-23</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Two types of spectral changes are described as resulting from substrate interaction with a hepatic microsomal cytochrome; the magnitude of these spectral changes is dependent on protein concn. and substrate concn. as well as the substrate employed.  In 2 of the 3 types of substrates examd. the concn. of substrate necessary to evoke half-max. enzyme activity was similar to the concn. of the same substrate necessary for half-max. spectral changes.  The addn. of NADPH, a corequirement for the microsomal mixed function oxidase, causes a modification of both types of spectral changes, without altering substrate affinity.  Three possible hypotheses are advanced, based upon the exptl. observations, to explain the two types of spectral changes observed.  24 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoInUTNOrGCNbVg90H21EOLACvtfcHk0ljHrMTeVuOLCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXosVCjtQ%253D%253D&md5=8f1a923fb13a3c6bbeed43c6d0e80e5e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchenkman%26aufirst%3DJ.%2BB.%26aulast%3DRemmer%26aufirst%3DH.%26aulast%3DEstabrook%26aufirst%3DR.%2BW.%26atitle%3DSpectral%2520studies%2520of%2520drug%2520interaction%2520with%2520hepatic%2520microsomal%2520cytochrome%26jtitle%3DMol.%2520Pharmacol.%26date%3D1967%26volume%3D3%26spage%3D113%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mailman, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, E.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P-450 difference spectra: effect of chemical structure on Type II spectra in mouse hepatic microsomes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=4152826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADyaE2cXltFGit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1974&pages=301-308&author=R.+B.+Mailmanauthor=A.+P.+Kulkarniauthor=R.+C.+Bakerauthor=E.+Hodgson&title=Cytochrome+P-450+difference+spectra%3A+effect+of+chemical+structure+on+Type+II+spectra+in+mouse+hepatic+microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P-450 difference spectra.  Effect of chemical structure on type II spectra in mouse hepatic microsomes</span></div><div class="casAuthors">Mailman, Richard B.; Kulkarni, A. P.; Baker, Rodney C.; Hodgson, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">301-8</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    </div><div class="casAbstract">The difference spectra of oxidized cytochrome P 450 [9035-51-2] in liver microsomes showed two types of perturbations when treated with different potential ligands, and the effects of many compds. indicated the structural features assocd. with induction of the type II spectrum (max. 425-35 nm,min. 390-410 nm).  Binding of this type was correlated with the presence of a N atom in which sp2 or sp3 nonbonded electrons were sterically accessible, and the spectral size was either reduced or eliminated as substituents were placed close to this N.  A modified type II binding, i.e., a bathochromic shift, was caused by other nucleophilic atoms with relatively free steric access.  Minor structural changes in the compds. could affect both the size and type of spectrum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIZGXS6ExPGbVg90H21EOLACvtfcHk0ljHrMTeVuOLCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXltFGit7w%253D&md5=cdd08b26dbf310f2ecb303089eff8ec7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMailman%26aufirst%3DR.%2BB.%26aulast%3DKulkarni%26aufirst%3DA.%2BP.%26aulast%3DBaker%26aufirst%3DR.%2BC.%26aulast%3DHodgson%26aufirst%3DE.%26atitle%3DCytochrome%2520P-450%2520difference%2520spectra%253A%2520effect%2520of%2520chemical%2520structure%2520on%2520Type%2520II%2520spectra%2520in%2520mouse%2520hepatic%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1974%26volume%3D2%26spage%3D301%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charvet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, C. D.</span></span> <span> </span><span class="NLM_article-title">Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">31783</span>– <span class="NLM_lpage">31795</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.143313</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1074%2Fjbc.M110.143313" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=20667828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=31783-31795&author=N.+Mastauthor=C.+Charvetauthor=I.+A.+Pikulevaauthor=C.+D.+Stout&title=Structural+basis+of+drug+binding+to+CYP46A1%2C+an+enzyme+that+controls+cholesterol+turnover+in+the+brain&doi=10.1074%2Fjbc.M110.143313"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Drug Binding to CYP46A1, an Enzyme That Controls Cholesterol Turnover in the Brain</span></div><div class="casAuthors">Mast, Natalia; Charvet, Casey; Pikuleva, Irina A.; Stout, C. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">31783-31795</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cytochrome P 450 46A1 (CYP46A1) initiates the major pathway of cholesterol elimination from the brain and thereby controls cholesterol turnover in this organ.  We detd. x-ray crystal structures of CYP46A1 in complex with four structurally distinct pharmaceuticals; antidepressant tranylcypromine (2.15 Å), anticonvulsant thioperamide (1.65 Å), antifungal voriconazole (2.35 Å), and antifungal clotrimazole (2.50 Å).  All four drugs are nitrogen-contg. compds. that have nanomolar affinity for CYP46A1 in vitro yet differ in size, shape, hydrophobicity, and type of the nitrogen ligand.  Structures of the co-complexes demonstrate that each drug binds in a single orientation to the active site with tranylcypromine, thioperamide, and voriconazole coordinating the heme iron via their nitrogen atoms and clotrimazole being at a 4 Å distance from the heme iron.  We show here that clotrimazole is also a substrate for CYP46A1.  High affinity for CYP46A1 is detd. by a set of specific interactions, some of which were further investigated by soln. studies using structural analogs of the drugs and the T306A CYP46A1 mutant.  Collectively, our results reveal how diverse inhibitors can be accommodated in the CYP46A1 active site and provide an explanation for the obsd. differences in the drug-induced spectral response.  Co-complexes with tranylcypromine, thioperamide, and voriconazole represent the first structural characterization of the drug binding to a P 450 enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq9TvdcFkRG7Vg90H21EOLACvtfcHk0ligx1MuPekXkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7zI&md5=3ce22203cf3b9ffde9ff0b0b9c1ccdc4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.143313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.143313%26sid%3Dliteratum%253Aachs%26aulast%3DMast%26aufirst%3DN.%26aulast%3DCharvet%26aufirst%3DC.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26aulast%3DStout%26aufirst%3DC.%2BD.%26atitle%3DStructural%2520basis%2520of%2520drug%2520binding%2520to%2520CYP46A1%252C%2520an%2520enzyme%2520that%2520controls%2520cholesterol%2520turnover%2520in%2520the%2520brain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D31783%26epage%3D31795%26doi%3D10.1074%2Fjbc.M110.143313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nebert, D. W.</span></span> <span> </span><span class="NLM_article-title">Correlation of Type I, Type II, and Reverse Type I difference spectra with absolute changes in spin state of hepatic microsomal cytochrome P-450 iron from five mammalian species</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>253</i></span>,  <span class="NLM_fpage">1048</span>– <span class="NLM_lpage">1058</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=203579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADyaE1cXhtFKlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1978&pages=1048-1058&author=K.+Kumakiauthor=M.+Satoauthor=H.+Konauthor=D.+W.+Nebert&title=Correlation+of+Type+I%2C+Type+II%2C+and+Reverse+Type+I+difference+spectra+with+absolute+changes+in+spin+state+of+hepatic+microsomal+cytochrome+P-450+iron+from+five+mammalian+species"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation of type I, type II, and reverse type I difference spectra with absolute changes in spin state of hepatic microsomal cytochrome P-450 iron from five mammalian species</span></div><div class="casAuthors">Kumaki, Kenji; Sato, Mitsuo; Kon, Hideo; Nebert, Daniel W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1048-58</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The spin state of cytochrome P-450 ferric iron in vivo and in vitro was examd. in freshly prepd. liver microsomes from rabbit, guinea pig, hamster, mouse, and rat by low temp. EPR spectroscopy and compared with room temp. difference spectral changes.  The in vivo spin state in intact freshly prepd. microsomes reflects the environment of the P-450 iron itself in the vicinity of the heme protein, which may include bound endogenous compds., whereas the in vitro spin state reflects binding of added exogenous compds. to the iron (or binding in the vicinity of the heme iron).  A method is proposed for detg. the percentage of high spin P-450 iron in vivo per total P-450 content, by knowing the gy ≃ 8.0/gy ≃ 2.24 ratio of EPR signal heights.  This method gives a good approxn. among all 5 mammalian species examd. and during various in vivo treatments with inducers of certain forms of P-450 and during in vitro addns. of chems.  The EPR data with a series of compds. of increasing ligand field strengths added in vitro are consistent with the hypothesis that the 6th coordination site for in vivo low spin P-450 ferric iron is an O atom from an adjacent amino acid residue or a water mol.  The greater the amt. of high spin P-450 iron in vivo at the start of the expt., the lesser the peak-to-trough spectral height produced by pure type I substrates added in vitro, and the greater the peak-to-trough spectral height produced by pure reverse type I or type II compds. added in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn_iUhKUBdKbVg90H21EOLACvtfcHk0ligx1MuPekXkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhtFKlt7s%253D&md5=90532e27840af9cd3c6bce9cc35edd0b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumaki%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DKon%26aufirst%3DH.%26aulast%3DNebert%26aufirst%3DD.%2BW.%26atitle%3DCorrelation%2520of%2520Type%2520I%252C%2520Type%2520II%252C%2520and%2520Reverse%2520Type%2520I%2520difference%2520spectra%2520with%2520absolute%2520changes%2520in%2520spin%2520state%2520of%2520hepatic%2520microsomal%2520cytochrome%2520P-450%2520iron%2520from%2520five%2520mammalian%2520species%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1978%26volume%3D253%26spage%3D1048%26epage%3D1058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vogt, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Cera, E.</span></span> <span> </span><span class="NLM_article-title">Conformational selection or induced fit? A critical appraisal of the kinetic mechanism</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5894</span>– <span class="NLM_lpage">5902</span>, <span class="refDoi"> DOI: 10.1021/bi3006913</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi3006913" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVKltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=5894-5902&author=A.+D.+Vogtauthor=E.+Di+Cera&title=Conformational+selection+or+induced+fit%3F+A+critical+appraisal+of+the+kinetic+mechanism&doi=10.1021%2Fbi3006913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational selection or induced fit? A critical appraisal of the kinetic mechanism</span></div><div class="casAuthors">Vogt, Austin D.; Di Cera, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">5894-5902</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">For almost 5 decades, 2 competing mechanisms of ligand recognition, conformational selection and induced fit, have dominated the interpretation of ligand binding in biol. macromols.  When binding-dissocn. events are fast compared to conformational transitions, the rate of approach to equil., kobs, becomes diagnostic of conformational selection or induced fit based on whether it decreases or increases, resp., with the ligand concn. [L].  However, this simple conclusion based on the rapid equil. approxn. is not valid in general.  Here, the authors show that conformational selection is assocd. with a rich repertoire of kinetic properties, with kobs decreasing or increasing with [L] depending on the relative magnitude of the rate of ligand dissocn., koff, and the rate of conformational isomerization, kr.  The authors prove that, even for the simplest 2-step mechanism of ligand binding, a decrease in kobs with [L] is unequivocal evidence of conformational selection, but an increase in kobs with [L] is not unequivocal evidence of induced fit.  Ligand binding to glucokinase, thrombin, and its precursor, prethrombin-2, are used as relevant examples.  It is concluded that conformational selection as a mechanism for ligand binding to its target may be far more common than currently believed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdButaqMoNzLVg90H21EOLACvtfcHk0ligx1MuPekXkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVKltbo%253D&md5=0f7c66027467c390967075c3be8e5254</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fbi3006913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi3006913%26sid%3Dliteratum%253Aachs%26aulast%3DVogt%26aufirst%3DA.%2BD.%26aulast%3DDi%2BCera%26aufirst%3DE.%26atitle%3DConformational%2520selection%2520or%2520induced%2520fit%253F%2520A%2520critical%2520appraisal%2520of%2520the%2520kinetic%2520mechanism%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D5894%26epage%3D5902%26doi%3D10.1021%2Fbi3006913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gianni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemth, P.</span></span> <span> </span><span class="NLM_article-title">Distinguishing induced fit from conformational selection</span>. <i>Biophys. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>189</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">39s</span>, <span class="refDoi"> DOI: 10.1016/j.bpc.2014.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1016%2Fj.bpc.2014.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=24747333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvVWltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2014&pages=33-39s&author=S.+Gianniauthor=J.+Doganauthor=P.+Jemth&title=Distinguishing+induced+fit+from+conformational+selection&doi=10.1016%2Fj.bpc.2014.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Distinguishing induced fit from conformational selection</span></div><div class="casAuthors">Gianni, Stefano; Dogan, Jakob; Jemth, Per</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">189</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">33-39</span>CODEN:
                <span class="NLM_cas:coden">BICIAZ</span>;
        ISSN:<span class="NLM_cas:issn">0301-4622</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The interactions between proteins and ligands often involve a conformational change in the protein.  This conformational change can occur before (conformational selection) or after (induced fit) the assocn. with ligand.  It is often very difficult to distinguish induced fit from conformational selection when hyperbolic binding kinetics are obsd.  In light of a recent paper in this journal (Vogt et al., Biophys. Chem., 186, 2014, 13-21) and the current interest in binding mechanisms emerging from obsd. sampling of distinct conformations in protein domains, as well as from the field of intrinsically disordered proteins, we here describe a kinetic method that, at least in some cases, unequivocally distinguishes induced fit from conformational selection.  The method relies on measuring the obsd. rate const. λ for binding and varying both the protein and the ligand in sep. expts.  Whereas induced fit always yields a hyperbolic dependence of increasing λ values, the conformational selection mechanism gives rise to distinct kinetics when the ligand and protein (displaying the conformational change) concn. is varied in sep. expts.  We provide examples from the literature and discuss the limitations of the approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBGtc2RoRf-7Vg90H21EOLACvtfcHk0ljaNnEVpNzSIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvVWltb0%253D&md5=ecbe065454d8d9315638b5960b800c38</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bpc.2014.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bpc.2014.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DGianni%26aufirst%3DS.%26aulast%3DDogan%26aufirst%3DJ.%26aulast%3DJemth%26aufirst%3DP.%26atitle%3DDistinguishing%2520induced%2520fit%2520from%2520conformational%2520selection%26jtitle%3DBiophys.%2520Chem.%26date%3D2014%26volume%3D189%26spage%3D33%26epage%3D39s%26doi%3D10.1016%2Fj.bpc.2014.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span> <span> </span><span class="NLM_article-title">Kinetic processivity of the two-step oxidations of progesterone and pregnenolone to androgens by human cytochrome P450 17A1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">13168</span>– <span class="NLM_lpage">13185</span>, <span class="refDoi"> DOI: 10.1074/jbc.M117.794917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1074%2Fjbc.M117.794917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=28684414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlWhur%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=13168-13185&author=E.+Gonzalezauthor=F.+P.+Guengerich&title=Kinetic+processivity+of+the+two-step+oxidations+of+progesterone+and+pregnenolone+to+androgens+by+human+cytochrome+P450+17A1&doi=10.1074%2Fjbc.M117.794917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic processivity of the two-step oxidations of progesterone and pregnenolone to androgens by human cytochrome P450 17A1</span></div><div class="casAuthors">Gonzalez, Eric; Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">13168-13185</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cytochrome P 450 (P 450, CYP) 17A1 plays a crit. role in steroid metab., catalyzing both the 17α-hydroxylation of pregnenolone and progesterone and the subsequent 17α,20-lyase reactions to form dehydroepiandrosterone (DHEA) and androstenedione (Andro), resp., crit. for generating glucocorticoids and androgens.  Human P 450 17A1 reaction rates examd. are enhanced by the accessory protein cytochrome b5 (b5), but the exact role of b5 in P 450 17A1-catalyzed reactions is unclear as are several details of these reactions.  Here, we examd. in detail the processivity of the 17α-hydroxylation and lyase steps.  B5 did not enhance reaction rates by decreasing the koff rates of any of the steroids.  Steroid binding to P 450 17A1 was more complex than a simple two-state system.  Pre-steady-state expts. indicated lag phases for Andro prodn. from progesterone and for DHEA from pregnenolone, indicating a distributive character of the enzyme.  However, we obsd. processivity in pregnenolone/DHEA pulse-chase expts.  (S)-Orteronel was three times more inhibitory toward the conversion of 17α-hydroxypregnenolone to DHEA than toward the 17α-hydroxylation of pregnenolone.  IC50 values for (S)-orteronel were identical for blocking DHEA formation from pregnenolone and for 17α-hydroxylation, suggestive of processivity.  Global kinetic modeling helped assign sets of rate consts. for individual or groups of reactions, indicating that human P 450 17A1 is an inherently distributive enzyme but that some processivity is present, i.e. some of the 17α-OH pregnenolone formed from pregnenolone did not dissoc. from P 450 17A1 before conversion to DHEA.  Our results also suggest multiple conformations of P 450 17A1, as previously proposed on the basis of NMR spectroscopy and X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY30m86m4cjbVg90H21EOLACvtfcHk0ljaNnEVpNzSIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlWhur%252FF&md5=938001edf69216fccd3c170ded30d58a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.794917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.794917%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%26aufirst%3DE.%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DKinetic%2520processivity%2520of%2520the%2520two-step%2520oxidations%2520of%2520progesterone%2520and%2520pregnenolone%2520to%2520androgens%2520by%2520human%2520cytochrome%2520P450%252017A1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D13168%26epage%3D13185%26doi%3D10.1074%2Fjbc.M117.794917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkey, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddish, M. J.</span></span> <span> </span><span class="NLM_article-title">Conformational selection dominates binding of steroids to human cytochrome P450 17A1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">10028</span>– <span class="NLM_lpage">10041</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA119.008860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1074%2Fjbc.RA119.008860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=31072872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A280%3ADC%252BB3M7ktF2hsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=10028-10041&author=F.+P.+Guengerichauthor=C.+J.+Wilkeyauthor=S.+M.+Glassauthor=M.+J.+Reddish&title=Conformational+selection+dominates+binding+of+steroids+to+human+cytochrome+P450+17A1&doi=10.1074%2Fjbc.RA119.008860"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational selection dominates binding of steroids to human cytochrome P450 17A1</span></div><div class="casAuthors">Guengerich F Peter; Wilkey Clayton J; Glass Sarah M; Reddish Michael J</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of biological chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10028-10041</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cytochrome P450 (P450, CYP) enzymes are the major catalysts involved in the oxidation of steroids as well as many other compounds.  Their versatility has been explained in part by flexibility of the proteins and complexity of the binding mechanisms.  However, whether these proteins bind their substrates via induced fit or conformational selection is not understood.  P450 17A1 has a major role in steroidogenesis, catalyzing the two-step oxidations of progesterone and pregnenolone to androstenedione and dehydroepiandrosterone, respectively, via 17α-hydroxy (OH) intermediates.  We examined the interaction of P450 17A1 with its steroid substrates by analyzing progress curves (UV-visible spectroscopy), revealing that the rates of binding of any of these substrates decreased with increasing substrate concentration, a hallmark of conformational selection.  Further, when the concentration of 17α-OH pregnenolone was held constant and the P450 concentration increased, the binding rate increased, and such opposite patterns are also diagnostic of conformational selection.  Kinetic simulation modeling was also more consistent with conformational selection than with an induced-fit mechanism.  Cytochrome b5 partially enhances P450 17A1 lyase activity by altering the P450 17A1 conformation but did not measurably alter the binding of 17α-OH pregnenolone or 17α-OH progesterone, as judged by the apparent Kd and binding kinetics.  The P450 17A1 inhibitor abiraterone also bound to P450 17A1 in a multistep manner, and modeling indicated that the selective inhibition of the two P450 17A1 steps by the drug orteronel can be rationalized only by a multiple-conformation model.  In conclusion, P450 17A1 binds its steroid substrates via conformational selection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuPFZGSPoZE3qj_yg7twvpfW6udTcc2ebc4ckkbdmwQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7ktF2hsA%253D%253D&md5=3a45e860f5ca51c1023354b885010b00</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA119.008860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA119.008860%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26aulast%3DWilkey%26aufirst%3DC.%2BJ.%26aulast%3DGlass%26aufirst%3DS.%2BM.%26aulast%3DReddish%26aufirst%3DM.%2BJ.%26atitle%3DConformational%2520selection%2520dominates%2520binding%2520of%2520steroids%2520to%2520human%2520cytochrome%2520P450%252017A1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26spage%3D10028%26epage%3D10041%26doi%3D10.1074%2Fjbc.RA119.008860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkey, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, T. T. N.</span></span> <span> </span><span class="NLM_article-title">Human cytochrome P450 enzymes bind drugs and other substrates mainly through conformational-selection modes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">10928</span>– <span class="NLM_lpage">10941</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA119.009305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1074%2Fjbc.RA119.009305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=31147443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A280%3ADC%252BB3M3hs1WhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=10928-10941&author=F.+P.+Guengerichauthor=C.+J.+Wilkeyauthor=T.+T.+N.+Phan&title=Human+cytochrome+P450+enzymes+bind+drugs+and+other+substrates+mainly+through+conformational-selection+modes&doi=10.1074%2Fjbc.RA119.009305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Human cytochrome P450 enzymes bind drugs and other substrates mainly through conformational-selection modes</span></div><div class="casAuthors">Guengerich F Peter; Wilkey Clayton J; Phan Thanh T N</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of biological chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">10928-10941</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cytochrome P450 (P450) enzymes are major catalysts involved in the oxidations of most drugs, steroids, carcinogens, fat-soluble vitamins, and natural products.  The binding of substrates to some of the 57 human P450s and other mammalian P450s is more complex than a two-state system and has been proposed to involve mechanisms such as multiple ligand occupancy, induced-fit, and conformational-selection.  Here, we used kinetic analysis of binding with multiple concentrations of substrates and computational modeling of these data to discern possible binding modes of several human P450s.  We observed that P450 2D6 binds its ligand rolapitant in a mechanism involving conformational-selection.  P450 4A11 bound the substrate lauric acid via conformational-selection, as did P450 2C8 with palmitic acid.  Binding of the steroid progesterone to P450 21A2 was also best described by a conformational-selection model.  Hexyl isonicotinate binding to P450 2E1 could be described by either a conformational-selection or an induced-fit model.  Simulation of the binding of the ligands midazolam, bromocriptine, testosterone, and ketoconazole to P450 3A4 was consistent with an induced-fit or a conformational-selection model, but the concentration dependence of binding rates for varying both P450 3A4 and midazolam concentrations revealed discordance in the parameters, indicative of conformational-selection.  Binding of the P450s 2C8, 2D6, 3A4, 4A11, and 21A2 was best described by conformational-selection, and P450 2E1 appeared to fit either mode.  These findings highlight the complexity of human P450-substrate interactions and that conformational-selection is a dominant feature of many of these interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaT5SunVS7rLZpSb_XWfMrfW6udTcc2ea2ceHMe9dJdrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3hs1WhsA%253D%253D&md5=cf1b5d5c34e4a3bb0a6681618087d35a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA119.009305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA119.009305%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26aulast%3DWilkey%26aufirst%3DC.%2BJ.%26aulast%3DPhan%26aufirst%3DT.%2BT.%2BN.%26atitle%3DHuman%2520cytochrome%2520P450%2520enzymes%2520bind%2520drugs%2520and%2520other%2520substrates%2520mainly%2520through%2520conformational-selection%2520modes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26spage%3D10928%26epage%3D10941%26doi%3D10.1074%2Fjbc.RA119.009305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddish, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span> <span> </span><span class="NLM_article-title">Human cytochrome P450 11B2 produces aldosterone by a processive mechanism due to the lactol form of the intermediate 18-hydroxycorticosterone</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">12975</span>– <span class="NLM_lpage">12991</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA119.009830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1074%2Fjbc.RA119.009830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=31296661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntlyntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=12975-12991&author=M.+J.+Reddishauthor=F.+P.+Guengerich&title=Human+cytochrome+P450+11B2+produces+aldosterone+by+a+processive+mechanism+due+to+the+lactol+form+of+the+intermediate+18-hydroxycorticosterone&doi=10.1074%2Fjbc.RA119.009830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Human cytochrome P450 11B2 produces aldosterone by a processive mechanism due to the lactol form of the intermediate 18-hydroxycorticosterone</span></div><div class="casAuthors">Reddish, Michael J.; Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">12975-12991</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human cytochrome P 450 11B2 catalyzes the formation of aldosterone, the major endogenous human mineralocorticoid.  Aldosterone is important for the regulation of electrolyte homeostasis.  Mutations and overexpression of P 450 11B2 (also known as aldosterone synthase) can lead to hypertension, congestive heart failure, and diabetic nephropathy.  The enzyme is therefore a target for drug development to manage these various disorders.  P 450 11B2 catalyzes aldosterone formation from 11-deoxycorticosterone through three distinct oxidn. steps.  It is currently unknown to which degree these reactions happen in sequence without the intermediate products dissocg. from the enzyme (i.e. processively) or whether these reactions happen solely distributively, in which the intermediate products must first dissoc. and then rebind to the enzyme before subsequent oxidn.  We present here a comprehensive investigation of processivity in P 450 11B2-catalyzed reactions using steady-state, pre-steady-state, pulse-chase, equil.-binding titrns., and stopped-flow binding studies.  We utilized the data obtained to develop a kinetic model for P 450 11B2 and tested this model by enzyme kinetics simulations.  We found that although aldosterone is produced processively, the enzyme preferentially utilizes a distributive mechanism that ends with the prodn. of 18-OH corticosterone.  This seemingly contradictory observation could be resolved by considering the ability of the intermediate product 18-OH corticosterone to exist as a lactol form, with the equil. favoring the ring-closed lactol configuration.  In summary, our refined model for P 450 11B2 catalysis indicates isomerization of the intermediate to a lactol can explain why P 450 11B2 must produce aldosterone through a processive mechanism despite favoring a distributive mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9bIHofma1mLVg90H21EOLACvtfcHk0li7dX1E8XwNmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntlyntA%253D%253D&md5=83e9ab1eaf06b943c30f327a5c400e99</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA119.009830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA119.009830%26sid%3Dliteratum%253Aachs%26aulast%3DReddish%26aufirst%3DM.%2BJ.%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DHuman%2520cytochrome%2520P450%252011B2%2520produces%2520aldosterone%2520by%2520a%2520processive%2520mechanism%2520due%2520to%2520the%2520lactol%2520form%2520of%2520the%2520intermediate%252018-hydroxycorticosterone%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26spage%3D12975%26epage%3D12991%26doi%3D10.1074%2Fjbc.RA119.009830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britcher, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lumma, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyle, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huff, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. S.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2602</span>– <span class="NLM_lpage">2605</span>, <span class="refDoi"> DOI: 10.1128/AAC.39.12.2602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1128%2FAAC.39.12.2602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=8592986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADyaK2MXps1Orsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1995&pages=2602-2605&author=S.+D.+Youngauthor=S.+F.+Britcherauthor=L.+O.+Tranauthor=L.+S.+Payneauthor=W.+C.+Lummaauthor=T.+A.+Lyleauthor=J.+R.+Huffauthor=P.+S.+Andersonauthor=D.+B.+Olsenauthor=S.+S.+Carroll&title=L-743%2C+726+%28DMP-266%29%3A+a+novel%2C+highly+potent+nonnucleoside+inhibitor+of+the+human+immunodeficiency+virus+type+1+reverse+transcriptase&doi=10.1128%2FAAC.39.12.2602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">L-743,726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase</span></div><div class="casAuthors">Young, Steven D.; Britcher, Susan F.; Tran, Lee O.; Payne, Linda S.; Lumma, William C.; Lyle, Terry A.; Huff, Joel R.; Anderson, Paul S.; Olsen, David B.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2602-5</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The clin. benefit of the human immunodeficiency virus type 1 (HIV-1) nonnucleoside reverse transcriptase (RT) inhibitors (NNRTIs) is limited by the rapid selection of inhibitor-resistant viral variants.  However, it may be possible to enhance the clin. utility of this inhibitor class by deriving compds. that express both high levels of antiviral activity and an augmented pharmacokinetic profile.  Accordingly, we developed a new class of NNRTIs, the 1,4-dihydro-2H-3,1-benzoxazin-2-ones.  L-743,726 (DMP-266), a member of this class, was chosen for clin. evaluation because of its in vitro properties.  The compd. was a potent inhibitor of the wild-type HIV-1 RT (Ki = 2.93 nM) and exhibited a 95% inhibitor concn. of 1.5 nM for the inhibition of HIV-1 replicative spread in cell culture.  In addn., L-743,726 was found to be capable of inhibiting, with 95% inhibitor concns. of ≤1.5 μM, a panel of NNRTI-resistant mutant viruses, each of which expressed a single RT amino acid substitution.  Derivation of virus with notably reduced susceptibility to the inhibitor required prolonged cell culture selection and was mediated by a combination of at least two RT amino acid substitutions.  Studies of L-743,726 in rats, monkeys, and a chimpanzee demonstrated the compd.'s potential for good oral bioavailability and pharmacokinetics in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOICv4Hf4CarVg90H21EOLACvtfcHk0li7dX1E8XwNmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXps1Orsrc%253D&md5=c37f9d3d472a21a0078e69082f5f45e4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1128%2FAAC.39.12.2602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.39.12.2602%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DS.%2BD.%26aulast%3DBritcher%26aufirst%3DS.%2BF.%26aulast%3DTran%26aufirst%3DL.%2BO.%26aulast%3DPayne%26aufirst%3DL.%2BS.%26aulast%3DLumma%26aufirst%3DW.%2BC.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DAnderson%26aufirst%3DP.%2BS.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26atitle%3DL-743%252C%2520726%2520%2528DMP-266%2529%253A%2520a%2520novel%252C%2520highly%2520potent%2520nonnucleoside%2520inhibitor%2520of%2520the%2520human%2520immunodeficiency%2520virus%2520type%25201%2520reverse%2520transcriptase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1995%26volume%3D39%26spage%3D2602%26epage%3D2605%26doi%3D10.1128%2FAAC.39.12.2602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Apostolova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blas-Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galindo, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esplugues, J. V.</span></span> <span> </span><span class="NLM_article-title">Efavirenz: What is known about the cellular mechanisms responsible for its adverse effects</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>812</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2017.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1016%2Fj.ejphar.2017.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=28690189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtF2hsL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=812&publication_year=2017&pages=163-173&author=N.+Apostolovaauthor=A.+Blas-Garciaauthor=M.+J.+Galindoauthor=J.+V.+Esplugues&title=Efavirenz%3A+What+is+known+about+the+cellular+mechanisms+responsible+for+its+adverse+effects&doi=10.1016%2Fj.ejphar.2017.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Efavirenz: What is known about the cellular mechanisms responsible for its adverse effects</span></div><div class="casAuthors">Apostolova, Nadezda; Blas-Garcia, Ana; Galindo, Maria J.; Esplugues, Juan V.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">812</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">163-173</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The HIV infection remains an important health problem worldwide.  However, due to the efficacy of combined antiretroviral therapy (cART), it has ceased to be a mortal condition, becoming a chronic disease instead.  Efavirenz, the most prescribed non-nucleoside analog reverse transcriptase inhibitor (NNRTI), has been a key component of cART since its commercialization in 1998.  Though still a drug of choice in many countries, its primacy has been challenged by the arrival of newer antiretroviral agents with better toxicity profiles and treatment adherence.  The major side effects related to EFV have been widely described in clin. studies, however the mechanisms that participate in their pathogenesis remain largely ununderstood.  This review provides an insight into the cellular and mol. mechanisms responsible for the development of the most significant undesired effects induced by efavirenz, both short- and long-term, revealed by in vitro and in vivo exptl. pharmacol. research.  Growing evidence implicates the drug in energy metab., mitochondrial function, and other cellular processes involved in stress responses including oxidative stress, inflammation and autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb5l6cCQUj5LVg90H21EOLACvtfcHk0lgQZ15vWQrAsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtF2hsL7O&md5=56e877278ccb81be99c1aad7ae9b953b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2017.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2017.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DApostolova%26aufirst%3DN.%26aulast%3DBlas-Garcia%26aufirst%3DA.%26aulast%3DGalindo%26aufirst%3DM.%2BJ.%26aulast%3DEsplugues%26aufirst%3DJ.%2BV.%26atitle%3DEfavirenz%253A%2520What%2520is%2520known%2520about%2520the%2520cellular%2520mechanisms%2520responsible%2520for%2520its%2520adverse%2520effects%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D812%26spage%3D163%26epage%3D173%26doi%3D10.1016%2Fj.ejphar.2017.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Apostolova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funes, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blas-Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galindo, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esplugues, J. V.</span></span> <span> </span><span class="NLM_article-title">Efavirenz and the CNS: what we already know and questions that need to be answered</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">2693</span>– <span class="NLM_lpage">2708</span>, <span class="refDoi"> DOI: 10.1093/jac/dkv183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1093%2Fjac%2Fdkv183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=26203180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslartbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2015&pages=2693-2708&author=N.+Apostolovaauthor=H.+A.+Funesauthor=A.+Blas-Garciaauthor=M.+J.+Galindoauthor=A.+Alvarezauthor=J.+V.+Esplugues&title=Efavirenz+and+the+CNS%3A+what+we+already+know+and+questions+that+need+to+be+answered&doi=10.1093%2Fjac%2Fdkv183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Efavirenz and the CNS: what we already know and questions that need to be answered</span></div><div class="casAuthors">Apostolova, Nadezda; Funes, Haryes A.; Blas-Garcia, Ana; Galindo, Maria J.; Alvarez, Angeles; Esplugues, Juan V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2693-2708</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  The NNRTI efavirenz has long been one of the most frequently employed antiretroviral drugs in the multidrug regimens used to treat HIV infection, in accordance with its well-demonstrated antiretroviral efficacy and favorable pharmacokinetics.  However, growing concern about its adverse effects has sometimes led to efavirenz being replaced by other drugs in the initial treatment selection or to switching of therapy to efavirenz-free regimens in experienced patients.  Neurol. and neuropsychiatric reactions are the manifestations most frequently experienced by efavirenz-treated patients and range from transitory effects, such as nightmares, dizziness, insomnia, nervousness and lack of concn., to more severe symptoms including depression, suicidal ideation or even psychosis.  In addn., efavirenz has recently been assocd. with mild/moderate neurocognitive impairment, which is of specific relevance given that half of the patients receiving ART eventually suffer some form of HIV-assocd. neurocognitive disorder.  The mechanisms responsible for efavirenz-induced neurotoxicity are unclear, although growing evidence points to disturbances in brain mitochondrial function and bioenergetics.  This review offers a comprehensive overview of the current evidence on the interaction that efavirenz displays with the CNS, including the penetration and concn. of the drug in the brain.  The authors discuss the prevalence, types and specificities of its side effects and recently uncovered cellular mechanisms that may be involved in their development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ6L7H98mW9bVg90H21EOLACvtfcHk0lgQZ15vWQrAsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslartbbI&md5=a4f4eb06f650302f3c1befe6c270ee8e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkv183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkv183%26sid%3Dliteratum%253Aachs%26aulast%3DApostolova%26aufirst%3DN.%26aulast%3DFunes%26aufirst%3DH.%2BA.%26aulast%3DBlas-Garcia%26aufirst%3DA.%26aulast%3DGalindo%26aufirst%3DM.%2BJ.%26aulast%3DAlvarez%26aufirst%3DA.%26aulast%3DEsplugues%26aufirst%3DJ.%2BV.%26atitle%3DEfavirenz%2520and%2520the%2520CNS%253A%2520what%2520we%2520already%2520know%2520and%2520questions%2520that%2520need%2520to%2520be%2520answered%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2015%26volume%3D70%26spage%3D2693%26epage%3D2708%26doi%3D10.1093%2Fjac%2Fdkv183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalwadi, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozuna, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viljoen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schetz, J. A.</span></span> <span> </span><span class="NLM_article-title">Adverse neuropsychiatric events and recreational use of efavirenz and other HIV-1 antiretroviral drugs</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">684</span>– <span class="NLM_lpage">711</span>, <span class="refDoi"> DOI: 10.1124/pr.117.013706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1124%2Fpr.117.013706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=29945900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvVKnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2018&pages=684-711&author=D.+A.+Dalwadiauthor=L.+Ozunaauthor=B.+H.+Harveyauthor=M.+Viljoenauthor=J.+A.+Schetz&title=Adverse+neuropsychiatric+events+and+recreational+use+of+efavirenz+and+other+HIV-1+antiretroviral+drugs&doi=10.1124%2Fpr.117.013706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Adverse neuropsychiatric events and recreational use of efavirenz and other HIV-1 antiretroviral drugs</span></div><div class="casAuthors">Dalwadi, Dhwanil A.; Ozuna, Luis; Harvey, Brian H.; Viljoen, Michelle; Schetz, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">684-711</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Efavirenz is a highly effective HIV-1 antiretrovira drug.  Efavirenz-based treatment is generally well-tolerated in children, although some experience persistent concn. problems, as well as sleep disturbances, psychotic reactions, and seizures.  In an effort to link basic with clin. research, parameters assocd. with efavirenz brain exposure are discussed, and factors that increase efavirenz levels are explored in depth as they are expected to contribute to NPAE risk.  These include the role of modifiable and nonmodifiable risk factors such as diet, wt., and drug-drug interactions and sex, age, and ethnicity/pharmacogenetics.  In addn. to NPAEs, this review explores what is known about antiretroviral (ARV) drugs being used for recreational purposes.  Although multiple ARV drugs are covered, special attention is devoted to efavirenz given that the majority of reports of NPAEs and illicit use of ARV drugs concern efavirenz.  The evolving mol. mechanistic basis of NPAEs and abuse of efavirenz point to a complex and polymodal receptor pharmacol.  Animal studies to date primarily point to a serotonergic mechanism of action.  Recently emerging assocns. between HIV-assocd. neurocognitive disorder and efavirenz use, and possible contributions of the mitochondrial-immune-inflammatory-redox cascade are explored in the context of the signaling mechanisms that appear to be involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNBRRK9ByIr7Vg90H21EOLACvtfcHk0lgQZ15vWQrAsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvVKnsbg%253D&md5=7af51e02e8c22e647490db003e68d3e8</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1124%2Fpr.117.013706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.117.013706%26sid%3Dliteratum%253Aachs%26aulast%3DDalwadi%26aufirst%3DD.%2BA.%26aulast%3DOzuna%26aufirst%3DL.%26aulast%3DHarvey%26aufirst%3DB.%2BH.%26aulast%3DViljoen%26aufirst%3DM.%26aulast%3DSchetz%26aufirst%3DJ.%2BA.%26atitle%3DAdverse%2520neuropsychiatric%2520events%2520and%2520recreational%2520use%2520of%2520efavirenz%2520and%2520other%2520HIV-1%2520antiretroviral%2520drugs%26jtitle%3DPharmacol.%2520Rev.%26date%3D2018%26volume%3D70%26spage%3D684%26epage%3D711%26doi%3D10.1124%2Fpr.117.013706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bumpus, N. N.</span></span> <span> </span><span class="NLM_article-title">Efavirenz and 8-hydroxyefavirenz induce cell death via a JNK- and BimEL-dependent mechanism in primary human hepatocytes</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>257</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2011.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1016%2Fj.taap.2011.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=21958719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2mtLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=2011&pages=227-234&author=N.+N.+Bumpus&title=Efavirenz+and+8-hydroxyefavirenz+induce+cell+death+via+a+JNK-+and+BimEL-dependent+mechanism+in+primary+human+hepatocytes&doi=10.1016%2Fj.taap.2011.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Efavirenz and 8-hydroxyefavirenz induce cell death via a JNK- and BimEL-dependent mechanism in primary human hepatocytes</span></div><div class="casAuthors">Bumpus, Namandje N.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">257</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">227-234</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Chronic use of efavirenz (EFV) has been linked to incidences of hepatotoxicity in patients receiving EFV to treat HIV-1.  While recent studies have demonstrated that EFV stimulates hepatic cell death a role for the metabolites of efavirenz in this process has yet to be examd.  In the present study, incubation of primary human hepatocytes with synthetic 8-hydroxyEFV (8-OHEFV), which is the primary metabolite of EFV, resulted in cell death, caspase-3 activation and reactive oxygen species formation.  The metabolite exerted these effects at earlier time points and using lower concns. than were required for the parent compd.  In addn., pharmacol. inhibition of cytochrome P 450-dependent metab. of EFV using 1-aminobenzotriazole markedly decreased reactive oxygen species formation and cell death.  Treatment of primary human hepatocytes with EFV and 8-OHEFV also stimulated phosphorylation of c-Jun N-terminal kinase (JNK) as well as phosphorylation of the JNK substrate c-Jun.  Further, the mRNA and protein expression of an isoform of Bim (Bcl-2 interacting mediator of cell death) denoted as BimEL, which is proapoptotic and has been shown to be modulated by JNK, was increased.  Inhibition of JNK using SP600125 prevented the EFV- and 8-OHEFV-mediated cell death.  Silencing of Bim using siRNA transfected into hepatocytes also prevented cell death resulting from 8-OHEFV-treatment.  These data suggest that the oxidative metabolite 8-OHEFV is a more potent inducer of hepatic cell death than the parent compd. EFV.  Further, activation of the JNK signaling pathway and BimEL mRNA expression appear to be required for EFV- and 8-OHEFV-mediated hepatocyte death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq1qgK17j9W7Vg90H21EOLACvtfcHk0ljgGfXCE_2wbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2mtLnO&md5=bee59d25f4f081b5e4f07ad5193126c5</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2011.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2011.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DBumpus%26aufirst%3DN.%2BN.%26atitle%3DEfavirenz%2520and%25208-hydroxyefavirenz%2520induce%2520cell%2520death%2520via%2520a%2520JNK-%2520and%2520BimEL-dependent%2520mechanism%2520in%2520primary%2520human%2520hepatocytes%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2011%26volume%3D257%26spage%3D227%26epage%3D234%26doi%3D10.1016%2Fj.taap.2011.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tovar-Y-Romo, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bumpus, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomerantz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacktor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McArthur, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haughey, N. J.</span></span> <span> </span><span class="NLM_article-title">Dendritic spine injury induced by the 8-hydroxy metabolite of efavirenz</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>343</i></span>,  <span class="NLM_fpage">696</span>– <span class="NLM_lpage">703</span>, <span class="refDoi"> DOI: 10.1124/jpet.112.195701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1124%2Fjpet.112.195701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=22984227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslyjs7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2012&pages=696-703&author=L.+B.+Tovar-Y-Romoauthor=N.+N.+Bumpusauthor=D.+Pomerantzauthor=L.+B.+Averyauthor=N.+Sacktorauthor=J.+C.+McArthurauthor=N.+J.+Haughey&title=Dendritic+spine+injury+induced+by+the+8-hydroxy+metabolite+of+efavirenz&doi=10.1124%2Fjpet.112.195701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Dendritic spine injury induced by the 8-hydroxy metabolite of efavirenz</span></div><div class="casAuthors">Tovar-y-Romo, Luis B.; Bumpus, Namandje N.; Pomerantz, Daniel; Avery, Lindsay B.; Sacktor, Ned; McArthur, Justin C.; Haughey, Norman J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">696-703</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Despite combination antiretroviral therapies (cARTs), a significant proportion of HIV-infected patients develop HIV-assocd. neurocognitive disorders (HAND).  Ongoing viral replication in the central nervous system (CNS) caused by poor brain penetration of cART may contribute to HAND.  However, it has also been proposed that the toxic effects of long-term cART may contribute to HAND.  A better understanding of the neurotoxic potential of cART is critically needed in light of the use of CNS-penetrating cARTs to contend with the virus reservoir in the brain.  The efavirenz (EFV) metabolites 7-hydroxyefavirenz (7-OH-EFV) and 8-hydroxyefavirenz (8-OH-EFV) were synthesized and purified, and their chem. structures were confirmed by mass spectrometry and NMR.  The effects of EFV, 7-OH-EFV, and 8-OH-EFV on calcium, dendritic spine morphol., and survival were detd. in primary neurons.  EFV, 7-OH-EFV, and 8-OH-EFV each induced neuronal damage in a dose-dependent manner.  However, 8-OH-EFV was at least an order of magnitude more toxic than EFV or 7-OH-EFV, inducing considerable damage to dendritic spines at a 10 nM concn.  The 8-OH-EFV metabolite evoked calcium flux in neurons, which was mediated primarily by L-type voltage-operated calcium channels (VOCCs).  Blockade of L-type VOCCs protected dendritic spines from 8-OH-EFV-induced damage.  Concns. of EFV and 8-OH-EFV in the cerebral spinal fluid of HIV-infected subjects taking EFV were within the range that damaged neurons in culture.  These findings demonstrate that the 8-OH metabolite of EFV is a potent neurotoxin and highlight the importance of directly detg. the effects of antiretroviral drugs and drug metabolites on neurons and other brain cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4SOdUynFJ5LVg90H21EOLACvtfcHk0ljgGfXCE_2wbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslyjs7zP&md5=f3e404f2c06de376abf274c191925aca</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.195701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.195701%26sid%3Dliteratum%253Aachs%26aulast%3DTovar-Y-Romo%26aufirst%3DL.%2BB.%26aulast%3DBumpus%26aufirst%3DN.%2BN.%26aulast%3DPomerantz%26aufirst%3DD.%26aulast%3DAvery%26aufirst%3DL.%2BB.%26aulast%3DSacktor%26aufirst%3DN.%26aulast%3DMcArthur%26aufirst%3DJ.%2BC.%26aulast%3DHaughey%26aufirst%3DN.%2BJ.%26atitle%3DDendritic%2520spine%2520injury%2520induced%2520by%2520the%25208-hydroxy%2520metabolite%2520of%2520efavirenz%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D343%26spage%3D696%26epage%3D703%26doi%3D10.1124%2Fjpet.112.195701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brandmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehls, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dringen, R.</span></span> <span> </span><span class="NLM_article-title">8-Hydroxy-efavirenz, the primary metabolite of the antiretroviral drug Efavirenz, stimulates the glycolytic flux in cultured rat astrocytes</span>. <i>Neurochem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2524</span>– <span class="NLM_lpage">2534</span>, <span class="refDoi"> DOI: 10.1007/s11064-013-1165-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1007%2Fs11064-013-1165-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=24091996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKjtrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=2524-2534&author=M.+Brandmannauthor=U.+Nehlsauthor=R.+Dringen&title=8-Hydroxy-efavirenz%2C+the+primary+metabolite+of+the+antiretroviral+drug+Efavirenz%2C+stimulates+the+glycolytic+flux+in+cultured+rat+astrocytes&doi=10.1007%2Fs11064-013-1165-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">8-Hydroxy-efavirenz, the Primary Metabolite of the Antiretroviral Drug Efavirenz, Stimulates the Glycolytic Flux in Cultured Rat Astrocytes</span></div><div class="casAuthors">Brandmann, Maria; Nehls, Uwe; Dringen, Ralf</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2524-2534</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In active antiretroviral therapy antiretroviral drugs are employed for the restoration of a functional immune system in patients suffering from the acquired immunodeficiency syndrome.  However, potential adverse effects of such compds. to brain cells are discussed in connection with the development of neurocognitive impairments in patients.  To investigate potential effects of antiretroviral drugs on cell viability and the glycolytic flux of brain cells, astrocyte-rich primary cultures were exposed to various antiretroviral compds., including the non-nucleoside reverse transcriptase inhibitor efavirenz.  In a concn. of 10μM, neither efavirenz nor any of the other investigated antiretroviral compds. acutely compromised the cell viability nor altered glucose consumption or lactate prodn.  In contrast, the primary metabolite of efavirenz, 8-hydroxy-efavirenz, stimulated the glycolytic flux in viable astrocytes in a time- and concn.-dependent manner with half-maximal and maximal effects at concns. of 5 and 10μM, resp.  The stimulation of glycolytic flux by 8-hydroxy-efavirenz was not additive to that obtained for astrocytes that were treated with the respiratory chain inhibitor rotenone and was abolished by removal of extracellular 8-hydroxy-efavirenz.  In a concn. of 10μM, 8-hydroxy-efavirenz and efavirenz did not affect mitochondrial respiration, while both compds. lowered in a concn. of 60μM significantly the oxygen consumption by mitochondria that had been isolated form cultured astrocytes, suggesting that the stimulation of glycolytic flux by 8-hydroxy-efavirenz is not caused by direct inhibition of respiration.  The obsd. alteration of astrocytic glucose metab. by 8-hydroxy-efavirenz could contribute to the adverse neurol. side effects reported for patients that are chronically treated with efavirenz-contg. medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpndDlmo7_ic7Vg90H21EOLACvtfcHk0ljgGfXCE_2wbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKjtrvO&md5=a3de597ea9bbf59e6ab0ac340c0ae59e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs11064-013-1165-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-013-1165-2%26sid%3Dliteratum%253Aachs%26aulast%3DBrandmann%26aufirst%3DM.%26aulast%3DNehls%26aufirst%3DU.%26aulast%3DDringen%26aufirst%3DR.%26atitle%3D8-Hydroxy-efavirenz%252C%2520the%2520primary%2520metabolite%2520of%2520the%2520antiretroviral%2520drug%2520Efavirenz%252C%2520stimulates%2520the%2520glycolytic%2520flux%2520in%2520cultured%2520rat%2520astrocytes%26jtitle%3DNeurochem.%2520Res.%26date%3D2013%26volume%3D38%26spage%3D2524%26epage%3D2534%26doi%3D10.1007%2Fs11064-013-1165-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neiner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharasch, E. D.</span></span> <span> </span><span class="NLM_article-title">Efavirenz metabolism: influence of polymorphic CYP2B6 variants and stereochemistry</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1195</span>– <span class="NLM_lpage">1205</span>, <span class="refDoi"> DOI: 10.1124/dmd.119.086348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1124%2Fdmd.119.086348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=31324697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVOmtbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2019&pages=1195-1205&author=P.+F.+Wangauthor=A.+Neinerauthor=E.+D.+Kharasch&title=Efavirenz+metabolism%3A+influence+of+polymorphic+CYP2B6+variants+and+stereochemistry&doi=10.1124%2Fdmd.119.086348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Efavirenz metabolism: influence of polymorphic CYP2B6 variants and stereochemistry</span></div><div class="casAuthors">Wang, Pan-Fen; Neiner, Alicia; Kharasch, Evan D.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1195-1205</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Efavirenz (more specifically the S-enantiomer) is a cornerstone antiretroviral therapy for treatment of HIV infection.  The major primary metabolite is S-8-hydroxyefavirenz, which does not have antiretroviral activity but is neurotoxic.  Cytochrome P 450 2B6 (CYP2B6) is the major enzyme catalyzing S-8-hydroxyefavirenz formation.  CYP2B6 genetics and drug interactions are major determinants of clin. efavirenz disposition and dose adjustment.  In addn., as a prototypic CYP2B6 substrate, S-efavirenz and analogs can inform on the structure, activity, catalytic mechanisms, and stereoselectivity of CYP2B6.  Metab. of R-efavirenz by CYP2B6 remains unexplored.  This investigation assessed S-efavirenz metab. by clin. relevant CYP2B6 genetic variants.  This investigation also evaluated R-efavirenz hydroxylation by wild-type CYP2B6.1 and CYP2B6 variants.  S-Efavirenz 8-hydroxylation by wild-type CYP2B6.1 and variants exhibited pos. cooperativity and apparent cooperative substrate inhibition.  On the basis of Clmax values, relative activities for S-efavirenz 8-hydroxylation were in the order CYP2B6.4 > CYP2B6.1 ≈ CYP2B6.5 ≈ CYP2B6.17 > CYP2B6.6 ≈ CYP2B6.7 ≈ CYP2B6.9 ≈ CYP2B6.19 ≈ CYP2B6.26; CYP2B6.16 and CYP2B6.18 showed minimal activity.  Rates of R-efavirenz metab. were approx. 1/10 those of S-efavirenz for wild-type CYP2B6.1 and variants.  On the basis of Clmax values, there was 14-fold enantioselectivity (S > R-efavirenz) for wild-type CYP2B6.1, and 5- to 22-fold differences for other CYP2B6 variants.  These results show that both CYP2B6 516G > T (CYP2B6*6 and CYP2B6*9) and 983T > C (CYP2B6*16 and CYP2B6*18) polymorphisms cause canonical diminishment or losS-of-function variants for S-efavirenz 8-hydroxylation, provide a mechanistic basis for known clin. pharmacogenetic differences in efavirenz disposition, and may predict addnl. clin. important variant alleles.  Efavirenz is the most stereoselective CYP2B6 drug substrate yet identified and may be a useful probe for the CYP2B6 active site and catalytic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3WodX_xkejrVg90H21EOLACvtfcHk0ljgGfXCE_2wbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVOmtbzM&md5=2da30d2ed544db1715ec545836d3db02</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1124%2Fdmd.119.086348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.119.086348%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%2BF.%26aulast%3DNeiner%26aufirst%3DA.%26aulast%3DKharasch%26aufirst%3DE.%2BD.%26atitle%3DEfavirenz%2520metabolism%253A%2520influence%2520of%2520polymorphic%2520CYP2B6%2520variants%2520and%2520stereochemistry%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2019%26volume%3D47%26spage%3D1195%26epage%3D1205%26doi%3D10.1124%2Fdmd.119.086348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Best, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koopmans, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letendre, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capparelli, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifford, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collier, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelman, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mbeo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCutchan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haubrich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, I.</span></span>; <span class="NLM_contrib-group">Charter Group.</span> <span> </span><span class="NLM_article-title">Efavirenz concentrations in CSF exceed IC50 for wild-type HIV</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">354</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1093/jac/dkq434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1093%2Fjac%2Fdkq434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=21098541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsFaisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2011&pages=354-357&author=B.+M.+Bestauthor=P.+P.+Koopmansauthor=S.+L.+Letendreauthor=E.+V.+Capparelliauthor=S.+S.+Rossiauthor=D.+B.+Cliffordauthor=A.+C.+Collierauthor=B.+B.+Gelmanauthor=G.+Mbeoauthor=J.+A.+McCutchanauthor=D.+M.+Simpsonauthor=R.+Haubrichauthor=R.+Ellisauthor=I.+Grantauthor=Charter+Group.&title=Efavirenz+concentrations+in+CSF+exceed+IC50+for+wild-type+HIV&doi=10.1093%2Fjac%2Fdkq434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Efavirenz concentrations in CSF exceed IC50 for wild-type HIV</span></div><div class="casAuthors">Best, Brookie M.; Koopmans, Peter P.; Letendre, Scott L.; Capparelli, Edmund V.; Rossi, Steven S.; Clifford, David B.; Collier, Ann C.; Gelman, Benjamin B.; Mbeo, Gilbert; McCutchan, J. Allen; Simpson, David M.; Haubrich, Richard; Ellis, Ronald; Grant, Igor; Grant, Igor; McCutchan, J. Allen; Ellis, Ronald J.; Marcotte, Thomas D.; Franklin, Donald; Ellis, Ronald J.; McCutchan, J. Allen; Alexander, Terry; Letendre, Scott; Capparelli, Edmund; Heaton, Robert K.; Atkinson, J. Hampton; Woods, Steven Paul; Dawson, Matthew; Wong, Joseph K.; Fennema-Notestine, Christine; Taylor, Michael J.; Theilmann, Rebecca; Gamst, Anthony C.; Cushman, Clint; Abramson, Ian; Vaida, Florin; Marcotte, Thomas D.; von Jaeger, Rodney; McArthur, Justin; Smith, Mary; Morgello, Susan; Simpson, David; Mintz, Letty; McCutchan, J. Allen; Toperoff, Will; Collier, Ann; Marra, Christina; Jones, Trudy; Gelman, Benjamin; Head, Eleanor; Clifford, David; Al-Lozi, Muhammad; Teshome, Mengesha</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">354-357</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">HIV-assocd. neurocognitive disorders remain common despite use of potent antiretroviral therapy (ART).  Ongoing viral replication due to poor distribution of antivirals into the CNS may increase risk for HIV-assocd. neurocognitive disorders.  This study's objective was to det. penetration of a commonly prescribed antiretroviral drug, efavirenz, into CSF.  CHARTER is an ongoing, North American, multicenter, observational study to det. the effects of ART on HIV-assocd. neurol. disease.  Single random blood plasma and CSF samples were drawn within 1 h of each other from subjects taking efavirenz between Sept. 2003 and July 2007.  Samples were assayed by HPLC or HPLC/mass spectrometry with detection limits of 39 ng/mL (plasma) and <0.1 ng/mL (CSF).  Eighty participants (age 44 years; 79 kg; 20 females) had samples drawn 12.5 h post-dose.  The median efavirenz concns. after a median of 7 mo [interquartile range (IQR) 2-17] of therapy were 2145 ng/mL in plasma (IQR 1384-4423) and 13.9 ng/mL in CSF (IQR 4.1-21.2).  The CSF/plasma concn. ratio from paired samples drawn within 1 h of each other was 0.005 (IQR 0.0026-0.0076; n = 69).  The CSF/IC50 ratio was 26 (IQR 8-41) using the published IC50 for wild-type HIV (0.51 ng/mL).  Two CSF samples had concns. below the efavirenz IC50 for wild-type HIV.  Efavirenz concns. in the CSF are only 0.5% of plasma concns. but exceed the wild-type IC50 in nearly all individuals.  Since CSF drug concns. reflect those in brain interstitial fluids, efavirenz reaches therapeutic concns. in brain tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSJFkOSQw5LrVg90H21EOLACvtfcHk0liKdCZpXFE0RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsFaisQ%253D%253D&md5=a16eb97e47a1fed373bcc8f31ebd2938</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkq434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkq434%26sid%3Dliteratum%253Aachs%26aulast%3DBest%26aufirst%3DB.%2BM.%26aulast%3DKoopmans%26aufirst%3DP.%2BP.%26aulast%3DLetendre%26aufirst%3DS.%2BL.%26aulast%3DCapparelli%26aufirst%3DE.%2BV.%26aulast%3DRossi%26aufirst%3DS.%2BS.%26aulast%3DClifford%26aufirst%3DD.%2BB.%26aulast%3DCollier%26aufirst%3DA.%2BC.%26aulast%3DGelman%26aufirst%3DB.%2BB.%26aulast%3DMbeo%26aufirst%3DG.%26aulast%3DMcCutchan%26aufirst%3DJ.%2BA.%26aulast%3DSimpson%26aufirst%3DD.%2BM.%26aulast%3DHaubrich%26aufirst%3DR.%26aulast%3DEllis%26aufirst%3DR.%26aulast%3DGrant%26aufirst%3DI.%26aulast%3D%26atitle%3DEfavirenz%2520concentrations%2520in%2520CSF%2520exceed%2520IC50%2520for%2520wild-type%2520HIV%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2011%26volume%3D66%26spage%3D354%26epage%3D357%26doi%3D10.1093%2Fjac%2Fdkq434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avery, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakshi, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, C. W.</span></span> <span> </span><span class="NLM_article-title">The male genital tract is not a pharmacological sanctuary from efavirenz</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1038/clpt.2011.99</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1038%2Fclpt.2011.99" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=21633344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvVaks7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2011&pages=151-156&author=L.+B.+Averyauthor=R.+P.+Bakshiauthor=Y.+J.+Caoauthor=C.+W.+Hendrix&title=The+male+genital+tract+is+not+a+pharmacological+sanctuary+from+efavirenz&doi=10.1038%2Fclpt.2011.99"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The Male Genital Tract Is Not a Pharmacological Sanctuary From Efavirenz</span></div><div class="casAuthors">Avery, L. B.; Bakshi, R. P.; Cao, Y. J.; Hendrix, C. W.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">151-156</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Many antiretroviral (ARV) drugs have large blood plasma-to-seminal plasma (BP/SP) concn. ratios.  Concern exists that these drugs do not adequately penetrate the male genital tract (MGT), resulting in the MGT becoming a "pharmacol. sanctuary" from these agents, with ineffective MGT concns. despite effective blood concns.  Efavirenz (EFV) is the most highly protein-bound ARV drug, with >99% binding in blood plasma and the largest BP/SP total EFV concn. ratio, reportedly ranging from 11 to 33.  To evaluate protein binding as an explanation for the differences between the drug concns. in blood and semen, we developed a novel ultrafiltration method, cor. for the duration of centrifugation, to measure protein binding in the two matrixes.  In six subjects, protein-free EFV concns. were the same in blood and semen; the median (interquartile range (IQR)) protein-free EFV SP/BP ratio was 1.21 (0.99-1.35); EFV protein binding was 99.82% (99.79-99.86) in BP and 95.26% (93.24-96.67) in SP.  This shows that the MGT is not a sanctuary from EFV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjRn_27qMLKLVg90H21EOLACvtfcHk0liKdCZpXFE0RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvVaks7Y%253D&md5=d80016bd7474396e968b6fd19f02a7e0</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2011.99&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2011.99%26sid%3Dliteratum%253Aachs%26aulast%3DAvery%26aufirst%3DL.%2BB.%26aulast%3DBakshi%26aufirst%3DR.%2BP.%26aulast%3DCao%26aufirst%3DY.%2BJ.%26aulast%3DHendrix%26aufirst%3DC.%2BW.%26atitle%3DThe%2520male%2520genital%2520tract%2520is%2520not%2520a%2520pharmacological%2520sanctuary%2520from%2520efavirenz%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2011%26volume%3D90%26spage%3D151%26epage%3D156%26doi%3D10.1038%2Fclpt.2011.99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avery, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacktor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McArthur, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, C. W.</span></span> <span> </span><span class="NLM_article-title">Protein-free efavirenz concentrations in cerebrospinal fluid and blood plasma are equivalent: applying the law of mass action to predict protein-free drug concentration</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1409</span>– <span class="NLM_lpage">1414</span>, <span class="refDoi"> DOI: 10.1128/AAC.02329-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1128%2FAAC.02329-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=23295919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2htLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=1409-1414&author=L.+B.+Averyauthor=N.+Sacktorauthor=J.+C.+McArthurauthor=C.+W.+Hendrix&title=Protein-free+efavirenz+concentrations+in+cerebrospinal+fluid+and+blood+plasma+are+equivalent%3A+applying+the+law+of+mass+action+to+predict+protein-free+drug+concentration&doi=10.1128%2FAAC.02329-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Protein-free efavirenz concentrations in cerebrospinal fluid and blood plasma are equivalent: applying the law of mass action to predict protein-free drug concentration</span></div><div class="casAuthors">Avery, L. B.; Sacktor, N.; McArthur, J. C.; Hendrix, C. W.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1409-1414</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Efavirenz (EFV) is one of the most commonly prescribed antiretroviral drugs (ARVs) for the treatment of HIV.  Highly protein-bound drugs, like EFV, have limited central nervous system (CNS) penetration when measured using total drug concn. gradients between blood plasma (BP) and cerebrospinal fluid (CSF).  However, the more relevant pharmacol. active protein-free drug concns. are rarely assessed directly in clin. studies.  Using paired BP and CSF samples obtained from 13 subjects on an EFV-contg. regimen, both the protein-free and total concns. of EFV were detd.  Despite a median (interquartile range [IQR]) total EFV BP/CSF concn. ratio of 134 (116 to 198), the protein-free EFV BP/CSF concn. ratio was 1.20 (0.97 to 2.12).  EFV median (IQR) protein binding was 99.78% (99.74 to 99.80%) in BP and 76.19% (74.47 to 77.15%) in CSF.  In addn., using the law of mass action and an in vitro-derived EFV-human serum albumin dissocn. const., we have demonstrated that the predicted median (IQR) protein-free concn. in BP, 4.59 ng/mL (4.02 to 9.44 ng/mL), compared well to that obsd. in BP, 4.77 ng/mL (3.68 to 6.75 ng/mL).  Similar results were also obsd. in CSF and seminal plasma.  This method provides a useful predictive tool for estg. protein binding in varied anat. compartments.  Our results of equiv. protein-free EFV concns. in BP and CSF do not support prior concerns of the CNS as a pharmacol. sanctuary from EFV.  As CSF penetration of ARVs may increase our understanding of HIV-assocd. neurol. dysfunction and antiretroviral effect, assessment of protein-free CSF concns. of other highly protein-bound ARVs is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou0Cqn80c2hLVg90H21EOLACvtfcHk0lh1qrzQMntJQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2htLY%253D&md5=d615662548b7ad218435ba8894f03f6d</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1128%2FAAC.02329-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02329-12%26sid%3Dliteratum%253Aachs%26aulast%3DAvery%26aufirst%3DL.%2BB.%26aulast%3DSacktor%26aufirst%3DN.%26aulast%3DMcArthur%26aufirst%3DJ.%2BC.%26aulast%3DHendrix%26aufirst%3DC.%2BW.%26atitle%3DProtein-free%2520efavirenz%2520concentrations%2520in%2520cerebrospinal%2520fluid%2520and%2520blood%2520plasma%2520are%2520equivalent%253A%2520applying%2520the%2520law%2520of%2520mass%2520action%2520to%2520predict%2520protein-free%2520drug%2520concentration%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D1409%26epage%3D1414%26doi%3D10.1128%2FAAC.02329-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winston, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Else, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jessen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avihingsanon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chetchotisakd, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emery, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puls, R.</span></span>; <span class="NLM_contrib-group">ENCORE Cerebrospinal Fluid (CSF) Substudy Team.</span> <span> </span><span class="NLM_article-title">Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trial</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1026</span>– <span class="NLM_lpage">1032</span>, <span class="refDoi"> DOI: 10.1093/cid/ciu976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1093%2Fcid%2Fciu976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=25501988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVKksLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2015&pages=1026-1032&author=A.+Winstonauthor=J.+Aminauthor=A.+Clarkeauthor=L.+Elseauthor=A.+Amaraauthor=A.+Owenauthor=T.+Barberauthor=H.+Jessenauthor=A.+Avihingsanonauthor=P.+Chetchotisakdauthor=S.+Khooauthor=D.+A.+Cooperauthor=S.+Emeryauthor=R.+Pulsauthor=ENCORE+Cerebrospinal+Fluid+%28CSF%29+Substudy+Team.&title=Cerebrospinal+fluid+exposure+of+efavirenz+and+its+major+metabolites+when+dosed+at+400+mg+and+600+mg+once+daily%3A+a+randomized+controlled+trial&doi=10.1093%2Fcid%2Fciu976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trial</span></div><div class="casAuthors">Winston, Alan; Amin, Janaki; Clarke, Amanda; Else, Laura; Amara, Alieu; Owen, Andrew; Barber, Tristan; Jessen, Heiko; Avinghsanon, Anchalee; Chetchotisakd, Ploenchan; Khoo, Saye; Cooper, David A.; Emery, Sean; Puls, Rebekah</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1026-1032</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: The optimal penetration of antiretroviral agents into the central nervous system may be a balance between providing adequate drug exposure to inhibit human immunodeficiency virus (HIV) replication while avoiding concns. assocd. with neuronal toxicities.  Methods: Cerebrospinal fluid (CSF) exposure of efavirenz and the metabolites 7-hydroxy (7OH) and 8-hydroxy (8OH) efavirenz were assessed after at least 12 wk of therapy in HIV-infected subjects randomized to commence antiretroviral regimens contg. efavirenz at either 400 mg or 600 mg once daily.  Results: Of 28 subjects (14 and 14 on efavirenz 400 mg and 600 mg, resp.), CSF HIV RNA was undetectable in all.  Geometric mean CSF efavirenz, 7OH-, and 8OH-efavirenz concns. (with 90% confidence intervals [CIs]) for the 400-mg and 600-mg dosing groups were 16.5 (13-21) and 19.5 (15-25) ng/mL; 0.6 (.4-.9) and 0.6 (.4-1) ng/mL; and 5.1 (4.0-6.4) and 3.1 (2.1-4.4) ng/mL, resp.  Efavirenz concn. in CSF was >0.51 ng/mL (proposed CSF 50% maximal inhibitory concn. for wild-type virus) in all subjects, and 8OH-efavirenz concn. in CSF was >3.3 ng/mL (a proposed toxicity threshold) in 11 of 14 and 7 of 14 subjects randomized to the 400 mg and 600 mg doses of efavirenz, resp.  Whereas CSF efavirenz concn. was significantly assocd. with plasma concn. (P < .001) and cytochrome P 450 2B6 genotype (CSF efavirenz GG to GT/TT geometric mean ratio, 0.56 [90% CI, .42-.74]), CSF 8OH-efavirenz concn. was not (P = .242 for assocn. and CSF 8OH-efavirenz GG to GT/TT geometric mean ratio, 1.52 [90% CI, .97-2.36]).  Conclusions: With both doses of efavirenz studied, CSF concns. were considered adequate to inhibit HIV replication, although concns. of 8OH-efavirenz were greater than those reportedly assocd. with neuronal toxicity.  CSF exposure of 8OH-efavirenz was not dependent on plasma exposure and, as we postulate, may be subject to saturable pharmacokinetic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-pV1WlwiwALVg90H21EOLACvtfcHk0lh1qrzQMntJQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVKksLnO&md5=52a3100a789324429a0fe4ff4612f848</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fciu976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fciu976%26sid%3Dliteratum%253Aachs%26aulast%3DWinston%26aufirst%3DA.%26aulast%3DAmin%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DA.%26aulast%3DElse%26aufirst%3DL.%26aulast%3DAmara%26aufirst%3DA.%26aulast%3DOwen%26aufirst%3DA.%26aulast%3DBarber%26aufirst%3DT.%26aulast%3DJessen%26aufirst%3DH.%26aulast%3DAvihingsanon%26aufirst%3DA.%26aulast%3DChetchotisakd%26aufirst%3DP.%26aulast%3DKhoo%26aufirst%3DS.%26aulast%3DCooper%26aufirst%3DD.%2BA.%26aulast%3DEmery%26aufirst%3DS.%26aulast%3DPuls%26aufirst%3DR.%26aulast%3D%26atitle%3DCerebrospinal%2520fluid%2520exposure%2520of%2520efavirenz%2520and%2520its%2520major%2520metabolites%2520when%2520dosed%2520at%2520400%2520mg%2520and%2520600%2520mg%2520once%2520daily%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2015%26volume%3D60%26spage%3D1026%26epage%3D1032%26doi%3D10.1093%2Fcid%2Fciu976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nightingale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winston, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Else, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ustianowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Back, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirmohamed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torok, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoo, S.</span></span> <span> </span><span class="NLM_article-title">Efavirenz and metabolites in cerebrospinal fluid: relationship with CYP2B6 c.516G—>T genotype and perturbed blood-brain barrier due to tuberculous meningitis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4511</span>– <span class="NLM_lpage">4518</span>, <span class="refDoi"> DOI: 10.1128/AAC.00280-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1128%2FAAC.00280-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=27161633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2nsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=4511-4518&author=S.+Nightingaleauthor=T.+T.+Chauauthor=M.+Fisherauthor=M.+Nelsonauthor=A.+Winstonauthor=L.+Elseauthor=D.+F.+Carrauthor=S.+Taylorauthor=A.+Ustianowskiauthor=D.+Backauthor=M.+Pirmohamedauthor=T.+Solomonauthor=J.+Farrarauthor=M.+E.+Torokauthor=S.+Khoo&title=Efavirenz+and+metabolites+in+cerebrospinal+fluid%3A+relationship+with+CYP2B6+c.516G%E2%80%94%3ET+genotype+and+perturbed+blood-brain+barrier+due+to+tuberculous+meningitis&doi=10.1128%2FAAC.00280-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Efavirenz and metabolites in cerebrospinal fluid: relationship with CYP2B6 c.516G→T genotype and perturbed blood-brain barrier due to tuberculous meningitis</span></div><div class="casAuthors">Nightingale, Sam; Chau, Tran Thi Hong; Fisher, Martin; Nelson, Mark; Winston, Alan; Else, Laura; Carr, Daniel F.; Taylor, Steven; Ustianowski, Andrew; Back, David; Pirmohamed, Munir; Solomon, Tom; Farrar, Jeremy; Toerok, M. Estee; Khoo, Saye</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4511-4518</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Efavirenz (EFZ) has been assocd. with neuropsychiatric side effects.  Recently, the 8-hydroxy-EFZ (8OH-EFZ) metabolite has been shown to be a potent neurotoxin in vitro, inducing neuronal damage at concns. of 3.3 ng/mL.  EFZ induced similar neuronal damage at concns. of 31.6 ng/mL.  We investigated the effect of genotype and blood-brain barrier integrity on EFZ metabolite concns. in cerebrospinal fluid (CSF).  We measured CSF drug concns. in subjects from two sep. study populations: 47 subjects with tuberculous meningitis (TBM) coinfection in Vietnam receiving 800 mg EFZ with std. antituberculous treatment and 25 subjects from the PARTITION study in the United Kingdom without central nervous system infection receiving 600 mg EFZ.  EFZ and metabolite concns. in CSF and plasma were measured and compared with ests. of effectiveness and neurotoxicity from available published in vitro and in vivo data.  The effect of the CYP2B6 c.516G→T genotype (GG genotype, fast EFV metabolizer status; GT genotype, intermediate EFV metabolizer status; TT genotype, slow EFV metabolizer status) was examd.  The mean CSF concns. of EFZ and 8OH-EFZ in the TBM group were 60.3 and 39.3 ng/mL, resp., and those in the no-TBM group were 15.0 and 5.9 ng/mL, resp.  Plasma EFZ and 8OHEFZ concns. were similar between the two groups.  CSF EFZ concns. were above the in vitro toxic concn. in 76% of samples (GG genotype, 61%; GT genotype, 90%; TT genotype, 100%) in the TBM group and 13% of samples (GG genotype, 0%; GT genotype, 18%; TT genotype, 50%) in the no-TBM group.  CSF 8OH-EFZ concns. were above the in vitro toxic concn. in 98% of the TBM group and 87% of the no-TBM group; levels were independent of genotype but correlated with the CSF/plasma albumin ratio.  Potentially neurotoxic concns. of 8OH-EFZ are frequently obsd. in CSF independently of the CYP2B6 genotype, particularly in those with impaired blood-brain barrier integrity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq86zTKlLIKN7Vg90H21EOLACvtfcHk0lh1qrzQMntJQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2nsbnN&md5=d176f206071bd863c100eefb477396c6</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1128%2FAAC.00280-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00280-16%26sid%3Dliteratum%253Aachs%26aulast%3DNightingale%26aufirst%3DS.%26aulast%3DChau%26aufirst%3DT.%2BT.%26aulast%3DFisher%26aufirst%3DM.%26aulast%3DNelson%26aufirst%3DM.%26aulast%3DWinston%26aufirst%3DA.%26aulast%3DElse%26aufirst%3DL.%26aulast%3DCarr%26aufirst%3DD.%2BF.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DUstianowski%26aufirst%3DA.%26aulast%3DBack%26aufirst%3DD.%26aulast%3DPirmohamed%26aufirst%3DM.%26aulast%3DSolomon%26aufirst%3DT.%26aulast%3DFarrar%26aufirst%3DJ.%26aulast%3DTorok%26aufirst%3DM.%2BE.%26aulast%3DKhoo%26aufirst%3DS.%26atitle%3DEfavirenz%2520and%2520metabolites%2520in%2520cerebrospinal%2520fluid%253A%2520relationship%2520with%2520CYP2B6%2520c.516G%25E2%2580%2594%253ET%2520genotype%2520and%2520perturbed%2520blood-brain%2520barrier%2520due%2520to%2520tuberculous%2520meningitis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D4511%26epage%3D4518%26doi%3D10.1128%2FAAC.00280-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ngaimisi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugusi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minzi, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedel, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janabi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugusi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haefeli, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burhenne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aklillu, E.</span></span> <span> </span><span class="NLM_article-title">Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patients</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">676</span>– <span class="NLM_lpage">684</span>, <span class="refDoi"> DOI: 10.1038/clpt.2010.172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1038%2Fclpt.2010.172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=20881953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlWmurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2010&pages=676-684&author=E.+Ngaimisiauthor=S.+Mugusiauthor=O.+M.+Minziauthor=P.+Sasiauthor=K.+D.+Riedelauthor=A.+Sudaauthor=N.+Uedaauthor=M.+Janabiauthor=F.+Mugusiauthor=W.+E.+Haefeliauthor=J.+Burhenneauthor=E.+Aklillu&title=Long-term+efavirenz+autoinduction+and+its+effect+on+plasma+exposure+in+HIV+patients&doi=10.1038%2Fclpt.2010.172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patients</span></div><div class="casAuthors">Ngaimisi, E.; Mugusi, S.; Minzi, O. M.; Sasi, P.; Riedel, K.-D.; Suda, A.; Ueda, N.; Janabi, M.; Mugusi, F.; Haefeli, W. E.; Burhenne, J.; Aklillu, E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">676-684</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We investigated the influence of gender and pharmacogenetic variations on long-term efavirenz autoinduction and disposition among patients with HIV in Tanzania (N = 129).  Plasma concns. (at 16 h) of efavirenz and 8-hydroxyefavirenz were quantified at weeks 4 and 16 of therapy.  Genotyping was performed to identify cytochrome P 450 (CYP) 2B6*6, CYP3A5*3, *6, and *7, and ABCB1-3435 C/T genotypes.  There were redns. in the median efavirenz concn. (Wilcoxon matched-pair test P < 0.001) and efavirenz/8-hydroxyefavirenz ratio (P < 0.001) by 19 and 32%, resp., at week 16 as compared with week 4.  The proportion of patients with efavirenz concn. <1 μg/mL at week 16 was higher by 67, 25, and 5% in CYP2B6*1/*1, *1/*6, and *6/*6 genotypes, resp.  The defined therapeutic range based on obsd. plasma concns. is affected by the time point of sampling and the CYP2B6 genotype.  The effect of efavirenz autoinduction on reducing plasma exposure continues up to week 16 and predominantly affects CYP2B6 extensive metabolizers.  Among CYP2B6 slow metabolizers, the presence of a CYP3A5 genotype allele is assocd. with greater effects of efavirenz autoinduction on plasma concns. of the drug.  The cumulative induction may influence the long-term antiretroviral therapy outcome, particularly in CYP2B6*1 carriers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQJQEn9W8anbVg90H21EOLACvtfcHk0li5nbBRDCCFhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlWmurjI&md5=055c36fd0226217fbe57b00f25b04583</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2010.172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2010.172%26sid%3Dliteratum%253Aachs%26aulast%3DNgaimisi%26aufirst%3DE.%26aulast%3DMugusi%26aufirst%3DS.%26aulast%3DMinzi%26aufirst%3DO.%2BM.%26aulast%3DSasi%26aufirst%3DP.%26aulast%3DRiedel%26aufirst%3DK.%2BD.%26aulast%3DSuda%26aufirst%3DA.%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DJanabi%26aufirst%3DM.%26aulast%3DMugusi%26aufirst%3DF.%26aulast%3DHaefeli%26aufirst%3DW.%2BE.%26aulast%3DBurhenne%26aufirst%3DJ.%26aulast%3DAklillu%26aufirst%3DE.%26atitle%3DLong-term%2520efavirenz%2520autoinduction%2520and%2520its%2520effect%2520on%2520plasma%2520exposure%2520in%2520HIV%2520patients%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2010%26volume%3D88%26spage%3D676%26epage%3D684%26doi%3D10.1038%2Fclpt.2010.172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span> <span> </span><span class="NLM_article-title">Structure-brain exposure relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">7559</span>– <span class="NLM_lpage">7583</span>, <span class="refDoi"> DOI: 10.1021/jm060642i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure-brain+exposure+relationships&doi=10.1021%2Fjm060642i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-brain exposure relationships</span></div><div class="casAuthors">Hitchcock, Stephen A.; Pennington, Lewis D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7559-7583</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the use of structure modification to influence blood-brain barrier penetration by modulating either passive diffusion or active transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3V-TERRGy07Vg90H21EOLACvtfcHk0li5nbBRDCCFhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK&md5=97dff583ffae6d0ef66512ffbee38c34</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure-brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583%26doi%3D10.1021%2Fjm060642i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dirson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hindlet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">German-Fattal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gimenez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farinotti, R.</span></span> <span> </span><span class="NLM_article-title">Efavirenz does not interact with the ABCB1 transporter at the blood-brain barrier</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1525</span>– <span class="NLM_lpage">1532</span>, <span class="refDoi"> DOI: 10.1007/s11095-006-0279-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1007%2Fs11095-006-0279-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=16779703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFOmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2006&pages=1525-1532&author=G.+Dirsonauthor=C.+Fernandezauthor=P.+Hindletauthor=F.+Rouxauthor=M.+German-Fattalauthor=F.+Gimenezauthor=R.+Farinotti&title=Efavirenz+does+not+interact+with+the+ABCB1+transporter+at+the+blood-brain+barrier&doi=10.1007%2Fs11095-006-0279-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Efavirenz does not interact with the ABCB1 transporter at the blood-brain barrier</span></div><div class="casAuthors">Dirson, Gregoire; Fernandez, Christine; Hindlet, Patrick; Roux, Francoise; German-Fattal, Michele; Gimenez, Francois; Farinotti, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1525-1532</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">This work characterizes the interactions between efavirenz (EFV) and P-glycoprotein (P-gp/ABCB1) at the blood-brain barrier (BBB) and predicts the possible consequences on the brain uptake of coadministered P-gp substrates.  The uptake of EFV was measured in whole brains of rat and mdr1a-/- and mdr1a+/+ mice, and in GPNT cells (rat brain endothelial cell line) with and without P-gp inhibitors (PSC833, S9788, Quinidine).  The effect of a single dose or multiple doses of EFV on the P-gp functionality was evaluated in vivo and in vitro by measuring the brain and cell uptake of digoxin, completed by the anal. of the P-gp expression at the rat BBB after repeated administrations of EFV.  Inhibition of P-gp did not alter the uptake of EFV in rat brain and GPNT cells.  The EFV brain/plasma ratio in mdr1a-/- mice, lacking the expression of P-gp, was not different from that in mdr1a+/+ mice.  Moreover, a single dose of EFV did not modify the uptake of digoxin in rat brain and GPNT cells.  Finally, the 3-day exposure of GPNT cells to EFV did not have any effect on the uptake of digoxin.  Similarly, the 7-day treatment with EFV did not change the uptake of digoxin in rat brain nor the expression of P-gp at the BBB.  EFV is strongly distributed in the brain, but is neither a substrate nor an inhibitor of the P-gp at the blood-brain barrier.  On the other hand, EFV did not induce P-gp, allowing to sustain the brain accumulation of assocd. P-gp substrates such as protease inhibitors.  These findings make EFV suitable for combinations circumventing the brain HIV-1 residency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTZ_KOTO18LrVg90H21EOLACvtfcHk0li5nbBRDCCFhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFOmtbc%253D&md5=cf726428f5b0f5a72db84205db4d6c7c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1007%2Fs11095-006-0279-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-006-0279-5%26sid%3Dliteratum%253Aachs%26aulast%3DDirson%26aufirst%3DG.%26aulast%3DFernandez%26aufirst%3DC.%26aulast%3DHindlet%26aufirst%3DP.%26aulast%3DRoux%26aufirst%3DF.%26aulast%3DGerman-Fattal%26aufirst%3DM.%26aulast%3DGimenez%26aufirst%3DF.%26aulast%3DFarinotti%26aufirst%3DR.%26atitle%3DEfavirenz%2520does%2520not%2520interact%2520with%2520the%2520ABCB1%2520transporter%2520at%2520the%2520blood-brain%2520barrier%26jtitle%3DPharm.%2520Res.%26date%3D2006%26volume%3D23%26spage%3D1525%26epage%3D1532%26doi%3D10.1007%2Fs11095-006-0279-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miksys, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyndale, R. F.</span></span> <span> </span><span class="NLM_article-title">Drug-metabolizing cytochrome P450s in the brain</span>. <i>J. Psychiatry Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">406</span>– <span class="NLM_lpage">415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=12491573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A280%3ADC%252BD38jivFKjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=406-415&author=S.+L.+Miksysauthor=R.+F.+Tyndale&title=Drug-metabolizing+cytochrome+P450s+in+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-metabolizing cytochrome P450s in the brain</span></div><div class="casAuthors">Miksys Sharon L; Tyndale Rachel F</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatry & neuroscience : JPN</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">406-15</span>
        ISSN:<span class="NLM_cas:issn">1180-4882</span>.
    </div><div class="casAbstract">Most CYP subfamilies have been identified in brain, but there is much more information available on the distribution and metabolic activity of CYP subfamilies in brain of rodents than in humans, and what we do know still lags far behind our knowledge of hepatic CYPs.  With the constant acquisition of data on the genetics, molecular structure and metabolic capacity of brain CYPs, we are increasingly able to investigate their role in the brain and the possible consequences of altered local metabolism.  However, at this stage, the contribution of brain CYPs to local metabolism of drugs, toxins and endogenous compounds is still speculative, as is the role for these CYPs in modulating brain function and in the development of brain diseases.  Much investigative work remains to be done to firmly establish the links between the presence of CYPs in brain, their function in this highly heterogeneous and complex organ and the consequences on overall brain function and health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQBOEzlWYddxtts4TFFB11gfW6udTcc2eYZx2U1TrEHJbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38jivFKjsA%253D%253D&md5=0e3a0f568b9e61a3aecda38ae05aeb52</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiksys%26aufirst%3DS.%2BL.%26aulast%3DTyndale%26aufirst%3DR.%2BF.%26atitle%3DDrug-metabolizing%2520cytochrome%2520P450s%2520in%2520the%2520brain%26jtitle%3DJ.%2520Psychiatry%2520Neurosci.%26date%3D2002%26volume%3D27%26spage%3D406%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McFadyen, M. C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melvin, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, G. I.</span></span> <span> </span><span class="NLM_article-title">Regional distribution of individual forms of cytochrome P450 mRNA in normal adult human brain</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">825</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.1016/S0006-2952(97)00516-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1016%2FS0006-2952%2897%2900516-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=9586955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADyaK1cXitVKgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1998&pages=825-830&author=M.+C.+E.+McFadyenauthor=W.+T.+Melvinauthor=G.+I.+Murray&title=Regional+distribution+of+individual+forms+of+cytochrome+P450+mRNA+in+normal+adult+human+brain&doi=10.1016%2FS0006-2952%2897%2900516-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Regional distribution of individual forms of cytochrome P450 mRNA in normal adult human brain</span></div><div class="casAuthors">Mcfadyen, Morag C. E.; Melvin, William T.; Murray, Graeme I.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">825-830</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Cytochrome P 450 (CYP) isoforms represent a large family of hemoproteins which play a major role in the oxidative metab. of a wide range of xenobiotics and some endogenous compds.  Here, the presence of individual members of the CYP1, CYP2 and CYP3 P 450 families was investigated by reverse transcriptase-PCR in different regions of normal human brain consisting of frontal and temporal cortices, midbrain, cerebellum, pons, and medulla.  All cytochrome P 450 isoforms were identified in specific regions of brain with CYP1A1 and CYP2C being the most frequently expressed forms.  Sequencing identified the CYP2C PCR product as CYP2C8.  This study indicated that individual P 450 mRNAs are present in human brain and are found in specific brain regions.  The distribution of individual P 450 isoforms in different regions of the human brain is likely to be highly important in detg. the response of the brain to toxic foreign compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr20U11D82RrVg90H21EOLACvtfcHk0ljwUS7z_dZ90Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitVKgsr8%253D&md5=07d7737abd7e31a594f7f7f9af9e2991</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2897%2900516-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252897%252900516-9%26sid%3Dliteratum%253Aachs%26aulast%3DMcFadyen%26aufirst%3DM.%2BC.%2BE.%26aulast%3DMelvin%26aufirst%3DW.%2BT.%26aulast%3DMurray%26aufirst%3DG.%2BI.%26atitle%3DRegional%2520distribution%2520of%2520individual%2520forms%2520of%2520cytochrome%2520P450%2520mRNA%2520in%2520normal%2520adult%2520human%2520brain%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1998%26volume%3D55%26spage%3D825%26epage%3D830%26doi%3D10.1016%2FS0006-2952%2897%2900516-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klose, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaisdell, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, J. A.</span></span> <span> </span><span class="NLM_article-title">Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs</span>. <i>J. Biochem. Mol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">295</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1099-0461(1999)13:6<289::AID-JBT1>3.0.CO;2-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1002%2F%28SICI%291099-0461%281999%2913%3A6%3C289%3A%3AAID-JBT1%3E3.0.CO%3B2-N" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10487415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADyaK1MXlvVWisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=289-295&author=T.+S.+Kloseauthor=J.+A.+Blaisdellauthor=J.+A.+Goldstein&title=Gene+structure+of+CYP2C8+and+extrahepatic+distribution+of+the+human+CYP2Cs&doi=10.1002%2F%28SICI%291099-0461%281999%2913%3A6%3C289%3A%3AAID-JBT1%3E3.0.CO%3B2-N"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs</span></div><div class="casAuthors">Klose, Theresa S.; Blaisdell, Joyce A.; Goldstein, Joyce A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemical and Molecular Toxicology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">289-295</span>CODEN:
                <span class="NLM_cas:coden">JBMTFQ</span>;
        ISSN:<span class="NLM_cas:issn">1095-6670</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Extrahepatic tissue distribution of the mRNAs for the four human CYP2Cs (2C8, 2C9, 2C18, and 2C19) was examd. in kidney, testes, adrenal gland, prostate, brain, uterus, mammary gland, ovary, lung, and duodenum.  CYP2C mRNAs were detected by RT-PCR using specific primers for each individual CYP2C.  CYP2C8 mRNA was detected in the kidney, adrenal gland, brain, uterus, mammary gland, ovary, and duodenum.  CYP2C9 mRNA was detected in the kidney, testes, adrenal gland, prostate, ovary, and duodenum.  CYP2C18 mRNA was found only in the brain, uterus, mammary gland, kidney, and duodenum and CYP2C19 mRNA was found only in the duodenum.  Immunoblot anal. of small intestinal microsomes detected both 2C9 and 2C19 proteins.  In addn., genomic clones for CYP2C8 were sequenced, and long-distance PCR was performed to det. the complete gene structure.  CYP2C8 spanned a 31 kb region.  Comparative anal. of the 2.4 kb upstream region of CYP2C8 with CYP2C9 revealed two previously unidentified transcription factors sites, C/EBP and HPF-1, and the latter might be involved in hepatic expression.  Although CYP2C8 has been shown to be phenobarbital inducible, neither a barbiturate-responsive regulatory sequence (a Barbie box) nor a phenobarbital-responsive enhancer module (PBREM) was found within the upstream region analyzed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9boqLhgNEGLVg90H21EOLACvtfcHk0ljwUS7z_dZ90Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvVWisbc%253D&md5=dee35e42b32864a1de8e63da144493c6</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291099-0461%281999%2913%3A6%3C289%3A%3AAID-JBT1%3E3.0.CO%3B2-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291099-0461%25281999%252913%253A6%253C289%253A%253AAID-JBT1%253E3.0.CO%253B2-N%26sid%3Dliteratum%253Aachs%26aulast%3DKlose%26aufirst%3DT.%2BS.%26aulast%3DBlaisdell%26aufirst%3DJ.%2BA.%26aulast%3DGoldstein%26aufirst%3DJ.%2BA.%26atitle%3DGene%2520structure%2520of%2520CYP2C8%2520and%2520extrahepatic%2520distribution%2520of%2520the%2520human%2520CYP2Cs%26jtitle%3DJ.%2520Biochem.%2520Mol.%2520Toxicol.%26date%3D1999%26volume%3D13%26spage%3D289%26epage%3D295%26doi%3D10.1002%2F%28SICI%291099-0461%281999%2913%3A6%3C289%3A%3AAID-JBT1%3E3.0.CO%3B2-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björkhem, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Use of complementary cation and anion heavy-atom salt derivatives to solve the structure of cytochrome P450 46A1</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">495</span>, <span class="refDoi"> DOI: 10.1107/S0907444908004046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1107%2FS0907444908004046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=18453684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlagtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=487-495&author=M.+A.+Whiteauthor=N.+Mastauthor=I.+Bj%C3%B6rkhemauthor=E.+F.+Johnsonauthor=C.+D.+Stoutauthor=I.+A.+Pikuleva&title=Use+of+complementary+cation+and+anion+heavy-atom+salt+derivatives+to+solve+the+structure+of+cytochrome+P450+46A1&doi=10.1107%2FS0907444908004046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Use of complementary cation and anion heavy-atom salt derivatives to solve the structure of cytochrome P 450 46A1</span></div><div class="casAuthors">White, Mark Andrew; Mast, Natalia; Bjorkhem, Ingemar; Johnson, Eric F.; Stout, C. David; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">487-495</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Human cytochrome P 450 46A1 (CYP46A1) is one of the key enzymes in cholesterol homeostasis in the brain.  Here, the crystn. and heavy-atom structure soln. of an active truncated CYP46A1 in complex with the high-affinity substrate analog cholesterol 3-sulfate (CH-3S) is reported.  The 2.6 Å structure of CYP46A1-CH-3S was solved using both anion and cation heavy-atom salts.  In addn. to the native anomalous signal from the heme Fe, an NaI anion halide salt deriv. and a complementary CsCl alkali-metal cation salt deriv. were used.  The general implications of the use of halide and alkali-metal quick soaks are discussed.  The importance of using isoionic strength buffers, the titrn. of heavy-atom salts into different ionic species, and the role of concn. were considered.  It was obsd. that cation/anion-binding sites would occasionally overlap, which could neg. impact upon mixed RbBr soaks used for multiple anomalous scatterer MAD (MMAD).  The use of complementary cation and anion heavy-atom salt derivs. is a convenient and powerful tool for MIR(AS) structure soln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKdGXukX3OtLVg90H21EOLACvtfcHk0ljwUS7z_dZ90Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlagtrY%253D&md5=7db15bbf5f39f17751ea6f167850aeb6</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1107%2FS0907444908004046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444908004046%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DM.%2BA.%26aulast%3DMast%26aufirst%3DN.%26aulast%3DBj%25C3%25B6rkhem%26aufirst%3DI.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DStout%26aufirst%3DC.%2BD.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DUse%2520of%2520complementary%2520cation%2520and%2520anion%2520heavy-atom%2520salt%2520derivatives%2520to%2520solve%2520the%2520structure%2520of%2520cytochrome%2520P450%252046A1%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2008%26volume%3D64%26spage%3D487%26epage%3D495%26doi%3D10.1107%2FS0907444908004046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teiber, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokones, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenberg, P. F.</span></span> <span> </span><span class="NLM_article-title">Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activities</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">324</span>– <span class="NLM_lpage">332</span>, <span class="refDoi"> DOI: 10.1006/abbi.1997.0534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1006%2Fabbi.1997.0534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=9473308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADyaK1cXhtVWgsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=1998&pages=324-332&author=I.+H.+Hannaauthor=J.+F.+Teiberauthor=K.+L.+Kokonesauthor=P.+F.+Hollenberg&title=Role+of+the+alanine+at+position+363+of+cytochrome+P450+2B2+in+influencing+the+NADPH-+and+hydroperoxide-supported+activities&doi=10.1006%2Fabbi.1997.0534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activities</span></div><div class="casAuthors">Hanna, Imad H.; Teiber, John F.; Kokones, Kristin L.; Hollenberg, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">324-332</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Escherichia coli was used to express the two closely related cytochromes P 450 2B1 and 2B2 and two mutants of 2B2 in which residues Gly-303 and Ala-363 were replaced by Ser and Val, resp.  The expressed proteins were partially purified and assayed for benzphetamine and n-octylamine (NOA) binding and 7-ethoxy-4-trifluoromethylcoumarin O-deethylation (EOD), benzphetamine N-demethylation (BND) and 7,12-dimethylbenz[a]anthracene (DMBA) hydroxylation activities in the presence and absence of cytochrome b5.  The Kd values for benzphetamine and NOA obtained for the wild-type enzymes were similar to reported values.  The Ala-363 → Val mutant (A363V) of 2B2 exhibited Kd values for both ligands that were more similar to 2B1 than to 2B2.  The EOD and BND activities of the A363V mutant were 10- and 3.8-fold those exhibited by 2B2, resp.  With DMBA, the A363V mutation led to a 6-fold increase in the hydroxylation activity at the 7-Me substituent while the hydroxylation activity at the 12-Me substituent was slightly suppressed.  The 7-hydroxymethyl:12-hydroxymethyl product ratio obtained with the A363V mutant (1.3) was much closer to the ratio obtained with 2B1 (1.9) than to that obtained with 2B2 (0.17).  Conversely, the Gly-303 → Ser substitution did not influence the characteristics of the 2B2-catalyzed metab. of DMBA to the same magnitude.  When cumene hydroperoxide (CHP) was used to support the EOD activities of the proteins, 2B2 exhibited a 2- to 20-fold greater activity than 2B1 or either of the mutants.  Examn. of the CHP-derived products of the EOD reactions revealed the formation of mainly 2-phenyl-2-propanol due to the heterolytic cleavage of CHP.  However, only the 2B1 EOD-reaction mixt. also contained the P 450-mediated CHP-isomerization products 2-phenyl-1,2-propanediol and 2-(p-hydroxyphenyl)-2-propanol.  The formation of these products with 2B1 but not 2B2 may explain why 2B1 is not as efficient as 2B2 or 2B2-G303S in carrying out the CHP-supported reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOjX6BJ2y4pbVg90H21EOLACvtfcHk0ljRj35Nvw_JMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtVWgsb8%253D&md5=62ba12f8077fd4efbde00af52193bb22</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1997.0534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1997.0534%26sid%3Dliteratum%253Aachs%26aulast%3DHanna%26aufirst%3DI.%2BH.%26aulast%3DTeiber%26aufirst%3DJ.%2BF.%26aulast%3DKokones%26aufirst%3DK.%2BL.%26aulast%3DHollenberg%26aufirst%3DP.%2BF.%26atitle%3DRole%2520of%2520the%2520alanine%2520at%2520position%2520363%2520of%2520cytochrome%2520P450%25202B2%2520in%2520influencing%2520the%2520NADPH-%2520and%2520hydroperoxide-supported%2520activities%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1998%26volume%3D350%26spage%3D324%26epage%3D332%26doi%3D10.1006%2Fabbi.1997.0534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reem, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bederman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiPatre, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björkhem, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Cholestenoic acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism with that in the brain</span>. <i>Invest. Ophthalmol. Visual Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">594</span>– <span class="NLM_lpage">603</span>, <span class="refDoi"> DOI: 10.1167/iovs.10-6021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1167%2Fiovs.10-6021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=20881306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVShtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=594-603&author=N.+Mastauthor=R.+Reemauthor=I.+Bedermanauthor=S.+Huangauthor=P.+L.+DiPatreauthor=I.+Bj%C3%B6rkhemauthor=I.+A.+Pikuleva&title=Cholestenoic+acid+is+an+important+elimination+product+of+cholesterol+in+the+retina%3A+comparison+of+retinal+cholesterol+metabolism+with+that+in+the+brain&doi=10.1167%2Fiovs.10-6021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Cholestenoic acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism with that in the brain</span></div><div class="casAuthors">Mast, Natalia; Reem, Rachel; Bederman, Ilya; Huang, Suber; DiPatre, Pier Luigi; Bjorkhem, Ingemar; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Investigative Ophthalmology & Visual Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">594-603</span>CODEN:
                <span class="NLM_cas:coden">IOVSDA</span>;
        ISSN:<span class="NLM_cas:issn">1552-5783</span>.
    
            (<span class="NLM_cas:orgname">Association for Research in Vision and Ophthalmology</span>)
        </div><div class="casAbstract">PURPOSE. Accumulating evidence indicates a link between cholesterol and age-related macular degeneration.  Yet, little is known about cholesterol elimination from the retina and retinal pigment epithelium (RPE), the two layers that are damaged in this blinding disease.  Several different pathways of enzymic cholesterol removal exist in extraocular tissues.  The authors tested whether metabolites from these pathways could also be quantified in the bovine and human retina and RPE.  For comparison, they measured cholesterol oxidn. products in two regions of the bovine and human brain and in the bovine liver and adrenal glands.  METHODS. Sterol quantification was carried out by isotope diln. gas chromatog.-mass spectrometry.  Bovine tissues were used first to optimize anal. procedures and to investigate postmortem changes in oxysterol concns.  Then human specimens were analyzed for oxysterol concns.  RESULTS. Qual., oxysterol profiles were similar in the bovine and human tissues.  In the human retina and RPE, the authors could not detect 27-hydroxycholesterol but unexpectedly found that its oxidn. product, 5-cholestenoic acid, is the most abundant oxysterol, varying up to threefold in different persons.  24S-Hydroxysterol and pregnenolone were also present in the retina, but at much lower quantities and without significant interindividual variability.  In the brain, the predominant oxysterol was 24S-hydroxycholesterol.  CONCLUSIONS. The oxysterol profile of the retina suggests that all known pathways of cholesterol elimination in extraocular organs are operative in the retina and that they likely vary depending on specific cell type.  However, overall oxidn. to 5-cholestenoic acid appears to be the predominant mechanism for cholesterol elimination from this organ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI2VlOcUrzmLVg90H21EOLACvtfcHk0ljRj35Nvw_JMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVShtro%253D&md5=e6125af623bff666cec1cc6c37076164</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1167%2Fiovs.10-6021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.10-6021%26sid%3Dliteratum%253Aachs%26aulast%3DMast%26aufirst%3DN.%26aulast%3DReem%26aufirst%3DR.%26aulast%3DBederman%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DDiPatre%26aufirst%3DP.%2BL.%26aulast%3DBj%25C3%25B6rkhem%26aufirst%3DI.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DCholestenoic%2520acid%2520is%2520an%2520important%2520elimination%2520product%2520of%2520cholesterol%2520in%2520the%2520retina%253A%2520comparison%2520of%2520retinal%2520cholesterol%2520metabolism%2520with%2520that%2520in%2520the%2520brain%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2011%26volume%3D52%26spage%3D594%26epage%3D603%26doi%3D10.1167%2Fiovs.10-6021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Binding of a cyano- and fluoro-containing drug bicalutamide to cytochrome P450 46A1: unusual features and spectral response</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">4613</span>– <span class="NLM_lpage">4624</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.438754</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1074%2Fjbc.M112.438754" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=23288837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1ajtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=4613-4624&author=N.+Mastauthor=W.+Zhengauthor=C.+D.+Stoutauthor=I.+A.+Pikuleva&title=Binding+of+a+cyano-+and+fluoro-containing+drug+bicalutamide+to+cytochrome+P450+46A1%3A+unusual+features+and+spectral+response&doi=10.1074%2Fjbc.M112.438754"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of a Cyano- and Fluoro-containing Drug Bicalutamide to Cytochrome P450 46A1</span></div><div class="casAuthors">Mast, Natalia; Zheng, Wenchao; Stout, C. David; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4613-4624</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cytochrome P 450 46A1 (CYP46A1) is the cholesterol 24-hydroxylase initiating the major pathways of cholesterol removal from the brain, and bicalutamide (BIC) is a drug of choice for the treatment of progressive androgen-dependent prostate cancer.  We evaluated the interactions of BIC with CYP46A1 by x-ray crystallog. and by conducting soln. and mutagenesis studies.  Because BIC is administered to patients as a racemic mixt. of the S and R isomers, we studied all three, racemic BIC as well as the S and R isomers.  Co-crystn. of CYP46A1 with racemic BIC led to structure detns. at 2.1 Å resoln. with the drug complexes exhibiting novel properties.  Both BIC isomers bind to the CYP46A1 active site in very similar single orientation and adopt an energetically unfavorable folded conformation.  This folded BIC conformation is correlated with drug-induced localized shifts of amino acid side chains in CYP46A1 and unusual interactions in the CYP46A1-BIC complex.  One of these interactions involves a water mol. that is coordinated to the P 450 heme iron and also hydrogen-bonded to the BIC nitrile.  Due to polarization of the water in this environment, the heme elicits previously unreported types of P 450 spectral responses.  We also obsd. that access to the P 450 active site was affected by differential recognition of S vs. R isomers at the CYP46A1 surface arising from BIC conformational polymorphism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopKoqOyJxaTbVg90H21EOLACvtfcHk0ljRj35Nvw_JMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1ajtr0%253D&md5=084918e90d085e1dc4fc8831d7f4ba46</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.438754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.438754%26sid%3Dliteratum%253Aachs%26aulast%3DMast%26aufirst%3DN.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DStout%26aufirst%3DC.%2BD.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DBinding%2520of%2520a%2520cyano-%2520and%2520fluoro-containing%2520drug%2520bicalutamide%2520to%2520cytochrome%2520P450%252046A1%253A%2520unusual%2520features%2520and%2520spectral%2520response%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D4613%26epage%3D4624%26doi%3D10.1074%2Fjbc.M112.438754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frisch, M. J.</span>; <span class="NLM_string-name">Trucks, G. W.</span>; <span class="NLM_string-name">Schlegel, H. B.</span>; <span class="NLM_string-name">Scuseria, G. E.</span>; <span class="NLM_string-name">Robb, M. A.</span>; <span class="NLM_string-name">Cheeseman, J. R.</span>; <span class="NLM_string-name">Scalmani, G.</span>; <span class="NLM_string-name">Barone, V.</span>; <span class="NLM_string-name">Petersson, G. A.</span>; <span class="NLM_string-name">Nakatsuji, H.</span>; <span class="NLM_string-name">Li, X.</span>; <span class="NLM_string-name">Caricato, M.</span>; <span class="NLM_string-name">Marenich, A. V.</span>; <span class="NLM_string-name">Bloino, J.</span>; <span class="NLM_string-name">Janesko, B. G.</span>; <span class="NLM_string-name">Gomperts, R.</span>; <span class="NLM_string-name">Mennucci, B.</span>; <span class="NLM_string-name">Hratchian, H. P.</span>; <span class="NLM_string-name">Ortiz, J. V.</span>; <span class="NLM_string-name">Izmaylov, A. F.</span>; <span class="NLM_string-name">Sonnenberg, J. L.</span>; <span class="NLM_string-name">Williams</span>; ; <span class="NLM_string-name">Ding, F.</span>; <span class="NLM_string-name">Lipparini, F.</span>; <span class="NLM_string-name">Egidi, F.</span>; <span class="NLM_string-name">Goings, J.</span>; <span class="NLM_string-name">Peng, B.</span>; <span class="NLM_string-name">Petrone, A.</span>; <span class="NLM_string-name">Henderson, T.</span>; <span class="NLM_string-name">Ranasinghe, D.</span>; <span class="NLM_string-name">Zakrzewski, V. G.</span>; <span class="NLM_string-name">Gao, J.</span>; <span class="NLM_string-name">Rega, N.</span>; <span class="NLM_string-name">Zheng, G.</span>; <span class="NLM_string-name">Liang, W.</span>; <span class="NLM_string-name">Hada, M.</span>; <span class="NLM_string-name">Ehara, M.</span>; <span class="NLM_string-name">Toyota, K.</span>; <span class="NLM_string-name">Fukuda, R.</span>; <span class="NLM_string-name">Hasegawa, J.</span>; <span class="NLM_string-name">Ishida, M.</span>; <span class="NLM_string-name">Nakajima, T.</span>; <span class="NLM_string-name">Honda, Y.</span>; <span class="NLM_string-name">Kitao, O.</span>; <span class="NLM_string-name">Nakai, H.</span>; <span class="NLM_string-name">Vreven, T.</span>; <span class="NLM_string-name">Throssell, K.</span>; <span class="NLM_string-name">Montgomery, J. A.,  Jr.</span>; <span class="NLM_string-name">Peralta, J. E.</span>; <span class="NLM_string-name">Ogliaro, F.</span>; <span class="NLM_string-name">Bearpark, M. J.</span>; <span class="NLM_string-name">Heyd, J. J.</span>; <span class="NLM_string-name">Brothers, E. N.</span>; <span class="NLM_string-name">Kudin, K. N.</span>; <span class="NLM_string-name">Staroverov, V. N.</span>; <span class="NLM_string-name">Keith, T. A.</span>; <span class="NLM_string-name">Kobayashi, R.</span>; <span class="NLM_string-name">Normand, J.</span>; <span class="NLM_string-name">Raghavachari, K.</span>; <span class="NLM_string-name">Rendell, A. P.</span>; <span class="NLM_string-name">Burant, J. C.</span>; <span class="NLM_string-name">Iyengar, S. S.</span>; <span class="NLM_string-name">Tomasi, J.</span>; <span class="NLM_string-name">Cossi, M.</span>; <span class="NLM_string-name">Millam, J. M.</span>; <span class="NLM_string-name">Klene, M.</span>; <span class="NLM_string-name">Adamo, C.</span>; <span class="NLM_string-name">Cammi, R.</span>; <span class="NLM_string-name">Ochterski, J. W.</span>; <span class="NLM_string-name">Martin, R. L.</span>; <span class="NLM_string-name">Morokuma, K.</span>; <span class="NLM_string-name">Farkas, O.</span>; <span class="NLM_string-name">Foresman, J. B.</span>; <span class="NLM_string-name">Fox, D. J.</span></span> <i>Gaussian 16</i>, revision <span class="NLM_edition">A.03</span>; <span class="NLM_publisher-name">Gaussian, Inc.</span>: <span class="NLM_publisher-loc">Wallingford, CT</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+J.+Frisch&author=G.+W.+Trucks&author=H.+B.+Schlegel&author=G.+E.+Scuseria&author=M.+A.+Robb&author=J.+R.+Cheeseman&author=G.+Scalmani&author=V.+Barone&author=G.+A.+Petersson&author=H.+Nakatsuji&author=X.+Li&author=M.+Caricato&author=A.+V.+Marenich&author=J.+Bloino&author=B.+G.+Janesko&author=R.+Gomperts&author=B.+Mennucci&author=H.+P.+Hratchian&author=J.+V.+Ortiz&author=A.+F.+Izmaylov&author=J.+L.+Sonnenberg&author=+Williams&author=F.+Ding&author=F.+Lipparini&author=F.+Egidi&author=J.+Goings&author=B.+Peng&author=A.+Petrone&author=T.+Henderson&author=D.+Ranasinghe&author=V.+G.+Zakrzewski&author=J.+Gao&author=N.+Rega&author=G.+Zheng&author=W.+Liang&author=M.+Hada&author=M.+Ehara&author=K.+Toyota&author=R.+Fukuda&author=J.+Hasegawa&author=M.+Ishida&author=T.+Nakajima&author=Y.+Honda&author=O.+Kitao&author=H.+Nakai&author=T.+Vreven&author=K.+Throssell&author=J.+A.+Montgomery&author=J.+E.+Peralta&author=F.+Ogliaro&author=M.+J.+Bearpark&author=J.+J.+Heyd&author=E.+N.+Brothers&author=K.+N.+Kudin&author=V.+N.+Staroverov&author=T.+A.+Keith&author=R.+Kobayashi&author=J.+Normand&author=K.+Raghavachari&author=A.+P.+Rendell&author=J.+C.+Burant&author=S.+S.+Iyengar&author=J.+Tomasi&author=M.+Cossi&author=J.+M.+Millam&author=M.+Klene&author=C.+Adamo&author=R.+Cammi&author=J.+W.+Ochterski&author=R.+L.+Martin&author=K.+Morokuma&author=O.+Farkas&author=J.+B.+Foresman&author=D.+J.+Fox&title=Gaussian+16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DFrisch%26aufirst%3DM.%2BJ.%26jtitle%3DGaussian%252016%26pub%3DGaussian%252C%2520Inc%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belew, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2785</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDockTools4%3A+automated+docking+with+selective+receptor+flexibility&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0lhA0LhdzQTkag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520automated%2520docking%2520with%2520selective%2520receptor%2520flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trott, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2009&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span> <span> </span><span class="NLM_article-title">Enriching screening libraries with bioactive fragment space</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3594</span>– <span class="NLM_lpage">3597</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1016%2Fj.bmcl.2016.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=27311891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvF2qur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3594-3597&author=N.+Zhangauthor=H.+Zhao&title=Enriching+screening+libraries+with+bioactive+fragment+space&doi=10.1016%2Fj.bmcl.2016.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Enriching screening libraries with bioactive fragment space</span></div><div class="casAuthors">Zhang, Na; Zhao, Hongtao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3594-3597</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">By deconvoluting 238,073 bioactive mols. in the ChEMBL library into extended Murcko ring systems, we identified a set of 2245 ring systems present in at least 10 mols.  These ring systems belong to 2221 clusters by ECFP4 fingerprints with a min. intracluster similarity of 0.8.  Their overlap with ring systems in com. libraries was further quantified.  Our findings suggest that success of a small fragment library is driven by the convergence of effective coverage of bioactive ring systems (e.g., 10% coverage by 1000 fragments vs. 40% by 2 million HTS compds.), high enrichment of bioactive ring systems, and low mol. complexity enhancing the probability of a match with the protein targets.  Reconciling with the previous studies, bioactive ring systems are underrepresented in screening libraries.  As such, we propose a library of virtual fragments with key functionalities via fragmentation of bioactive mols.  Its utility is exemplified by a prospective application on protein kinase CK2, resulting in the discovery of a series of novel inhibitors with the most potent compd. having an IC50 of 0.5 μM and a ligand efficiency of 0.41 kcal/mol per heavy atom.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4bxc8wtSc1bVg90H21EOLACvtfcHk0lhA0LhdzQTkag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvF2qur8%253D&md5=d4a071d6ca7785c654b08964659eed22</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DH.%26atitle%3DEnriching%2520screening%2520libraries%2520with%2520bioactive%2520fragment%2520space%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3594%26epage%3D3597%26doi%3D10.1016%2Fj.bmcl.2016.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span> <span> </span><span class="NLM_article-title">Python: a programming language for software integration and development</span>. <i>J. Mol. Graphics Modell.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10660911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtV2rsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=57-61&author=M.+F.+Sanner&title=Python%3A+a+programming+language+for+software+integration+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Python: a programming language for software integration and development</span></div><div class="casAuthors">Sanner, M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-61</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The use of interpreted languages in biocomputing has been investigated to create a programmable, dynamic environment in which components can be tied together at a high level.  This work has demonstrated the benefits of such an approach and the features of the interpreted language that are key to successful component integration.  This involved Python, an interpreted, interactive, object-oriented programming language.  It provides high-level data structures such as list and associative arrays, dynamic typing and dynamic binding, modules, classes, exceptions, automatic memory management and others.  Python has been found to be instrumental in the mol. modeling research environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaCFXA1JC8X7Vg90H21EOLACvtfcHk0liK1bsseP9NKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtV2rsA%253D%253D&md5=3bf94934548080055dda54f68468c656</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanner%26aufirst%3DM.%2BF.%26atitle%3DPython%253A%2520a%2520programming%2520language%2520for%2520software%2520integration%2520and%2520development%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D1999%26volume%3D17%26spage%3D57%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Boyle, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banck, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandermeersch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchison, G. R.</span></span> <span> </span><span class="NLM_article-title">Open Babel: An open chemical toolbox</span>. <i>J. Cheminf.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">33</span>, <span class="refDoi"> DOI: 10.1186/1758-2946-3-33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1186%2F1758-2946-3-33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=21982300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVWjurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=33&author=N.+M.+O%E2%80%99Boyleauthor=M.+Banckauthor=C.+A.+Jamesauthor=C.+Morleyauthor=T.+Vandermeerschauthor=G.+R.+Hutchison&title=Open+Babel%3A+An+open+chemical+toolbox&doi=10.1186%2F1758-2946-3-33"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Open Babel: an open chemical toolbox</span></div><div class="casAuthors">O'Boyle, Noel M.; Banck, Michael; James, Craig A.; Morley, Chris; Vandermeersch, Tim; Hutchison, Geoffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cheminformatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">33</span>CODEN:
                <span class="NLM_cas:coden">JCOHB3</span>;
        ISSN:<span class="NLM_cas:issn">1758-2946</span>.
    
            (<span class="NLM_cas:orgname">Chemistry Central Ltd.</span>)
        </div><div class="casAbstract">Background: A frequent problem in computational modeling is the interconversion of chem. structures between different formats.  While std. interchange formats exist (for example, Chem. Markup Language) and de facto stds. have arisen (for example, SMILES format), the need to interconvert formats is a continuing problem due to the multitude of different application areas for chem. data, differences in the data stored by different formats (0D vs. 3D, for example), and competition between software along with a lack of vendor-neutral formats.  Results: We discuss, for the first time, Open Babel, an open-source chem. toolbox that speaks the many languages of chem. data.  Open Babel version 2.3 interconverts over 110 formats.  The need to represent such a wide variety of chem. and mol. data requires a library that implements a wide range of cheminformatics algorithms, from partial charge assignment and aromaticity detection, to bond order perception and canonicalization.  We detail the implementation of Open Babel, describe key advances in the 2.3 release, and outline a variety of uses both in terms of software products and scientific research, including applications far beyond simple format interconversion.  Conclusions: Open Babel presents a soln. to the proliferation of multiple chem. file formats.  In addn., it provides a variety of useful utilities from conformer searching and 2D depiction, to filtering, batch conversion, and substructure and similarity searching.  For developers, it can be used as a programming library to handle chem. data in areas such as org. chem., drug design, materials science, and computational chem.  It is freely available under an open-source license.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfQ1lvaS5767Vg90H21EOLACvtfcHk0liK1bsseP9NKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVWjurbF&md5=74e4f19b7f87417f916d57f7abcfb761</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1186%2F1758-2946-3-33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1758-2946-3-33%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DN.%2BM.%26aulast%3DBanck%26aufirst%3DM.%26aulast%3DJames%26aufirst%3DC.%2BA.%26aulast%3DMorley%26aufirst%3DC.%26aulast%3DVandermeersch%26aufirst%3DT.%26aulast%3DHutchison%26aufirst%3DG.%2BR.%26atitle%3DOpen%2520Babel%253A%2520An%2520open%2520chemical%2520toolbox%26jtitle%3DJ.%2520Cheminf.%26date%3D2011%26volume%3D3%26spage%3D33%26doi%3D10.1186%2F1758-2946-3-33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blom, T.</span></span> <span> </span><span class="NLM_article-title">Global kinetic explorer: a new computer program for dynamic simulation and fitting of kinetic data</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>387</i></span>,  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2008.12.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1016%2Fj.ab.2008.12.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=19154726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFKjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2009&pages=20-29&author=K.+A.+Johnsonauthor=Z.+B.+Simpsonauthor=T.+Blom&title=Global+kinetic+explorer%3A+a+new+computer+program+for+dynamic+simulation+and+fitting+of+kinetic+data&doi=10.1016%2Fj.ab.2008.12.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Global Kinetic Explorer: A new computer program for dynamic simulation and fitting of kinetic data</span></div><div class="casAuthors">Johnson, Kenneth A.; Simpson, Zachary B.; Blom, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-29</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We describe a new dynamic kinetic simulation program that allows multiple data sets to be fit simultaneously to a single model based on numerical integration of the rate equations describing the reaction mechanism.  Unlike other programs that allow fitting based on numerical integration of rate equations, in the dynamic simulation rate consts., output factors, and starting concns. of reactants can be scrolled while observing the change in the shape of the simulated reaction curves.  Fast dynamic simulation facilitates the exploration of initial parameters that serve as the starting point for nonlinear regression in fitting data and facilitates exploration of the relationships between individual consts. and observable reactions.  The exploration of parameter space by dynamic simulation provides a powerful tool for learning kinetics and for evaluating the extent to which parameters are constrained by the data.  This feature is crit. to avoid overly complex models that are not supported by the data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTFFZnhMRb-rVg90H21EOLACvtfcHk0liK1bsseP9NKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFKjt7c%253D&md5=1d0227c91a334f47edae70f5a89478ff</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2008.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2008.12.024%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DK.%2BA.%26aulast%3DSimpson%26aufirst%3DZ.%2BB.%26aulast%3DBlom%26aufirst%3DT.%26atitle%3DGlobal%2520kinetic%2520explorer%253A%2520a%2520new%2520computer%2520program%2520for%2520dynamic%2520simulation%2520and%2520fitting%2520of%2520kinetic%2520data%26jtitle%3DAnal.%2520Biochem.%26date%3D2009%26volume%3D387%26spage%3D20%26epage%3D29%26doi%3D10.1016%2Fj.ab.2008.12.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Antifungal azoles: structural insights into undesired tight binding to cholesterol-metabolizing CYP46A1</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1124/mol.113.085902</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=10.1124%2Fmol.113.085902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=23604141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVajsbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=86-94&author=N.+Mastauthor=W.+Zhengauthor=C.+D.+Stoutauthor=I.+A.+Pikuleva&title=Antifungal+azoles%3A+structural+insights+into+undesired+tight+binding+to+cholesterol-metabolizing+CYP46A1&doi=10.1124%2Fmol.113.085902"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Antifungal azoles: structural insights into undesired tight binding to cholesterol-metabolizing CYP46A1</span></div><div class="casAuthors">Mast, Natalia; Zheng, Wenchao; Stout, C. David; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">86-94</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Although there are currently three generations of antifungal azoles on the market, even the third-generation agents show undesirable interactions with human cytochrome P 450 (P 450) enzymes.  CYP46A1 is a cholesterol-metabolizing P 450 in the brain that tightly binds a no. of structurally distinct azoles.  Previously, we detd. the crystal structures of CYP46A1 in complex with voriconazole and clotrimazole, and in the present work we cocrystd. the P 450 with posaconazole at 2.5 Å resoln.  This long antifungal drug coordinates the P 450 heme iron with the nitrogen atom of its terminal azole ring and adopts a linear configuration occupying the whole length of the substrate access channel and extending beyond the protein surface.  Numerous drug-protein interactions det. the submicromolar Kd of posaconazole for CYP46A1.  We compared the crystal structure of posaconazole-bound CYP46A1 with those of the P 450 in complex with other drugs, including the antifungal voriconazole and clotrimazole.  We also analyzed the accommodation of posaconazole in the active site of the target enzymes, CYPs 51, from several pathogenic species.  These and the soln. studies with different marketed azoles, collectively, allowed us to identify the determinants of tight azole binding to CYP46A1 and generate an overall picture of azole binding to this important P 450.  The data obtained suggest that development of CYP51-specific antifungal agents will continue to be a challenge.  Therefore, structural understanding of the azole binding not only to CYPs 51 from the pathogenic species but also to different human P450s is required to deal efficiently with this challenge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRLxgeEtx4YbVg90H21EOLACvtfcHk0lirZEWb4nKFIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVajsbjL&md5=6b5af98bb32f9a5f3be0e84248a82941</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.085902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.085902%26sid%3Dliteratum%253Aachs%26aulast%3DMast%26aufirst%3DN.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DStout%26aufirst%3DC.%2BD.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DAntifungal%2520azoles%253A%2520structural%2520insights%2520into%2520undesired%2520tight%2520binding%2520to%2520cholesterol-metabolizing%2520CYP46A1%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26spage%3D86%26epage%3D94%26doi%3D10.1124%2Fmol.113.085902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mast, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björkhem, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikuleva, I. A.</span></span> <span> </span><span class="NLM_article-title">Cholesterol binding to cytochrome P450 7A1, a key enzyme in bile acid biosynthrsis</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">3259</span>– <span class="NLM_lpage">3271</span>, <span class="refDoi"> DOI: 10.1021/bi047566a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi047566a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFehtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=3259-3271&author=N.+Mastauthor=S.+E.+Grahamauthor=U.+Anderssonauthor=I.+Bj%C3%B6rkhemauthor=C.+Hillauthor=J.+Petersonauthor=I.+A.+Pikuleva&title=Cholesterol+binding+to+cytochrome+P450+7A1%2C+a+key+enzyme+in+bile+acid+biosynthrsis&doi=10.1021%2Fbi047566a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Cholesterol Binding to Cytochrome P450 7A1, a Key Enzyme in Bile Acid Biosynthesis</span></div><div class="casAuthors">Mast, Natalia; Graham, Sandra E.; Andersson, Ulla; Bjorkhem, Ingemar; Hill, Courtney; Peterson, Julian; Pikuleva, Irina A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3259-3271</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The conversion of cholesterol to 7α-hydroxycholesterol catalyzed by cytochrome P 450 7A1 (CYP7A1) initiates the major pathway for cholesterol elimination in mammals.  In the present work we focused on identification of determinants of the CYP7A1 substrate specificity inside the active site using a homol. model with a novel P 450-fold, site-directed mutagenesis, and substrate-binding and kinetic studies.  Forty-one mutants, encompassing twenty-six amino acid residues, were generated and characterized, and of these, seven residues appear to det. cholesterol binding in the active site.  In addn., four cholesterol derivs. were used as active site probes in the wild type and the seven mutant enzymes, and the spectral binding consts. and products were analyzed.  It was concluded that Asn288 in the I helix plays a key role in the P 450-cholesterol contacts by hydrogen bonding to the steroid 3β-hydroxyl, while Val280 and Ala284 are beside and the Trp283 is above the steroid nucleus orienting the cholesterol mol.  Leu360 and Ala358 between the K helix and the β1-4 strand and Leu485 in the β4 sheet-turn appear to define the size of the active site over the heme pyrrole ring A, thus limiting the orientation and size of the substrate at the steroid A ring.  Addnl., the A358V mutant was found to form two new products, one being 7β-hydroxycholesterol.  Our data indicate that a tight fit of cholesterol in the enzyme active site is in part responsible for the high efficiency of cholesterol turnover by CYP7A1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRO2XJUx4RXbVg90H21EOLACvtfcHk0lirZEWb4nKFIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFehtLY%253D&md5=e0198a07b011f0062a8c7aef2f67ded1</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fbi047566a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi047566a%26sid%3Dliteratum%253Aachs%26aulast%3DMast%26aufirst%3DN.%26aulast%3DGraham%26aufirst%3DS.%2BE.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DBj%25C3%25B6rkhem%26aufirst%3DI.%26aulast%3DHill%26aufirst%3DC.%26aulast%3DPeterson%26aufirst%3DJ.%26aulast%3DPikuleva%26aufirst%3DI.%2BA.%26atitle%3DCholesterol%2520binding%2520to%2520cytochrome%2520P450%25207A1%252C%2520a%2520key%2520enzyme%2520in%2520bile%2520acid%2520biosynthrsis%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D3259%26epage%3D3271%26doi%3D10.1021%2Fbi047566a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Q9G" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Q9G','PDB','2Q9G'); return false;">PDB: 2Q9G</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i21"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01383">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_68440"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01383?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01383</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Figure S1 showing stopped-flow data for the <i>k</i><sub>off</sub> rate determination and Figures S2–S11 showing the certificates of analysis for EFV and EFV derivatives (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01383/suppl_file/jm9b01383_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01383/suppl_file/jm9b01383_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01383/suppl_file/jm9b01383_si_001.pdf">jm9b01383_si_001.pdf (12.65 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01383/suppl_file/jm9b01383_si_002.csv">jm9b01383_si_002.csv (0.74 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01383&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-12%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01383%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01383" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994e50f87d3ce2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
